Entry	Enzyme regulation
A0A075B6H9	
A0A075B6I0	
A0A075B6I1	
A0A075B6I4	
A0A075B6I9	
A0A075B6J1	
A0A075B6J6	
A0A075B6J9	
A0A075B6K0	
A0A075B6K2	
A0A075B6K4	
A0A075B6K5	
A0A075B6K6	
A0A075B6P5	
A0A075B6Q5	
A0A075B6R2	
A0A075B6S2	
A0A075B6S4	
A0A075B6S5	
A0A075B6S6	
A0A075B6T6	
A0A075B6T7	
A0A075B6T8	
A0A075B6U4	
A0A075B6V5	
A0A075B6W5	
A0A075B6X5	
A0A075B759	
A0A087WSX0	
A0A087WSY4	
A0A087WSY6	
A0A087WSZ0	
A0A087WSZ9	
A0A087WT01	
A0A087WT02	
A0A087WT03	
A0A087WTH1	
A0A087WTH5	
A0A087WUL8	
A0A087WVF3	
A0A087WW87	
A0A087WX78	
A0A087WXM9	
A0A087WXS9	
A0A087X179	
A0A087X1C5	
A0A087X1G2	
A0A096LNP1	
A0A096LP01	
A0A096LP49	
A0A096LP55	
A0A096LPI5	
A0A0A0MRZ7	
A0A0A0MRZ8	
A0A0A0MRZ9	
A0A0A0MS14	
A0A0A0MS15	
A0A0A0MT36	
A0A0A0MT76	
A0A0A0MT89	
A0A0A6YYC5	
A0A0A6YYJ7	
A0A0A6YYK1	
A0A0A6YYK6	
A0A0A6YYK7	
A0A0A6YYL3	
A0A0B4J1U3	
A0A0B4J1U7	
A0A0B4J1V0	
A0A0B4J1V1	
A0A0B4J1V2	
A0A0B4J1V6	
A0A0B4J1X5	
A0A0B4J1X8	
A0A0B4J1Y8	
A0A0B4J1Y9	
A0A0B4J1Z2	
A0A0B4J234	
A0A0B4J235	
A0A0B4J237	
A0A0B4J238	
A0A0B4J240	
A0A0B4J241	
A0A0B4J244	
A0A0B4J245	
A0A0B4J248	
A0A0B4J249	
A0A0B4J262	
A0A0B4J263	
A0A0B4J264	
A0A0B4J265	
A0A0B4J266	
A0A0B4J268	
A0A0B4J271	
A0A0B4J272	
A0A0B4J273	
A0A0B4J274	
A0A0B4J275	
A0A0B4J276	
A0A0B4J277	
A0A0B4J279	
A0A0B4J280	
A0A0B4J2A2	
A0A0B4J2D9	
A0A0B4J2F0	
A0A0B4J2H0	
A0A0C4DH24	
A0A0C4DH25	
A0A0C4DH29	
A0A0C4DH31	
A0A0C4DH32	
A0A0C4DH33	
A0A0C4DH34	
A0A0C4DH38	
A0A0C4DH39	
A0A0C4DH41	
A0A0C4DH42	
A0A0C4DH43	
A0A0C4DH55	
A0A0C4DH59	
A0A0C4DH62	
A0A0C4DH67	
A0A0C4DH68	
A0A0C4DH69	
A0A0C4DH72	
A0A0C4DH73	
A0A0C5B5G6	
A0A0G2JMD5	
A0A0G2JMI3	
A0A0G2JS06	
A0A0J9YVY3	
A0A0J9YWL9	
A0A0J9YX35	
A0A0J9YX94	
A0A0J9YXQ4	
A0A0J9YXX1	
A0A0U1RR37	
A0A0U1RRE5	
A0A183	
A0A1B0GTC6	
A0A1B0GTD5	
A0A1B0GTH6	
A0A1B0GTI8	
A0A1B0GTK4	
A0A1B0GTK5	
A0A1B0GTL2	
A0A1B0GTQ4	
A0A1B0GTR0	
A0A1B0GTR4	
A0A1B0GTS1	
A0A1B0GTU2	
A0A1B0GTY4	
A0A1B0GTZ2	
A0A1B0GU29	
A0A1B0GU33	
A0A1B0GUA5	
A0A1B0GUA6	
A0A1B0GUA7	
A0A1B0GUC4	
A0A1B0GUJ8	
A0A1B0GUQ0	
A0A1B0GUS0	
A0A1B0GUS4	
A0A1B0GUT2	
A0A1B0GUU1	
A0A1B0GUV7	
A0A1B0GUW6	
A0A1B0GUW7	
A0A1B0GUY1	
A0A1B0GV03	
A0A1B0GV22	
A0A1B0GV85	
A0A1B0GV90	
A0A1B0GVG4	
A0A1B0GVG6	
A0A1B0GVH4	
A0A1B0GVH6	
A0A1B0GVH7	
A0A1B0GVK7	
A0A1B0GVM6	
A0A1B0GVN3	
A0A1B0GVQ0	
A0A1B0GVS7	
A0A1B0GVT2	
A0A1B0GVV1	
A0A1B0GVY4	
A0A1B0GVZ2	
A0A1B0GVZ6	
A0A1B0GVZ9	
A0A1B0GW35	
A0A1B0GW64	
A0A1B0GWB2	
A0A1B0GWG4	
A0A1B0GWH4	
A0A1B0GWK0	
A0A1B0GX68	
A0A1W2PPG7	
A0A1W2PR48	
A0A286YF58	
A0A539	
A0A576	
A0A577	
A0A578	
A0A597	
A0A599	
A0A5B9	
A0AUZ9	
A0AV02	
A0AV96	
A0AVF1	
A0AVI2	
A0AVI4	
A0AVK6	
A0AVT1	
A0FGR8	
A0FGR9	
A0JD32	
A0JLT2	
A0JNW5	
A0JP26	
A0M8Q6	
A0MZ66	
A0PG75	
A0PJE2	
A0PJK1	
A0PJW6	
A0PJW8	
A0PJX0	
A0PJX2	
A0PJX4	
A0PJX8	
A0PJY2	
A0PJZ0	
A0PJZ3	
A0PK00	
A0PK05	
A0PK11	
A0ZSE6	
A1A4F0	
A1A4G5	
A1A4S6	
A1A4V9	
A1A4Y4	
A1A519	
A1A580	
A1A5B4	
A1A5C7	
A1A5D9	
A1E959	
A1IGU5	
A1KXE4	
A1KZ92	
A1L020	
A1L0T0	
A1L157	
A1L162	
A1L167	
A1L168	
A1L170	
A1L188	
A1L190	
A1L1A6	
A1L390	
A1L3X0	
A1L3X4	
A1L429	
A1L443	
A1L453	
A1L4H1	
A1L4K1	
A1L4L8	
A1L4Q6	
A1X283	
A1XBS5	
A1YPR0	
A1Z1Q3	ENZYME REGULATION: Subject to product inhibition by ADP-ribose. {ECO:0000269|PubMed:23474712}.
A2A288	
A2A2V5	
A2A2Y4	
A2A2Z9	
A2A368	
A2A3K4	
A2A3L6	
A2A3N6	
A2AJT9	
A2CJ06	
A2IDD5	
A2NJV5	
A2PYH4	
A2RRD8	
A2RRH5	
A2RRL7	
A2RRP1	
A2RTX5	
A2RTY3	
A2RU14	
A2RU30	
A2RU37	
A2RU48	
A2RU49	
A2RU54	
A2RU67	
A2RUB1	
A2RUB6	
A2RUC4	
A2RUG3	
A2RUH7	
A2RUQ5	
A2RUR9	
A2RUS2	
A2RUT3	
A2RUU4	
A2VCK2	
A2VCL2	
A2VDF0	
A2VDJ0	
A2VEC9	
A3KFT3	
A3KMH1	
A3KN83	
A3QJZ6	
A3QJZ7	
A4D0S4	
A4D0T2	
A4D0T7	
A4D0V7	
A4D0Y5	
A4D126	
A4D161	
A4D174	
A4D1B5	
A4D1E1	
A4D1E9	
A4D1F6	
A4D1N5	
A4D1P6	
A4D1S0	
A4D1S5	
A4D1T9	
A4D1U4	
A4D1Z8	
A4D250	
A4D256	
A4D263	
A4D2B0	
A4D2B8	
A4D2G3	
A4D2H0	
A4D2P6	
A4FU01	
A4FU28	
A4FU49	
A4FU69	
A4GXA9	
A4IF30	
A4QMS7	
A4QN01	
A4QPB2	
A4QPH2	
A4UGR9	
A5A3E0	
A5D6W6	
A5D8T8	
A5D8V6	
A5D8V7	
A5D8W1	
A5LHX3	
A5PKW4	
A5PL33	
A5PLK6	
A5PLL1	
A5PLL7	
A5PLN7	
A5PLN9	
A5X5Y0	
A5YKK6	
A5YM69	
A5YM72	
A6BM72	
A6H8M9	
A6H8Y1	
A6H8Z2	
A6NC05	
A6NC42	
A6NC51	
A6NC57	
A6NC62	
A6NC78	
A6NC86	
A6NC97	
A6NC98	
A6NCC3	
A6NCE7	
A6NCF5	
A6NCF6	
A6NCI4	
A6NCI5	
A6NCI8	
A6NCJ1	
A6NCK2	
A6NCL1	
A6NCL2	
A6NCL7	
A6NCM1	
A6NCN2	
A6NCN8	
A6NCQ9	
A6NCS4	
A6NCS6	
A6NCV1	
A6NCW0	
A6NCW3	
A6NCW7	
A6ND01	
A6ND36	
A6ND48	
A6ND91	
A6NDA9	
A6NDB9	
A6NDD5	
A6NDE4	
A6NDE8	
A6NDG6	
A6NDH6	
A6NDI0	
A6NDK9	
A6NDL7	
A6NDL8	
A6NDN3	
A6NDN8	
A6NDP7	
A6NDR6	
A6NDS4	
A6NDU8	
A6NDV4	
A6NDX4	
A6NDX5	
A6NDY0	
A6NDY2	
A6NDZ8	
A6NE01	
A6NE02	
A6NE21	
A6NE52	
A6NE82	
A6NEC2	
A6NED2	
A6NEE1	
A6NEF3	
A6NEH6	
A6NEH8	
A6NEK1	
A6NEL2	
A6NEL3	
A6NEM1	
A6NEN9	
A6NEQ0	
A6NEQ2	
A6NER0	
A6NER3	
A6NES4	
A6NET4	
A6NEV1	
A6NEW6	
A6NEY3	
A6NEY8	
A6NF01	
A6NF34	
A6NF36	
A6NF83	
A6NF89	
A6NFA0	
A6NFA1	ENZYME REGULATION: Inhibited by 1,10-phenanthroline, a metalloprotease inhibitor which is a divalent metal chelator. Also inhibited by EDTA. Not inhibited by Bestatin, an aminopeptidase inhibitor, nor to a mixture of inhibitors for serine, cysteine, and aspartic proteases and aminopeptidases. {ECO:0000269|PubMed:22726442}.
A6NFC5	
A6NFC9	
A6NFD8	
A6NFE2	
A6NFE3	
A6NFF2	
A6NFH5	
A6NFI3	
A6NFK2	
A6NFN3	
A6NFN9	
A6NFQ2	
A6NFQ7	
A6NFR6	
A6NFT4	
A6NFU0	
A6NFU8	
A6NFX1	
A6NFY4	
A6NFY7	
A6NFZ4	
A6NG13	
A6NGA9	
A6NGB0	
A6NGB7	
A6NGB9	
A6NGC4	
A6NGD5	
A6NGE4	
A6NGE7	
A6NGG3	
A6NGG8	
A6NGH7	
A6NGH8	
A6NGJ6	
A6NGK3	
A6NGN4	
A6NGN9	
A6NGQ2	
A6NGR9	
A6NGS2	
A6NGU5	
A6NGU7	
A6NGW2	
A6NGY1	
A6NGY3	
A6NGY5	
A6NGZ8	
A6NH00	
A6NH11	
A6NH13	
A6NH21	
A6NH52	
A6NH57	
A6NHA9	
A6NHC0	
A6NHG4	
A6NHG9	
A6NHJ4	
A6NHL2	
A6NHM9	
A6NHN0	
A6NHN6	
A6NHP3	
A6NHQ2	
A6NHQ4	
A6NHR8	
A6NHR9	
A6NHS1	
A6NHS7	
A6NHT5	
A6NHX0	
A6NHY2	
A6NHY6	
A6NHZ5	
A6NI03	
A6NI15	
A6NI28	
A6NI47	
A6NI56	
A6NI61	
A6NI72	
A6NI73	
A6NI79	
A6NI86	
A6NI87	
A6NIE6	
A6NIE9	
A6NIH7	
A6NIJ5	
A6NIJ9	
A6NIK2	
A6NIL9	
A6NIM6	
A6NIN4	
A6NIR3	
A6NIU2	
A6NIV6	
A6NIX2	
A6NIY4	
A6NIZ1	ENZYME REGULATION: Activated by guanine nucleotide-exchange factor (GEF) EPAC2 in a cAMP-dependent manner. {ECO:0000250}.
A6NJ08	
A6NJ46	
A6NJ64	
A6NJ69	
A6NJ78	
A6NJ88	
A6NJB7	
A6NJG2	
A6NJG6	
A6NJI1	
A6NJI9	
A6NJJ6	
A6NJL1	
A6NJQ4	
A6NJR5	
A6NJT0	
A6NJU9	
A6NJV1	
A6NJW4	
A6NJW9	
A6NJY1	
A6NJY4	
A6NJZ3	
A6NJZ7	
A6NK02	
A6NK06	
A6NK44	
A6NK53	
A6NK58	
A6NK59	
A6NK75	
A6NK89	
A6NK97	
A6NKB5	
A6NKC0	
A6NKC9	
A6NKD2	
A6NKD9	
A6NKF1	
A6NKF2	
A6NKF7	
A6NKG5	
A6NKH3	
A6NKK0	
A6NKL6	
A6NKN8	
A6NKP2	
A6NKQ9	
A6NKT7	
A6NKU9	
A6NKW6	
A6NKX1	
A6NKX4	
A6NL05	
A6NL08	
A6NL26	
A6NL46	
A6NL82	
A6NL88	
A6NL99	
A6NLC5	
A6NLC8	
A6NLE4	
A6NLF2	
A6NLI5	
A6NLJ0	
A6NLP5	
A6NLU0	
A6NLU5	
A6NLW8	
A6NLX3	
A6NLX4	
A6NM03	
A6NM10	
A6NM11	
A6NM28	
A6NM36	
A6NM43	
A6NM45	
A6NM62	
A6NM66	
A6NM76	
A6NMA1	
A6NMB1	
A6NMB9	
A6NMD0	
A6NMD2	
A6NMK7	
A6NMK8	
A6NML5	
A6NMN3	
A6NMS3	
A6NMS7	
A6NMT0	
A6NMU1	
A6NMX2	
A6NMY6	
A6NMZ2	
A6NMZ5	
A6NMZ7	
A6NN06	
A6NN14	
A6NN73	
A6NN90	
A6NN92	
A6NNA2	
A6NNA5	
A6NNB3	
A6NNC1	
A6NND4	
A6NNE9	
A6NNF4	
A6NNH2	
A6NNJ1	
A6NNL0	
A6NNL5	
A6NNM3	
A6NNM8	
A6NNN8	
A6NNP5	
A6NNS2	
A6NNT2	
A6NNV3	
A6NNW6	
A6NNX1	
A6NNY8	
A6NNZ2	
A6NP11	
A6NP61	
A6PVC2	
A6PVI3	
A6PVL3	
A6PVS8	
A6PVY3	
A6QL63	
A6QL64	
A6XGL0	
A6ZKI3	
A7E2F4	
A7E2S9	
A7E2U8	
A7E2V4	
A7E2Y1	
A7KAX9	
A7MBM2	
A7MCY6	
A7MD48	
A7XYQ1	
A8CG34	
A8K010	
A8K0R7	
A8K0S8	
A8K0Z3	
A8K2U0	
A8K4G0	
A8K554	
A8K5M9	
A8K7I4	
A8K830	
A8K855	
A8K8P3	
A8K8V0	
A8K979	
A8MPP1	
A8MPS7	
A8MPX8	
A8MPY1	
A8MQ03	
A8MQ11	
A8MQ14	
A8MQ27	
A8MQB3	
A8MQT2	
A8MRT5	
A8MSI8	
A8MT19	
A8MT33	
A8MT65	
A8MT66	
A8MT69	
A8MT70	
A8MTA8	
A8MTB9	
A8MTI9	
A8MTJ3	
A8MTJ6	
A8MTL0	
A8MTL3	
A8MTL9	
A8MTQ0	
A8MTT3	
A8MTW9	
A8MTY0	
A8MTY7	
A8MTZ0	
A8MTZ7	
A8MU10	
A8MU46	
A8MU76	
A8MU93	
A8MUA0	
A8MUH7	
A8MUI8	
A8MUK1	
A8MUL3	
A8MUM7	
A8MUN3	
A8MUP2	ENZYME REGULATION: Citrate synthase-lysine methyltransferase activity is inhibited by S-adenosylhomocysteine (AdoHcy) and oxaloacetate (OAA) (PubMed:28887308). {ECO:0000269|PubMed:28887308}.
A8MUP6	
A8MUU1	
A8MUU9	
A8MUV8	
A8MUX0	
A8MUZ8	
A8MV23	
A8MV24	
A8MV57	
A8MV65	
A8MV72	
A8MV81	
A8MVA2	
A8MVJ9	
A8MVM7	
A8MVS1	
A8MVS5	
A8MVU1	
A8MVW0	
A8MVW5	
A8MVX0	
A8MVZ5	
A8MW92	
A8MW95	
A8MW99	
A8MWA4	
A8MWA6	
A8MWD9	
A8MWE9	
A8MWK0	
A8MWL6	
A8MWL7	
A8MWP4	
A8MWP6	
A8MWV9	
A8MWX3	
A8MWY0	
A8MX19	
A8MX34	
A8MX76	
A8MX80	
A8MXD5	
A8MXE2	
A8MXJ8	
A8MXK1	
A8MXK9	
A8MXQ7	
A8MXT2	
A8MXU0	
A8MXV4	
A8MXV6	
A8MXY4	
A8MXZ1	
A8MXZ3	
A8MY62	
A8MYA2	
A8MYB1	
A8MYJ7	
A8MYP8	
A8MYU2	
A8MYV0	
A8MYX2	
A8MYZ0	
A8MYZ5	
A8MYZ6	
A8MZ25	
A8MZ26	
A8MZ36	
A8MZ59	
A8MZ97	
A8MZA4	
A8MZF0	
A8MZG2	
A8MZH6	
A8TX70	
A9QM74	
A9UHW6	
A9YTQ3	
A9Z1Z3	
B0FP48	
B0I1T2	
B0YJ81	
B1AH88	
B1AJZ1	
B1AJZ9	
B1AK53	
B1AK76	
B1AKI9	
B1AL46	
B1AL88	
B1AMM8	
B1ANH7	
B1ANS9	
B1ANY3	
B1APH4	
B1ATL7	
B2CW77	
B2RBV5	
B2RC85	
B2RD01	
B2RN74	
B2RNN3	
B2RPK0	
B2RTY4	
B2RU33	
B2RUY7	
B2RUZ4	
B2RV13	
B2RXF0	
B2RXF5	
B2RXH2	
B2RXH4	
B2RXH8	
B3EWF7	
B3EWG3	
B3EWG5	
B3EWG6	
B3GLJ2	
B3KS81	
B3KU38	
B3SHH9	
B4DH59	
B4DJY2	
B4DS77	
B4DU55	
B4DX44	
B4DXR9	
B4DYI2	
B4DZS4	
B4E2M5	
B5MCN3	
B5MCY1	
B5MD39	
B5ME19	
B6A8C7	
B6SEH8	
B6SEH9	
B7U540	
B7Z1M9	
B7Z368	
B7Z6K7	
B7Z8K6	
B7ZAP0	
B7ZAQ6	
B7ZBB8	
B7ZC32	
B7ZW38	
B8ZZ34	
B9A014	
B9A064	
B9A6J9	
B9EJG8	
B9ZVM9	
C4AMC7	
C9J069	
C9J1S8	
C9J202	
C9J2P7	
C9J302	
C9J3I9	
C9J3V5	
C9J442	
C9J6K1	
C9J798	
C9J7I0	
C9JBD0	
C9JC47	
C9JCN9	
C9JDP6	
C9JDV5	
C9JE40	
C9JFL3	
C9JG80	
C9JH25	
C9JI98	
C9JJ37	
C9JJH3	
C9JL84	
C9JLJ4	
C9JLR9	
C9JLW8	
C9JN71	
C9JPN9	
C9JQI7	
C9JQL5	
C9JR72	
C9JRZ8	
C9JSJ3	
C9JTQ0	
C9JUS6	
C9JVI0	
C9JVW0	
C9JXX5	
D3DTV9	
D3W0D1	
D6R901	
D6R9N7	
D6RA61	
D6RBM5	
D6RBQ6	
D6RCP7	
D6REC4	
D6RF30	
D6RGH6	
D6RJB6	
E0CX11	
E2RYF6	
E2RYF7	
E5RG02	
E5RHQ5	
E5RIL1	
E5RJ46	
E5RJM6	
E5RQL4	
E7EML9	
E7ERA6	
E7ETH6	
E7EU14	
E7EW31	
E9PAV3	
E9PB15	
E9PGG2	
E9PI22	
E9PIF3	
E9PJ23	
E9PJI5	
E9PKD4	
E9PQ53	
E9PQR5	
E9PQX1	
E9PRG8	
F2Z333	
F2Z398	
F2Z3F1	
F2Z3M2	
F5GYI3	
F5H284	
F5H4A9	
F5H4B4	
F7VJQ1	
F8VTS6	
F8W1W9	
F8WBI6	
F8WCM5	
F8WFD2	
G3V0H7	
G3V211	
G9CGD6	
H0UI37	
H0Y354	
H0Y7S4	
H0YKK7	
H0YL09	
H0YL14	
H0YM25	
H3BMG3	
H3BN30	
H3BNL1	
H3BNL8	
H3BPM6	
H3BQB6	
H3BQJ8	
H3BQW9	
H3BR10	
H3BRN8	
H3BS89	
H3BSY2	
H3BTG2	
H3BU77	
H3BUK9	
H3BV60	
H7BZ55	
H7C241	
H7C350	
I0J062	
I1YAP6	
I3L0S3	
I3L1E1	
I3L1I5	
I3L273	
I3L3R5	
I6L899	
J3KSC0	
K7EIQ3	
K7EJ46	
K9M1U5	
L0R6Q1	
L0R819	
L0R8F8	
M0QZC1	
M5A8F1	
O00110	
O00115	
O00116	
O00124	
O00139	
O00141	ENZYME REGULATION: Two specific sites, one in the kinase domain (Thr-256) and the other in the C-terminal regulatory region (Ser-422), need to be phosphorylated for its full activation. Phosphorylation at Ser-397 and Ser-401 are also essential for its activity. Activated by WNK1, WNK2, WNK3 and WNK4.
O00142	
O00144	
O00148	
O00151	
O00154	
O00155	
O00159	
O00160	
O00161	
O00165	
O00167	
O00168	
O00170	
O00175	
O00178	
O00180	ENZYME REGULATION: Inhibited by Ba(2+) ions and quinidine (PubMed:8605869). Inhibited by quinine (PubMed:8605869, PubMed:21653227). Is slightly inhibited by 10 mM tetraethylammonium (TEA), and only marginally inhibited by 4-aminopyridine, charybdotoxin and dendrotoxin (PubMed:8605869). Lowering the extracellular pH to below 6.5 transiently activates the channel, and then inhibits channel activity (PubMed:15820677, PubMed:22431633). Inhibited when the intracellular pH is decreased down to pH 6.0, but this may be due to indirect effects (PubMed:8605869). {ECO:0000269|PubMed:15820677, ECO:0000269|PubMed:21653227, ECO:0000269|PubMed:22431633, ECO:0000269|PubMed:8605869}.
O00182	
O00186	
O00187	
O00189	
O00192	
O00193	
O00194	
O00198	
O00203	
O00204	
O00206	
O00212	
O00213	
O00214	
O00217	
O00219	
O00220	
O00221	
O00222	
O00230	
O00231	
O00232	
O00233	
O00237	
O00238	
O00241	
O00244	
O00253	
O00254	
O00255	
O00257	
O00258	
O00264	
O00267	
O00268	
O00270	
O00273	
O00287	
O00291	
O00292	
O00294	
O00295	
O00299	
O00300	
O00303	
O00305	
O00308	ENZYME REGULATION: Activated by NDFIP1- and NDFIP2-binding. {ECO:0000269|PubMed:19343052}.
O00311	
O00321	
O00322	
O00327	ENZYME REGULATION: There is conflicting data about the effect of NAD cofactors on activity. PubMed:11441146 suggests that the redox state of the cell can modulate the transcriptional activity of the CLOCK-ARNTL/BMAL1 heterodimer; NADH and NADPH enhance the DNA-binding activity of the heterodimer. PubMed:23229515 reports that NADH and NADPH have no significant effect on DNA-binding activity of the CLOCK-ARNTL/BMAL1 heterodimer. {ECO:0000269|PubMed:11441146, ECO:0000269|PubMed:23229515}.
O00329	ENZYME REGULATION: Activated by growth factors and cytokine receptors through a tyrosine-kinase-dependent mechanism. Activated by RAS. IC87114 inhibits lipid kinase activity and is selective in cells at doses up to 5-10 uM. IC87114 blocks T-cell receptor signaling in naive and memory T-cells and reduces cytokine production by memory T-cells. {ECO:0000269|PubMed:20081091}.
O00330	
O00337	
O00338	
O00339	
O00341	
O00358	
O00370	
O00391	
O00398	
O00399	
O00400	
O00401	
O00408	
O00409	
O00410	
O00411	
O00418	ENZYME REGULATION: Undergoes calcium/calmodulin-dependent intramolecular autophosphorylation, and this results in it becoming partially calcium/calmodulin-independent. {ECO:0000250}.
O00421	
O00422	
O00423	
O00425	
O00429	ENZYME REGULATION: GTPase activity is increased by binding to phospholipid membranes. {ECO:0000269|PubMed:23977156}.
O00442	
O00443	ENZYME REGULATION: Activated by insulin (By similarity). Only slightly inhibited by wortmannin and LY294002. Activated by clathrin. {ECO:0000250, ECO:0000269|PubMed:10766823, ECO:0000269|PubMed:11239472, ECO:0000269|PubMed:9337861}.
O00444	
O00445	
O00451	
O00453	
O00458	
O00459	
O00461	
O00462	
O00463	
O00468	
O00469	
O00470	
O00471	
O00472	
O00476	
O00478	
O00479	
O00481	
O00482	
O00483	
O00487	
O00488	
O00499	
O00501	
O00505	
O00506	ENZYME REGULATION: Interaction with Golgi matrix protein GOLGA2 leads to autophosphorylation on Thr-174, possibly as a consequence of stabilization of dimer formation. The C-terminal non-catalytic region inhibits the kinase activity. {ECO:0000269|PubMed:15037601}.
O00507	
O00512	
O00515	
O00519	ENZYME REGULATION: Inhibited by O-aryl carbamates and alpha-keto heterocytes. {ECO:0000269|PubMed:17015445}.
O00522	
O00526	
O00533	
O00534	
O00541	
O00548	
O00555	
O00559	
O00560	
O00562	
O00566	
O00567	
O00570	
O00571	
O00574	
O00584	ENZYME REGULATION: Inhibited by Zn(2+) and Cu(2+). {ECO:0000269|PubMed:22735700}.
O00585	
O00587	
O00590	
O00591	
O00592	
O00602	
O00622	
O00623	
O00624	
O00625	ENZYME REGULATION: Inhibited by kojic acid, sodium diethyldithiocarbamate and 1,10-phenanthroline monohydrochloride. {ECO:0000269|PubMed:15951572}.
O00626	
O00628	
O00629	
O00631	
O00634	
O00635	
O00712	
O00716	
O00743	
O00744	
O00746	
O00748	
O00750	ENZYME REGULATION: Activated by GRB2. {ECO:0000269|PubMed:11533253}.
O00754	
O00755	
O00757	ENZYME REGULATION: Subject to complex allosteric regulation. The enzyme can assume an active R-state, or an inactive T-state. Intermediate conformations may exist. AMP acts as allosteric inhibitor. Fructose 2,6-bisphosphate acts as competitive inhibitor. Strongly inhibited by Ca(2+). {ECO:0000269|PubMed:16213487, ECO:0000269|PubMed:17350621, ECO:0000269|PubMed:18214967}.
O00762	
O00763	ENZYME REGULATION: Activity is increased by oligomerization. Activated by citrate. Citrate and MID1IP1 promote oligomerization. Inhibited by malonyl-CoA. {ECO:0000269|PubMed:16854592, ECO:0000269|PubMed:20952656}.
O00764	
O00767	
O14490	
O14492	
O14493	
O14494	ENZYME REGULATION: Inhibited by sphingosine, zinc ions and propanolol. Not inhibited by N-ethylmaleimide treatment.
O14495	ENZYME REGULATION: Inhibited by sphingosine, zinc ions and propanolol. Not inhibited by N-ethylmaleimide treatment.
O14497	
O14498	
O14503	
O14508	
O14511	
O14512	
O14513	
O14514	
O14519	
O14520	
O14521	
O14522	
O14523	
O14524	
O14525	
O14526	
O14529	
O14530	
O14531	
O14543	
O14544	
O14545	
O14548	
O14556	
O14558	
O14559	
O14561	
O14562	
O14569	
O14576	
O14578	
O14579	
O14581	
O14593	
O14594	
O14595	
O14598	
O14599	
O14602	
O14603	
O14604	
O14607	
O14609	
O14610	
O14613	
O14617	
O14618	
O14625	
O14626	
O14627	
O14628	
O14633	
O14638	ENZYME REGULATION: At low concentrations of ATP, a phosphorylated active site intermediate is formed which inhibits further ATP hydrolysis.
O14639	
O14640	
O14641	
O14645	
O14646	
O14647	
O14649	
O14653	
O14654	
O14656	
O14657	
O14662	
O14668	
O14669	
O14672	
O14678	
O14681	
O14682	
O14683	
O14684	
O14686	
O14709	
O14713	
O14715	
O14717	
O14718	
O14727	
O14730	
O14732	ENZYME REGULATION: Inhibited by high Li(+) and restricted Mg(2+) concentrations. {ECO:0000269|PubMed:15504365, ECO:0000269|PubMed:17068342}.
O14733	ENZYME REGULATION: Activated by phosphorylation by specific MAP kinase kinase kinases such as MAP3K1/MEKK1, MAP3K3/MEKK3, MAP3K11/MLK3 and MAP3K12/DLK. {ECO:0000269|PubMed:16442502, ECO:0000269|PubMed:9312068}.
O14734	ENZYME REGULATION: Inhibited by CoASH (IC(50)=10-15 uM). Also inhibited by cysteine-reactive agents. {ECO:0000250|UniProtKB:P58137}.
O14735	ENZYME REGULATION: Inhibited by PtdIns (product inhibition), phosphatidylinositol phosphate, and nucleoside di- and tri-phosphates.
O14737	
O14744	ENZYME REGULATION: Activity is increased by EGF, HGF, FGF1 or FGF2 treatments, and slightly decreased by NGF treatment. {ECO:0000269|PubMed:21917714}.
O14745	
O14746	
O14753	
O14756	
O14757	ENZYME REGULATION: Activated through phosphorylation predominantly by ATR but also by ATM in response to DNA damage or inhibition of DNA replication. Activation is modulated by several mediators including CLSPN, BRCA1 and FEM1B.
O14763	
O14764	
O14770	
O14771	
O14772	
O14773	
O14775	
O14776	
O14777	
O14782	
O14786	
O14787	
O14788	
O14791	
O14792	
O14793	
O14795	
O14796	
O14798	
O14802	
O14804	
O14807	
O14810	
O14813	
O14815	
O14817	
O14818	
O14827	
O14828	
O14829	ENZYME REGULATION: Activated by calcium.
O14830	ENZYME REGULATION: Activated by calcium. {ECO:0000250}.
O14832	
O14836	
O14841	
O14842	ENZYME REGULATION: The receptor is strongly activated by gamma-linolenic acid, while myristate gives a lower response. It is also activated by phytanic acid and pristanic acid (PubMed:21570468). Is also activated by synthetic agonists, such as TAK-875 (fasiglifam); this compound is a partial agonist and potentiates the activity of the endogenous ligand gamma-linolenic acid (PubMed:24130766). {ECO:0000269|PubMed:21570468, ECO:0000269|PubMed:24130766}.
O14843	
O14862	ENZYME REGULATION: In absence of dsDNA pyrin and HIN-20 domain can interact inducing a closed conformation; an autoinhibitory mechanism is proposed in which binding to dsDNA liberates the pyrin domain for homotypic downstream signaling interactions with PYCARD. {ECO:0000269|PubMed:22483801}.
O14863	
O14867	
O14874	
O14879	
O14880	
O14893	
O14894	
O14896	
O14901	
O14904	
O14905	
O14907	
O14908	
O14910	
O14917	
O14920	
O14921	
O14924	
O14925	
O14926	
O14929	
O14931	
O14933	
O14936	ENZYME REGULATION: Differs from archetypal CaMK members in that the kinase domain exhibits a constitutively active conformation and the autoinhibitory region does not engage in direct contact with the ATP-binding cleft, although it still binds Ca(2+)/CAM. {ECO:0000269|PubMed:18423203}.
O14939	ENZYME REGULATION: Stimulated by phosphatidylinositol 4,5-bisphosphate and activated by the ADP-ribosylation factor-1 (ARF-1).
O14944	
O14948	
O14949	
O14950	
O14957	
O14958	
O14960	
O14964	
O14965	ENZYME REGULATION: Activation of CDK1, appears to be an upstream event of AURKA activation. Phosphatase inhibitor-2 (PPP1R2) and TPX2 act also as activators. Inactivated by the G2 checkpoint. Inhibited by GADD45A and p53/TP53, and through dephosphorylation by protein phosphatase type 1 (PP1). MLN8054 is also a potent and selective inhibitor. Activated during the early phase of cilia disassembly in the presence of PIFO. {ECO:0000269|PubMed:11039908, ECO:0000269|PubMed:12390251, ECO:0000269|PubMed:17360485}.
O14966	
O14967	
O14972	
O14974	
O14975	
O14976	
O14977	
O14978	
O14979	
O14980	
O14981	
O14983	ENZYME REGULATION: Inhibited by sarcolipin (SLN), phospholamban (PLN) and myoregulin (MRLN) (By similarity). Reversibly inhibited by phospholamban (PLN) at low calcium concentrations (By similarity). Dephosphorylated PLN decreases the apparent affinity of the ATPase for calcium. This inhibition is regulated by the phosphorylation of PLN (By similarity). Enhanced by DWORF; DWORF increases activity by displacing sarcolipin (SLN), phospholamban (PLN) and myoregulin (MRLN) (By similarity). {ECO:0000250|UniProtKB:P04191, ECO:0000250|UniProtKB:Q8R429}.
O14986	
O14990	
O14994	
O15013	
O15014	
O15015	
O15016	
O15018	
O15020	
O15021	
O15027	
O15031	
O15033	
O15034	
O15037	
O15040	
O15041	
O15042	
O15047	
O15049	
O15050	
O15054	
O15055	
O15056	
O15060	
O15061	
O15062	
O15063	
O15066	
O15067	
O15068	
O15069	
O15072	
O15075	
O15078	
O15079	
O15083	
O15084	
O15085	
O15090	
O15091	
O15105	
O15111	ENZYME REGULATION: Activated when phosphorylated and inactivated when dephosphorylated.
O15116	
O15117	
O15118	
O15119	
O15120	
O15121	
O15123	
O15126	
O15127	
O15130	
O15131	
O15143	
O15144	
O15145	
O15146	ENZYME REGULATION: Positively regulated by CK2. {ECO:0000250}.
O15151	
O15155	
O15156	
O15160	
O15162	
O15164	
O15165	
O15169	
O15172	
O15173	
O15178	
O15182	
O15194	
O15195	
O15197	
O15198	
O15204	
O15205	
O15209	
O15211	
O15212	
O15213	
O15217	
O15218	
O15225	
O15226	
O15228	
O15229	
O15230	
O15231	
O15232	
O15234	
O15235	
O15239	
O15240	
O15243	
O15244	
O15245	
O15247	
O15254	
O15255	
O15258	
O15259	
O15260	
O15263	
O15264	ENZYME REGULATION: Activated by phosphorylation on threonine and tyrosine by dual specificity kinases, MAP2K3/MKK3, MAP2K6/MKK6, MAP2K4/MKK4 and MAP2K7/MKK7. Activation by ultraviolet radiation, hyperosmotic shock, anisomycin or by TNF-alpha is mediated by MAP2K3/MKK3. Inhibited by dual specificity phosphatase DUSP1. {ECO:0000269|PubMed:11500363, ECO:0000269|PubMed:9218798, ECO:0000269|PubMed:9374491}.
O15265	
O15266	
O15269	
O15270	
O15273	
O15287	
O15294	ENZYME REGULATION: Subject to product inhibition by UDP. {ECO:0000269|PubMed:21240259}.
O15296	
O15297	
O15303	
O15304	
O15305	
O15315	
O15318	
O15320	
O15321	
O15327	ENZYME REGULATION: Strongly inhibited by inositol hexakisphosphate. {ECO:0000250}.
O15335	
O15342	
O15344	
O15347	
O15350	
O15353	
O15354	
O15355	
O15357	ENZYME REGULATION: Activated upon translocation to the sites of synthesis of PtdIns(3,4,5)P3 in the membrane. Enzymatic activity is enhanced in the presence of phosphatidylserine. {ECO:0000269|PubMed:16824732}.
O15360	
O15370	
O15371	
O15372	
O15374	
O15375	
O15379	
O15381	
O15382	
O15389	
O15391	
O15392	
O15393	
O15394	
O15397	
O15399	
O15400	
O15403	
O15405	
O15409	
O15417	
O15427	
O15428	
O15431	
O15432	
O15438	
O15439	
O15440	
O15442	
O15444	
O15446	
O15453	
O15455	
O15457	
O15460	
O15466	
O15467	
O15479	
O15480	
O15481	
O15482	
O15484	
O15488	
O15492	
O15496	
O15498	
O15499	
O15503	
O15504	
O15511	
O15514	
O15516	ENZYME REGULATION: There is conflicting data about the effect of NAD cofactors on activity. PubMed:11441146 suggests that the redox state of the cell can modulate the transcriptional activity of the CLOCK-ARNTL/BMAL1 heterodimer; NADH and NADPH enhance the DNA-binding activity of the heterodimer. PubMed:23229515 reports that NADH and NADPH have no significant effect on DNA-binding activity of the CLOCK-ARNTL/BMAL1 heterodimer. {ECO:0000269|PubMed:11441146, ECO:0000269|PubMed:23229515}.
O15519	
O15520	
O15522	
O15523	
O15524	
O15525	
O15527	
O15528	
O15529	
O15530	ENZYME REGULATION: Homodimerization regulates its activity by maintaining the kinase in an autoinhibitory conformation. NPRL2 down-regulates its activity by interfering with tyrosine phosphorylation at the Tyr-9, Tyr-373 and Tyr-376 residues. The 14-3-3 protein YWHAQ acts as a negative regulator by association with the residues surrounding the Ser-241 residue. STRAP positively regulates its activity by enhancing its autophosphorylation and by stimulating its dissociation from YWHAQ. SMAD2, SMAD3, SMAD4 and SMAD7 also positively regulate its activity by stimulating its dissociation from YWHAQ. Activated by phosphorylation on Tyr-9, Tyr-373 and Tyr-376 by INSR in response to insulin. {ECO:0000269|PubMed:12177059, ECO:0000269|PubMed:16251192, ECO:0000269|PubMed:18616680, ECO:0000269|PubMed:20978239}.
O15533	
O15534	
O15535	
O15537	
O15539	
O15540	
O15541	
O15544	
O15547	
O15550	
O15551	
O15552	
O15553	
O15554	
O42043	
O43143	
O43147	
O43148	ENZYME REGULATION: Methyltransferase activity is activated by RAM/FAM103A1 (PubMed:27422871). {ECO:0000269|PubMed:27422871}.
O43149	
O43150	
O43151	
O43155	
O43156	
O43157	
O43159	
O43164	
O43166	
O43167	
O43169	
O43172	
O43173	
O43174	
O43175	
O43181	
O43182	
O43184	
O43186	
O43187	
O43189	
O43193	
O43194	
O43196	
O43236	
O43237	
O43240	
O43242	
O43246	
O43247	
O43248	
O43251	
O43252	ENZYME REGULATION: Inhibited by chlorate (PubMed:9576487). The kinase activity is subject to inhibition by the substrate adenylyl sulfate (PubMed:17540769). {ECO:0000269|PubMed:17540769, ECO:0000269|PubMed:9576487}.
O43255	ENZYME REGULATION: Inhibited by interaction with SNCAIP (isoform 2, but not isoform 1). May be inhibited by interaction with PEG10. {ECO:0000269|PubMed:19224863}.
O43257	
O43261	
O43264	
O43272	
O43278	
O43280	
O43281	
O43283	ENZYME REGULATION: Activated by autophosphorylation and homodimerization. {ECO:0000269|PubMed:11163770, ECO:0000269|PubMed:9353328}.
O43286	
O43290	
O43291	
O43292	
O43293	ENZYME REGULATION: A sequential activation is proposed: autophosphorylation at consensus sites is leading to dimerization of the catalytic domain stabilized by phosphorylation at Ser-50 and activation segment exchange (producing an active confirmation of both kinase modules in trans) followed by phosphorylation at Thr-180 in the activation segment and at other regulatory sites (Probable). Phosphorylation at Thr-180, Thr-225 and Thr-265 is essential for activity. Oligomerization is required for full enzymatic activity. Inhibited by pyridone 6 (K00225), a potent, ATP-competitive inhibitor. {ECO:0000269|PubMed:15611134, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:18239682, ECO:0000303|PubMed:18239682}.
O43294	
O43295	
O43296	
O43298	
O43299	
O43300	
O43301	
O43303	
O43304	
O43306	ENZYME REGULATION: Activated by forskolin (PubMed:17916776, PubMed:17110384). Inhibited by calcium ions, already at micromolar concentrations (By similarity). Inhibited by adenosine, AMP and their analogs (By similarity). Activated by GNAS (PubMed:17110384). Is further activated by the complex formed by GNB1 and GNG2 (PubMed:17110384). Phosphorylation by RAF1 results in its activation (By similarity). {ECO:0000250|UniProtKB:P30804, ECO:0000250|UniProtKB:Q01341, ECO:0000250|UniProtKB:Q03343, ECO:0000269|PubMed:17916776}.
O43307	
O43309	
O43310	
O43312	
O43313	
O43314	
O43315	
O43316	
O43318	ENZYME REGULATION: Activated by proinflammatory cytokines and in response to physical and chemical stresses, including osmotic stress, oxidative stress, arsenic and ultraviolet light irradiation. Activated by 'Lys-63'-linked polyubiquitination and by autophosphorylation. Association with TAB1/MAP3K7IP1 and TAB2/MAP3K7IP2 promotes activation through autophosphorylation, whereas PPM1B/PP2CB, PP2A and PPP6C dephosphorylation leads to inactivation. {ECO:0000269|PubMed:10702308, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:12242293, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:9079627}.
O43320	
O43323	
O43324	
O43325	
O43345	
O43347	
O43353	
O43361	
O43364	
O43365	
O43374	
O43379	
O43390	
O43395	
O43396	
O43399	
O43402	
O43405	
O43414	
O43422	
O43423	
O43424	
O43426	
O43427	
O43432	
O43435	
O43439	
O43447	ENZYME REGULATION: Inhibited by cyclosporin A.
O43448	
O43451	
O43462	
O43463	ENZYME REGULATION: Inhibited by S-adenosyl-L-homocysteine. Negatively regulated by CCAR2. {ECO:0000269|PubMed:16519522, ECO:0000269|PubMed:19218236}.
O43464	
O43474	
O43482	
O43488	
O43490	
O43491	
O43493	
O43497	
O43502	
O43504	
O43505	
O43506	
O43508	
O43511	
O43513	
O43516	
O43520	
O43521	
O43524	
O43525	
O43526	
O43529	
O43541	
O43542	
O43543	
O43548	
O43555	
O43556	
O43557	
O43559	
O43561	
O43566	
O43567	
O43570	ENZYME REGULATION: Inhibited by coumarins, saccharin, sulfonamide derivatives such as acetazolamide (AZA), benzenesulfonamide and derivatives (4-carboxyethylbenzene-sulfonamide, 4-carboxyethylbenzene-sulfonamide ethyl ester, 4-(acetyl-2-aminoethyl)benzene-sulfonamide, 4-aminoethylbenzene-sulfonamide) and Foscarnet (phosphonoformate trisodium salt). {ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17407288, ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.
O43572	
O43581	
O43583	
O43586	
O43592	
O43593	
O43597	
O43598	
O43602	
O43603	
O43609	
O43610	
O43612	
O43613	
O43614	
O43615	
O43617	
O43623	
O43633	
O43638	
O43639	
O43653	
O43657	
O43660	
O43663	
O43665	
O43670	
O43674	
O43676	
O43677	
O43678	
O43679	
O43680	
O43681	
O43683	ENZYME REGULATION: Autophosphorylated when the cells enters mitosis.
O43684	
O43687	
O43688	ENZYME REGULATION: Inhibited by sphingosine, zinc ions and propanolol.
O43692	
O43699	
O43704	
O43707	
O43708	
O43709	
O43711	
O43715	
O43716	
O43719	
O43731	
O43734	
O43736	
O43739	
O43741	
O43745	
O43747	
O43749	
O43752	
O43759	
O43760	
O43761	
O43763	
O43765	
O43766	
O43768	
O43772	
O43776	
O43781	ENZYME REGULATION: Inhibited by harmine, leucettamine B and leucettine L41.
O43790	
O43791	
O43795	
O43805	
O43808	
O43809	
O43812	
O43813	
O43815	
O43818	
O43819	
O43820	
O43822	
O43823	
O43824	
O43825	
O43826	ENZYME REGULATION: Inhibited by vanadate and chlorogenic acid. {ECO:0000269|PubMed:21949678}.
O43827	
O43829	
O43830	
O43837	ENZYME REGULATION: The heterotetramer and the heterodimer composed of IDH3A and IDH3G subunits can be allosterically activated by citrate (CIT) or/and ADP, and the two activators can act independently or synergistically. The heterodimer composed of IDH3A and IDH3B subunits cannot be allosterically regulated and the allosteric regulation of the heterotetramer is through the IDH3G subunit and not the IDH3B subunit. The IDH3G subunit contains the allosteric site which consists of a CIT-binding site and an ADP-binding site, and the binding of CIT and ADP causes conformational changes at the allosteric site which are transmitted to the active site in the catalytic subunit (IDH3A) through a cascade of conformational changes at the heterodimer interface, leading to stabilization of the isocitrate-binding at the active site and thus activation of the enzyme. ATP can activate the heterotetramer and the heterodimer composed of IDH3A and IDH3G subunits at low concentrations but inhibits their activities at high concentrations, whereas ATP exhibits only inhibitory effect on the heterodimer composed of IDH3A and IDH3B subunits. {ECO:0000269|PubMed:28098230, ECO:0000269|PubMed:28139779}.
O43847	
O43852	
O43854	
O43861	
O43865	
O43866	
O43868	ENZYME REGULATION: Inhibited by formycin B.
O43869	
O43889	
O43895	ENZYME REGULATION: Inhibited by apstatin and the chelating agent 1,10-phenanthroline. Also inhibited by high concentrations of Zn(2+). Not significantly inhibited by bestatin or phosphoramidon. {ECO:0000269|PubMed:15361070}.
O43896	
O43897	
O43900	
O43903	
O43908	
O43909	
O43913	
O43914	
O43915	
O43916	
O43918	
O43920	
O43921	
O43924	
O43927	
O43929	
O43930	
O43933	
O43934	
O60216	
O60218	ENZYME REGULATION: Inhibited by tolrestat. {ECO:0000269|PubMed:18087047}.
O60220	
O60224	
O60225	
O60229	
O60231	
O60232	
O60234	
O60235	ENZYME REGULATION: Strongly inhibited by diisopropyl fluorophosphate, leupeptin, antipain, aprotinin, and soybean trypsin inhibitor, but hardly inhibited by secretory leukocyte protease inhibitor at 10 microM.
O60237	
O60238	
O60239	
O60240	
O60241	ENZYME REGULATION: Receptor activity is regulated by proteolytic processing. The long N-terminal has a an inhibitory effect on the constitutive signaling activity. Removal of the N-terminal region induces an increase of the receptor activity. {ECO:0000269|PubMed:20367554, ECO:0000269|PubMed:28891236}.
O60242	
O60243	
O60244	
O60245	
O60248	
O60256	
O60258	
O60259	ENZYME REGULATION: Inhibited by a range of serine protease inhibitors including antipain, aprotinin, leupeptin, benzamidine and soybean trypsin inhibitor. {ECO:0000269|PubMed:16337200}.
O60260	ENZYME REGULATION: In the autoinhibited state the side chain of Phe-463 inserts into a hydrophobic groove in RING-0, occluding the ubiquitin acceptor site Cys-431, whereas the REP repressor element binds RING-1 and blocks its E2-binding site (PubMed:23727886, PubMed:23770887). Activation of PRKN requires 2 steps: (1) phosphorylation at Ser-65 by PINK1 and (2) binding to phosphorylated ubiquitin, leading to unlock repression of the catalytic Cys-431 by the RING-0 region via an allosteric mechanism and converting PRKN to its fully-active form (PubMed:24660806, PubMed:24784582, PubMed:25527291). According to another report, phosphorylation at Ser-65 by PINK1 is not essential for activation and only binding to phosphorylated ubiquitin is essential to unlock repression (PubMed:24751536). {ECO:0000269|PubMed:23727886, ECO:0000269|PubMed:23770887, ECO:0000269|PubMed:24660806, ECO:0000269|PubMed:24751536, ECO:0000269|PubMed:24784582, ECO:0000269|PubMed:25527291}.
O60262	
O60264	
O60266	ENZYME REGULATION: Activated by forskolin. After forskolin treatment, activity is further increased by calcium/calmodulin. In the absence of forskolin, calcium/calmodulin has little effect on enzyme activity. {ECO:0000250|UniProtKB:P21932}.
O60268	
O60269	
O60271	
O60279	
O60281	
O60282	
O60284	
O60285	ENZYME REGULATION: Activated by phosphorylation on Thr-211. Activated by phosphorylation at Ser-600 AKT1 during glucose starvation; the relevance of such activation in normal cells is however unsure. {ECO:0000269|PubMed:14976552}.
O60287	
O60290	
O60291	
O60292	
O60293	
O60294	
O60296	
O60299	
O60303	
O60304	
O60306	
O60307	
O60308	
O60309	
O60312	
O60313	
O60315	
O60318	
O60320	
O60330	
O60331	ENZYME REGULATION: Activated by interaction with TLN2. {ECO:0000269|PubMed:12422219}.
O60333	
O60336	
O60337	
O60341	
O60343	
O60346	ENZYME REGULATION: Insensitive to okadaic acid (PubMed:15808505). Deubiquitination by WDR48-USP12 complex positively regulates PHLPP1 stability (PubMed:24145035). {ECO:0000269|PubMed:15808505, ECO:0000269|PubMed:24145035}.
O60347	
O60353	
O60356	
O60359	
O60361	
O60381	
O60383	
O60384	
O60391	
O60393	
O60397	
O60403	
O60404	
O60412	
O60422	
O60423	
O60427	
O60431	
O60437	
O60443	
O60447	
O60449	
O60462	
O60469	
O60476	ENZYME REGULATION: Inhibited by both 1-deoxymannojirimycin and kifunensine.
O60477	
O60478	
O60479	
O60481	
O60486	
O60487	
O60488	
O60493	
O60494	
O60496	
O60499	
O60500	
O60502	ENZYME REGULATION: Inhibited by N-acetylglucosamine and not N-acetylgalactosamine. {ECO:0000269|PubMed:11148210}.
O60503	ENZYME REGULATION: Insensitive to calcium/calmodulin, forskolin and somatostatin. Stimulated by beta-adrenergic receptor activation (PubMed:9628827). Activity is down-regulated by calcium/calcineurin (PubMed:10987815). {ECO:0000269|PubMed:10987815, ECO:0000269|PubMed:9628827}.
O60504	
O60506	
O60507	
O60508	
O60512	
O60513	
O60516	
O60518	
O60519	
O60522	
O60524	
O60542	
O60543	
O60547	
O60548	
O60551	
O60563	
O60565	
O60566	ENZYME REGULATION: Kinase activity stimulated by CENPE. {ECO:0000269|PubMed:12925705}.
O60568	
O60573	
O60575	
O60583	
O60602	
O60603	
O60609	
O60610	
O60613	
O60635	
O60636	
O60637	
O60641	
O60645	
O60656	
O60658	ENZYME REGULATION: Inhibited by dipyridimole. Insensitive to selective PDE inhibitors including rolipram and zaprinast as well as to the non-selective inhibitor, IBMX. Unaffected by cGMP. {ECO:0000250|UniProtKB:O95263}.
O60662	
O60663	
O60664	
O60667	
O60669	
O60671	
O60673	
O60674	ENZYME REGULATION: Regulated by autophosphorylation, can both activate or decrease activity (By similarity). Heme regulates its activity by enhancing the phosphorylation on Tyr-1007 and Tyr-1008 (PubMed:21036157). {ECO:0000250|UniProtKB:Q62120, ECO:0000269|PubMed:21036157}.
O60675	
O60676	
O60678	ENZYME REGULATION: Inhibited by N-ethylmaleimide and high concentrations of zinc chloride. {ECO:0000250}.
O60682	
O60683	
O60684	
O60687	
O60688	
O60701	ENZYME REGULATION: UDP-alpha-D-xylose (UDX) acts as a feedback inhibitor by activating an allosteric switch. {ECO:0000269|PubMed:21961565}.
O60704	
O60706	
O60711	
O60716	
O60721	
O60725	
O60729	
O60732	
O60733	ENZYME REGULATION: Inhibited by calcium-activated calmodulin. {ECO:0000250}.
O60739	
O60741	ENZYME REGULATION: Activated by cAMP, and at 10-100 times higher concentrations, also by cGMP. cAMP binding promotes tetramerization and formation of an active channel. Compared to other family members, cAMP has less stimulatory effect on HCN1 because part of the molecules already contain bound cAMP and form homotetramers when cAMP levels are low. Inhibited by Cs(1+), zatebradine, capsazepine and ZD7288. {ECO:0000269|PubMed:15351778, ECO:0000269|PubMed:28086084}.
O60749	
O60755	
O60756	
O60759	
O60760	ENZYME REGULATION: Prostaglandin PGD2 synthesis is stimulated by calcium and magnesium ions. One calcium or magnesium ion is bound between the subunits of the homodimer. The interactions with the protein are for the most part mediated via water molecules. Magnesium increases the affinity for glutathione, while calcium has no effect on the affinity for glutathione. {ECO:0000269|PubMed:12627223}.
O60762	
O60763	
O60765	
O60774	
O60779	
O60783	
O60784	
O60806	
O60809	
O60810	
O60811	
O60812	
O60813	
O60814	
O60825	ENZYME REGULATION: Phosphorylation results in the activation of the kinase activity.
O60826	
O60828	
O60829	
O60830	
O60831	
O60832	
O60840	
O60841	
O60844	
O60858	
O60861	
O60869	
O60870	
O60879	
O60880	
O60882	
O60883	
O60884	
O60885	
O60888	
O60890	
O60894	
O60895	
O60896	
O60902	
O60906	
O60907	
O60909	
O60911	
O60921	
O60925	
O60927	
O60928	
O60930	ENZYME REGULATION: In the presence of magnesium, manganese is inhibitory.
O60931	
O60934	
O60936	
O60938	
O60939	
O60941	
O60942	
O71037	
O75015	
O75019	
O75022	
O75023	
O75027	
O75030	
O75031	
O75037	
O75038	
O75044	
O75051	
O75052	
O75054	
O75056	
O75061	
O75063	
O75064	
O75069	
O75071	
O75072	
O75074	
O75077	
O75078	
O75081	
O75083	
O75084	
O75093	
O75094	
O75095	
O75096	
O75106	
O75110	
O75112	
O75113	
O75116	ENZYME REGULATION: Activated by RHOA binding. Inhibited by Y-27632 (By similarity). {ECO:0000250}.
O75121	
O75122	
O75123	
O75127	
O75128	
O75129	
O75131	
O75132	
O75140	
O75143	
O75144	
O75145	
O75146	
O75147	
O75150	
O75151	ENZYME REGULATION: Enzymatically inactive by itself, and become active following phosphorylation by PKA.
O75152	
O75153	
O75154	
O75155	
O75157	
O75159	
O75161	
O75164	ENZYME REGULATION: Several specific inhibitors are being developed and tested. {ECO:0000269|PubMed:26741168}.
O75165	
O75167	
O75170	
O75173	
O75175	
O75177	
O75179	
O75182	
O75185	
O75190	
O75191	
O75192	
O75197	
O75200	
O75204	
O75208	
O75223	
O75251	
O75264	
O75290	
O75293	
O75298	
O75306	
O75309	
O75310	
O75311	
O75312	
O75317	ENZYME REGULATION: Activated by interaction with WDR20 and WDR48 through different allosteric mechanisms. {ECO:0000269|PubMed:20147737, ECO:0000269|PubMed:27373336}.
O75319	
O75323	
O75324	
O75325	
O75326	
O75330	
O75333	
O75334	
O75335	
O75339	
O75340	
O75342	
O75343	ENZYME REGULATION: Activated by nitric oxide in the presence of magnesium or manganese ions.
O75344	
O75346	
O75347	
O75348	
O75351	
O75352	
O75354	
O75355	
O75356	
O75360	
O75362	
O75363	
O75364	
O75365	ENZYME REGULATION: Inhibited by sodium orthovanadate and peroxovanadium compounds, and by pentamidine. {ECO:0000269|PubMed:11355880, ECO:0000269|PubMed:12516958}.
O75366	
O75367	
O75368	
O75369	
O75373	
O75376	
O75379	
O75380	
O75381	
O75382	
O75385	
O75386	
O75387	
O75388	
O75390	
O75391	
O75394	
O75396	
O75398	
O75400	
O75409	
O75410	
O75414	
O75417	
O75419	
O75420	
O75425	
O75426	
O75427	
O75431	
O75436	
O75437	
O75438	
O75439	
O75443	
O75444	
O75445	
O75446	
O75448	
O75449	ENZYME REGULATION: ATPase activity is stimulated by microtubules, which promote homooligomerization. ATP-dependent microtubule severing is stimulated by interaction with KATNB1. {ECO:0000255|HAMAP-Rule:MF_03023}.
O75452	ENZYME REGULATION: Inhibited by citral, perillyl alcohol, geraniol, farnesol and geranyl geraniol. {ECO:0000269|PubMed:9677409}.
O75459	
O75460	ENZYME REGULATION: The kinase domain is activated by trans-autophosphorylation following homodimerization (PubMed:12637535, PubMed:9637683). Kinase activity is required for activation of the endoribonuclease domain (PubMed:12637535, PubMed:9637683). Endoribonuclease activity is specifically inhibited by hydroxy-aryl-aldehydes (HAA) (By similarity). {ECO:0000250|UniProtKB:Q9EQY0, ECO:0000269|PubMed:12637535, ECO:0000269|PubMed:9637683}.
O75461	
O75462	
O75467	
O75469	
O75473	
O75474	
O75475	
O75477	
O75478	
O75486	
O75487	
O75489	
O75493	
O75494	
O75496	
O75503	
O75506	
O75508	
O75509	
O75521	
O75525	
O75526	
O75528	
O75529	
O75530	
O75531	
O75533	
O75534	
O75541	
O75553	
O75554	
O75556	
O75558	
O75563	
O75564	
O75569	
O75570	
O75575	
O75578	
O75581	
O75582	ENZYME REGULATION: Activated by phosphorylation at Ser-360, Thr-581 and Thr-700 by MAPK1/ERK2, MAPK3/ERK1 and MAPK14/p38-alpha, and by further autophosphorylation of Ser-212, Ser-376 and Ser-381 by the activated C-terminal kinase domain. The active N-terminal kinase domain finally phosphorylates downstream substrates, as well as Ser-750, Ser-752 and Ser-758 in its own C-terminal region. {ECO:0000269|PubMed:15568999, ECO:0000269|PubMed:9687510}.
O75586	
O75592	
O75593	
O75594	
O75596	
O75600	
O75602	
O75603	
O75604	ENZYME REGULATION: Cleavage is inhibited by ubiquitin in a dosage-dependent manner. Cleavage is blocked by ubiquitin aldehyde. {ECO:0000269|PubMed:16905103}.
O75607	
O75608	ENZYME REGULATION: Inhibited by palmostatin-B, leading to impair depalmitoylating of Ras. {ECO:0000269|PubMed:20418879}.
O75610	
O75616	
O75618	
O75626	
O75628	
O75629	
O75631	
O75635	
O75636	
O75638	
O75643	
O75648	
O75663	
O75665	
O75674	
O75676	ENZYME REGULATION: Activated by phosphorylation at Ser-343, Thr-568 and Thr-687 by MAPK1/ERK2, MAPK3/ERK1 and MAPK14/p38-alpha, and by further autophosphorylation of Ser-196, Ser-360 and Ser-365 by the activated C-terminal kinase domain. {ECO:0000250}.
O75677	
O75678	
O75679	
O75683	
O75688	
O75689	
O75690	
O75691	
O75694	
O75695	
O75711	
O75712	
O75715	
O75716	
O75717	
O75718	
O75746	
O75747	
O75751	
O75752	
O75762	ENZYME REGULATION: Inhibited by ruthenium red, a potent blocker of TRPV channels. {ECO:0000269|PubMed:20547126}.
O75764	
O75771	
O75781	
O75783	
O75787	
O75791	
O75792	
O75794	
O75795	
O75800	
O75807	
O75808	
O75815	
O75817	
O75818	
O75820	
O75821	
O75822	
O75828	
O75829	
O75830	
O75832	
O75838	
O75840	
O75841	
O75843	
O75844	
O75845	
O75864	
O75865	
O75871	
O75874	
O75879	
O75880	
O75881	
O75882	
O75884	
O75886	
O75888	
O75891	
O75896	
O75897	
O75899	
O75900	ENZYME REGULATION: Inhibited by TIMP2. {ECO:0000250}.
O75901	
O75907	ENZYME REGULATION: XP620 is a selective DGAT1 inhibitor. {ECO:0000269|PubMed:16214399}.
O75908	
O75909	
O75911	
O75912	
O75914	ENZYME REGULATION: Activated by binding small G proteins. Binding of GTP-bound CDC42 or RAC1 to the autoregulatory region releases monomers from the autoinhibited dimer, enables phosphorylation of Thr-436 and allows the kinase domain to adopt an active structure (By similarity). {ECO:0000250}.
O75915	
O75916	
O75920	
O75923	
O75925	
O75928	
O75934	
O75935	
O75936	
O75937	
O75940	
O75943	
O75947	
O75949	
O75951	
O75952	
O75953	
O75954	
O75955	
O75956	
O75962	
O75964	
O75969	
O75970	
O75971	
O75973	
O75976	
O75995	
O76000	
O76001	
O76002	
O76003	
O76009	
O76011	
O76013	
O76014	
O76015	
O76021	
O76024	
O76027	
O76031	
O76036	
O76038	
O76039	
O76041	
O76042	
O76050	
O76054	
O76061	
O76062	
O76064	
O76070	
O76071	
O76074	ENZYME REGULATION: Sildenafil (Viagra) is a highly selective and potent inhibitor of PDE5A and is effective in the treatment of penile erectile dysfunction. Also inhibited by zaprinast. {ECO:0000269|PubMed:12955149}.
O76075	ENZYME REGULATION: Inhibited by DFFA (DFF45).
O76076	
O76080	
O76081	
O76082	
O76083	ENZYME REGULATION: Inhibited by zaprinast; inhibitor is however not specific to PDE9A (PubMed:9624146). Specifically inhibited by BAY-73-6691 (1-(2-chlorophenyl)-6-((2R)-3,3,3- trifluoro-2-methylpropyl)-1,5-dihydro-4H-pyrazolo(3,4-d)pyrimidine-4-one) (PubMed:16150925). BAY-73-9961 has two enantiomers, (R) and (S), due to the presence of a chiral center, and both forms vary in their pattern of interaction (PubMed:20121115, PubMed:21483814). Specifically inhibited by PF-4181366 (4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1- cyclopentyl-1,5-dihydro-6-[(3S,4S)-4-methyl- 1-(6-quinoxalinylmethyl)-3-pyrrolidinyl]-one) (PubMed:19919087). Specifically inhibited by PF-4449613 ((R)-6-(1-(3-phenoxyazetidin-1-yl)ethyl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-d]pyrimidin- 4(5H)-one) (PubMed:25799991). Specifically inhibited by inhibitor 28 (2-((1-(2-Chlorophenyl)-4-hydroxy-1Hpyrazolo[ 3,4-d]pyrimidin-6-yl)amino)-N-(4- methoxyphenyl)propanamide): inhibitor forms a hydrogen bond with Tyr-484 and Gln-513 (PubMed:22985069). Specifically inhibited by 1-Cyclopentyl-6-[(1r)-1-(3-phenoxyazetidin- 1-Yl)ethyl]-1,5-dihydro-4h-pyrazolo[3,4-D] pyrimidin-4-one: inhibitor forms a hydrogen bond with Tyr-484 and Gln-513 (PubMed:23025719). {ECO:0000269|PubMed:16150925, ECO:0000269|PubMed:19919087, ECO:0000269|PubMed:20121115, ECO:0000269|PubMed:21483814, ECO:0000269|PubMed:22985069, ECO:0000269|PubMed:23025719, ECO:0000269|PubMed:25799991, ECO:0000269|PubMed:9624146, ECO:0000303|PubMed:24746902}.
O76087	
O76090	
O76093	
O76094	
O76095	
O76096	
O76099	
O76100	
O77932	
O94759	ENZYME REGULATION: Inactivated by exposure to extracellular pH between 4.0 and 6.5; irreversibly inactivated when open channels are exposed to extracellular pH between 4.0 and 6.5, while pre-exposure of closed channels to extracellular pH 5.5 gives rise to currents that rapidly inactivate, but protects against irreversible inactivation (PubMed:20660597). Inactivated by intracellular ATP (PubMed:11509734). Activated by arachidonic acid (PubMed:11804595). {ECO:0000269|PubMed:11509734, ECO:0000269|PubMed:11804595, ECO:0000269|PubMed:20660597}.
O94760	ENZYME REGULATION: Inhibited by zinc ions (By similarity). Enzyme purified in the absence of 1,10-phenanthroline contains on average 0.4 zinc atoms per subunit. Inhibited by 4-hydroxy-nonenal through the formation of a covalent adduct with His-173. Competitively inhibited by N(5)-iminopropyl-ornithine. {ECO:0000250, ECO:0000269|PubMed:18171027, ECO:0000269|PubMed:19663506}.
O94761	
O94762	
O94763	
O94766	ENZYME REGULATION: Inhibited by EDTA.
O94768	
O94769	
O94772	
O94776	
O94777	
O94778	
O94779	
O94782	
O94788	
O94804	ENZYME REGULATION: Inhibited by the pyrrole-indolinone inhibitor SU11274 (K00593): intercalates between the ATP-binding Lys-65 and alpha-C glutamate (Glu-81), resulting in a partial disordering of the lysine side chain. Also specifically inhibited by erlotinib. Slightly inhibited by gefitinib. {ECO:0000269|PubMed:18239682, ECO:0000269|PubMed:21606217}.
O94805	
O94806	ENZYME REGULATION: Activated by DAG and phorbol esters. Phorbol-ester/DAG-type domains 1 and 2 bind both DAG and phorbol ester with high affinity and mediate translocation to the cell membrane. Autophosphorylation of Ser-735 and phosphorylation of Ser-731 by PKC relieves auto-inhibition by the PH domain. {ECO:0000269|PubMed:18076381}.
O94808	
O94810	
O94811	
O94812	
O94813	
O94817	
O94818	
O94819	
O94822	
O94823	
O94826	
O94827	
O94829	
O94830	
O94832	
O94842	
O94844	
O94850	
O94851	ENZYME REGULATION: Specifically inhibited by CCG-1423, a small molecule inhibitor of SRF:MKL1/MRTF-A-dependent transcription. {ECO:0000269|PubMed:24440334}.
O94854	
O94855	
O94856	
O94864	
O94868	
O94874	
O94875	
O94876	
O94880	
O94885	
O94886	
O94887	
O94888	
O94889	
O94892	
O94898	
O94900	
O94901	
O94903	
O94905	
O94906	
O94907	
O94910	
O94911	
O94913	
O94915	
O94916	
O94919	
O94921	ENZYME REGULATION: Serine/threonine-protein kinase activity is promoted by associated cyclins CCDN3 and CCNY and repressed by CDKN1A.
O94923	
O94925	ENZYME REGULATION: Isoform 1 and isoform 3 are activated by phosphate. Inhibited by BPTES. BPTES binds between subunits and favors dissociation of the tetramer into dimers. {ECO:0000269|PubMed:22049910}.
O94927	
O94929	
O94933	
O94941	
O94952	
O94953	
O94955	
O94956	
O94964	
O94966	
O94967	
O94972	
O94973	
O94979	
O94983	
O94985	
O94986	
O94988	
O94989	
O94991	
O94992	
O94993	
O95006	
O95007	
O95013	
O95025	
O95045	ENZYME REGULATION: A conditional disulfide bridge can form within the protein that dislocates a critical phosphate-coordinating arginine Arg-100 away from the active site, disabling the enzyme. {ECO:0000269|PubMed:21855639}.
O95047	
O95049	
O95050	
O95057	
O95059	
O95067	
O95069	
O95070	
O95071	
O95072	
O95073	
O95076	
O95081	
O95084	
O95096	
O95104	
O95125	
O95136	
O95139	
O95140	
O95147	
O95149	
O95150	
O95153	
O95154	
O95155	
O95156	
O95157	
O95158	
O95159	
O95163	
O95164	
O95166	
O95167	
O95168	
O95169	
O95170	
O95171	
O95177	
O95178	
O95180	ENZYME REGULATION: Channel activity is strongly inhibited by mibefradil (PubMed:9670923, PubMed:9930755). Channel activity is strongly inhibited by Ni(2+) ions (PubMed:9930755). {ECO:0000269|PubMed:9670923, ECO:0000269|PubMed:9930755}.
O95182	
O95183	
O95185	
O95190	
O95196	
O95197	
O95198	
O95199	
O95201	
O95202	ENZYME REGULATION: Inhibited by ruthenium red or its derivative Ru360. {ECO:0000269|PubMed:19797662}.
O95206	
O95208	
O95210	
O95214	
O95218	
O95219	
O95221	
O95222	
O95229	
O95231	
O95232	
O95235	
O95236	
O95237	ENZYME REGULATION: Inhibited by all-trans-retinyl alpha-bromoacetate and N-boc-L-biocytinyl-11-aminoundecane chloro-methyl ketone (BACMK). {ECO:0000269|PubMed:9920938}.
O95238	
O95239	
O95243	
O95248	
O95249	
O95251	
O95255	
O95256	
O95257	
O95258	
O95259	ENZYME REGULATION: Channel activity is inhibited by interaction with Ca(2+)-bound calmodulin (PubMed:10880439, PubMed:27325704, PubMed:27005320, PubMed:27618660). Interaction of a single pore-forming alpha subunit with a calmodulin chain is sufficient to promote channel closure (PubMed:10880439). Channel activity is not regulated by cyclic nucleotides (By similarity). Channel activity is inhibited by binding intracellular phosphatidylinositol-3,5-bisphosphate and phosphatidylinositol-4,5-bisphosphate (PIP2), but is not inhibited by phosphatidylinositol 4-phosphate (PubMed:27005320). {ECO:0000250|UniProtKB:Q60603, ECO:0000269|PubMed:10880439, ECO:0000269|PubMed:27005320, ECO:0000269|PubMed:27325704, ECO:0000269|PubMed:27618660}.
O95260	
O95263	ENZYME REGULATION: Inhibited by dipyridimole. Insensitive to selective PDE inhibitors including rolipram and milrinone as well as to the non-selective inhibitor, IBMX. Unaffected by cGMP. {ECO:0000269|PubMed:12681444}.
O95264	
O95267	ENZYME REGULATION: Autoinhibited. Activated by diacylglycerol and calcium binding, which induces a conformational change releasing the autoinhibitory state (PubMed:23908768). Regulated by DGKA (PubMed:11919165). Regulated by DGKZ (PubMed:11257115). Regulated by PLC gamma and F-actin polymerization (PubMed:12839994). {ECO:0000269|PubMed:11257115, ECO:0000269|PubMed:11919165, ECO:0000269|PubMed:12839994, ECO:0000269|PubMed:23908768}.
O95271	ENZYME REGULATION: Specifically inhibited by XAV939, a small molecule, leading to inhibit the Wnt signaling pathway by stabilizing AXIN1 and AXIN2. {ECO:0000269|PubMed:19759537}.
O95273	
O95274	
O95278	
O95279	
O95292	
O95294	
O95295	
O95297	
O95298	
O95299	
O95302	ENZYME REGULATION: Inhibited by FK506. {ECO:0000250}.
O95319	
O95336	
O95340	
O95342	
O95343	
O95347	
O95352	
O95359	
O95361	
O95363	
O95365	
O95371	
O95372	
O95373	
O95376	ENZYME REGULATION: Autoinhibited by the ariadne domain, which masks the second RING-type zinc finger that contains the active site and inhibits the E3 activity (By similarity). Inhibition is relieved upon binding to neddylated cullin-RING ubiquitin ligase complexes, which activate the E3 ligase activity of ARIH1 (PubMed:24076655). {ECO:0000250|UniProtKB:Q9Y4X5, ECO:0000269|PubMed:24076655}.
O95377	
O95379	
O95382	ENZYME REGULATION: Activated by phosphorylation on Thr-806. Catalytically active only when complexed with MAP3K5, with MAP3K5 supporting the stability and the active configuration of MAP3K6 and MAP3K6 activating MAP3K5 by direct phosphorylation. {ECO:0000269|PubMed:17210579}.
O95388	
O95389	
O95390	
O95391	
O95393	
O95394	
O95395	
O95396	
O95397	
O95398	
O95399	
O95400	
O95402	
O95405	
O95406	
O95407	
O95409	
O95411	
O95415	
O95416	
O95424	
O95425	
O95427	
O95428	
O95429	
O95433	
O95436	
O95445	
O95447	
O95450	
O95452	
O95453	
O95455	
O95456	
O95460	
O95461	
O95466	
O95467	
O95470	
O95471	
O95473	
O95475	
O95476	
O95477	
O95478	
O95479	
O95484	
O95486	
O95487	
O95490	
O95497	
O95498	
O95500	
O95502	
O95503	
O95521	
O95522	
O95528	
O95544	
O95551	
O95561	
O95562	
O95563	
O95567	
O95568	
O95571	ENZYME REGULATION: Glutathione increases enzyme activity. {ECO:0000269|PubMed:23144459}.
O95573	
O95600	
O95602	
O95613	
O95619	
O95620	
O95622	ENZYME REGULATION: Activated by forskolin (PubMed:24700542). Activated by GNAS. Activity is further increased by interaction with the G-protein beta and gamma subunit complex formed by GNB1 and GNG2 (PubMed:26206488). Is not activated by calmodulin. Inhibited by adenosine and ATP analogs. Inhibited by calcium ions, already at micromolar concentrations (By similarity). Phosphorylation by RAF1 results in its activation (PubMed:15385642). {ECO:0000250|UniProtKB:P30803, ECO:0000269|PubMed:15385642, ECO:0000269|PubMed:26206488}.
O95625	
O95626	
O95628	
O95630	ENZYME REGULATION: Inhibited by N-ethylmaleimide.
O95631	
O95633	
O95639	
O95644	
O95661	
O95665	
O95670	
O95671	
O95672	
O95674	
O95677	
O95678	
O95684	
O95685	
O95696	
O95704	
O95707	
O95711	
O95714	
O95715	
O95716	
O95718	
O95721	
O95727	
O95741	
O95744	
O95747	ENZYME REGULATION: By autophosphorylation on threonine. {ECO:0000269|PubMed:14707132}.
O95749	ENZYME REGULATION: Subject to product inhibition by geranylgeranyl diphosphate. {ECO:0000269|PubMed:16698791}.
O95750	
O95751	
O95754	
O95755	
O95757	
O95758	
O95759	
O95760	
O95772	
O95777	
O95780	
O95782	
O95785	
O95786	
O95789	
O95793	
O95800	
O95801	
O95803	
O95807	
O95810	
O95813	
O95816	
O95817	
O95819	
O95822	ENZYME REGULATION: Malonyl-CoA decarboxylase activity does not require any cofactors or divalent metal ions. Formation of interchain disulfide bonds leads to positive cooperativity between active sites and increases the affinity for malonyl-CoA and the catalytic efficiency (in vitro). {ECO:0000269|PubMed:15003260, ECO:0000269|PubMed:23482565}.
O95825	
O95831	
O95832	
O95833	
O95834	
O95835	
O95837	
O95838	
O95841	
O95843	
O95847	
O95848	
O95857	
O95858	
O95859	
O95861	ENZYME REGULATION: Uncompetitive inhibition by micromolar concentrations of lithium. Competitive inhibition by inositol 1,4-bisphosphate. {ECO:0000269|PubMed:10224133}.
O95863	
O95864	
O95865	
O95866	
O95867	
O95868	
O95870	
O95872	
O95873	
O95876	
O95881	
O95886	
O95897	
O95900	
O95905	
O95907	
O95918	
O95922	
O95925	
O95926	
O95931	
O95932	
O95935	
O95936	
O95944	
O95947	
O95948	
O95954	
O95965	
O95967	
O95968	
O95969	
O95970	
O95971	
O95972	
O95976	
O95977	
O95980	
O95983	
O95985	
O95988	
O95989	ENZYME REGULATION: Inhibited by fluoride and InsP6. {ECO:0000269|PubMed:19585659}.
O95990	
O95992	
O95994	
O95995	
O95996	
O95997	
O95998	
O95999	
O96000	
O96001	
O96002	
O96004	
O96005	
O96006	
O96007	
O96008	
O96009	
O96011	
O96013	ENZYME REGULATION: Inhibited by FAM212A/INKA1; which inhibits the serine/threonine-protein kinase activity by binding PAK4 in a substrate-like manner (PubMed:26607847). {ECO:0000269|PubMed:26607847}.
O96014	
O96015	
O96017	ENZYME REGULATION: Activated through phosphorylation at Thr-68 by ATM in response to DNA double-strand breaks. Activation is modulated by several mediators including MDC1 and TP53BP1. Induces homodimerization with exchange of the T-loop/activation segment between protomers and transphosphorylation of the protomers. The autophosphorylated kinase dimer is fully active. Negatively regulated by PPM1D through dephosphorylation of Thr-68. {ECO:0000269|PubMed:15342622}.
O96018	
O96019	
O96020	
O96024	
O96028	
O96033	
O97980	
P00156	
P00167	
P00325	
P00326	
P00338	
P00352	ENZYME REGULATION: Inhibited by citral, disulfiram, and cyanamide. Activated by diethylstilbestrol (PubMed:19296407). Inhibited by duocarmycin analogs (PubMed:26373694). {ECO:0000269|PubMed:19296407, ECO:0000269|PubMed:26373694}.
P00367	ENZYME REGULATION: Subject to allosteric regulation. Activated by ADP. Inhibited by GTP and ATP. ADP can occupy the NADH binding site and activate the enzyme.
P00374	
P00387	
P00390	
P00395	
P00403	
P00414	
P00439	ENZYME REGULATION: N-terminal region of PAH is thought to contain allosteric binding sites for phenylalanine and to constitute an "inhibitory" domain that regulates the activity of a catalytic domain in the C-terminal portion of the molecule.
P00441	
P00450	
P00451	
P00480	ENZYME REGULATION: Negatively regulated by lysine acetylation. {ECO:0000269|PubMed:19318352}.
P00488	
P00491	
P00492	
P00505	
P00519	ENZYME REGULATION: Stabilized in the inactive form by an association between the SH3 domain and the SH2-TK linker region, interactions of the N-terminal cap, and contributions from an N-terminal myristoyl group and phospholipids. Activated by autophosphorylation as well as by SRC-family kinase-mediated phosphorylation. Activated by RIN1 binding to the SH2 and SH3 domains. Also stimulated by cell death inducers and DNA-damage. Phosphatidylinositol 4,5-bisphosphate (PIP2), a highly abundant phosphoinositide known to regulate cytoskeletal and membrane proteins, inhibits also the tyrosine kinase activity (By similarity). Activated by 5-(1,3-diaryl-1H-pyrazol-4-yl)hydantoin, 5-[3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl]-2,4-imidazolidinedione (DPH) (PubMed:28428613). Inhibited by ABI1, whose activity is controlled by ABL1 itself through tyrosine phosphorylation. Also inhibited by imatinib mesylate (Gleevec) which is used for the treatment of chronic myeloid leukemia (CML), and by VX-680, an inhibitor that acts also on imatinib-resistant mutants (PubMed:28428613). {ECO:0000250, ECO:0000269|PubMed:10391250, ECO:0000269|PubMed:12654251, ECO:0000269|PubMed:16424036, ECO:0000269|PubMed:16543148, ECO:0000269|PubMed:18328268, ECO:0000269|PubMed:28428613}.
P00533	ENZYME REGULATION: Endocytosis and inhibition of the activated EGFR by phosphatases like PTPRJ and PTPRK constitute immediate regulatory mechanisms. Upon EGF-binding phosphorylates EPS15 that regulates EGFR endocytosis and activity. Moreover, inducible feedback inhibitors including LRIG1, SOCS4, SOCS5 and ERRFI1 constitute alternative regulatory mechanisms for the EGFR signaling. {ECO:0000269|PubMed:15282549, ECO:0000269|PubMed:15590694, ECO:0000269|PubMed:18046415, ECO:0000269|PubMed:19836242}.
P00540	
P00558	
P00568	
P00709	
P00734	ENZYME REGULATION: Inhibited by SERPINA5. {ECO:0000269|PubMed:6323392}.
P00736	
P00738	
P00739	
P00740	
P00742	ENZYME REGULATION: Inhibited by SERPINA5 and SERPINA10. {ECO:0000269|PubMed:20427285, ECO:0000269|PubMed:6323392}.
P00746	
P00747	ENZYME REGULATION: Converted into plasmin by plasminogen activators, both plasminogen and its activator being bound to fibrin. Activated with catalytic amounts of streptokinase. Plasmin activity inhibited by SERPINE2. {ECO:0000269|PubMed:14699093}.
P00748	
P00749	ENZYME REGULATION: Inhibited by SERPINA5. {ECO:0000269|PubMed:14696115, ECO:0000269|PubMed:3501295}.
P00750	ENZYME REGULATION: Inhibited by SERPINA5. {ECO:0000269|PubMed:10340997}.
P00751	
P00797	ENZYME REGULATION: Interaction with ATP6AP2 results in a 5-fold increased efficiency in angiotensinogen processing.
P00813	ENZYME REGULATION: Inhibited by Cu(2+) and Hg(2+), coformycin, deoxycoformycin (dCF), 2-deoxyadenosine, 6-methylaminopurine riboside, 2-3-iso-propylidene-adenosine and erythro-9-(2-hydroxy-3-nonyl)adenine. {ECO:0000269|PubMed:16670267, ECO:0000269|PubMed:8452534}.
P00846	
P00915	ENZYME REGULATION: Activated by histamine, imidazole, L-adrenaline, L- and D-histidine, and L- and D-phenylalanine. Inhibited by coumarins, sulfonamide derivatives such as acetazolamide, benzenesulfonamide and derivatives (4-carboxyethylbenzene-sulfonamide, 4-carboxyethylbenzene-sulfonamide ethyl ester, 4-(acetyl-2-aminoethyl)benzene-sulfonamide, 4-aminoethylbenzene-sulfonamide), and 'prong inhibitors' BR15, BR17, BR22 and BR30. Activated by a short exposition to Foscarnet (phosphonoformate trisodium salt), but inhibited by a long one. Esterase activity weakly reduced by cyanamide. {ECO:0000269|PubMed:16506782, ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16807956, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17407288, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.
P00918	ENZYME REGULATION: Activated by X-ray, histamine, L-adrenaline, L- and D-phenylalanine, L- and D-histidine, L-His-OMe and beta-Ala-His (carnosine). Competitively inhibited by saccharin, thioxolone, coumarins, 667-coumate, celecoxib (Celebrex), valdecoxib (Bextra), SC-125, SC-560, diclofenac, acetate, azide, bromide, sulfonamide derivatives such as acetazolamide (AZA), methazolamide (MZA), ethoxzolamide (EZA), dichlorophenamide (DCP), brinzolamide, dansylamide, thiabendazole-5-sulfonamide, trifluoromethane sulfonamide and N-hydroxysulfamide, fructose-based sugar sulfamate RWJ-37497, and Foscarnet (phosphonoformate trisodium salt). Repressed strongly by hydrogen sulfide(HS) and weakly by nitrate (NO(3)). Esterase activity weakly reduced by cyanamide. N-hydroxyurea interfers with zinc binding and inhibit activity. {ECO:0000269|PubMed:11802772, ECO:0000269|PubMed:1336460, ECO:0000269|PubMed:14736236, ECO:0000269|PubMed:16214338, ECO:0000269|PubMed:16290146, ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16759856, ECO:0000269|PubMed:16807956, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17540563, ECO:0000269|PubMed:17588751, ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:18024029, ECO:0000269|PubMed:18162396, ECO:0000269|PubMed:18266323, ECO:0000269|PubMed:18374572, ECO:0000269|PubMed:18481843, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:18640037, ECO:0000269|PubMed:1910042, ECO:0000269|PubMed:19170619, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230, ECO:0000269|PubMed:19520834, ECO:0000269|PubMed:19778001, ECO:0000269|PubMed:9265618}.
P00966	
P00973	ENZYME REGULATION: Produced as a latent enzyme which is activated by dsRNA generated during the course of viral infection. The dsRNA activator must be at least 15 nucleotides long, and no modification of the 2'-hydroxyl group is tolerated. ssRNA or dsDNA do not act as activators. {ECO:0000269|PubMed:12799444, ECO:0000269|PubMed:23319625}.
P00995	
P01008	
P01009	
P01011	
P01019	
P01023	
P01024	
P01031	
P01033	
P01034	
P01036	
P01037	
P01040	
P01042	
P01100	
P01106	
P01111	ENZYME REGULATION: Alternates between an inactive form bound to GDP and an active form bound to GTP. Activated by a guanine nucleotide-exchange factor (GEF) and inactivated by a GTPase-activating protein (GAP).
P01112	ENZYME REGULATION: Alternates between an inactive form bound to GDP and an active form bound to GTP. Activated by a guanine nucleotide-exchange factor (GEF) and inactivated by a GTPase-activating protein (GAP).
P01116	ENZYME REGULATION: Alternates between an inactive form bound to GDP and an active form bound to GTP. Activated by a guanine nucleotide-exchange factor (GEF) and inactivated by a GTPase-activating protein (GAP). Interaction with SOS1 promotes exchange of bound GDP by GTP. {ECO:0000269|PubMed:22431598, ECO:0000269|PubMed:22566140, ECO:0000269|PubMed:22711838}.
P01127	
P01130	
P01133	
P01135	
P01137	
P01138	
P01148	
P01160	
P01178	
P01185	
P01189	
P01210	
P01213	
P01215	
P01222	
P01225	
P01229	
P01236	
P01241	
P01242	
P01258	
P01266	
P01270	
P01275	
P01282	
P01286	
P01298	
P01303	
P01308	
P01344	
P01350	
P01358	
P01374	
P01375	
P01562	
P01563	
P01566	
P01567	
P01568	
P01569	
P01570	
P01571	
P01574	
P01579	
P01583	
P01584	
P01588	
P01589	
P01591	
P01593	
P01594	
P01597	
P01599	
P01601	
P01602	
P01611	
P01614	
P01615	
P01619	
P01624	
P01699	
P01700	
P01701	
P01703	
P01704	
P01705	
P01706	
P01709	
P01714	
P01715	
P01717	
P01718	
P01721	
P01730	
P01732	
P01733	
P01737	
P01742	
P01743	
P01762	
P01763	
P01764	
P01766	
P01767	
P01768	
P01772	
P01780	
P01782	
P01814	
P01817	
P01824	
P01825	
P01833	
P01834	
P01848	
P01850	
P01854	
P01857	
P01858	
P01859	
P01860	
P01861	
P01871	
P01876	
P01877	
P01880	
P01889	
P01891	
P01892	
P01893	
P01903	
P01906	
P01909	
P01911	
P01912	
P01920	
P02008	
P02042	
P02100	
P02144	
P02452	
P02458	
P02461	
P02462	
P02489	
P02511	
P02533	
P02538	
P02545	
P02549	
P02585	
P02647	
P02649	
P02652	
P02654	
P02655	
P02656	
P02671	
P02675	
P02679	
P02686	
P02689	
P02708	
P02724	
P02728	
P02729	
P02730	ENZYME REGULATION: Phenyl isothiocyanate inhibits anion transport in vitro.
P02741	
P02743	
P02745	
P02746	
P02747	
P02748	
P02749	
P02750	
P02751	
P02753	
P02760	
P02763	
P02765	
P02766	
P02768	
P02771	
P02774	
P02775	
P02776	
P02778	
P02786	
P02787	
P02788	
P02790	
P02792	
P02794	
P02795	
P02808	
P02810	
P02812	
P02814	
P02818	
P03372	
P03886	
P03891	
P03897	
P03901	
P03905	
P03915	
P03923	
P03928	
P03950	
P03951	ENZYME REGULATION: Inhibited by SERPINA5. {ECO:0000269|PubMed:2844223}.
P03952	ENZYME REGULATION: Inhibited by SERPINA5. {ECO:0000269|PubMed:2844223}.
P03956	ENZYME REGULATION: Can be activated without removal of the activation peptide.
P03971	
P03973	
P03979	
P03986	
P03989	
P03999	
P04000	
P04001	
P04003	
P04004	
P04035	ENZYME REGULATION: Regulated by a negative feedback mechanism through sterols and non-sterol metabolites derived from mevalonate. Inhibited by statins, a class of hypolipidemic agents used as pharmaceuticals to lower cholesterol levels in individuals at risk from cardiovascular disease due to hypercholesterolemia. Inhibition of HMGCR in the liver stimulates the LDL-receptors, which results in an increased clearance of LDL from the bloodstream and a decrease in blood cholesterol levels. The first results can be seen after one week of statin use and the effect is maximal after four to six weeks. {ECO:0000269|PubMed:6995544}.
P04040	
P04049	ENZYME REGULATION: Regulation is a highly complex process involving membrane recruitment, protein-protein interactions, dimerization, and phosphorylation/dephosphorylation events. Ras-GTP recruits RAF1 to the membrane, thereby promoting its activation. The inactive conformation of RAF1 is maintained by autoinhibitory interactions occurring between the N-terminal regulatory and the C-terminal catalytic domains and by the binding of a 14-3-3 protein that contacts two phosphorylation sites, Ser-259 and Ser-621. Upon mitogenic stimulation, Ras and PPP2R1A cooperate to release autoinhibition and the subsequent phosphorylation of activating sites: Ser-338, Tyr-341, Thr-491, and Ser-494, yields a fully active kinase. Through a negative feedback mechanism involving MAPK1/ERK2, RAF1 is phosphorylated on Ser-29, Ser-43, Ser-289, Ser-296, Ser-301 and Ser-642 by MAPK1/ERK2, which yields an inactive, desensitized kinase. The signaling-competent conformation of RAF1 is finally re-established by the coordinated action of PIN1, a prolyl isomerase that converts pSer and pThr residues from the cis to the trans conformation, which is preferentially recognized and dephosphorylated by PPP2R1A. Activated by homodimerization and heterodimerization (with BRAF). Also regulated through association with other proteins such as KSR2, CNKSR1/CNK1, PEBP1/RKIP, PHB/prohibitin and SPRY4. PEBP1/RKIP acts by dissociating RAF1 from its substrates MAP2K1/MEK1 and MAP2K2/MEK2. PHB/prohibitin facilitates the displacement of 14-3-3 from RAF1 by activated Ras, thereby promoting cell membrane localization and phosphorylation of RAF1 at the activating Ser-338. SPRY4 inhibits Ras-independent, but not Ras-dependent, activation of RAF1. CNKSR1/CNK1 regulates Src-mediated RAF1 activation. {ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10801873, ECO:0000269|PubMed:11447113, ECO:0000269|PubMed:11733498, ECO:0000269|PubMed:12717443, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:18294816, ECO:0000269|PubMed:19710016}.
P04053	
P04054	
P04062	ENZYME REGULATION: Requires saposin-C and anionic phospholipids for activity.
P04066	
P04070	
P04075	
P04080	
P04083	
P04085	
P04090	
P04114	
P04118	
P04141	
P04150	
P04155	
P04156	
P04179	
P04180	ENZYME REGULATION: APOA1 is the most potent activator in plasma. Also activated by APOE, APOC1 and APOA4. {ECO:0000269|PubMed:19065001}.
P04181	
P04183	
P04196	
P04198	
P04201	
P04211	
P04216	
P04217	
P04222	
P04229	
P04233	
P04234	
P04259	
P04264	
P04271	
P04275	
P04278	
P04279	
P04280	
P04350	
P04406	
P04424	ENZYME REGULATION: Enzyme activity is regulated by acetylation. {ECO:0000250}.
P04430	
P04432	
P04433	
P04435	
P04436	
P04437	
P04439	
P04440	
P04553	
P04554	
P04626	ENZYME REGULATION: Activated by dimerization. Not activated by EGF, TGF-alpha and amphiregulin. Interaction with PTK6 increases its intrinsic kinase activity. {ECO:0000269|PubMed:18719096, ECO:0000269|PubMed:21454582}.
P04628	
P04629	ENZYME REGULATION: The pro-survival signaling effect of NTRK1 in neurons requires its endocytosis into signaling early endosomes and its retrograde axonal transport. This is regulated by different proteins including CFL1, RAC1 and SORT1. NTF3 is unable to induce this signaling probably due to the lability of the NTF3-NTRK1 complex in endosomes. SH2D1A inhibits the autophosphorylation of the receptor, and alters the recruitment and activation of downstream effectors and signaling cascades (By similarity). Regulated by NGFR (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q3UFB7}.
P04632	
P04637	
P04731	
P04732	
P04733	
P04745	
P04746	
P04792	
P04798	
P04808	
P04818	
P04839	
P04843	
P04844	
P04899	
P04908	
P04920	
P04921	
P05000	
P05013	
P05014	
P05015	
P05019	
P05023	
P05026	
P05060	
P05062	
P05067	
P05089	
P05090	
P05091	
P05093	ENZYME REGULATION: Regulated predominantly by intracellular cAMP levels.
P05106	
P05107	
P05108	
P05109	
P05111	
P05112	
P05113	
P05114	
P05120	
P05121	
P05129	ENZYME REGULATION: Classical (or conventional) PKCs (PRKCA, PRKCB and PRKCG) are activated by calcium and diacylglycerol (DAG) in the presence of phosphatidylserine. Three specific sites; Thr-514 (activation loop of the kinase domain), Thr-655 (turn motif) and Thr-674 (hydrophobic region), need to be phosphorylated for its full activation.
P05141	
P05154	ENZYME REGULATION: Its inhibitory activity is greatly enhanced in the presence of glycosaminoglycans, heparin, thrombomodulin and phospholipids vesicles.
P05155	
P05156	
P05160	
P05161	
P05162	
P05164	
P05165	
P05166	
P05177	
P05181	
P05186	
P05187	
P05198	
P05204	
P05230	
P05231	
P05305	
P05362	
P05386	
P05387	
P05388	
P05408	
P05412	
P05413	
P05423	
P05451	
P05452	
P05455	
P05496	
P05534	
P05538	
P05543	
P05546	
P05549	
P05556	
P05771	ENZYME REGULATION: Classical (or conventional) PKCs (PRKCA, PRKCB and PRKCG) are activated by calcium and diacylglycerol (DAG) in the presence of phosphatidylserine. Three specific sites; Thr-500 (activation loop of the kinase domain), Thr-642 (turn motif) and Ser-661 (hydrophobic region), need to be phosphorylated for its full activation. Specifically inhibited by enzastaurin (LY317615). {ECO:0000269|PubMed:16103100}.
P05783	
P05787	
P05813	
P05814	
P05937	
P05976	
P05981	
P05997	
P06028	
P06126	
P06127	
P06132	
P06133	
P06213	ENZYME REGULATION: Activated in response to insulin. Autophosphorylation activates the kinase activity. PTPN1, PTPRE and PTPRF dephosphorylate important tyrosine residues, thereby reducing INSR activity. Inhibited by ENPP1. GRB10 and GRB14 inhibit the catalytic activity of the INSR, they block access of substrates to the activated receptor. SOCS1 and SOCS3 act as negative regulators of INSR activity, they bind to the activated INRS and interfere with the phosphorylation of INSR substrates. {ECO:0000269|PubMed:10615944, ECO:0000269|PubMed:11598120, ECO:0000269|PubMed:11726652, ECO:0000269|PubMed:12493740, ECO:0000269|PubMed:2211730}.
P06239	ENZYME REGULATION: The relative activities of the inhibitory tyrosine-protein kinase CSK and the activating tyrosine-protein phosphatase PTPRC/CD45 determine the level of LCK activity. These interactions allow rapid and efficient activation of LCK in response to TCR stimulation. {ECO:0000269|PubMed:21917715}.
P06241	ENZYME REGULATION: Inhibited by phosphorylation of Tyr-531 by leukocyte common antigen and activated by dephosphorylation of this site.
P06276	ENZYME REGULATION: Inhibited by mercury. Inhibited by Tabun. Tabun forms a covalent adduct with Ser-226 that becomes irreversible upon aging. {ECO:0000269|PubMed:17355286, ECO:0000269|PubMed:18975951, ECO:0000269|PubMed:19368529}.
P06280	
P06307	
P06310	
P06312	
P06315	
P06331	
P06340	
P06396	
P06400	
P06401	
P06454	
P06493	ENZYME REGULATION: Phosphorylation at Thr-14 or Tyr-15 inactivates the enzyme, while phosphorylation at Thr-161 activates it. Activated through a multistep process; binding to cyclin-B is required for relocation of cyclin-kinase complexes to the nucleus, activated by CAK/CDK7-mediated phosphorylation on Thr-161, and CDC25-mediated dephosphorylation of inhibitory phosphorylation on Thr-14 and Tyr-15. Inhibited by flavopiridol and derivatives, pyrimidine derivatives, pyridine derivatives, purine derivatives, staurosporine, paullones, oxoindoles, indazole analogs, indolin-2-ones, pyrazolo[3,4-b]pyridines, imidazo[1,2-a]pyridine (AZ703), thiazolinone analogs(RO-3306), thiazol urea, macrocyclic quinoxalin-2-one, pyrrolo[2,3-a]carbazole, pyrazolo[1,5-a]-1,3,5-triazine, pyrazolo[1,5-a]pyrimidine (Dinaciclib, SCH 727965), 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine (roscovitine), olomoucine, AG-024322, AT-7519, P276-00, R547/Ro-4584820 and SNS-032/BMS-387032. Repressed by the CDK inhibitors CDKN1A/p21 and CDKN1B/p27 during the G1 phase and by CDKN1A/p21 at the G1-S checkpoint upon DNA damage. Transient activation by rapid and transient dephosphorylation at Tyr-15 triggered by TGFB1. {ECO:0000269|PubMed:17459720, ECO:0000269|PubMed:9030781}.
P06576	
P06681	
P06702	
P06703	
P06727	
P06729	
P06730	
P06731	
P06732	
P06733	
P06734	
P06737	ENZYME REGULATION: Activity of phosphorylase is controlled both by allosteric means (through the noncovalent binding of metabolites) and by covalent modification. Thus AMP allosterically activates, whereas ATP, ADP, and glucose-6-phosphate allosterically inhibit, phosphorylase B.
P06744	
P06746	
P06748	
P06753	
P06756	
P06850	
P06858	
P06865	
P06870	
P06881	
P06899	
P07093	
P07098	
P07099	
P07101	ENZYME REGULATION: Phosphorylation leads to an increase in the catalytic activity.
P07108	
P07148	
P07195	
P07196	
P07197	
P07199	
P07202	
P07203	
P07204	
P07205	
P07225	
P07237	
P07288	ENZYME REGULATION: Inhibited by SERPINA5. Activity is strongly inhibited by Zn2+, 100 times more abundant in semen than in serum. This inhibition is relieved by exposure to semenogelins, which are avid zinc binders. {ECO:0000269|PubMed:1725227, ECO:0000269|PubMed:18187150}.
P07305	
P07306	
P07307	
P07311	
P07315	
P07316	
P07320	
P07327	
P07332	ENZYME REGULATION: Kinase activity is tightly regulated. Activated in response to signaling from a cell surface receptor. Activation probably requires binding of a substrate via the SH2 domain, plus autophosphorylation at Tyr-713. Present in an inactive form in the absence of activating stimuli. {ECO:0000269|PubMed:18775312, ECO:0000269|PubMed:8955135}.
P07333	ENZYME REGULATION: Present in an inactive conformation in the absence of bound ligand. CSF1 or IL34 binding leads to dimerization and activation by autophosphorylation on tyrosine residues. Inhibited by imatinib/STI-571 (Gleevec), dasatinib, sunitinib/SU11248, lestaurtinib/CEP-701, midostaurin/PKC-412, Ki20227, linifanib/ABT-869, Axitinib/AG013736, sorafenib/BAY 43-9006 and GW2580. {ECO:0000269|PubMed:16170366, ECO:0000269|PubMed:16648572, ECO:0000269|PubMed:17121910, ECO:0000269|PubMed:18814279, ECO:0000269|PubMed:20137931, ECO:0000269|PubMed:20156689, ECO:0000269|PubMed:20489731}.
P07339	
P07355	
P07357	
P07358	
P07359	
P07360	
P07384	ENZYME REGULATION: Activated by micromolar concentrations of calcium and inhibited by calpastatin. {ECO:0000269|PubMed:8954105, ECO:0000269|PubMed:9271093}.
P07437	
P07438	
P07451	ENZYME REGULATION: Activated by proton donors such as imidazole and the dipeptide histidylhistidine. Inhibited by coumarins and sulfonamide derivatives such as acetazolamide. {ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.
P07476	
P07477	
P07478	
P07492	
P07498	
P07510	
P07550	
P07585	
P07602	
P07686	
P07711	
P07737	
P07738	ENZYME REGULATION: At alkaline pH BPGM favors the synthase reaction; however, at lower pH the phosphatase reaction is dominant. Inhibited by citrate. {ECO:0000269|PubMed:10477269, ECO:0000269|PubMed:21045285}.
P07741	
P07766	
P07814	ENZYME REGULATION: Inhibited by halofuginone. {ECO:0000269|PubMed:23263184, ECO:0000269|PubMed:24100331}.
P07858	
P07864	
P07900	ENZYME REGULATION: In the resting state, through the dimerization of its C-terminal domain, HSP90 forms a homodimer which is defined as the open conformation. Upon ATP-binding, the N-terminal domain undergoes significant conformational changes and comes in contact to form an active closed conformation. After HSP90 finishes its chaperoning tasks of assisting the proper folding, stabilization and activation of client proteins under the active state, ATP molecule is hydrolyzed to ADP which then dissociates from HSP90 and directs the protein back to the resting state. {ECO:0000269|PubMed:18400751}.
P07902	
P07910	
P07911	
P07919	
P07942	
P07947	
P07948	ENZYME REGULATION: Subject to autoinhibition, mediated by intramolecular interactions between the SH2 domain and the C-terminal phosphotyrosine. Phosphorylation at Tyr-397 is required for optimal activity. Phosphorylated by CSK at Tyr-508; phosphorylation at Tyr-508 inhibits kinase activity. Kinase activity is modulated by dephosphorylation by PTPRC/CD45. Inhibited by Dasatinib, PP2, and SU6656. {ECO:0000269|PubMed:16920712, ECO:0000269|PubMed:7935444}.
P07949	ENZYME REGULATION: Repressed by 4-(3-hydroxyanilino)-quinolines derivatives, indolin-2-one-derivatives, 2-(alkylsulfanyl)-4-(3-thienyl) nicotinonitrile analogs, 3- and 4-substituted beta-carbolin-1-ones, vandetanib, motesanib, sorafenib (BAY 43-9006), cabozantinib (XL184), sunitinib, and withaferin A (WA). Inactivation by sorafenib both reduces kinase activity and promotes lysosomal degradation. {ECO:0000269|PubMed:17664273, ECO:0000269|PubMed:17884497, ECO:0000269|PubMed:19053769, ECO:0000269|PubMed:20117004, ECO:0000269|PubMed:20409618, ECO:0000269|PubMed:20605972, ECO:0000269|PubMed:21134556}.
P07951	
P07954	
P07988	
P07992	
P07996	
P07998	
P08034	
P08047	
P08048	
P08069	ENZYME REGULATION: Activated by autophosphorylation at Tyr-1165, Tyr-1161 and Tyr-1166 on the kinase activation loop; phosphorylation at all three tyrosine residues is required for optimal kinase activity. Inhibited by MSC1609119A-1, BMS-754807, PQIP, benzimidazole pyridinone, isoquinolinedione, bis-azaindole, 3-cyanoquinoline, 2,4-bis-arylamino-1,3-pyrimidine, pyrrolopyrimidine, pyrrole-5-carboxaldehyde, picropodophyllin (PPP), tyrphostin derivatives. While most inhibitors bind to the ATP binding pocket, MSC1609119A-1 functions as allosteric inhibitor and binds close to the DFG motif and the activation loop. {ECO:0000269|PubMed:11694888, ECO:0000269|PubMed:14729630, ECO:0000269|PubMed:17317169, ECO:0000269|PubMed:18566589, ECO:0000269|PubMed:19041240, ECO:0000269|PubMed:19778024, ECO:0000269|PubMed:20545947, ECO:0000269|PubMed:20675137, ECO:0000269|PubMed:21414779, ECO:0000269|PubMed:21441024, ECO:0000269|Ref.52}.
P08100	
P08118	
P08123	
P08133	
P08134	
P08138	
P08151	
P08172	
P08173	
P08174	
P08183	
P08185	
P08195	
P08217	
P08218	
P08235	
P08236	ENZYME REGULATION: Inhibited by L-aspartic acid.
P08237	ENZYME REGULATION: Allosterically activated by ADP, AMP, or fructose 2,6-bisphosphate, and allosterically inhibited by ATP or citrate.
P08238	ENZYME REGULATION: In the resting state, through the dimerization of its C-terminal domain, HSP90 forms a homodimer which is defined as the open conformation. Upon ATP-binding, the N-terminal domain undergoes significant conformational changes and comes in contact to form an active closed conformation. After HSP90 finishes its chaperoning tasks of assisting the proper folding, stabilization and activation of client proteins under the active state, ATP molecule is hydrolyzed to ADP which then dissociates from HSP90 and directs the protein back to the resting state. {ECO:0000269|PubMed:18400751}.
P08240	
P08243	
P08246	
P08247	
P08253	ENZYME REGULATION: Inhibited by histatin-3 1/24 (histatin-5). {ECO:0000269|PubMed:11179305}.
P08254	
P08263	
P08294	
P08311	ENZYME REGULATION: Inhibited by soybean trypsin inhibitor, benzamidine, the synthetic peptide R13K, Z-Gly-Leu-Phe-CH2Cl, phenylmethylsulfonyl fluoride, 3,4-dichloroisocoumarin, DFP, SBTI and alpha-1-antitrypsin. Inhibited by LPS from P.aeruginosa but not by LPS from S.minnesota. Not inhibited by elastinal, CMK, TLCK and ETDA. {ECO:0000269|PubMed:1861080, ECO:0000269|PubMed:1937776, ECO:0000269|PubMed:8194606}.; ENZYME REGULATION: (Microbial infection) Serine protease activity is inhibited by the M.tuberculosis protein Rv3364c, which leads to the suppression of downstream caspase-1-dependent apoptosis in macrophages. {ECO:0000269|PubMed:22275911}.
P08319	
P08397	
P08473	ENZYME REGULATION: Inhibited in a dose dependent manner by opiorphin. {ECO:0000269|PubMed:17101991}.
P08476	
P08493	
P08514	
P08519	
P08559	ENZYME REGULATION: Pyruvate dehydrogenase activity is inhibited by phosphorylation of PDHA1; it is reactivated by dephosphorylation. {ECO:0000269|PubMed:17474719, ECO:0000269|PubMed:19081061, ECO:0000269|PubMed:7782287}.
P08567	
P08571	
P08572	
P08574	
P08575	
P08579	
P08581	ENZYME REGULATION: In its inactive state, the C-terminal tail interacts with the catalytic domain and inhibits the kinase activity. Upon ligand binding, the C-terminal tail is displaced and becomes phosphorylated, thus increasing the kinase activity.
P08582	
P08588	
P08590	
P08603	
P08620	
P08621	
P08631	ENZYME REGULATION: Subject to autoinhibition, mediated by intramolecular interactions involving the SH2 and SH3 domains. Kinase activity is also regulated by phosphorylation at regulatory tyrosine residues. Phosphorylation at Tyr-411 is required for optimal activity. Phosphorylation at Tyr-522 inhibits kinase activity. Inhibited by PP1 and A-770041. {ECO:0000269|PubMed:10644735, ECO:0000269|PubMed:10779760, ECO:0000269|PubMed:10973280, ECO:0000269|PubMed:16216497, ECO:0000269|PubMed:16849330, ECO:0000269|PubMed:20810664, ECO:0000269|PubMed:7535819, ECO:0000269|PubMed:9218412, ECO:0000269|PubMed:9406996}.
P08637	
P08648	
P08651	
P08670	
P08684	
P08686	
P08697	
P08700	
P08708	
P08709	
P08727	
P08729	
P08754	
P08758	
P08779	
P08833	
P08842	
P08861	
P08865	
P08887	
P08908	
P08910	ENZYME REGULATION: Acylglycerol lipase activity is activated upon binding to progesterone. {ECO:0000269|PubMed:26989199}.
P08912	
P08913	
P08922	ENZYME REGULATION: Inhibited by dephosphorylation by PTPN6. {ECO:0000250}.
P08949	
P08962	
P08F94	
P09001	
P09012	
P09016	
P09017	
P09038	
P09067	
P09086	
P09093	
P09104	
P09105	
P09110	
P09131	
P09132	
P09172	
P09210	
P09211	
P09228	
P09234	
P09237	
P09238	
P09326	
P09327	
P09341	
P09382	
P09417	
P09429	
P09430	
P09455	
P09466	
P09467	ENZYME REGULATION: Subject to complex allosteric regulation. The enzyme can assume an active R-state, or an inactive T-state. Intermediate conformations may exist. AMP acts as allosteric inhibitor. AMP binding affects the turnover of bound substrate and not the affinity for substrate. Fructose 2,6-bisphosphate acts as competitive inhibitor. Fructose 2,6-bisphosphate and AMP have synergistic effects. {ECO:0000269|PubMed:16442285, ECO:0000269|PubMed:16446092, ECO:0000269|PubMed:17350621, ECO:0000269|PubMed:18650089, ECO:0000269|PubMed:7809062}.
P09471	
P09486	
P09488	
P09493	
P09496	
P09497	
P09525	
P09529	
P09543	
P09544	
P09564	
P09565	
P09601	
P09603	
P09619	ENZYME REGULATION: Present in an inactive conformation in the absence of bound ligand. Binding of PDGFB and/or PDGFD leads to dimerization and activation by autophosphorylation on tyrosine residues. Inhibited by imatinib. {ECO:0000269|PubMed:15492236}.
P09622	ENZYME REGULATION: Disruption of native heterodimer state inhibits primary dihydrolipoamide dehydrogenase activity and induces serine protease activity. {ECO:0000269|PubMed:17404228}.
P09629	
P09630	
P09651	
P09661	
P09668	
P09669	
P09681	
P09683	
P09693	
P09758	
P09769	ENZYME REGULATION: Activated by autophosphorylation. Prior phosphorylation at Tyr-523 by SRC inhibits ulterior autophosphorylation at Tyr-412. Activated by phorbol myristate acetate, phosphatidic acid and poly-Lys. Binding (via SH2 domain) of HCLS1 that is already phosphorylated by SYK strongly increases kinase activity. {ECO:0000269|PubMed:11078731, ECO:0000269|PubMed:8327512, ECO:0000269|PubMed:8603737}.
P09848	
P09871	ENZYME REGULATION: Inhibited by SERPING1. {ECO:0000269|PubMed:11527969}.
P09874	
P09884	
P09912	
P09913	
P09914	
P09917	
P09919	
P09923	
P09936	
P09958	ENZYME REGULATION: Inhibited by the not secondly cleaved propeptide (PubMed:9130696, PubMed:11799113). Inhibited by m-guanidinomethyl-phenylacetyl-Arg-Val-Arg-(amidomethyl)-benzamidine (m-guanidinomethyl-Phac-RVR-Amb) and 4-guanidinomethyl-phenylacteyl-Arg-Tle-Arg-4-amidinobenzylamide (MI-1148) (PubMed:24666235, PubMed:25974265). {ECO:0000269|PubMed:11799113, ECO:0000269|PubMed:24666235, ECO:0000269|PubMed:25974265, ECO:0000269|PubMed:9130696}.
P09960	ENZYME REGULATION: Inhibited by bestatin. Subject to suicide inhibition by leukotriene A4, due to the formation of a covalent adduct at Tyr-379. {ECO:0000269|PubMed:7667299}.
P09972	
P0C024	ENZYME REGULATION: Inhibited by fluoride. {ECO:0000250}.
P0C025	
P0C091	
P0C0E4	
P0C0L4	
P0C0L5	
P0C0P6	
P0C0S5	
P0C0S8	
P0C1H6	
P0C1S8	
P0C1Z6	
P0C221	
P0C263	
P0C264	
P0C2L3	
P0C2S0	
P0C2W1	
P0C2W7	
P0C2Y1	
P0C5J1	
P0C5K6	
P0C5K7	
P0C5Y4	
P0C5Y9	
P0C5Z0	
P0C604	
P0C617	
P0C623	
P0C626	
P0C628	
P0C629	
P0C645	
P0C646	
P0C671	
P0C672	
P0C6A0	
P0C6C1	
P0C6P0	
P0C6S8	
P0C6T2	
P0C7A2	
P0C7H8	
P0C7H9	
P0C7I0	
P0C7I6	
P0C7L1	
P0C7M3	
P0C7M4	
P0C7M6	
P0C7M7	
P0C7M8	
P0C7N1	
P0C7N4	
P0C7N5	
P0C7N8	
P0C7P0	
P0C7P1	
P0C7P2	
P0C7P3	
P0C7P4	
P0C7Q2	
P0C7Q3	
P0C7Q5	
P0C7Q6	
P0C7T2	
P0C7T3	
P0C7T4	
P0C7T5	
P0C7T7	
P0C7T8	
P0C7U0	
P0C7U1	
P0C7U3	
P0C7U9	
P0C7V0	
P0C7V4	
P0C7V6	
P0C7V7	
P0C7V8	
P0C7V9	
P0C7W0	
P0C7W6	
P0C7W8	
P0C7W9	
P0C7X0	
P0C7X1	
P0C7X2	
P0C7X3	
P0C7X4	
P0C7X5	
P0C841	
P0C842	
P0C843	
P0C851	
P0C853	
P0C854	
P0C860	
P0C862	
P0C864	
P0C866	
P0C869	ENZYME REGULATION: Stimulated by cytosolic Ca(2+). {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:10358058}.
P0C870	
P0C874	
P0C875	
P0C879	
P0C880	
P0C881	
P0C8F1	
P0CAP1	
P0CAP2	
P0CAT3	
P0CB33	
P0CB38	
P0CB47	
P0CB48	
P0CE67	
P0CE71	
P0CE72	
P0CF51	
P0CF74	
P0CF75	
P0CF97	
P0CG00	
P0CG01	
P0CG04	
P0CG08	
P0CG12	
P0CG13	
P0CG20	
P0CG21	
P0CG22	
P0CG23	
P0CG24	
P0CG29	
P0CG30	
P0CG31	
P0CG32	
P0CG33	
P0CG34	
P0CG35	
P0CG36	
P0CG37	
P0CG38	
P0CG39	
P0CG40	
P0CG41	
P0CG42	
P0CG43	
P0CG47	
P0CG48	
P0CH98	
P0CH99	
P0CI00	
P0CI01	
P0CI25	
P0CI26	
P0CJ68	
P0CJ69	
P0CJ70	
P0CJ71	
P0CJ72	
P0CJ73	
P0CJ74	
P0CJ75	
P0CJ76	
P0CJ77	
P0CJ78	
P0CJ79	
P0CJ85	
P0CJ86	
P0CJ87	
P0CJ88	
P0CJ89	
P0CJ90	
P0CJ92	
P0CK96	
P0CK97	
P0CL80	
P0CL81	
P0CL82	
P0CL83	
P0CL84	
P0CL85	
P0CV98	
P0CV99	
P0CW00	
P0CW01	
P0CW18	
P0CW19	
P0CW20	
P0CW21	
P0CW23	
P0CW24	
P0CW27	
P0CZ25	
P0DH78	
P0DI80	
P0DI81	
P0DI82	
P0DI83	
P0DJ07	
P0DJ93	
P0DJD0	
P0DJD1	
P0DJD3	
P0DJD4	
P0DJD7	
P0DJD8	
P0DJD9	
P0DJG4	
P0DJH9	
P0DJI8	
P0DJI9	
P0DJJ0	
P0DJR0	
P0DKB5	
P0DKB6	
P0DKL9	
P0DKV0	
P0DKX0	
P0DKX4	
P0DL12	
P0DM35	
P0DM63	
P0DMB1	
P0DMB2	
P0DMC3	
P0DME0	
P0DML2	
P0DML3	
P0DMM9	
P0DMN0	
P0DMP1	
P0DMP2	
P0DMQ5	
P0DMQ9	
P0DMR1	
P0DMR2	
P0DMR3	
P0DMS8	
P0DMS9	
P0DMT0	
P0DMU2	
P0DMU3	
P0DMU4	
P0DMU5	
P0DMU7	
P0DMU8	
P0DMU9	
P0DMV0	
P0DMV1	
P0DMV2	
P0DMV8	
P0DMV9	
P0DMW2	
P0DMW3	
P0DMW4	
P0DMW5	
P0DN24	
P0DN25	
P0DN26	
P0DN37	
P0DN76	
P0DN77	
P0DN78	
P0DN79	ENZYME REGULATION: Allosterically activated by S-adenosyl-methionine/AdoMet. Activated by S-adenosylhomocysteine/AdoHcy. Binds non-covalently to a heme group that may control the redox sensitivity of the enzyme. {ECO:0000250|UniProtKB:P35520}.
P0DN80	
P0DN81	
P0DN82	
P0DN84	
P0DN86	
P0DN87	
P0DO92	
P0DO97	
P0DOX2	
P0DOX3	
P0DOX4	
P0DOX5	
P0DOX6	
P0DOX7	
P0DOX8	
P0DOY2	
P0DOY3	
P0DOY5	
P0DP01	
P0DP02	
P0DP03	
P0DP04	
P0DP06	
P0DP07	
P0DP08	
P0DP09	
P0DP23	
P0DP24	
P0DP25	
P0DP42	
P0DP57	
P0DP58	
P0DP71	
P0DP72	
P0DP73	
P0DP74	
P0DP75	
P0DP91	
P0DPA2	
P0DPA3	
P0DPB3	
P0DPB5	
P0DPB6	
P0DPD5	
P0DPD6	
P0DPD7	
P0DPD8	ENZYME REGULATION: Inhibited by phosphoramidon. {ECO:0000250|UniProtKB:P0DPE2}.
P0DPE3	
P0DPE8	
P0DPF2	
P0DPF3	
P10070	
P10071	
P10072	
P10073	
P10074	
P10075	
P10082	
P10092	
P10109	
P10114	ENZYME REGULATION: Activated by the guanine nucleotide-exchange factors RAPGEF3 and RAPGEF4 in a cAMP-dependent manner. Nucleotide exchange is also specifically stimulated by RAPGEF5, RASGEF1A and RASGEF1B. {ECO:0000269|PubMed:23894443}.
P10124	
P10144	ENZYME REGULATION: Inactivated by the serine protease inhibitor diisopropylfluorophosphate. {ECO:0000269|PubMed:8258716}.
P10145	
P10147	
P10153	
P10155	
P10163	
P10176	
P10242	
P10243	
P10244	
P10253	
P10265	ENZYME REGULATION: Resistant to a number of clinically useful HIV-1 PR inhibitors. Inhibited by cyclic urea SD146.
P10266	
P10275	ENZYME REGULATION: AIM-100 (4-amino-5,6-biaryl-furo[2,3-d]pyrimidine) suppresses TNK2-mediated phosphorylation at Tyr-269. Inhibits the binding of the Tyr-269 phosphorylated form to androgen-responsive enhancers (AREs) and its transcriptional activity. {ECO:0000269|PubMed:20623637}.
P10276	
P10301	
P10314	
P10316	
P10319	
P10321	
P10323	ENZYME REGULATION: Inhibited by SERPINA5. {ECO:0000269|PubMed:7521127}.
P10398	
P10412	
P10415	
P10451	
P10515	
P10523	
P10586	
P10588	
P10589	
P10599	
P10600	
P10606	
P10619	
P10620	ENZYME REGULATION: Can be activated by reagents that attack Cys-50 sulfhydryl, such as N-ethylmaleimide. Activation also occurs via nitration of Tyr-93 by peroxynitrite (By similarity). {ECO:0000250}.
P10632	
P10635	
P10636	
P10643	
P10644	
P10645	
P10646	
P10696	
P10720	
P10721	ENZYME REGULATION: Present in an inactive conformation in the absence of bound ligand. KITLG/SCF binding leads to dimerization and activation by autophosphorylation on tyrosine residues. Activity is down-regulated by PRKCA-mediated phosphorylation on serine residues. Inhibited by imatinib/STI-571 (Gleevec) and sunitinib; these compounds maintain the kinase in an inactive conformation. {ECO:0000269|PubMed:15123710, ECO:0000269|PubMed:19164557, ECO:0000269|PubMed:21640708, ECO:0000269|PubMed:7520444, ECO:0000269|PubMed:7539802}.
P10745	
P10746	
P10747	
P10767	
P10768	
P10809	
P10826	
P10827	
P10828	
P10909	
P10911	
P10912	
P10914	ENZYME REGULATION: Activated by MYD88. {ECO:0000250}.
P10915	
P10916	
P10966	
P10997	
P11021	ENZYME REGULATION: The chaperone activity is regulated by ATP-induced allosteric coupling of the nucleotide-binding (NBD) and substrate-binding (SBD) domains. In the ADP-bound and nucleotide-free (apo) states, the two domains have little interaction (PubMed:26655470). In contrast, in the ATP-bound state the two domains are tightly coupled, which results in drastically accelerated kinetics in both binding and release of polypeptide substrates (PubMed:26655470). J domain-containing co-chaperones (DNAJB9/ERdj4 or DNAJC10/ERdj5) stimulate the ATPase activity and are required for efficient substrate recognition by HSPA5/BiP (By similarity). Homooligomerization inactivates participating HSPA5/BiP protomers and probably act as reservoirs to store HSPA5/BiP molecules when they are not needed by the cell (By similarity). {ECO:0000250|UniProtKB:G3I8R9, ECO:0000269|PubMed:26655470, ECO:0000303|PubMed:28286085}.
P11047	
P11049	
P11055	
P11086	
P11117	
P11137	
P11142	
P11150	
P11161	
P11166	
P11168	
P11169	
P11171	
P11172	
P11177	
P11182	
P11215	
P11216	ENZYME REGULATION: Activity of phosphorylase is controlled both by allosteric means (through the non-covalent binding of metabolites) and by covalent modification. Thus AMP allosterically activates, whereas ATP, ADP, and glucose-6-phosphate allosterically inhibit, phosphorylase B. Activated upon phosphorylation. {ECO:0000269|PubMed:27402852}.
P11217	ENZYME REGULATION: Activity of phosphorylase is controlled both by allosteric means (through the noncovalent binding of metabolites) and by covalent modification. Thus AMP allosterically activates, whereas ATP, ADP, and glucose-6-phosphate allosterically inhibit, phosphorylase B.
P11226	
P11229	
P11230	
P11233	ENZYME REGULATION: Alternates between an inactive form bound to GDP and an active form bound to GTP. Activated by a guanine nucleotide-exchange factor (GEF) and inactivated by a GTPase-activating protein (GAP).
P11234	ENZYME REGULATION: Alternates between an inactive form bound to GDP and an active form bound to GTP. Activated by a guanine nucleotide-exchange factor (GEF) and inactivated by a GTPase-activating protein (GAP).
P11245	
P11274	
P11277	
P11279	
P11308	
P11309	
P11310	
P11362	ENZYME REGULATION: Present in an inactive conformation in the absence of bound ligand. Ligand binding leads to dimerization and activation by sequential autophosphorylation on tyrosine residues. Inhibited by ARQ 069; this compound maintains the kinase in an inactive conformation and inhibits autophosphorylation. Inhibited by PD173074. {ECO:0000269|PubMed:18480409, ECO:0000269|PubMed:19224897, ECO:0000269|PubMed:21454610, ECO:0000269|PubMed:8622701}.
P11387	ENZYME REGULATION: Specifically inhibited by camptothecin (CPT), a plant alkaloid with antitumor activity.
P11388	ENZYME REGULATION: Specifically inhibited by the intercalating agent amsacrine.
P11413	
P11441	
P11464	
P11465	
P11473	
P11474	
P11487	
P11488	
P11498	
P11509	
P11511	
P11532	
P11586	
P11597	
P11678	
P11684	
P11686	
P11712	
P11717	
P11766	
P11801	ENZYME REGULATION: Activity depends on Ca(2+) concentration.
P11802	ENZYME REGULATION: Both phosphorylation at Thr-172 and binding of a D-type cyclin are necessary for enzymatic activity. Full activation of the cyclin-D-CDK4 complex appears to require other factors such as recruitment of the substrate via a substrate recruitment motif, and/or formation of the CDKN1B ternary complex. Inhibited by INK4 family members. In resting cells, the non-tyrosine-phosphorylated form of CDKN1B prevents phosphorylation at Thr-172 and inactivation, while, in proliferating cells, tyrosine phosphorylation of CDKN1B allows phosphorylation of Thr-172 of CDK4 and subsequennt activation. {ECO:0000269|PubMed:19487459}.
P11831	
P11836	
P11844	
P11908	ENZYME REGULATION: Activated by magnesium and inorganic phosphate. Competitively or non-competitively inhibited by ADP, 2,3-bisphosphoglyceride or GDP.
P11912	
P11926	ENZYME REGULATION: Inhibited by S-nitrosylation (PubMed:10462479, PubMed:11461922). Inhibited by antizymes (AZs) OAZ1, OAZ2 and OAZ3 in response to polyamine levels. AZs inhibit the assembly of the functional homodimer by binding to ODC monomers. Additionally, OAZ1 targets ODC monomers for ubiquitin-independent proteolytic destruction by the 26S proteasome (PubMed:17900240). Inhibited by 1-amino-oxy-3-aminopropane (APA, an isosteric analog of putrescine) (PubMed:17407445). Irreversibly inhibited by alpha-difluoromethylornithine (DFMO) (PubMed:17407445). {ECO:0000269|PubMed:10462479, ECO:0000269|PubMed:11461922, ECO:0000269|PubMed:17407445, ECO:0000269|PubMed:17900240}.
P11940	
P12004	
P12018	
P12034	
P12035	
P12036	
P12074	
P12081	
P12104	
P12107	
P12109	
P12110	
P12111	
P12235	
P12236	
P12259	ENZYME REGULATION: Inhibited by SERPINA5. {ECO:0000269|PubMed:15140131, ECO:0000269|PubMed:2844223, ECO:0000269|PubMed:6323392, ECO:0000269|PubMed:9556620}.
P12268	ENZYME REGULATION: Mycophenolic acid (MPA) is a non-competitive inhibitor that prevents formation of the closed enzyme conformation by binding to the same site as the amobile flap. In contrast, mizoribine monophosphate (MZP) is a competitive inhibitor that induces the closed conformation. MPA is a potent inhibitor of mammalian IMPDHs but a poor inhibitor of the bacterial enzymes. MZP is a more potent inhibitor of bacterial IMPDH. Subject to product inhibition by XMP and NADH. Also inhibited by ADP. {ECO:0000255|HAMAP-Rule:MF_03156, ECO:0000269|PubMed:7903306}.
P12270	
P12271	
P12272	
P12273	
P12277	
P12314	
P12318	
P12319	
P12429	
P12524	
P12525	
P12532	
P12544	
P12643	
P12644	
P12645	
P12694	
P12724	
P12755	
P12757	
P12814	
P12821	ENZYME REGULATION: Strongly activated by chloride. Specifically inhibited by lisinopril, captopril and enalaprilat.
P12829	
P12830	
P12838	
P12872	
P12882	
P12883	
P12931	ENZYME REGULATION: Phosphorylation by CSK at Tyr-530 inhibits kinase activity. Inhibitory phosphorylation at Tyr-530 is enhanced by heme. Further phosphorylation by CDK1 partially reactivates CSK-inactivated SRC and facilitates complete reactivation by protein tyrosine phosphatase PTPRC. Integrin engagement stimulates kinase activity. Phosphorylation by PTK2/FAK1 enhances kinase activity. Butein and pseudosubstrate-based peptide inhibitors like CIYKYYF act as inhibitors. Phosphorylation at Tyr-419 increases kinase activity. {ECO:0000269|PubMed:14632929, ECO:0000269|PubMed:21036157, ECO:0000269|PubMed:7929427, ECO:0000269|PubMed:8759729, ECO:0000269|PubMed:9571170}.
P12955	
P12956	
P12980	
P13010	
P13051	
P13056	
P13073	
P13164	
P13196	
P13224	
P13232	
P13236	
P13284	
P13349	
P13378	
P13385	
P13473	
P13489	
P13497	ENZYME REGULATION: Activity is increased by the procollagen C-endopeptidase enhancer protein.
P13498	
P13500	
P13501	
P13521	
P13533	
P13535	
P13569	
P13584	
P13591	
P13598	
P13611	
P13612	
P13631	
P13637	
P13639	
P13640	
P13645	
P13646	
P13647	
P13667	
P13671	
P13674	
P13682	
P13686	
P13688	
P13693	
P13716	ENZYME REGULATION: Can alternate between a fully active homooctamer and a low-activity homohexamer. A bound magnesium ion may promote the assembly of the fully active homooctamer. The magnesium-binding site is absent in the low-activity homohexamer. Inhibited by compounds that favor the hexameric state. Inhibited by divalent lead ions. The lead ions partially displace the zinc cofactor. {ECO:0000269|PubMed:11032836, ECO:0000269|PubMed:12897770, ECO:0000269|PubMed:19812033}.
P13725	
P13726	
P13727	
P13746	
P13747	
P13760	
P13761	
P13762	
P13765	
P13796	
P13797	
P13798	
P13804	
P13805	
P13807	ENZYME REGULATION: Allosteric activation by glucose-6-phosphate. Phosphorylation reduces the activity towards UDP-glucose. When in the non-phosphorylated state, glycogen synthase does not require glucose-6-phosphate as an allosteric activator; when phosphorylated it does (By similarity). {ECO:0000250}.
P13861	
P13866	
P13928	
P13929	
P13942	
P13945	
P13984	
P13985	
P13987	
P13994	
P13995	
P14060	
P14061	
P14091	
P14136	
P14138	
P14151	
P14174	
P14207	
P14209	
P14210	
P14222	
P14314	
P14316	
P14317	
P14324	ENZYME REGULATION: Inactivated by interferon-induced RSAD2. This inactivation may result of disruption of lipid rafts at the plasma membrane, and thus have an antiviral effect since many enveloped viruses need lipid rafts to bud efficiently out of the cell. {ECO:0000269|PubMed:18005724}.
P14373	
P14384	ENZYME REGULATION: Inhibited by O-phenanthroline and MGTA and activated by cobalt.
P14406	
P14410	
P14415	
P14416	
P14543	
P14550	
P14555	
P14598	
P14616	
P14618	ENZYME REGULATION: Isoform M2 is allosterically activated by D-fructose 1,6-bisphosphate (FBP). Inhibited by oxalate and 3,3',5-triiodo-L-thyronine (T3). The activity of the tetrameric form is inhibited by PML. Selective binding to tyrosine-phosphorylated peptides releases the allosteric activator FBP, leading to inhibition of PKM enzymatic activity, this diverts glucose metabolites from energy production to anabolic processes when cells are stimulated by certain growth factors. Glycolytic flux are highly dependent on de novo biosynthesis of serine and glycine, and serine is a natural ligand and allosteric activator of isoform M2. {ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:18298799, ECO:0000269|PubMed:18337815, ECO:0000269|PubMed:1854723, ECO:0000269|PubMed:23064226, ECO:0000269|PubMed:2813362}.
P14621	
P14625	
P14635	
P14649	
P14651	
P14652	
P14653	
P14672	
P14678	
P14679	
P14735	ENZYME REGULATION: Activated by small peptides (By similarity). Activated by ATP and GTP, and to a lesser extent by CTP, TTP and PPPi. Inhibited by bacitracin. Inhibited by S-nitrosylation and oxidation agents. {ECO:0000250, ECO:0000269|PubMed:17613531, ECO:0000269|PubMed:18986166}.
P14770	
P14778	
P14780	ENZYME REGULATION: Inhibited by histatin-3 1/24 (histatin-5). Inhibited by ECM1. {ECO:0000269|PubMed:11179305, ECO:0000269|PubMed:16512877}.
P14784	
P14854	
P14859	
P14866	
P14867	
P14868	
P14902	ENZYME REGULATION: Activity is inhibited by and MTH-trp (methylthiohydantoin-DL-tryptophan), modestly inhibited by L-1MT (1-methyl-L-tryptophan) but not D-1MT (1-methyl-D-tryptophan). {ECO:0000269|PubMed:17671174}.
P14920	
P14921	
P14923	
P14927	
P15018	
P15036	
P15056	ENZYME REGULATION: Activity is increased by EGF and HGF.
P15085	
P15086	
P15088	
P15090	
P15104	
P15121	ENZYME REGULATION: Cys-299 may regulate the kinetic and inhibition properties of the enzyme, but does not participate in catalysis. {ECO:0000269|PubMed:8343525}.
P15144	
P15151	
P15153	ENZYME REGULATION: Regulated by guanine nucleotide exchange factors (GEFs) which promote the exchange of bound GDP for free GTP, GTPase activating proteins (GAPs) which increase the GTP hydrolysis activity, and GDP dissociation inhibitors which inhibit the dissociation of the nucleotide from the GTPase.
P15169	
P15170	
P15172	
P15173	
P15248	
P15259	
P15260	
P15289	ENZYME REGULATION: Inhibited by phosphate. The phosphate forms a covalent bond with the active site 3-oxoalanine. {ECO:0000269|PubMed:12888274}.
P15291	
P15309	ENZYME REGULATION: Phosphatase activity inhibited by L(+)-tartrate, and by its derivative, alpha-benzylaminobenzylphosphonic acid. {ECO:0000269|PubMed:9584846}.
P15311	ENZYME REGULATION: A head-to-tail association, of the N-terminal and C-terminal halves results in a closed conformation (inactive form) which is incapable of actin or membrane-binding. {ECO:0000250}.
P15313	
P15328	
P15336	
P15374	ENZYME REGULATION: Inhibited by monoubiquitin and diubiquitin. {ECO:0000269|PubMed:19154770}.
P15382	
P15391	
P15407	
P15408	
P15421	
P15428	
P15498	
P15502	
P15509	
P15514	
P15515	
P15516	
P15529	
P15531	ENZYME REGULATION: Autophosphorylation at His-118 increases serine/threonine protein kinase activity of the enzyme. Interaction with the SET complex inhibits the endonuclease activity. {ECO:0000269|PubMed:12628186}.
P15538	
P15559	ENZYME REGULATION: Inhibited by dicoumarol.
P15586	
P15621	
P15622	
P15692	
P15735	
P15812	
P15813	
P15814	
P15822	
P15848	ENZYME REGULATION: Inhibited by ethanol (By similarity). {ECO:0000250|UniProtKB:P50430}.
P15863	
P15880	
P15882	
P15884	
P15907	ENZYME REGULATION: Inhibited by CTP. {ECO:0000269|PubMed:23999306}.
P15918	
P15923	
P15924	
P15927	
P15941	
P15954	
P15976	
P16035	
P16050	ENZYME REGULATION: Activity is increased by binding phosphatidylinositol phosphates, especially phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 4,5-bisphosphate. {ECO:0000269|PubMed:17052953}.
P16066	
P16070	
P16083	ENZYME REGULATION: Inhibited by melatonin, resveratrol and 5-hydroxytryptamine. {ECO:0000269|PubMed:18254726}.
P16104	
P16109	
P16112	
P16118	ENZYME REGULATION: Phosphorylation at Ser-33 inhibits the kinase and activates the bisphosphatase. {ECO:0000250}.
P16144	
P16150	
P16152	ENZYME REGULATION: Inhibited by quercetin, rutenin and its derivatives. {ECO:0000269|PubMed:17344335, ECO:0000269|PubMed:18449627}.
P16157	
P16188	
P16189	
P16190	
P16219	
P16220	
P16233	
P16234	ENZYME REGULATION: Present in an inactive conformation in the absence of bound ligand. Binding of PDGFA and/or PDGFB leads to dimerization and activation by autophosphorylation on tyrosine residues. Inhibited by imatinib, nilotinib and sorafenib. {ECO:0000269|PubMed:15928335, ECO:0000269|PubMed:20972453, ECO:0000269|PubMed:21224473}.
P16260	
P16278	
P16284	
P16298	
P16333	
P16383	
P16389	ENZYME REGULATION: Inhibited by 4-aminopyridine (4-AP) and charybdotoxin (CTX), but not by tetraethylammonium (TEA) (PubMed:19912772). Inhibited by dendrotoxin (DTX) (By similarity). Inhibited by tityustoxin-K alpha (TsTX-Kalpha), a toxin that is highly specific for KCNA2 (By similarity). Inhibited by maurotoxin (By similarity). Inhibited by kappaM conotoxins kappaM-RIIIJ and kappaM-RIIIK; kappaM-RIIIJ has much higher affinity for channels containing KCNA2 than kappaM-RIIIK, with the exception of heterodimers formed by KCNA2 and KCNA7 where the opposite is true (PubMed:20220134). {ECO:0000250|UniProtKB:P63141, ECO:0000250|UniProtKB:P63142, ECO:0000269|PubMed:19912772, ECO:0000269|PubMed:20220134}.
P16401	
P16402	
P16403	
P16410	
P16415	
P16422	
P16435	
P16442	
P16444	ENZYME REGULATION: Inhibited by L-penicillamine. {ECO:0000250}.
P16452	
P16455	
P16471	
P16473	
P16499	
P16519	
P16520	
P16562	
P16581	
P16591	ENZYME REGULATION: Activated by phosphatidic acid binding. Activated by hydrogen peroxide (in vitro). Activated by reactive oxygen species (ROS). {ECO:0000269|PubMed:19738202}.
P16615	ENZYME REGULATION: Reversibly inhibited by phospholamban (PLN) at low calcium concentrations (By similarity). Inhibited by sarcolipin (SLN) and myoregulin (MRLN) (By similarity). Enhanced by DWORF; DWORF increases activity by displacing sarcolipin (SLN), phospholamban (PLN) and myoregulin (MRLN) (By similarity). {ECO:0000250|UniProtKB:O55143, ECO:0000250|UniProtKB:P04191, ECO:0000250|UniProtKB:Q8R429}.
P16619	
P16662	
P16671	
P16860	
P16870	
P16871	
P16885	
P16930	
P16949	
P16989	
P17010	
P17014	
P17017	
P17019	
P17020	
P17021	
P17022	
P17023	
P17024	
P17025	
P17026	
P17027	
P17028	
P17029	
P17030	
P17031	
P17032	
P17035	
P17036	
P17038	
P17039	
P17040	
P17041	
P17050	
P17066	
P17081	ENZYME REGULATION: Regulated by guanine nucleotide exchange factors (GEFs) which promote the exchange of bound GDP for free GTP, GTPase activating proteins (GAPs) which increase the GTP hydrolysis activity, and GDP dissociation inhibitors which inhibit the dissociation of the nucleotide from the GTPase.
P17096	
P17097	
P17098	
P17152	
P17174	
P17181	
P17213	
P17252	ENZYME REGULATION: Classical (or conventional) PKCs (PRKCA, PRKCB and PRKCG) are activated by calcium and diacylglycerol (DAG) in the presence of phosphatidylserine. Three specific sites; Thr-497 (activation loop of the kinase domain), Thr-638 (turn motif) and Ser-657 (hydrophobic region), need to be phosphorylated for its full activation.
P17275	
P17301	
P17302	
P17342	
P17405	
P17480	
P17481	
P17482	
P17483	
P17509	
P17516	
P17535	
P17538	
P17540	
P17542	
P17544	
P17568	
P17600	
P17612	ENZYME REGULATION: Allosterically activated by various compounds, including ATP. Activated by cAMP; the nucleotide acts as a dynamic and allosteric activator by coupling the two lobes of apo PKA, enhancing the enzyme dynamics synchronously and priming it for catalysis. Inhibited by H89 (N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide), spiroindoline, azole-based inhibitors, (3s)-amino-aminomethylbenzamide analogs, ARC-1032 (6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-4-carbamimidamido-1-carbamoylbutyl]hexanamide), ARC-1034 (6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]hexanamide), ARC-582, ARC-902 (Adc-6-aminohexanoic acid-(D-Arg)(6)-NH(2)), ARC-1012 ((2R)-6-amino-2-(6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}hexanamido)-N-(5-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}pentyl)hexanamide) and ARC-1039 (6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-1-[(5-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}pentyl)carbamoyl]ethyl]he xanamide). {ECO:0000269|PubMed:17909264, ECO:0000269|PubMed:18178622, ECO:0000269|PubMed:19949837, ECO:0000269|PubMed:20137943, ECO:0000269|PubMed:20481595, ECO:0000269|PubMed:20732331}.
P17643	ENZYME REGULATION: The activity depends critically on the nature of the bound metal ion. Catalyzes the oxidation of 5,6-dihydroxyindole-2-carboxylic acid (DHICA) in the presence of bound Cu(2+) ions, but lacks activity in the presence of bound Zn(2+) ions. {ECO:0000269|PubMed:28661582}.
P17655	ENZYME REGULATION: Activated by 200-1000 micromolar concentrations of calcium and inhibited by calpastatin.
P17658	
P17661	
P17676	
P17677	
P17693	
P17706	
P17707	ENZYME REGULATION: Both proenzyme processing and catalytic activity are stimulated by putrescine. Catalytic activity is inhibited by iodoacetic acid.
P17735	
P17752	
P17787	
P17812	ENZYME REGULATION: Activated by GTP and inhibited by CTP.
P17813	
P17844	
P17858	ENZYME REGULATION: Allosterically activated by ADP, AMP, or fructose 2,6-bisphosphate, and allosterically inhibited by ATP or citrate. GlcNAcylation by OGT overcomes allosteric regulation. {ECO:0000255|HAMAP-Rule:MF_03184, ECO:0000269|PubMed:22923583}.
P17861	
P17900	
P17927	
P17931	
P17936	
P17947	
P17948	ENZYME REGULATION: Present in an inactive conformation in the absence of bound ligand. Binding of VEGFA, VEGFB or PGF leads to dimerization and activation by autophosphorylation on tyrosine residues.
P17980	
P17987	
P18031	
P18054	ENZYME REGULATION: Activated by EGF. {ECO:0000269|PubMed:8912711}.
P18065	
P18074	
P18075	
P18077	
P18084	
P18085	
P18089	
P18124	
P18146	
P18206	
P18283	
P18405	
P18428	
P18433	
P18440	
P18462	
P18463	
P18464	
P18465	
P18505	
P18507	
P18509	
P18510	
P18545	
P18564	
P18577	
P18583	
P18615	
P18621	
P18627	
P18669	
P18754	
P18825	
P18827	
P18846	
P18847	
P18848	
P18850	
P18858	
P18859	
P18887	
P19012	
P19013	
P19021	ENZYME REGULATION: Inhibited by EDTA, phenylglyoxal and diethyl pyrocarbonate. {ECO:0000269|PubMed:12699694}.
P19022	
P19075	
P19086	
P19087	
P19099	
P19105	
P19113	
P19174	ENZYME REGULATION: Activated by phosphorylation on tyrosine residues.
P19224	
P19235	
P19237	
P19256	
P19320	
P19338	
P19367	ENZYME REGULATION: Hexokinase is an allosteric enzyme inhibited by its product Glc-6-P.
P19387	
P19388	
P19397	
P19404	
P19419	
P19429	
P19438	
P19440	ENZYME REGULATION: Activated by autocatalytic cleavage. {ECO:0000269|PubMed:23682772}.
P19447	
P19474	
P19484	
P19525	ENZYME REGULATION: Initially produced in an inactive form and is activated by binding to viral dsRNA, which causes dimerization and autophosphorylation in the activation loop and stimulation of function. ISGylation can activate it in the absence of viral infection. Can also be activated by heparin, proinflammatory stimuli, growth factors, cytokines, oxidative stress and the cellular protein PRKRA. Activity is markedly stimulated by manganese ions. Activation is blocked by the viral components HIV-1 Tat protein and large amounts of HIV-1 trans-activation response (TAR) RNA element as well as by the cellular proteins TARBP2, DUS2L, NPM1, NCK1 and ADAR. Down-regulated by Toscana virus (TOS) and Rift valley fever virus (RVFV) NSS which promote its proteasomal degradation. Inhibited by vaccinia virus protein E3, probably via dsRNA sequestering. {ECO:0000269|PubMed:12882984, ECO:0000269|PubMed:18096616, ECO:0000269|PubMed:18835251, ECO:0000269|PubMed:23229543, ECO:0000269|PubMed:23325696}.
P19526	
P19532	
P19544	
P19622	
P19623	ENZYME REGULATION: The activity is thought to be regulated mainly by the availability of decarboxylated S-adenosylmethionine.
P19634	
P19652	
P19784	ENZYME REGULATION: Constitutively active protein kinase whose activity is not directly affected by phosphorylation. Seems to be regulated by level of expression and localization (By similarity). {ECO:0000250}.
P19793	
P19801	ENZYME REGULATION: Inhibited by isoniazid, cimetidine, clonidine, pentamidine, berenil and pentamidine. {ECO:0000269|PubMed:19764817}.
P19823	
P19827	
P19835	ENZYME REGULATION: Activated by bile salts containing a 7-hydroxyl group.
P19838	
P19875	
P19876	
P19878	
P19883	
P19957	
P19961	
P19971	
P20020	
P20023	
P20036	
P20039	
P20042	
P20061	
P20062	
P20073	
P20132	
P20138	
P20142	
P20151	
P20155	
P20160	
P20226	
P20231	
P20248	
P20264	
P20265	
P20273	
P20290	
P20292	
P20309	
P20333	
P20336	
P20337	
P20338	
P20339	ENZYME REGULATION: Regulated by guanine nucleotide exchange factors (GEFs) which promote the exchange of bound GDP for free GTP.
P20340	
P20366	
P20382	
P20393	
P20396	
P20472	
P20585	
P20591	
P20592	
P20594	
P20618	
P20645	
P20648	
P20671	
P20674	
P20700	
P20701	
P20702	
P20711	
P20718	ENZYME REGULATION: Inhibited by SERPINB1. {ECO:0000269|PubMed:23269243}.
P20719	
P20742	
P20749	
P20774	
P20783	
P20794	
P20800	
P20807	ENZYME REGULATION: Activated by micromolar concentrations of calcium and inhibited by calpastatin.
P20809	
P20810	
P20813	
P20815	
P20823	
P20827	
P20839	ENZYME REGULATION: Mycophenolic acid (MPA) is a non-competitive inhibitor that prevents formation of the closed enzyme conformation by binding to the same site as the amobile flap. In contrast, mizoribine monophosphate (MZP) is a competitive inhibitor that induces the closed conformation. MPA is a potent inhibitor of mammalian IMPDHs but a poor inhibitor of the bacterial enzymes. MZP is a more potent inhibitor of bacterial IMPDH. Subject to product inhibition by XMP and NADH. Also inhibited by ADP. {ECO:0000255|HAMAP-Rule:MF_03156, ECO:0000269|PubMed:7903306}.
P20848	
P20849	
P20851	
P20853	
P20908	
P20916	
P20929	
P20930	
P20933	
P20936	
P20941	
P20962	
P20963	
P21108	ENZYME REGULATION: Activated by magnesium and inorganic phosphate.
P21127	ENZYME REGULATION: Phosphorylation at Thr-448 or Tyr-449 inactivates the enzyme, while phosphorylation at Thr-595 activates it. {ECO:0000250}.
P21128	
P21145	
P21217	
P21246	
P21266	
P21281	
P21283	
P21291	
P21333	
P21359	
P21397	
P21399	
P21439	ENZYME REGULATION: Translocation activity is inhibited by the ATPase inhibitor vanadate and the calcium channel blocker verapamil (PubMed:17523162, PubMed:23468132). Translocation activity is enhanced by the addition of the bile salt taurocholate (PubMed:17523162, PubMed:23468132). {ECO:0000269|PubMed:17523162, ECO:0000269|PubMed:23468132}.
P21452	
P21453	
P21462	
P21506	
P21549	
P21554	
P21579	
P21580	
P21583	
P21589	
P21673	
P21675	ENZYME REGULATION: Autophosphorylates on Ser residues. Inhibited by retinoblastoma tumor suppressor protein, RB1. Binding to TAF1 or CIITA inhibits the histone acetyltransferase activity. {ECO:0000269|PubMed:22711989}.
P21695	ENZYME REGULATION: Inhibited by zinc ions and sulfate. {ECO:0000269|PubMed:16460752}.
P21709	
P21728	
P21730	
P21731	
P21741	
P21754	
P21757	
P21781	
P21796	ENZYME REGULATION: Inhibited by nitric oxide. {ECO:0000269|PubMed:21156174}.
P21802	ENZYME REGULATION: Present in an inactive conformation in the absence of bound ligand. Ligand binding leads to dimerization and activation by autophosphorylation on tyrosine residues. Inhibited by ARQ 523 and ARQ 069; these compounds maintain the kinase in an inactive conformation and inhibit autophosphorylation. {ECO:0000269|PubMed:17803937, ECO:0000269|PubMed:21454610}.
P21810	
P21815	
P21817	ENZYME REGULATION: Channel activity is modulated by the alkaloid ryanodine that binds to the open Ca-release channel with high affinity. At low concentrations, ryanodine maintains the channel in an open conformation. High ryanodine concentrations inhibit channel activity (By similarity). Channel activity is regulated by calmodulin (CALM) (PubMed:18650434). The calcium release is activated by increased cytoplasmic calcium levels, by nitric oxyde (NO), caffeine and ATP (PubMed:18268335, PubMed:16163667). Channel activity is inhibited by magnesium ions, possibly by competition for calcium binding sites (By similarity). {ECO:0000250|UniProtKB:P11716, ECO:0000269|PubMed:16163667, ECO:0000269|PubMed:18268335, ECO:0000269|PubMed:18650434}.
P21854	
P21860	
P21912	
P21917	ENZYME REGULATION: Signaling in response to agonists such as dopamine, epinephrine and norepinephrine is modulated by Na(+); lower Na(+) levels result in higher receptor activity (in vitro). {ECO:0000269|PubMed:16423344, ECO:0000269|PubMed:29051383}.
P21918	
P21926	
P21941	
P21953	
P21964	
P21980	
P22001	
P22003	
P22004	
P22033	ENZYME REGULATION: Inhibited by itaconyl-CoA, a metabolite that inactivates the coenzyme B12 cofactor (PubMed:29056341).
P22059	
P22061	
P22079	
P22083	
P22087	
P22090	
P22102	
P22103	
P22105	
P22223	
P22234	
P22301	
P22303	
P22304	
P22307	
P22309	
P22310	
P22314	
P22352	
P22362	
P22392	
P22413	ENZYME REGULATION: At low concentrations of ATP, a phosphorylated intermediate is formed which inhibits further hydrolysis.
P22415	
P22455	ENZYME REGULATION: Present in an inactive conformation in the absence of bound ligand. Ligand binding leads to dimerization and activation by autophosphorylation on tyrosine residues. {ECO:0000269|PubMed:18480409}.
P22459	ENZYME REGULATION: Inhibited by 4-aminopyridine (4-AP), but not by tetraethylammonium (TEA) and charybdotoxin (CTX). {ECO:0000269|PubMed:19912772}.
P22460	
P22466	
P22492	
P22528	
P22531	
P22532	
P22557	
P22570	
P22607	ENZYME REGULATION: Present in an inactive conformation in the absence of bound ligand. Ligand binding leads to dimerization and activation by autophosphorylation on tyrosine residues. Inhibited by SU5402. {ECO:0000269|PubMed:14732692, ECO:0000269|PubMed:17145761, ECO:0000269|PubMed:17509076}.
P22612	ENZYME REGULATION: Activated by cAMP.
P22626	
P22670	
P22674	
P22676	
P22680	
P22681	
P22692	
P22694	ENZYME REGULATION: Activated by cAMP.
P22695	
P22732	ENZYME REGULATION: The uptake of 2-deoxyglucose is inhibited by cytochalasin B. {ECO:0000269|PubMed:1695905}.
P22735	
P22736	
P22748	ENZYME REGULATION: Activated by histamine, L-adrenaline, D-phenylalanine, L- and D-histidine. Inhibited by coumarins, saccharin, sulfonamide derivatives such as acetazolamide and Foscarnet (phosphonoformate trisodium salt). {ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16807956, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.
P22749	
P22760	
P22792	
P22794	
P22830	ENZYME REGULATION: Inhibited by nitric oxide (NO). The 2Fe-2S cluster could act as a NO sensor.
P22888	
P22891	
P22894	ENZYME REGULATION: Cannot be activated without removal of the activation peptide.
P22897	
P22914	
P23025	
P23083	
P23109	
P23141	ENZYME REGULATION: Activated by CHAPS. {ECO:0000269|PubMed:9490062}.
P23142	
P23193	
P23219	
P23229	
P23246	
P23258	
P23276	
P23280	ENZYME REGULATION: Inhibited by coumarins, sulfonamide derivatives such as acetazolamide (AZA), saccharin and Foscarnet (phosphonoformate trisodium salt). {ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.
P23284	ENZYME REGULATION: Cyclosporin A (CsA) inhibits CYPB.
P23297	
P23327	
P23352	
P23368	ENZYME REGULATION: Subject to allosteric activation by fumarate.
P23378	ENZYME REGULATION: Stimulated by lipoic acid. Inhibited in presence of methylamine (By similarity). {ECO:0000250|UniProtKB:P15505}.
P23381	
P23396	ENZYME REGULATION: Endonuclease activity is inhibited by MgCl2 on apurinic/apyrimidinic DNA but not on UV-irradiated DNA. {ECO:0000269|PubMed:15707971}.
P23409	
P23415	ENZYME REGULATION: Channel activity is potentiated by nanomolar concentrations of Zn(2+); half-maximal activation is observed with 37 nM Zn(2+) (PubMed:16144831). Inhibited by higher Zn(2+) levels; haf-maximal inhibition occurs at 20 uM Zn(2+) (PubMed:16144831). Inhibited by strychnine (PubMed:2155780, PubMed:16144831, PubMed:25445488). Inhibited by lindane (PubMed:25445488). Inhibited by picrotoxin (PubMed:22715885, PubMed:23994010, PubMed:25730860). Strychnine binding locks the channel in a closed conformation and prevents channel opening in response to extracellular glycine (By similarity). {ECO:0000250|UniProtKB:O93430, ECO:0000269|PubMed:16144831, ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:22715885, ECO:0000269|PubMed:23994010, ECO:0000269|PubMed:25445488, ECO:0000269|PubMed:25730860}.
P23416	ENZYME REGULATION: Inhibited by strychnine (PubMed:2155780, PubMed:15302677). Inhibited by picrotoxin (PubMed:15302677). Channel activity is potentiated by 10-100 uM Zn(2+) (PubMed:15302677, PubMed:16144831, PubMed:23895467). Channel activity is marginally increased by 50 mM ethanol; it is strongly increased by a combination of 0.5 uM Zn(2+) and 50 mM ethanol (PubMed:23895467). Channel activity is inhibited by 100-1000 uM Zn(2+) (PubMed:15302677). {ECO:0000269|PubMed:15302677, ECO:0000269|PubMed:16144831, ECO:0000269|PubMed:2155780, ECO:0000269|PubMed:23895467}.
P23434	
P23435	
P23443	ENZYME REGULATION: Activation requires multiple phosphorylation events on serine/threonine residues. Activation appears to be first mediated by phosphorylation of multiple sites in the autoinhibitory domain, which facilitates phosphorylation at Thr-412, disrupting the autoinhibitory mechanism and allowing phosphorylation of Thr-252 by PDPK1. The active conformation of the kinase is believed to be stabilized by a mechanism involving three conserved phosphorylation sites located in the kinase domain activation loop (Thr-252) and in the AGC-kinase C-terminal domain (Ser-394 in the middle of the tail/linker region and Thr-412 within a hydrophobic motif at its end). Activated by mTORC1; isoform Alpha I and isoform Alpha II are sensitive to rapamycin, which inhibits activating phosphorylation at Thr-412. Activated by PDPK1. {ECO:0000269|PubMed:17446865, ECO:0000269|PubMed:19570988, ECO:0000269|PubMed:9445476}.
P23458	
P23467	
P23468	
P23469	
P23470	
P23471	
P23490	
P23497	
P23508	
P23510	
P23511	
P23515	
P23526	
P23527	
P23528	
P23560	
P23582	
P23588	
P23610	
P23634	ENZYME REGULATION: Activated by calcium/calmodulin. {ECO:0000269|PubMed:8530416}.
P23677	ENZYME REGULATION: IP3K is activated by calmodulin.
P23743	ENZYME REGULATION: Stimulated by calcium and phosphatidylserine. Phosphorylated by protein kinase C.
P23759	
P23760	
P23763	
P23769	
P23771	
P23786	
P23919	
P23921	ENZYME REGULATION: Under complex allosteric control mediated by deoxynucleoside triphosphates and ATP binding to separate specificity and activation sites on the M1 subunit. The type of nucleotide bound at the specificity site determines substrate preference. It seems probable that ATP makes the enzyme reduce CDP and UDP, dGTP favors ADP reduction and dTTP favors GDP reduction. Stimulated by ATP and inhibited by dATP binding to the activity site, the dATP inhibition is mediated by AHCYL1 which stabilizes dATP in the site. {ECO:0000269|PubMed:16376858, ECO:0000269|PubMed:1867633, ECO:0000269|PubMed:25237103}.
P23942	
P23945	
P23946	
P23975	
P24001	
P24043	
P24046	
P24071	
P24158	ENZYME REGULATION: Inhibited by phenylmethanesulfonyl fluoride (PMSF) and diisopropyl fluorophosphate (DFP). {ECO:0000269|PubMed:3198760}.
P24278	
P24298	
P24310	
P24311	
P24347	
P24385	
P24386	
P24387	
P24390	
P24394	
P24462	
P24468	
P24522	
P24530	
P24534	
P24539	
P24557	
P24588	
P24592	
P24593	
P24666	ENZYME REGULATION: Inhibited by sulfhydryl reagents.
P24723	ENZYME REGULATION: Novel PKCs (PRKCD, PRKCE, PRKCH and PRKCQ) are calcium-insensitive, but activated by diacylglycerol (DAG) and phosphatidylserine. Three specific sites; Thr-513 (activation loop of the kinase domain), Thr-656 (turn motif) and Ser-675 (hydrophobic region), need to be phosphorylated for its full activation.
P24752	ENZYME REGULATION: Activated by potassium ions, but not sodium ions. {ECO:0000269|PubMed:17371050}.
P24821	
P24844	
P24855	
P24863	
P24864	
P24903	
P24928	
P24941	ENZYME REGULATION: Phosphorylation at Thr-14 or Tyr-15 inactivates the enzyme, while phosphorylation at Thr-160 activates it (PubMed:1396589). Inhibited by 1,25-dihydroxyvitamin D(3) (1,25-(OH)(2)D(3)), AG-024322, N-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), R547 (Ro-4584820), purine, pyrimidine and pyridine derivatives, 2-aminopyrimidines, paullones, thiazo derivatives, macrocyclic quinoxalin-2-one, pyrazolo[1,5-a]-1,3,5-triazine, pyrazolo[1,5-a]pyrimidine, 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine (roscovitine, seliciclib and CYC202), SNS-032 (BMS-387032), triazolo[1,5-a]pyrimidines, staurosporine and olomoucine. Stimulated by MYC. Inactivated by CDKN1A (p21). {ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:20147522, ECO:0000269|PubMed:28666995, ECO:0000269|PubMed:9030781, ECO:0000269|PubMed:9334743}.
P25021	
P25024	
P25025	
P25054	
P25063	
P25067	
P25089	
P25090	
P25092	
P25098	ENZYME REGULATION: In contrast to other AGC family kinases, the catalytic activity is solely regulated by the binding of substrates and ligands, not by phosphorylation of the kinase domain. {ECO:0000250|UniProtKB:P21146}.
P25100	
P25101	
P25103	
P25105	
P25106	
P25116	
P25189	
P25205	
P25208	
P25311	
P25325	ENZYME REGULATION: By oxidative stress, and thioredoxin. Under oxidative stress conditions, the catalytic cysteine site is converted to a sulfenate which inhibits the MPST enzyme activity. Reduced thioredoxin cleaves an intersubunit disulfide bond to turn on the redox switch and reactivate the enzyme. {ECO:0000250|UniProtKB:P97532}.
P25391	
P25398	
P25440	
P25445	
P25490	
P25685	
P25686	
P25705	
P25713	
P25774	
P25786	
P25787	
P25788	
P25789	
P25791	
P25800	
P25815	
P25874	ENZYME REGULATION: Has no constitutive proton transporter activity and has to be activated by long-chain fatty acids/LCFAs. Inhibited by purine nucleotides. Both purine nucleotides and LCFAs bind the cytosolic side of the transporter and directly compete to activate or inhibit it. Activated by noradrenaline and reactive oxygen species. {ECO:0000250|UniProtKB:P12242}.
P25929	
P25940	
P25942	
P25963	
P26006	
P26010	
P26012	
P26022	
P26038	ENZYME REGULATION: A head-to-tail association, of the N-terminal and C-terminal halves results in a closed conformation (inactive form) which is incapable of actin or membrane-binding. {ECO:0000250}.
P26045	
P26196	
P26232	
P26358	
P26367	
P26368	
P26371	
P26373	
P26374	
P26378	
P26436	
P26439	
P26440	
P26441	
P26447	
P26572	
P26583	
P26599	
P26639	ENZYME REGULATION: Inhibited by borrelidin (BN, IC 50 is 7 nM), which binds to 4 distinct subsites in the protein, preventing binding of all 3 substrates (PubMed:25824639). {ECO:0000269|PubMed:25824639}.
P26640	ENZYME REGULATION: Can be regulated by protein kinase C-dependent phosphorylation.
P26641	
P26651	
P26678	
P26715	
P26717	
P26718	
P26842	
P26885	ENZYME REGULATION: Inhibited by both FK506 and rapamycin.
P26927	
P26951	
P26992	
P26998	
P27037	
P27105	
P27144	
P27169	
P27216	
P27338	
P27348	
P27352	
P27361	ENZYME REGULATION: Phosphorylated by MAP2K1/MEK1 and MAP2K2/MEK2 on Thr-202 and Tyr-204 in response to external stimuli like insulin or NGF. Both phosphorylations are required for activity. This phosphorylation causes dramatic conformational changes, which enable full activation and interaction of MAPK1/ERK2 with its substrates. Dephosphorylated and inactivated by DUSP3, DUSP6 and DUSP9. {ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:19060905}.
P27448	ENZYME REGULATION: Activated by phosphorylation on Thr-211. Inhibited by phosphorylation on Thr-564. {ECO:0000269|PubMed:14976552}.
P27449	
P27469	
P27482	
P27487	ENZYME REGULATION: Inhibited by GPC3 and diprotin A. {ECO:0000269|PubMed:17549790, ECO:0000269|PubMed:18708048}.
P27539	
P27540	
P27544	
P27635	
P27658	
P27694	
P27695	ENZYME REGULATION: NPM1 stimulates endodeoxyribonuclease activity on double-stranded DNA with AP sites, but inhibits endoribonuclease activity on single-stranded RNA containing AP sites.
P27701	
P27707	
P27708	ENZYME REGULATION: Allosterically regulated and controlled by phosphorylation. 5-phosphoribose 1-diphosphate (PRPP) is an activator while UMP and UTP are inhibitors of the CPSase reaction. {ECO:0000269|PubMed:11872754}.
P27797	
P27815	ENZYME REGULATION: Isoform 1, isoform 2, isoform 6 and isoform 7 are inhibited by rolipram and cilomilast. Isoform 1, isoform 2 and isoform 6 are inhibited by 4-[(3-butoxy-4-methoxyphenyl)-methyl]-2-imidazolidinone (Ro 20-1724), roflumilast and denbufylline. {ECO:0000269|PubMed:11306681, ECO:0000269|PubMed:15738310, ECO:0000269|PubMed:18095939}.
P27816	
P27824	
P27918	
P27930	
P27986	
P27987	ENZYME REGULATION: IP3K is activated by calmodulin. Form B is much more sensitive to calcium/calmodulin than form A.
P28039	
P28062	
P28065	
P28066	
P28067	
P28068	
P28069	
P28070	
P28072	
P28074	
P28161	
P28221	
P28222	
P28223	
P28288	
P28289	
P28290	
P28300	
P28324	
P28325	
P28328	
P28329	
P28330	
P28331	
P28332	
P28335	
P28336	
P28340	ENZYME REGULATION: Regulated by alteration of quaternary structure. Exhibits burst rates of DNA synthesis are about 5 times faster in the presence of POLD4 (Pol-delta4 complex) than in its absence (Pol-delta3 complex), while the affinity of the enzyme for its DNA and dNTP substrates appears unchanged. The Pol-delta3 complex is more likely to proofread DNA synthesis because it cleaves single-stranded DNA twice as fast and transfers mismatched DNA from the polymerase to the exonuclease sites 9 times faster compared to the Pol-delta3 complex. Pol-delta3 also extends mismatched primers 3 times more slowly in the absence of POLD4. The conversion of Pol-delta4 into Pol-delta3 is induced by genotoxic stress or by replication stress leading POLD4 degradation (PubMed:19074196, PubMed:20334433). Stimulated in the presence of PCNA (PubMed:11328591, PubMed:12403614, PubMed:12522211, PubMed:16510448, PubMed:24022480, PubMed:24939902). This stimulation is further increased in the presence of KCTD13/PDIP1, most probably via direct interaction between KCTD13 and POLD2 (By similarity). {ECO:0000250|UniProtKB:P28339, ECO:0000269|PubMed:11328591, ECO:0000269|PubMed:12403614, ECO:0000269|PubMed:12522211, ECO:0000269|PubMed:16510448, ECO:0000269|PubMed:19074196, ECO:0000269|PubMed:20334433, ECO:0000269|PubMed:24022480, ECO:0000269|PubMed:24939902}.
P28347	
P28356	
P28358	
P28360	
P28370	
P28472	
P28476	
P28482	ENZYME REGULATION: Phosphorylated by MAP2K1/MEK1 and MAP2K2/MEK2 on Thr-185 and Tyr-187 in response to external stimuli like insulin or NGF. Both phosphorylations are required for activity. This phosphorylation causes dramatic conformational changes, which enable full activation and interaction of MAPK1/ERK2 with its substrates. Phosphorylation on Ser-29 by SGK1 results in its activation by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Dephosphorylated and inactivated by DUSP3, DUSP6 and DUSP9. Inactivated by pyrimidylpyrrole inhibitors. {ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:19060905}.
P28562	
P28566	
P28676	
P28698	
P28702	
P28715	
P28749	
P28799	
P28827	
P28838	
P28845	
P28906	
P28907	ENZYME REGULATION: ATP inhibits the hydrolyzing activity.
P28908	
P29016	
P29017	
P29033	
P29034	
P29074	
P29083	
P29084	
P29120	
P29122	
P29144	
P29218	ENZYME REGULATION: Activity with myo-inositol monophosphate and D-galactose 1-phosphate is inhibited by Li(+), Ca(2+) and Mn(2+), but also by Mg(2+) at concentrations above 3 mM. {ECO:0000269|PubMed:17068342, ECO:0000269|PubMed:8718889, ECO:0000269|PubMed:9462881}.
P29274	
P29275	
P29279	
P29317	
P29320	
P29322	
P29323	
P29350	
P29353	
P29371	
P29372	ENZYME REGULATION: Binding to SSBP1 in mitochondria inhibits glycosylase activity in the context of a single-stranded DNA (ssDNA), but not a double-stranded DNA (dsDNA) substrates. {ECO:0000269|PubMed:23290262}.
P29373	
P29374	
P29375	ENZYME REGULATION: The inhibitors KDOAM-25, CPI-455 and others inhibits its demethylase activity, resulting to cell growth arrest in cancer cells. {ECO:0000269|PubMed:27214401, ECO:0000269|PubMed:27427228}.
P29376	
P29377	
P29400	
P29401	
P29459	
P29460	
P29466	ENZYME REGULATION: Specifically inhibited by the cowpox virus Crma protein.
P29474	ENZYME REGULATION: Stimulated by calcium/calmodulin. Inhibited by NOSIP and NOSTRIN. {ECO:0000269|PubMed:11149895, ECO:0000269|PubMed:12446846}.
P29475	ENZYME REGULATION: Stimulated by calcium/calmodulin. Inhibited by n-Nos-inhibiting protein (PIN) which may prevent the dimerization of the protein. Inhibited by NOSIP.
P29508	
P29536	
P29558	
P29590	
P29597	
P29622	
P29692	
P29728	ENZYME REGULATION: Produced as a latent enzyme which is activated by double stranded RNA (dsRNA) generated during the course of viral infection(PubMed:9880569). The dsRNA activator must be at least 15 nucleotides long, and no modification of the 2'-hydroxyl group is tolerated (PubMed:9880569). ssRNA or dsDNA do not act as activators (PubMed:9880569). Strongly inhibited by copper, iron and zinc ions (PubMed:11682059). Partially inhibited by cobalt and nickel ions (PubMed:11682059). {ECO:0000269|PubMed:11682059, ECO:0000269|PubMed:9880569}.
P29762	
P29803	ENZYME REGULATION: Pyruvate dehydrogenase activity is inhibited by phosphorylation of PDHA2; it is reactivated by dephosphorylation.
P29965	
P29966	
P29972	
P29973	
P29992	
P30038	
P30039	
P30040	
P30041	
P30042	
P30043	ENZYME REGULATION: Mesobiliverdin acts as competitve inhibitor for flavin reduction, indicating that flavin and tetrapyrrole substrates compete for the same site. {ECO:0000269|PubMed:10620517}.
P30044	
P30046	
P30047	
P30048	
P30049	
P30050	
P30084	
P30085	
P30086	
P30101	
P30153	
P30154	
P30203	
P30260	
P30273	
P30279	
P30281	
P30291	ENZYME REGULATION: Synthesis is increased during S and G2 phases, presumably by an increase in transcription; activity is decreased by phosphorylation during m phase. Protein levels fall in M phase as a result of decreased synthesis combined with degradation. Activity seems to be negatively regulated by phosphorylation upon entry into mitosis, although N-terminal phosphorylation might also regulate the protein stability via protection from proteolysis or might regulate the subcellular location.
P30301	
P30304	ENZYME REGULATION: Stimulated by B-type cyclins. Stimulated by PIM1-mediated phosphorylation.
P30305	ENZYME REGULATION: Stimulated by B-type cyclins.
P30307	
P30405	ENZYME REGULATION: Binds cyclosporin A (CsA). Is displaced by CsA from the mPTP leading to a lower open probability of the mPTP.
P30408	
P30411	
P30414	
P30419	
P30443	
P30447	
P30450	
P30453	
P30455	
P30456	
P30457	
P30459	
P30460	
P30461	
P30462	
P30464	
P30466	
P30475	
P30479	
P30480	
P30481	
P30483	
P30484	
P30485	
P30486	
P30487	
P30488	
P30490	
P30491	
P30492	
P30493	
P30495	
P30498	
P30499	
P30501	
P30504	
P30505	
P30508	
P30510	
P30511	
P30512	
P30518	
P30519	
P30520	
P30530	ENZYME REGULATION: Activated by GAS6-binding and subsequent autophosphorylation. {ECO:0000269|PubMed:15507525, ECO:0000269|PubMed:8621659}.
P30531	
P30532	
P30533	
P30536	
P30542	
P30550	
P30556	
P30559	
P30566	ENZYME REGULATION: The enzyme reaction kinetics indicate cooperativity between subunits. {ECO:0000269|PubMed:19405474, ECO:0000269|PubMed:22812634}.
P30613	ENZYME REGULATION: Allosterically activated by fructose 1,6-bisphosphate. {ECO:0000269|PubMed:11960989}.
P30622	
P30626	
P30679	
P30685	
P30711	
P30740	
P30793	ENZYME REGULATION: GTP shows a positive allosteric effect, and tetrahydrobiopterin inhibits the enzyme activity. Zinc is required for catalytic activity. Inhibited by Mg(2+). {ECO:0000269|PubMed:14717702, ECO:0000269|PubMed:16778797, ECO:0000269|PubMed:3753653}.
P30825	
P30837	
P30838	
P30872	
P30874	
P30876	
P30926	
P30939	
P30953	
P30954	
P30968	
P30988	
P30989	
P30990	
P31025	
P31040	
P31146	
P31150	
P31151	
P31152	ENZYME REGULATION: Activated by phosphorylation at Ser-186.
P31153	
P31213	
P31249	
P31260	
P31267	
P31268	
P31269	
P31270	
P31271	
P31273	
P31274	
P31275	
P31276	
P31277	
P31314	
P31321	
P31323	
P31327	ENZYME REGULATION: Requires N-acetyl-L-glutamate (NAG) as an allosteric activator. Activated by glycerol in the absence of NAG, whereas in the presence of NAG it is inhibited by increasing concentrations of glycerol. {ECO:0000269|PubMed:19754428, ECO:0000269|PubMed:23649895}.
P31350	
P31358	
P31371	
P31391	
P31415	
P31431	
P31483	
P31512	
P31513	
P31629	
P31639	
P31641	
P31644	
P31645	
P31689	
P31749	ENZYME REGULATION: Three specific sites, one in the kinase domain (Thr-308) and the two other ones in the C-terminal regulatory region (Ser-473 and Tyr-474), need to be phosphorylated for its full activation. Inhibited by pyrrolopyrimidine inhibitors like aniline triazole and spiroindoline. {ECO:0000269|PubMed:18456494, ECO:0000269|PubMed:20481595, ECO:0000269|PubMed:20810279, ECO:0000269|PubMed:21392984, ECO:0000269|PubMed:9512493, ECO:0000269|PubMed:9736715}.
P31751	ENZYME REGULATION: Two specific sites, one in the kinase domain (Thr-309) and the other in the C-terminal regulatory region (Ser-474), need to be phosphorylated for its full activation. Aminofurazans are potent AKT2 inhibitors. {ECO:0000269|PubMed:18800763, ECO:0000269|PubMed:19179070}.
P31785	
P31930	
P31937	
P31939	
P31941	
P31942	
P31943	
P31944	ENZYME REGULATION: Inhibited by caspase-1 inhibitor YVAD-FMK and the pan-caspase inhibitor VAD-FMK. {ECO:0000269|PubMed:19960512}.
P31946	
P31947	
P31948	
P31949	
P31994	
P31995	
P31997	
P32004	
P32019	
P32119	
P32121	
P32189	
P32238	
P32239	
P32241	
P32242	
P32243	
P32245	
P32246	
P32247	
P32248	
P32249	
P32297	
P32298	ENZYME REGULATION: Inhibited by heparin. {ECO:0000269|PubMed:19520868}.
P32302	
P32314	
P32320	
P32321	ENZYME REGULATION: Allosteric enzyme whose activity is greatly influenced by the end products of its metabolic pathway, dCTP and dTTP.
P32322	ENZYME REGULATION: Subject to competitive inhibition by the reaction product proline. Subject to competitive inhibition by stearoyl coenzyme A. {ECO:0000269|PubMed:16730026}.
P32418	ENZYME REGULATION: Activated by micromolar levels of Ca(2+). {ECO:0000305}.
P32455	
P32456	
P32519	
P32745	
P32754	
P32780	
P32856	
P32881	
P32926	
P32927	
P32929	ENZYME REGULATION: Inhibited by propargylglycine, trifluoroalanine and aminoethoxyvinylglycine. {ECO:0000269|PubMed:10212249, ECO:0000269|PubMed:19019829}.
P32942	
P32969	
P32970	
P32971	
P33032	
P33076	
P33121	
P33151	
P33176	
P33240	
P33241	
P33260	
P33261	
P33316	ENZYME REGULATION: Phosphorylation is necessary for activity.
P33402	ENZYME REGULATION: Activated by nitric oxide in the presence of magnesium or manganese ions.
P33527	
P33552	
P33681	
P33763	
P33764	
P33778	
P33897	
P33908	ENZYME REGULATION: Inhibited by both 1-deoxymannojirimycin and kifunensine.
P33947	
P33981	ENZYME REGULATION: Inhibited by the ATP-competitive kinase inhibitor, SP600125.
P33991	
P33992	
P33993	
P34059	
P34096	
P34130	
P34741	
P34810	
P34820	
P34896	ENZYME REGULATION: Inhibited by tetrahydrofolate concentrations above 40 uM. {ECO:0000269|PubMed:24698160}.
P34897	ENZYME REGULATION: Hydroxymethyltransferase is inhibited by succinylation at Lys-280. {ECO:0000269|PubMed:29180469}.
P34903	
P34910	
P34913	ENZYME REGULATION: Inhibited by 1-(1-acetylpiperidin-4-yl)-3-(4-(trifl uoromethoxy)phenyl)urea (TPAU), 1-cyclohexyl-3-dodecylurea (CDU), 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA), 1-((3S, 5S, 7S)-adamantan-1-yl)-3-(5-(2-(2-ethoxyethoxy) ethoxy)pentyl)urea (AEPU), N-adamantyl-N[']-cyclohexyl urea (ACU), 4-(((1S, 4S)-4-(3-((3S, 5S, 7S)-adamantan-1-yl) ureido)cyclohexyl)oxy)benzoic acid (c-AUCB), 4-(((1R, 4R)-4-(3-((3S, 5S, 7S)-adamantan-1-yl)ureido)cyclohexyl)oxy)benzoic acid (t-AUCB), 4-(((1R, 4R)-4-(3-(4(trifluoromethoxy)phenyl)ureido)cyclohexyl)oxy)benzoic acid (t-TAUCB) and to a lesser extent by 8-(3-((3S, 5S, 7S)-adamantan-1-yl)ureido) octanoic acid (AUOA). {ECO:0000269|PubMed:22798687}.
P34925	
P34931	
P34932	
P34947	ENZYME REGULATION: Inhibited by calmodulin with an IC(50) of 50 nM. Calmodulin inhibits GRK5 association with receptor and phospholipid. {ECO:0000269|PubMed:9218466}.
P34949	
P34969	
P34972	
P34981	
P34982	
P34995	
P34998	
P35030	
P35052	
P35070	
P35080	
P35125	
P35212	
P35218	ENZYME REGULATION: Activated by histamine, L-adrenaline, L- and D-histidine, and L- and D-phenylalanine. Inhibited by coumarins, sulfonamide derivatives such as acetazolamide and Foscarnet (phosphonoformate trisodium salt). {ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16807956, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.
P35219	
P35221	
P35222	
P35225	
P35226	
P35227	
P35228	ENZYME REGULATION: Regulated by calcium/calmodulin. Aspirin inhibits expression and function of this enzyme and effects may be exerted at the level of translational/post-translational modification and directly on the catalytic activity (By similarity). {ECO:0000250}.
P35232	
P35236	ENZYME REGULATION: Inhibited in cells after FCER1A triggering. {ECO:0000250}.
P35237	
P35240	
P35241	ENZYME REGULATION: A head-to-tail association, of the N-terminal and C-terminal halves results in a closed conformation (inactive form) which is incapable of actin or membrane-binding. {ECO:0000250}.
P35243	
P35244	
P35247	
P35249	
P35250	
P35251	
P35268	
P35269	
P35270	
P35318	
P35321	
P35325	
P35326	
P35346	
P35348	
P35354	
P35367	
P35368	
P35372	
P35398	
P35408	
P35410	
P35414	
P35442	
P35443	
P35452	
P35453	
P35462	
P35475	
P35498	ENZYME REGULATION: Inactivation of this channel is specifically inhibited by the spider toxins Hm1a and Hm1b (H.maculata, AC P60992 and AC P0DOC5) in somatosensory neurons to elicit acute pain and mechanical allodynia. {ECO:0000250|UniProtKB:A2APX8}.
P35499	
P35503	
P35504	
P35520	ENZYME REGULATION: Allosterically activated by S-adenosyl-methionine/AdoMet. Activated by S-adenosylhomocysteine/AdoHcy (PubMed:20506325). Binds non-covalently to a heme group that may control the redox sensitivity of the enzyme (PubMed:11483494, PubMed:12173932, PubMed:22738154). {ECO:0000269|PubMed:11483494, ECO:0000269|PubMed:12173932, ECO:0000269|PubMed:20506325, ECO:0000269|PubMed:22738154, ECO:0000269|PubMed:23974653}.
P35523	
P35527	
P35542	
P35544	
P35548	
P35555	
P35556	
P35557	ENZYME REGULATION: The use of alternative promoters apparently enables the type IV hexokinase gene to be regulated by insulin in the liver and glucose in the beta cell. This may constitute an important feedback loop for maintaining glucose homeostasis. Subject to allosteric regulation. Low glucose and high fructose-6-phosphate triggers association with the inhibitor GKRP followed by sequestration in the nucleus. {ECO:0000269|PubMed:10456334, ECO:0000269|PubMed:15016359}.
P35558	ENZYME REGULATION: Enzyme activity is enhanced by acetylation. {ECO:0000269|PubMed:20167786}.
P35568	
P35573	
P35575	
P35579	
P35580	
P35590	
P35606	
P35609	
P35610	
P35611	
P35612	
P35613	
P35625	
P35626	
P35637	
P35638	
P35658	
P35659	
P35663	
P35670	
P35680	
P35711	
P35712	
P35713	
P35716	
P35749	
P35754	
P35789	
P35790	
P35813	
P35858	
P35869	
P35900	
P35908	
P35913	
P35914	ENZYME REGULATION: Stimulated by reducing agents such as dithiothreitol (DTT). {ECO:0000269|PubMed:12874287}.
P35916	ENZYME REGULATION: Present in an inactive conformation in the absence of bound ligand. Binding of VEGFC or VEGFD leads to dimerization and activation by autophosphorylation on tyrosine residues. Inhibited by MAZ51. {ECO:0000269|PubMed:15102829, ECO:0000269|PubMed:19779139, ECO:0000269|PubMed:20431062}.
P35968	ENZYME REGULATION: Present in an inactive conformation in the absence of bound ligand. Binding of VEGFA, VEGFC or VEGFD leads to dimerization and activation by autophosphorylation on tyrosine residues. Inhibited by the small molecule PTK inhibitor SU5614 ((3Z)-5-Chloro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-2H-indol-2-one). May be regulated by hydrogen sulfide (H(2)S) levels via a H(2)S-sensitive intracellular disulfide bond. {ECO:0000269|PubMed:10037737, ECO:0000269|PubMed:10102632, ECO:0000269|PubMed:15215251, ECO:0000269|PubMed:23199280}.
P35998	
P36021	
P36222	
P36268	
P36269	
P36382	
P36383	
P36402	
P36404	
P36405	
P36406	
P36507	
P36508	
P36537	
P36542	
P36543	
P36544	
P36551	
P36575	
P36578	
P36639	ENZYME REGULATION: 2-hydroxy-dATPase activity is inhibited by 2-OH-dADP, 8-OH-dGDP and 8-OH-dGTP. 8-OH-dGTPase activity is inhibited by 8-OH-dGDP, 2-OH-dADP and 2-OH-dATP. {ECO:0000269|PubMed:10373420}.
P36776	ENZYME REGULATION: Peptidase activity is subject to substrate inhibition by ATP. {ECO:0000269|PubMed:24520911}.
P36871	ENZYME REGULATION: Glucose-1,6-bisphosphate enhances phosphorylation of the active site Ser-117, and thereby increases enzyme activity. {ECO:0000269|PubMed:25288802}.
P36873	ENZYME REGULATION: Inactivated by binding to URI1. The phosphatase activity of the PPP1R15A-PP1 complex toward EIF2S1 is specifically inhibited by Salubrinal, a drug that protects cells from endoplasmic reticulum stress. {ECO:0000269|PubMed:15705855, ECO:0000269|PubMed:17936702}.
P36888	ENZYME REGULATION: Present in an inactive conformation in the absence of bound ligand. FLT3LG binding leads to dimerization and activation by autophosphorylation. {ECO:0000269|PubMed:14759363, ECO:0000269|PubMed:21516120}.
P36894	
P36896	ENZYME REGULATION: Activin receptor type-2 (ACVR2A or ACVR2B) activates the type-1 receptor through phosphorylation of its regulatory GS domain. {ECO:0000269|PubMed:11266516, ECO:0000269|PubMed:11909953}.
P36897	ENZYME REGULATION: Kept in an inactive conformation by FKBP1A preventing receptor activation in absence of ligand. CD109 is another inhibitor of the receptor. {ECO:0000269|PubMed:9233797}.
P36915	
P36941	
P36952	
P36954	
P36955	
P36956	
P36957	
P36959	
P36969	
P36980	
P37023	
P37058	
P37059	
P37088	ENZYME REGULATION: Activated by WNK1, WNK2, WNK3 and WNK4. {ECO:0000250|UniProtKB:Q61180}.
P37108	
P37173	
P37198	
P37231	ENZYME REGULATION: PDPK1 activates its transcriptional activity independently of its kinase activity. {ECO:0000269|PubMed:16150867}.
P37235	
P37268	
P37275	
P37287	
P37288	
P37802	
P37837	
P37840	
P38117	
P38159	
P38398	ENZYME REGULATION: The E3 ubiquitin-protein ligase activity is inhibited by phosphorylation by AURKA. Activity is increased by phosphatase treatment. {ECO:0000269|PubMed:18056443}.
P38405	
P38432	
P38435	
P38484	
P38567	
P38570	
P38571	
P38606	
P38646	
P38919	ENZYME REGULATION: The ATPase activity is increased some 4-fold in the presence of RNA. {ECO:0000269|PubMed:22961380}.
P38935	
P38936	
P39019	
P39023	
P39059	
P39060	
P39086	
P39210	
P39656	
P39687	
P39748	
P39877	
P39880	
P39900	
P39905	
P40121	
P40123	
P40126	
P40145	ENZYME REGULATION: Activated by calcium/calmodulin.
P40189	
P40197	
P40198	
P40199	
P40200	
P40205	
P40222	
P40225	
P40227	
P40238	
P40259	
P40261	
P40305	
P40306	
P40313	
P40337	
P40394	
P40424	
P40425	
P40426	
P40429	
P40616	
P40617	
P40692	
P40763	
P40818	
P40855	
P40879	
P40925	
P40926	ENZYME REGULATION: Enzyme activity is enhanced by acetylation. {ECO:0000269|PubMed:20167786}.
P40933	
P40937	
P40938	
P40939	
P40967	
P41002	
P41091	
P41134	
P41143	
P41145	
P41146	
P41159	
P41161	
P41162	
P41180	ENZYME REGULATION: In resting state, adopts an open conformation, anion-binding promoting the inactive configuration (PubMed:27434672). Upon aromatic amino acid-binding, the groove in the extracellular venus flytrap module is closed, thereby inducing the formation of a novel homodimer interface between subunits (PubMed:27434672, PubMed:27386547). Calcium ions stabilize the active state by enhancing homodimer interactions between membrane-proximal domains to fully activate the receptor (PubMed:27434672, PubMed:27386547). Activated by AMG 416, a D-amino acid-containing peptide agonist that is being evaluated for the treatment of secondary hyperparathyroidism in chronic kidney disease patients receiving hemodialysis (PubMed:26290606). AMG 416 agonist acts by forming a disulfide bond with Cys-482 (PubMed:26290606). {ECO:0000269|PubMed:26290606, ECO:0000269|PubMed:27386547, ECO:0000269|PubMed:27434672}.
P41181	
P41182	
P41208	
P41212	
P41214	
P41217	
P41218	
P41219	
P41220	
P41221	
P41222	
P41223	
P41225	
P41226	
P41227	
P41229	ENZYME REGULATION: The inhibitor KDOAM-25 and others inhibit its demethylase activity, resulting to cell cycle arrest in myeloma cells. {ECO:0000269|PubMed:28262558}.
P41231	
P41235	
P41236	
P41238	
P41240	
P41247	
P41250	
P41252	
P41271	
P41273	
P41279	
P41439	
P41440	
P41567	
P41586	
P41587	
P41594	
P41595	
P41597	
P41732	
P41743	ENZYME REGULATION: Atypical PKCs (PRKCI and PRKCZ) exhibit an elevated basal enzymatic activity (that may be due to the interaction with SMG1 or SQSTM1) and are not regulated by diacylglycerol, phosphatidylserine, phorbol esters or calcium ions. Two specific sites, Thr-412 (activation loop of the kinase domain) and Thr-564 (turn motif), need to be phosphorylated for its full activation (By similarity). Might also be a target for novel lipid activators that are elevated during nutrient-stimulated insulin secretion. {ECO:0000250, ECO:0000269|PubMed:8524286}.
P41968	
P41970	
P42025	
P42081	
P42126	
P42127	
P42166	
P42167	
P42224	
P42226	
P42229	
P42261	
P42262	
P42263	
P42285	
P42330	ENZYME REGULATION: Strongly inhibited by nonsteroidal anti-inflammatory drugs (NSAID) including flufenamic acid and indomethacin. Also inhibited by the flavinoid, rutin, and by selective serotonin inhibitors (SSRIs).
P42331	
P42336	
P42338	
P42345	ENZYME REGULATION: Activation of mTORC1 by growth factors such as insulin involves AKT1-mediated phosphorylation of TSC1-TSC2, which leads to the activation of the RHEB GTPase a potent activator of the protein kinase activity of mTORC1. Insulin-stimulated and amino acid-dependent phosphorylation at Ser-1261 promotes autophosphorylation and the activation of mTORC1. Activation by amino acids requires relocalization of the mTORC1 complex to lysosomes that is mediated by the Ragulator complex, SLC38A9, and the Rag GTPases RRAGA, RRAGB, RRAGC and RRAGD (PubMed:18497260, PubMed:20381137, PubMed:25561175, PubMed:25567906). On the other hand, low cellular energy levels can inhibit mTORC1 through activation of PRKAA1 while hypoxia inhibits mTORC1 through a REDD1-dependent mechanism which may also require PRKAA1. The kinase activity of MTOR within the mTORC1 complex is positively regulated by MLST8 and negatively regulated by DEPTOR and AKT1S1. MTOR phosphorylates RPTOR which in turn inhibits mTORC1. MTOR is the target of the immunosuppressive and anti-cancer drug rapamycin which acts in complex with FKBP1A/FKBP12, and specifically inhibits its kinase activity. mTORC2 is also activated by growth factors, but seems to be nutrient-insensitive. It may be regulated by RHEB but in an indirect manner through the PI3K signaling pathway. {ECO:0000269|PubMed:14651849, ECO:0000269|PubMed:15545625, ECO:0000269|PubMed:17386266, ECO:0000269|PubMed:18497260, ECO:0000269|PubMed:19446321, ECO:0000269|PubMed:20381137, ECO:0000269|PubMed:25561175, ECO:0000269|PubMed:25567906}.
P42356	ENZYME REGULATION: Activated by Triton X-100, insensitive to inhibition by adenosine and inhibited by wortmannin (By similarity). Isoform 2 is activated by detergents such as Triton X-100 and inhibited by adenosine (PubMed:7961848). The PI4K complex acts as a regulator of phosphatidylinositol 4-phosphate (PtdIns(4)P) synthesis (PubMed:23229899, PubMed:26571211). Interaction with TMEM150A regulates PtdIns(4)P synthesis (PubMed:25608530). {ECO:0000250|UniProtKB:O08662, ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:25608530, ECO:0000269|PubMed:26571211, ECO:0000269|PubMed:7961848}.
P42357	
P42566	
P42568	
P42574	ENZYME REGULATION: Inhibited by isatin sulfonamides.
P42575	
P42658	
P42677	
P42679	
P42680	ENZYME REGULATION: Activated by tyrosine phosphorylation by a wide range of cytokine stimulations. When T-cells or B-cells receptors are activated, a series of phosphorylation leads to the recruitment of TEC to the cell membrane, where it is phosphorylated at Tyr-519. Also activated in response to SCF. Integrin engagement induces tyrosine phosphorylation of TEC in platelets. STAP1 participates in a positive feedback loop by increasing the activity of TEC. SOCS1 is an inhibitor of TEC kinase activity. {ECO:0000269|PubMed:10518561, ECO:0000269|PubMed:7526158, ECO:0000269|PubMed:9341160, ECO:0000269|PubMed:9652744}.
P42681	ENZYME REGULATION: Activated by phosphorylation by FYN. {ECO:0000269|PubMed:12081135}.
P42684	ENZYME REGULATION: Stabilized in the inactive form by an association between the SH3 domain and the SH2-TK linker region, interactions of the N-terminal cap, and contributions from an N-terminal myristoyl group and phospholipids. Activated by autophosphorylation as well as by SRC-family kinase-mediated phosphorylation. Activated by RIN1 binding to the SH2 and SH3 domains. Inhibited by imatinib mesylate (Gleevec) which is used for the treatment of chronic myeloid leukemia (CML). Phosphatidylinositol 4,5-bisphosphate (PIP2), a highly abundant phosphoinositide known to regulate cytoskeletal and membrane proteins, inhibits the tyrosine kinase activity (By similarity). {ECO:0000250}.
P42685	
P42694	
P42695	
P42696	
P42701	
P42702	
P42704	
P42765	
P42766	
P42768	
P42771	
P42772	
P42773	
P42785	
P42830	
P42857	
P42858	
P42892	ENZYME REGULATION: Inhibited by phosphoramidon.
P42898	ENZYME REGULATION: Allosterically regulated by S-adenosylmethionine.
P43003	
P43004	
P43005	
P43007	
P43026	
P43034	
P43080	
P43088	
P43115	
P43116	
P43119	
P43121	
P43146	
P43155	
P43166	ENZYME REGULATION: Activated by histamine, L-adrenaline, L- and D-histidine, and L- and D-phenylalanine. Inhibited by coumarins, sulfonamide derivatives such as acetazolamide (AZA), by saccharin and Foscarnet (phosphonoformate trisodium salt). {ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16807956, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.
P43220	ENZYME REGULATION: The allosteric modulators NNC0640, PF-06372222 and MK-0893 inhibit the increase of intracellular cAMP levels in response to GLP-1. {ECO:0000269|PubMed:28514449}.
P43234	
P43235	
P43243	
P43246	
P43250	
P43251	
P43268	
P43304	ENZYME REGULATION: Calcium-binding enhance the activity of the enzyme.
P43307	
P43308	
P43320	
P43351	
P43353	
P43354	
P43355	
P43356	
P43357	
P43358	
P43359	
P43360	
P43361	
P43362	
P43363	
P43364	
P43365	
P43366	
P43378	
P43403	ENZYME REGULATION: Activated by phosphorylation at Tyr-493 in the activation loop. Inhibited by staurosporine. {ECO:0000269|PubMed:15292186}.
P43405	ENZYME REGULATION: Autoinhibited. Intramolecular binding of the interdomains A and B (also called linker region) to parts of the catalytic domain keep the catalytic center in an inactive conformation. The phosphorylation of the interdomains or the binding of the SH2 domains with dually phosphorylated ITAM domains on transmembrane proteins disrupt those intramolecular interactions allowing the kinase domain to adopt an active conformation. The phosphorylation of SYK and of the ITAM domains which is responsible for SYK activation is essentially mediated by SRC subfamily kinases, like LYN, upon transmembrane receptors engagement. May also be negatively regulated by PTPN6 through dephosphorylation. Downstream signaling adapters and intermediates like BLNK or RHOH may mediate positive and/or negative feedback regulation. Negatively regulated by CBL and CBLB through ubiquitination and probable degradation. Phosphorylates SH3BP2 which in turn may regulate SYK through LYN (By similarity). {ECO:0000250}.
P43487	
P43489	
P43490	ENZYME REGULATION: Inhibited by FK866. FK866 competes for the same binding site as nicotinamide, but due to its very low dissociation rate, it is essentially an irreversible inhibitor. {ECO:0000269|PubMed:16783377}.
P43626	
P43627	
P43628	
P43629	
P43630	
P43631	
P43632	
P43652	
P43657	
P43681	
P43686	
P43694	
P43699	
P43897	
P45378	
P45379	
P45381	
P45452	ENZYME REGULATION: Inhibited by TIMP1, TIMP2 and TIMP3. Inhibited by acetohydroxamic acid and other zinc chelators. {ECO:0000269|PubMed:22689580, ECO:0000269|PubMed:8576151, ECO:0000269|PubMed:9065415}.
P45844	
P45877	ENZYME REGULATION: Cyclosporin A (CsA) inhibits CYPC.
P45880	
P45954	
P45973	
P45974	
P45983	ENZYME REGULATION: Activated by threonine and tyrosine phosphorylation by either of two dual specificity kinases, MAP2K4 and MAP2K7. MAP2K4 shows a strong preference for Tyr-185 while MAP2K7 phosphorylates Tyr-183 preferentially. Inhibited by dual specificity phosphatases, such as DUSP1. Inhibited by SERPINB3. {ECO:0000269|PubMed:19166818}.
P45984	ENZYME REGULATION: Activated by threonine and tyrosine phosphorylation by either of two dual specificity kinases, MAP2K4 and MAP2K7. MAP2K4 shows a strong preference for Tyr-185 while MAP2K7 phosphorylates Tyr-183 preferentially. Inhibited by dual specificity phosphatases, such as DUSP1.
P45985	ENZYME REGULATION: Activated in response to a variety of cellular stresses, including UV and gamma-irradiation, heat shock, hyperosmolarity, T-cell receptor stimulation, peroxide and inflammatory cytokines. Also activated by developmental cues. MAP2K4/MKK4 is activated by the majority of MKKKs, such as MAP3K5/ASK1, MAP3K1/MEKK1, MAP3K7/TAK1, MAP3K10/MLK2, MAP3K11/MLK3, MAP3K12/DLK and MAP3K13/LZK. {ECO:0000269|PubMed:9003778}.
P46013	
P46019	ENZYME REGULATION: By phosphorylation of various serine residues and by calcium.
P46020	ENZYME REGULATION: By phosphorylation of various serine residues. Allosteric regulation by calcium.
P46059	
P46060	
P46063	
P46087	
P46089	
P46091	
P46092	
P46093	
P46094	
P46095	
P46098	
P46100	
P46108	
P46109	
P46199	
P46379	
P46439	
P46459	
P46527	
P46531	
P46597	
P46663	
P46695	
P46721	
P46734	ENZYME REGULATION: Activated by dual phosphorylation on Ser-218 and Thr-222. {ECO:0000269|PubMed:8622669}.
P46736	
P46776	
P46777	
P46778	
P46779	
P46781	
P46782	
P46783	
P46821	
P46926	
P46934	ENZYME REGULATION: Activated by NDFIP1- and NDFIP2-binding. {ECO:0000250}.
P46937	
P46939	
P46940	
P46952	
P46976	
P46977	
P47211	
P47224	
P47710	
P47712	ENZYME REGULATION: Stimulated by agonists such as ATP, EGF, thrombin and bradykinin as well as by cytosolic Ca(2+).
P47736	
P47755	
P47756	
P47775	
P47804	
P47813	
P47869	
P47870	
P47871	
P47872	
P47874	
P47881	
P47883	
P47884	
P47887	
P47888	
P47890	
P47893	
P47895	
P47897	
P47898	
P47900	
P47901	
P47902	
P47914	
P47928	
P47929	
P47944	
P47972	
P47974	
P47985	
P47989	ENZYME REGULATION: Can be converted from the dehydrogenase form (D) to the oxidase form (O) irreversibly by proteolysis or reversibly through the oxidation of sulfhydryl groups. {ECO:0000250}.
P47992	
P48023	
P48029	
P48039	
P48047	
P48048	ENZYME REGULATION: Inhibited by WNK3. {ECO:0000269|PubMed:16357011}.
P48050	
P48051	
P48052	
P48058	
P48059	
P48060	
P48061	
P48065	
P48066	
P48067	
P48145	
P48146	
P48147	
P48163	
P48165	
P48167	
P48169	
P48200	
P48201	
P48230	
P48304	
P48307	
P48357	
P48378	
P48380	
P48382	
P48426	
P48431	
P48436	
P48443	
P48444	
P48448	
P48449	
P48454	
P48506	ENZYME REGULATION: Feedback inhibition by glutathione.
P48507	
P48509	
P48539	
P48544	
P48546	
P48547	
P48549	
P48551	
P48552	
P48553	
P48556	
P48594	
P48595	
P48634	
P48637	
P48643	
P48645	
P48651	ENZYME REGULATION: Requires calcium ions. Activated by exogenous phosphatidylethanolamine. {ECO:0000269|PubMed:19014349, ECO:0000269|PubMed:9539713}.
P48664	
P48668	
P48681	
P48723	
P48728	
P48729	
P48730	ENZYME REGULATION: Exhibits substrate-dependent heparin activation. Drug-mediated inhibition leads to a delay of the oscillations with the magnitude of this effect dependent upon the timing of drug administration. Inhibited by phosphorylation. Repressed by 3-[(2,4,6-trimethoxyphenyl)methylidenyl]-indolin-2-one (IC261), N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide (CKI-7), 4-[4-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide (D4476), 3,4-diaryl-isoxazoles and -imidazoles, and 4-(3-cyclohexyl-5-(4-fluoro-phenyl)-3H-imidazol-4-yl) pyrimidin-2-ylamine (PF670462, PF670). {ECO:0000269|PubMed:14761950, ECO:0000269|PubMed:16027726, ECO:0000269|PubMed:19043076, ECO:0000269|PubMed:19591487, ECO:0000269|PubMed:20407760, ECO:0000269|PubMed:20696890, ECO:0000269|PubMed:21084295, ECO:0000269|PubMed:21258417, ECO:0000269|PubMed:21422228, ECO:0000269|PubMed:9632646}.
P48735	
P48736	ENZYME REGULATION: Activated by both the alpha and the beta-gamma G proteins following stimulation of G protein-coupled receptors (GPCRs). Activation by GPCRs is assisted by the regulatory subunits (PIK3R5 or PIK3R6) leading to the translocation from the cytosol to the plasma membrane and to kinase activation. Inhibited by AS-604850 and AS-605240. {ECO:0000269|PubMed:16127437, ECO:0000269|PubMed:7624799}.
P48739	
P48740	ENZYME REGULATION: Inhibited by SERPING1 and A2M. {ECO:0000269|PubMed:11527969, ECO:0000269|PubMed:12538697}.
P48741	
P48742	
P48745	
P48751	
P48764	
P48775	
P48788	
P48960	
P48995	
P49005	
P49006	
P49019	
P49023	
P49069	
P49116	
P49137	ENZYME REGULATION: Activated following phosphorylation by p38-alpha/MAPK14 following various stresses. Inhibited following sumoylation. Specifically inhibited by pyrrolopyridine inhibitors.
P49146	
P49184	
P49189	
P49190	
P49207	
P49221	
P49223	
P49238	
P49247	
P49257	
P49279	
P49281	
P49286	
P49321	
P49326	
P49327	
P49335	
P49336	
P49354	ENZYME REGULATION: Activated by the AGRIN-induced phosphorylation which is mediated by MUSK. {ECO:0000250}.
P49356	
P49366	
P49368	
P49406	
P49407	
P49411	
P49418	
P49419	
P49427	ENZYME REGULATION: CDC34-catalyzed polyubiquitin chain assembly activity is stimulated by the conjugation of NEDD8 to the CUL1 SCF E3 ligase complex subunit. {ECO:0000269|PubMed:11675391}.
P49441	ENZYME REGULATION: Inhibited by Li(+).
P49447	
P49448	
P49450	
P49454	
P49458	
P49459	
P49585	ENZYME REGULATION: By phosphorylation. {ECO:0000250}.
P49588	
P49589	
P49590	
P49591	
P49593	
P49619	ENZYME REGULATION: Requires phosphatidylserine for maximal activity.
P49638	
P49639	
P49640	
P49641	
P49642	
P49643	
P49662	ENZYME REGULATION: Activated by homooligomerization induced by direct binding to cytosolic LPS, in a TLR4-independent manner (PubMed:25119034). {ECO:0000269|PubMed:25119034}.; ENZYME REGULATION: (Microbial infection) Inhibited by the effector protein NleF produced by pathogenic E.coli; this inhibits apoptosis (PubMed:23516580). {ECO:0000269|PubMed:23516580}.
P49674	ENZYME REGULATION: Phosphorylation leads to a decrease of the catalytic activity. {ECO:0000269|PubMed:16790549}.
P49675	
P49682	
P49683	
P49685	
P49703	
P49711	
P49715	
P49716	
P49720	
P49721	
P49736	
P49746	
P49747	
P49748	
P49750	
P49753	
P49754	
P49755	
P49756	
P49757	
P49758	
P49759	ENZYME REGULATION: Regulates splicing of its own pre-mRNA according to its kinase activity; increased expression of the catalytically active form influences splicing to generate the catalytically inactive splicing variant lacking the kinase domain. Leucettine L41 inhibits its kinase activity and affects the regulation of alternative splicing mediated by phosphorylation of SR proteins (By similarity). {ECO:0000250}.
P49760	ENZYME REGULATION: 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole (DRB) inhibits autophosphorylation. TG003 inhibits its kinase activity and affects the regulation of alternative splicing mediated by phosphorylation of SR proteins (By similarity). {ECO:0000250}.
P49761	ENZYME REGULATION: Leucettine L41 inhibits its kinase activity and affects the regulation of alternative splicing mediated by phosphorylation of SR proteins.
P49763	
P49765	
P49767	
P49768	
P49770	
P49771	
P49773	
P49788	
P49789	
P49790	
P49792	
P49795	
P49796	
P49798	
P49802	
P49810	
P49815	
P49821	
P49840	ENZYME REGULATION: Activated by phosphorylation at Tyr-279. In response to insulin, inhibited by phosphorylation at Ser-21 by PKB/AKT1; phosphorylation at this site causes a conformational change, preventing access of substrates to the active site. Inhibited by lithium. {ECO:0000269|PubMed:11749387, ECO:0000269|PubMed:19366350}.
P49841	ENZYME REGULATION: Activated by phosphorylation at Tyr-216. In response to insulin, inhibited by phosphorylation at Ser-9 by PKB/AKT1 and RPS6KA3; phosphorylation at this site causes a conformational change, preventing access of substrates to the active site. Inhibited by lithium. {ECO:0000269|PubMed:11749387, ECO:0000269|PubMed:12554650, ECO:0000269|PubMed:19366350, ECO:0000269|PubMed:8524413}.
P49842	
P49848	
P49862	ENZYME REGULATION: Inhibited by Zn2+ and Cu2+ at low micromolar concentrations. Inhibited by SERPINA12. {ECO:0000269|PubMed:23370777}.
P49863	
P49888	
P49895	
P49901	
P49902	ENZYME REGULATION: Allosterically activated by various compounds, including ATP.
P49903	ENZYME REGULATION: Activated by phosphate ions and by potassium ions. {ECO:0000269|PubMed:19477186}.
P49908	
P49910	
P49913	
P49914	
P49915	
P49916	
P49917	
P49918	
P49959	
P49961	
P50052	
P50053	ENZYME REGULATION: Requires potassium. Inhibition by ADP.
P50120	
P50135	
P50148	
P50150	
P50151	
P50213	ENZYME REGULATION: The heterotetramer and the heterodimer composed of IDH3A and IDH3G subunits can be allosterically activated by citrate (CIT) or/and ADP, and the two activators can act independently or synergistically. The heterodimer composed of IDH3A and IDH3B subunits cannot be allosterically regulated and the allosteric regulation of the heterotetramer is through the IDH3G subunit and not the IDH3B subunit. The IDH3G subunit contains the allosteric site which consists of a CIT-binding site and an ADP-binding site, and the binding of CIT and ADP causes conformational changes at the allosteric site which are transmitted to the active site in the catalytic subunit (IDH3A) through a cascade of conformational changes at the heterodimer interface, leading to stabilization of the isocitrate-binding at the active site and thus activation of the enzyme. ATP can activate the heterotetramer and the heterodimer composed of IDH3A and IDH3G subunits at low concentrations but inhibits their activities at high concentrations, whereas ATP exhibits only inhibitory effect on the heterodimer composed of IDH3A and IDH3B subunits. {ECO:0000269|PubMed:28098230, ECO:0000269|PubMed:28139779}.
P50219	
P50221	
P50222	
P50225	
P50226	
P50238	
P50281	
P50336	
P50391	
P50395	
P50402	
P50406	
P50416	ENZYME REGULATION: Inhibited by malonyl-CoA. {ECO:0000269|PubMed:14517221}.
P50440	
P50443	
P50452	
P50453	
P50454	
P50458	
P50461	
P50479	
P50502	
P50539	
P50542	
P50548	
P50549	
P50552	
P50553	
P50570	
P50579	
P50583	
P50591	
P50607	
P50613	ENZYME REGULATION: Inactivated by phosphorylation. Repressed by roscovitine (seliciclib, CYC202), R547 (Ro-4584820) and SNS-032 (BMS-387032). The association of p53/TP53 to the CAK complex in response to DNA damage reduces kinase activity toward CDK2 and RNA polymerase II repetitive C-terminal domain (CTD), thus stopping cell cycle progression. The inactivation by roscovitine promotes caspase-mediated apoptosis in leukemic cells. {ECO:0000269|PubMed:19911397, ECO:0000269|PubMed:9840937}.
P50616	
P50747	
P50748	
P50749	
P50750	ENZYME REGULATION: Inhibited by CDKI-71, CR8, GPC-286199, AG-024322, flavopiridol (alvocidib), RBG-286147, anilinopyrimidine 32, arylazopyrazole 31b, indirubin 3'-monoxime, meriolin 3,P276-00, olomoucine II, pyrazolotriazine, meriolin, variolin, thiazolyl-pyrimidine, thiazolyl-pyrimidine, indirubin-30-monoxime, ZK 304709, AG-012986, AT7519, R547, RGB-286638, imidazole pyrimidine, EXEL-3700, EXEL-8647, 5,6-dichloro-1-b-ribofur-anosyl-benzimidazole (DRB), P276-00, roscovitine (seliciclib, CYC202) and SNS-032 (BMS-387032). Activation by Thr-186 phosphorylation is calcium Ca(2+) signaling pathway-dependent; actively inactivated by dephosphorylation mediated by PPP1CA, PPM1A and PPM1B. Reversibly repressed by acetylation at Lys-44 and Lys-48. {ECO:0000269|PubMed:18250157, ECO:0000269|PubMed:18483222, ECO:0000269|PubMed:19238148, ECO:0000269|PubMed:21448926, ECO:0000269|PubMed:21484792, ECO:0000269|PubMed:21779453}.
P50851	
P50876	
P50895	
P50897	
P50914	
P50990	
P50991	
P50993	
P50995	
P51003	
P51114	
P51116	
P51124	
P51148	
P51149	
P51151	
P51153	ENZYME REGULATION: Rab activation is generally mediated by a guanine exchange factor (GEF), while inactivation through hydrolysis of bound GTP is catalyzed by a GTPase activating protein (GAP). That Rab may be activated by DENND1C, a guanine exchange factor. Activated in response to insulin. {ECO:0000269|PubMed:20937701}.
P51157	
P51159	
P51160	
P51161	
P51164	
P51168	ENZYME REGULATION: Activated by WNK1, WNK2, WNK3 and WNK4. {ECO:0000250|UniProtKB:Q9WU38}.
P51170	ENZYME REGULATION: Activated by WNK1, WNK2, WNK3 and WNK4. {ECO:0000250|UniProtKB:Q9WU39}.
P51172	
P51178	
P51397	
P51398	
P51449	
P51451	ENZYME REGULATION: Antibody-mediated surface engagement of the B-cell antigen receptor (BCR) which results in the phosphorylation of BLK on tyrosine residues, stimulates the enzymatic activity. {ECO:0000250}.
P51452	
P51460	
P51504	
P51508	
P51511	
P51512	ENZYME REGULATION: TIMP-2 shows little inhibitory activity compared to TIMP-1. TIMP-1 seems to have less binding affinity than TIMP-2 for the short isoform.
P51513	
P51522	
P51523	
P51530	
P51531	
P51532	
P51553	ENZYME REGULATION: The heterotetramer and the heterodimer composed of IDH3A and IDH3G subunits can be allosterically activated by citrate (CIT) or/and ADP, and the two activators can act independently or synergistically. The heterodimer composed of IDH3A and IDH3B subunits cannot be allosterically regulated and the allosteric regulation of the heterotetramer is through the IDH3G subunit and not the IDH3B subunit. The IDH3G subunit contains the allosteric site which consists of a CIT-binding site and an ADP-binding site, and the binding of CIT and ADP causes conformational changes at the allosteric site which are transmitted to the active site in the catalytic subunit (IDH3A) through a cascade of conformational changes at the heterodimer interface, leading to stabilization of the isocitrate-binding at the active site and thus activation of the enzyme. ATP can activate the heterotetramer and the heterodimer composed of IDH3A and IDH3G subunits at low concentrations but inhibits their activities at high concentrations, whereas ATP exhibits only inhibitory effect on the heterodimer composed of IDH3A and IDH3B subunits. {ECO:0000269|PubMed:28098230, ECO:0000269|PubMed:28139779}.
P51570	
P51571	
P51572	
P51575	
P51580	ENZYME REGULATION: Inhibited by S-adenosyl-L-homocysteine (SAH).
P51582	
P51587	
P51589	
P51606	
P51608	
P51610	
P51617	
P51636	
P51648	
P51649	ENZYME REGULATION: Redox-regulated. Inhibited under oxydizing conditions. Inhibited by hydrogen peroxide H(2)O(2). {ECO:0000269|PubMed:19300440}.
P51654	
P51659	
P51665	
P51668	
P51671	
P51674	
P51677	
P51679	
P51681	
P51684	
P51685	
P51686	
P51687	
P51688	
P51689	
P51690	ENZYME REGULATION: Inhibited by millimolar concentrations of warfarin.
P51692	
P51693	
P51784	
P51786	
P51787	
P51788	
P51790	
P51793	
P51795	
P51797	
P51798	
P51800	ENZYME REGULATION: Activated by extracellular calcium and inhibited by extracellular protons. {ECO:0000305|PubMed:23148261}.
P51801	
P51805	
P51808	
P51809	
P51810	
P51811	
P51812	ENZYME REGULATION: Upon extracellular signal or mitogen stimulation, phosphorylated at Thr-577 in the C-terminal kinase domain (CTKD) by MAPK1/ERK2 and MAPK3/ERK1. The activated CTKD then autophosphorylates Ser-386, allowing binding of PDPK1, which in turn phosphorylates Ser-227 in the N-terminal kinase domain (NTDK) leading to the full activation of the protein and subsequent phosphorylation of the substrates by the NTKD.
P51813	ENZYME REGULATION: TEK and vascular endothelial growth factor receptor 1 (FLT1) stimulate BMX tyrosine kinase activity (By similarity). Activated by integrins through the mediation of PTK2/FAK1. Activated by TNF through the mediation of TNFRSF1B. {ECO:0000250, ECO:0000269|PubMed:11331870, ECO:0000269|PubMed:12370298, ECO:0000269|PubMed:18292575}.
P51814	
P51815	
P51816	
P51817	ENZYME REGULATION: Binding of cAMP to the PRKAR1A or PRKAR1B regulatory subunits induces dissociation of the holoenzyme heterotetramer. The released monomeric PRKX is then active and able to phosphorylate its substrates. {ECO:0000269|PubMed:10026146, ECO:0000269|PubMed:12082174, ECO:0000269|PubMed:20819953}.
P51825	
P51826	
P51828	
P51841	ENZYME REGULATION: Activated by GCAP-1; inhibited by calcium.
P51843	
P51854	
P51857	ENZYME REGULATION: Subject to inhibition by high substrate concentrations. Inhibited by testosterone concentrations above 10 uM. {ECO:0000269|PubMed:18407998}.
P51858	
P51861	
P51864	
P51878	
P51884	
P51888	
P51911	
P51946	
P51948	
P51955	ENZYME REGULATION: Isoform 1 is inhibited by ionizing radiation in the presence of PPP1CA. Its catalytic activity is inhibited by the inhibitor CCT241950. In the presence of this inhibitor, displays an autoinhibited conformation: Tyr-70 side chain points into the active site, interacts with the activation loop, and blocks the alphaC helix. {ECO:0000269|PubMed:15161910, ECO:0000269|PubMed:17283141, ECO:0000269|PubMed:19941817}.
P51956	ENZYME REGULATION: Prolactin stimulates its activity. {ECO:0000269|PubMed:15618286}.
P51957	
P51959	
P51965	
P51970	
P51991	
P51993	
P52179	
P52198	
P52209	
P52272	
P52292	
P52294	
P52298	
P52306	
P52333	
P52429	
P52434	
P52435	
P52564	ENZYME REGULATION: Activated by dual phosphorylation on Ser-207 and Thr-211 in response to a variety of cellular stresses, including UV radiation, osmotic shock, hypoxia, inflammatory cytokines, interferon gamma (IFNG), and less often by growth factors. MAP2K6/MKK6 is activated by the majority of M3Ks, such as MAP3K5/ASK1, MAP3K1/MEKK1, MAP3K2/MEKK2, MAP3K3/MEKK3, MAP3K4/MEKK4, MAP3K7/TAK1, MAP3K11/MLK3 and MAP3K17/TAOK2. {ECO:0000269|PubMed:20364819, ECO:0000269|PubMed:8626699, ECO:0000269|PubMed:8663074}.
P52565	
P52566	
P52569	
P52594	
P52597	
P52630	
P52655	
P52657	
P52701	
P52732	
P52735	
P52736	
P52737	
P52738	
P52739	
P52740	
P52741	
P52742	
P52743	
P52744	
P52746	
P52747	
P52756	
P52757	ENZYME REGULATION: In the inactive state, the N terminus protrudes into the active site of the Rho-GAP domain, sterically blocking Rac binding. Phospholipid binding to the Phorbol-ester/DAG-type zinc-finger/C1 domain triggers the cooperative dissociation of these interactions, allowing the N-terminus to move out of the active site and thereby activating the enzyme. {ECO:0000269|PubMed:15507211}.
P52758	
P52788	
P52789	ENZYME REGULATION: Hexokinase is an allosteric enzyme inhibited by its product Glc-6-P.
P52790	ENZYME REGULATION: Hexokinase is an allosteric enzyme inhibited by its product Glc-6-P.
P52797	
P52798	
P52799	
P52803	
P52815	
P52823	
P52824	ENZYME REGULATION: Inactivated by binding to RHOA. Not inhibited by phosphatidylserine.
P52848	
P52849	
P52888	
P52895	ENZYME REGULATION: Inhibited by hexestrol with an IC(50) of 2.8 uM, 1,10-phenanthroline with an IC(50) of 2100 uM, 1,7-phenanthroline with an IC(50) of 1500 uM, flufenamic acid with an IC(50) of 0.9 uM, indomethacin with an IC(50) of 75 uM, ibuprofen with an IC(50) of 6.9 uM, lithocholic acid with an IC(50) of 0.07 uM, ursodeoxycholic acid with an IC(50) of 0.08 uM and chenodeoxycholic acid with an IC(50) of 0.13 uM. {ECO:0000269|PubMed:8573067}.
P52907	
P52926	
P52943	
P52945	
P52948	
P52951	
P52952	
P52954	
P52961	
P53004	
P53007	
P53041	ENZYME REGULATION: Autoinhibited. In the autoinhibited state, the TPR domain interacts with the catalytic region and prevents substrate access to the catalytic pocket. Allosterically activated by various polyunsaturated fatty acids, free long-chain fatty-acids and long-chain fatty acyl-CoA esters, arachidonic acid being the most effective activator. HSP90A and probably RAC1, GNA12 and GNA13 can also release the autoinhibition by the TPR repeat. Activation by RAC1, GNA12 and GNA13 is synergistic with the one produced by fatty acids binding. Inhibited by okadaic acid. {ECO:0000269|PubMed:15383005, ECO:0000269|PubMed:15577939, ECO:0000269|PubMed:19601647, ECO:0000269|PubMed:19948726, ECO:0000269|PubMed:22399290, ECO:0000269|PubMed:9000529}.
P53350	ENZYME REGULATION: Activated by phosphorylation of Thr-210 by AURKA; phosphorylation by AURKA is enhanced by BORA. Once activated, activity is stimulated by binding target proteins. Binding of target proteins has no effect on the non-activated kinase. Several inhibitors targeting PLKs are currently in development and are under investigation in a growing number of clinical trials, such as BI 2536, an ATP-competitive PLK1 inhibitor or BI 6727, a dihydropteridinone that specifically inhibits the catalytic activity of PLK1. {ECO:0000269|PubMed:17307877, ECO:0000269|PubMed:18615013}.
P53355	ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Regulated by a locking mechanism, involving autophosphorylation at Ser-308 and calmodulin binding. In the inactive state, Ser-308 is phosphorylated. Activation involves its dephosphorylation and a release-of-autoinhibition mechanism where binding of calmodulin induces a conformational change that relieves the steric block of the active site by the autoinhibitory domain. Activity is modulated by UNC5B and NTN1. UNC5B activates it by inhibiting the phosphorylation at Ser-308, whereas NTN1 inhibits UNC5B-mediated activation of DAPK1. Endoplasmic-stress activates by causing Ser-308 dephosphorylation. {ECO:0000269|PubMed:11579085, ECO:0000269|PubMed:15729359, ECO:0000269|PubMed:17056602}.
P53365	
P53367	
P53370	
P53384	
P53396	ENZYME REGULATION: Phosphorylation results in a 6-fold increase in V(max) and the conversion of citrate dependence from sigmoidal to hyperbolic. Fructose 6-phosphate (F6P) is also a potent activator. {ECO:0000269|PubMed:10653665}.
P53420	
P53539	
P53567	
P53582	
P53597	
P53602	
P53609	
P53611	ENZYME REGULATION: The enzymatic reaction requires the aid of a Rab escort protein (also called component A).
P53618	
P53621	
P53634	ENZYME REGULATION: Strongly inhibited by the cysteine peptidase inhibitors mersalyl acid, iodoacetic acid and cystatin. Inhibited by N-ethylmaleimide, Gly-Phe-diazomethane, TLCK, TPCK and, at low pH, by dithiodipyridine. Not inhibited by the serine peptidase inhibitor PMSF, the aminopeptidase inhibitor bestatin, or metal ion chelators. {ECO:0000269|PubMed:1586157}.
P53667	
P53671	
P53672	
P53673	
P53674	
P53675	
P53677	
P53680	
P53701	
P53708	
P53778	ENZYME REGULATION: Activated by phosphorylation on threonine and tyrosine. MAP2K3/MKK3 and MAP2K6/MKK6 are both essential for the activation of MAPK12 induced by environmental stress, whereas MAP2K6/MKK6 is the major MAPK12 activator in response to TNF-alpha. {ECO:0000269|PubMed:10212242, ECO:0000269|PubMed:9430721}.
P53779	ENZYME REGULATION: Activated by threonine and tyrosine phosphorylation by two dual specificity kinases, MAP2K4 and MAP2K7. MAP2K7 phosphorylates MAPK10 on Thr-221 causing a conformational change and a large increase in Vmax. MAP2K4 then phosphorylates Tyr-223 resulting in a further increase in Vmax. Inhibited by dual specificity phosphatases, such as DUSP1. Inhibited by HDAC9. {ECO:0000269|PubMed:11062067, ECO:0000269|PubMed:16611996}.
P53794	
P53801	
P53803	
P53804	
P53805	
P53814	
P53816	
P53985	
P53990	
P53992	
P53999	
P54098	
P54105	
P54107	
P54108	
P54132	
P54136	
P54198	
P54219	ENZYME REGULATION: Strongly inhibited by reserpine. Also inhibited to a lesser extent by ketanserin and fenfluramine. Not significantly inhibited by tetrabenazine. {ECO:0000269|PubMed:8643547}.
P54252	
P54253	
P54257	
P54259	
P54274	
P54277	
P54278	
P54284	
P54289	
P54296	
P54315	
P54317	ENZYME REGULATION: CLPS stimulates triacylglycerol lipase activity. Triacylglycerol lipase activity is not inhibited by increasing bile salt concentration. {ECO:0000250|UniProtKB:P17892}.
P54368	
P54577	
P54578	
P54619	
P54646	ENZYME REGULATION: Activated by phosphorylation on Thr-172. Binding of AMP to non-catalytic gamma subunit (PRKAG1, PRKAG2 or PRKAG3) results in allosteric activation, inducing phosphorylation on Thr-172. AMP-binding to gamma subunit also sustains activity by preventing dephosphorylation of Thr-172. ADP also stimulates Thr-172 phosphorylation, without stimulating already phosphorylated AMPK. ATP promotes dephosphorylation of Thr-172, rendering the enzyme inactive. Under physiological conditions AMPK mainly exists in its inactive form in complex with ATP, which is much more abundant than AMP. AMPK is activated by antihyperglycemic drug metformin, a drug prescribed to patients with type 2 diabetes: in vivo, metformin seems to mainly inhibit liver gluconeogenesis. However, metformin can be used to activate AMPK in muscle and other cells in culture or ex vivo (PubMed:11602624). Selectively inhibited by compound C (6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl)]-3-pyridin-4-yl-pyyrazolo[1,5-a] pyrimidine. Activated by resveratrol, a natural polyphenol present in red wine, and S17834, a synthetic polyphenol. Salicylate/aspirin directly activates kinase activity, primarily by inhibiting Thr-172 dephosphorylation. {ECO:0000269|PubMed:11602624, ECO:0000269|PubMed:15980064, ECO:0000269|PubMed:21543851, ECO:0000269|PubMed:22517326}.
P54652	
P54687	
P54707	
P54709	
P54710	
P54725	
P54727	
P54750	ENZYME REGULATION: Type I PDE are activated by the binding of calmodulin in the presence of Ca(2+).
P54753	
P54756	
P54760	
P54762	
P54764	
P54792	
P54793	ENZYME REGULATION: Not inhibited by DHEAS or warfarin.
P54802	
P54803	
P54819	
P54821	
P54826	
P54829	
P54840	ENZYME REGULATION: Allosteric activation by glucose-6-phosphate. Phosphorylation reduces the activity towards UDP-glucose. When in the non-phosphorylated state, glycogen synthase does not require glucose-6-phosphate as an allosteric activator; when phosphorylated it does (By similarity). {ECO:0000250}.
P54845	
P54849	
P54851	
P54852	
P54855	
P54868	
P54886	ENZYME REGULATION: Isoform Short: Inhibited by L-ornithine with a Ki of approximately 0.25 mm. Isoform Long: Insensitive to ornithine inhibition. This is due to the two amino acid insert which abolishes feedback inhibition of P5CS activity by L-ornithine. {ECO:0000269|PubMed:10037775}.
P54920	
P54922	
P55000	
P55001	
P55008	
P55010	
P55011	ENZYME REGULATION: Activated by WNK3. {ECO:0000269|PubMed:21613606}.
P55017	ENZYME REGULATION: Activated by WNK3. {ECO:0000269|PubMed:21613606}.
P55036	
P55039	
P55040	
P55042	
P55055	
P55056	
P55058	
P55060	
P55061	
P55064	
P55072	
P55073	
P55075	
P55081	
P55082	
P55083	
P55084	
P55085	
P55087	
P55089	
P55103	
P55107	
P55145	
P55157	
P55160	
P55196	
P55197	
P55198	
P55199	
P55201	
P55209	
P55210	ENZYME REGULATION: Inhibited by isatin sulfonamides.
P55211	ENZYME REGULATION: Inhibited by the effector protein NleF that is produced by pathogenic E.coli; this inhibits apoptosis. {ECO:0000269|PubMed:23516580}.
P55212	ENZYME REGULATION: Activation is suppressed by phosphorylation at Ser-257. {ECO:0000269|PubMed:15273717}.
P55259	
P55263	
P55265	
P55268	
P55273	
P55283	
P55285	
P55286	
P55287	
P55289	
P55290	
P55291	
P55316	
P55317	
P55318	
P55327	
P55344	
P55345	
P55347	
P55735	
P55769	
P55771	
P55773	
P55774	
P55786	ENZYME REGULATION: Strongly inhibited by bestatin, leuhistin, actinonin, amastatin, 1,10-phenanthroline, DFP, PCMBS, Zn(2+), Cd(2+), Co(2+), Cu(2+), Hg(2+), EDTA and puromycin. Not inhibited by PMSF, and only slightly inhibited by leupeptin and aprotinin. Activity is increased by Mg(2+) and Ca(2+). {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:17154549, ECO:0000269|PubMed:17318184}.
P55789	
P55795	
P55808	
P55809	
P55822	
P55851	
P55854	
P55884	
P55895	
P55899	
P55916	
P55957	
P56134	
P56159	
P56177	
P56178	
P56179	
P56180	
P56181	
P56182	
P56192	ENZYME REGULATION: Enzyme activity is increased by spermidine, EEF1A1, and when the Mg(2+) concentration is increased from 5 mM to 13 mM (in vitro), possibly by promoting the dissociation of the complex between the enzyme and its product. {ECO:0000269|PubMed:11714285}.
P56199	
P56202	
P56211	
P56270	
P56277	
P56278	
P56279	
P56282	
P56373	
P56377	
P56378	
P56381	
P56385	
P56470	
P56524	
P56537	
P56539	
P56545	
P56555	
P56556	
P56557	
P56559	
P56589	
P56597	
P56645	
P56693	
P56696	
P56703	
P56704	
P56705	
P56706	
P56715	
P56730	
P56746	
P56747	
P56748	
P56749	
P56750	
P56817	ENZYME REGULATION: Inhibited by RTN3 and RTN4. {ECO:0000269|PubMed:15286784, ECO:0000269|PubMed:16965550}.
P56851	
P56856	
P56880	
P56915	
P56937	
P56945	
P56962	
P56975	
P57052	
P57053	
P57054	
P57055	
P57057	ENZYME REGULATION: Inhibited by vanadate but not by chlorogenic acid. {ECO:0000269|PubMed:21949678}.
P57058	
P57059	ENZYME REGULATION: Activated by phosphorylation on Thr-182. Also activated by phosphorylation on Thr-322 in response to increases in intracellular sodium in parallel with elevations in intracellular calcium through the reversible sodium/calcium exchanger. {ECO:0000269|PubMed:14976552}.
P57060	
P57071	
P57073	
P57075	
P57076	
P57077	
P57078	
P57081	
P57082	
P57086	
P57087	
P57088	
P57103	ENZYME REGULATION: Calcium transport is down-regulated by Na(+) and stimulated by Ca(2+). {ECO:0000250|UniProtKB:P70549}.
P57105	
P57678	
P57679	
P57682	
P57721	
P57723	
P57727	
P57729	ENZYME REGULATION: Regulated by a guanine nucleotide-exchange factor (GEF) and a GTPase-activating protein (GAP) and alternates between an inactive GDP-bound and an active GTP-bound form. The BLOC-3 complex composed of HPS1 and HPS4 acts as its GEF, promotes the exchange of GDP to GTP, converting it from an inactive GDP-bound form into an active GTP-bound form. SGSM2 acts as its GAP and inactivates it by stimulating its GTPase activity. {ECO:0000250|UniProtKB:Q8QZZ8}.
P57730	
P57735	
P57737	
P57738	
P57739	
P57740	
P57764	
P57768	
P57771	
P57772	
P57773	
P57775	
P57789	
P57796	
P58004	
P58005	
P58012	
P58062	
P58107	
P58166	
P58170	
P58173	
P58180	
P58181	
P58182	
P58215	
P58294	
P58304	
P58317	
P58335	
P58340	
P58397	ENZYME REGULATION: Inhibited by alpha-2 macroglobulin. {ECO:0000269|PubMed:18485748}.
P58400	
P58401	
P58417	
P58418	
P58499	
P58505	
P58511	
P58512	
P58513	
P58546	
P58549	
P58550	
P58557	
P58658	
P58743	
P58753	
P58872	
P58876	
P59020	
P59022	
P59025	
P59036	
P59037	
P59044	
P59045	
P59046	
P59047	
P59051	
P59052	
P59074	
P59089	
P59090	
P59091	
P59095	
P59103	
P59190	
P59282	
P59510	
P59533	
P59534	
P59535	
P59536	
P59537	
P59538	
P59539	
P59540	
P59541	
P59542	
P59543	
P59544	
P59551	
P59646	
P59665	
P59666	
P59768	
P59773	
P59780	
P59796	
P59797	
P59817	
P59826	
P59827	
P59861	
P59894	
P59901	
P59910	
P59922	
P59923	
P59942	
P59990	
P59991	
P59998	
P60002	
P60006	
P60008	
P60014	
P60022	
P60033	
P60059	
P60153	
P60174	
P60201	
P60228	
P60321	
P60323	
P60328	
P60329	
P60331	
P60368	
P60369	
P60370	
P60371	
P60372	
P60409	
P60410	
P60411	
P60412	
P60413	
P60468	
P60484	
P60507	
P60508	
P60509	
P60510	
P60520	
P60568	
P60602	
P60604	
P60606	
P60608	
P60660	
P60673	
P60709	
P60763	
P60827	
P60842	ENZYME REGULATION: Helicase activity and function in translation are inhibited by interaction with PDCD4. {ECO:0000269|PubMed:19153607, ECO:0000269|PubMed:19204291}.
P60852	
P60866	
P60880	
P60891	ENZYME REGULATION: Activated by magnesium and inorganic phosphate.
P60893	
P60896	
P60900	
P60903	
P60953	ENZYME REGULATION: Regulated by guanine nucleotide exchange factors (GEFs) which promote the exchange of bound GDP for free GTP, GTPase activating proteins (GAPs) which increase the GTP hydrolysis activity, and GDP dissociation inhibitors which inhibit the dissociation of the nucleotide from the GTPase. {ECO:0000269|PubMed:12172552}.
P60981	
P60983	
P60985	
P61006	ENZYME REGULATION: Activated in response to insulin. {ECO:0000250}.
P61009	
P61011	
P61018	
P61019	
P61020	ENZYME REGULATION: Regulated by guanine nucleotide exchange factors (GEFs) which promote the exchange of bound GDP for free GTP.
P61024	
P61026	ENZYME REGULATION: Rab activation is generally mediated by a guanine exchange factor (GEF), while inactivation through hydrolysis of bound GTP is catalyzed by a GTPase activating protein (GAP) (By similarity). That Rab is activated by the DENND4C guanine exchange factor (GEF). {ECO:0000250, ECO:0000269|PubMed:20937701}.
P61073	
P61077	
P61081	
P61086	
P61088	ENZYME REGULATION: Activity is inhibited by binding to OTUB1, which prevents 'Lys-63'-linked polyubiquitination. {ECO:0000269|PubMed:20725033, ECO:0000269|PubMed:22325355, ECO:0000269|PubMed:22367539}.
P61106	
P61129	
P61158	
P61160	
P61163	
P61165	
P61201	
P61204	
P61218	
P61221	
P61224	ENZYME REGULATION: Activated by binding to the GTPase-activating protein RAP1GAP. Activated by guanine nucleotide-exchange factor (GEF) EPAC2 in a cAMP-dependent manner. {ECO:0000269|PubMed:18309292}.
P61225	
P61236	
P61244	
P61247	
P61254	
P61266	
P61278	
P61289	
P61296	
P61313	
P61326	
P61328	
P61353	
P61366	
P61371	
P61421	
P61457	
P61513	
P61550	
P61565	
P61566	
P61567	
P61568	
P61570	
P61571	
P61572	
P61573	
P61574	
P61575	
P61576	
P61578	
P61579	
P61580	
P61581	
P61582	
P61583	
P61586	ENZYME REGULATION: GTP hydrolysis is stimulated by ARHGAP30. {ECO:0000269|PubMed:21565175}.
P61587	
P61599	
P61601	
P61604	
P61619	
P61626	
P61647	
P61758	
P61764	
P61769	
P61803	
P61812	
P61916	
P61923	
P61925	
P61927	
P61952	
P61956	
P61960	
P61962	
P61964	
P61966	
P61968	
P61970	
P61978	
P61981	
P62068	ENZYME REGULATION: Activated by interaction with WDR48. {ECO:0000269|PubMed:26388029}.
P62070	
P62072	
P62079	
P62081	
P62136	ENZYME REGULATION: The phosphatase activity of the PPP1R15A-PP1 complex toward EIF2S1 is specifically inhibited by Salubrinal, a drug that protects cells from endoplasmic reticulum stress. {ECO:0000269|PubMed:15705855}.
P62140	ENZYME REGULATION: Inhibited by the toxins okadaic acid, tautomycin and microcystin Leu-Arg (By similarity). The phosphatase activity of the PPP1R15A-PP1 complex toward EIF2S1 is specifically inhibited by Salubrinal, a drug that protects cells from endoplasmic reticulum stress. {ECO:0000250, ECO:0000269|PubMed:15705855}.
P62166	
P62191	
P62195	
P62241	
P62244	
P62249	
P62253	
P62256	
P62258	
P62263	
P62266	
P62269	
P62273	
P62277	
P62280	
P62304	
P62306	
P62308	
P62310	
P62312	
P62314	
P62316	
P62318	
P62324	
P62328	
P62330	ENZYME REGULATION: Activation is generally mediated by a guanine exchange factor (GEF), while inactivation through hydrolysis of bound GTP is catalyzed by a GTPase activating protein (GAP). Activated by ASAP3. Inactivated by ACAP1 and ACAP2. {ECO:0000269|PubMed:11062263, ECO:0000269|PubMed:18400762}.
P62333	
P62341	
P62380	
P62424	
P62487	
P62491	
P62495	
P62502	
P62508	
P62633	
P62683	
P62684	
P62685	
P62699	
P62701	
P62714	
P62736	
P62745	
P62750	
P62753	
P62760	
P62805	
P62807	
P62820	
P62826	
P62829	
P62834	ENZYME REGULATION: Activated by guanine nucleotide-exchange factors (GEF) EPAC and EPAC2 in a cAMP-dependent manner, and GFR.
P62837	
P62841	
P62847	
P62851	
P62854	
P62857	
P62861	
P62873	
P62875	
P62877	
P62879	
P62888	
P62891	
P62899	
P62906	
P62910	
P62913	
P62917	
P62937	ENZYME REGULATION: Binds cyclosporin A (CsA). CsA mediates some of its effects via an inhibitory action on PPIase.
P62942	ENZYME REGULATION: Inhibited by both FK506 and rapamycin.
P62945	
P62952	
P62955	
P62979	
P62987	
P62993	
P62995	
P63000	ENZYME REGULATION: Regulated by guanine nucleotide exchange factors (GEFs) which promote the exchange of bound GDP for free GTP, GTPase activating proteins (GAPs) which increase the GTP hydrolysis activity, and GDP dissociation inhibitors which inhibit the dissociation of the nucleotide from the GTPase. GTP hydrolysis is stimulated by ARHGAP30. {ECO:0000269|PubMed:21565175}.
P63010	
P63027	
P63092	
P63096	
P63098	
P63104	
P63119	
P63120	
P63121	
P63122	
P63123	
P63124	
P63125	
P63126	
P63127	
P63128	
P63129	
P63130	
P63131	
P63132	
P63133	
P63135	
P63136	
P63145	
P63146	
P63151	
P63162	
P63165	
P63167	
P63172	
P63173	
P63208	
P63211	
P63215	
P63218	
P63220	
P63241	
P63244	
P63252	
P63261	
P63267	
P63272	
P63279	
P63302	
P63313	
P63316	
P67775	
P67809	
P67812	
P67870	
P67936	
P68032	
P68036	
P68104	
P68106	ENZYME REGULATION: Inhibited by both FK506 and rapamycin.
P68133	
P68363	
P68366	
P68371	
P68400	ENZYME REGULATION: Constitutively active protein kinase whose activity is not directly affected by phosphorylation. Seems to be regulated by level of expression and localization.
P68402	
P68431	
P68543	
P68871	
P69208	
P69849	
P69891	
P69892	
P69905	
P78310	
P78312	
P78314	
P78316	
P78317	
P78318	
P78324	
P78325	
P78329	
P78330	ENZYME REGULATION: Inhibited by calcium ions. {ECO:0000269|PubMed:15291819}.
P78332	
P78333	
P78334	
P78337	
P78344	
P78345	
P78346	
P78347	
P78348	ENZYME REGULATION: Inhibited by the diuretic amiloride. Inhibited by Cs(1+) ions. Inhibited by spider venom psalmotoxin-1; this locks the channel into its desensitized conformation. {ECO:0000269|PubMed:22760635}.
P78352	
P78356	
P78357	
P78358	
P78362	ENZYME REGULATION: Activated by phosphorylation on Ser-52 and Ser-588. {ECO:0000250|UniProtKB:Q96SB4}.
P78363	
P78364	
P78367	
P78368	ENZYME REGULATION: Stimulated by estrogen. Repressed by 5-iodotubercidin (DB04604). {ECO:0000269|PubMed:15077195}.
P78369	
P78371	
P78380	
P78381	
P78382	
P78383	
P78385	
P78386	
P78395	
P78396	
P78406	
P78410	
P78411	
P78412	
P78413	
P78414	
P78415	
P78417	ENZYME REGULATION: Monomethylarsonic acid reductase activity is competitively inhibited by 1-chloro 2,4-dinitrobenzene (CDNB) and by deoxycholate.
P78423	
P78424	
P78426	
P78504	
P78508	
P78509	
P78524	
P78527	ENZYME REGULATION: Inhibited by wortmannin. Activity of the enzyme seems to be attenuated by autophosphorylation. {ECO:0000269|PubMed:9766667}.
P78536	
P78537	
P78539	
P78540	
P78543	
P78545	
P78549	ENZYME REGULATION: APE1 displaces NTHL1 from the N-glycosylase-generated AP site in DNA, thereby increasing the turnover of the DNA N-glycosylase activity. AP lyase activity is stimulated by YBX1. {ECO:0000269|PubMed:11287425, ECO:0000269|PubMed:12519758}.
P78552	
P78556	
P78559	
P78560	
P78562	
P78563	
P79483	
P79522	
P80075	
P80098	
P80108	
P80162	
P80188	
P80192	ENZYME REGULATION: Homodimerization via the leucine zipper domains is required for autophosphorylation of multiple sites in the activation loop and subsequent activation. Autophosphorylation at Thr-312 is the key step in activation of MAP3K9/MLK1 and is required for full phosphorylation. Autophosphorylation at Thr-304 and Ser-308 have been shown to be of secondary importance in the activation of MAP3K9/MLK1. CEP-1347 and many indolocarbazole analogs have been shown to act as inhibitors of MAP3K9/MLK1 activity. {ECO:0000269|PubMed:11325962, ECO:0000269|PubMed:11755341, ECO:0000269|PubMed:15610029}.
P80217	
P80294	
P80297	
P80303	
P80365	ENZYME REGULATION: Inhibited by glycyrrhetinic acid (derived from liquorice), carbenoloxone and 11-alpha-OH-progesterone. {ECO:0000250}.
P80370	
P80404	
P80511	
P80723	
P80748	
P81133	
P81172	
P81274	
P81277	
P81408	
P81534	
P81605	
P81877	
P82094	
P82251	
P82279	
P82650	
P82663	
P82664	
P82673	
P82675	
P82909	
P82912	
P82914	
P82921	
P82930	
P82932	
P82933	
P82970	
P82979	
P82980	
P82987	
P83105	
P83110	
P83111	
P83369	
P83436	
P83731	
P83859	
P83876	
P83881	
P83916	
P84022	
P84074	
P84077	
P84085	
P84090	
P84095	
P84098	
P84101	
P84103	
P84157	
P84243	
P84550	
P84996	
P85037	
P85298	
P85299	
P86397	
P86434	
P86452	
P86478	
P86479	
P86480	
P86481	
P86496	
P86790	
P86791	
P87889	
P98066	
P98073	
P98077	
P98082	
P98088	
P98095	
P98153	
P98155	
P98160	
P98161	
P98164	
P98168	
P98169	
P98170	
P98171	
P98172	
P98173	
P98174	
P98175	
P98177	
P98179	
P98182	
P98187	
P98194	
P98196	
P98198	
P99999	
Q00005	
Q00013	
Q00056	
Q00059	
Q00169	
Q00266	
Q00325	
Q00341	
Q00403	
Q00444	
Q00526	
Q00532	
Q00534	ENZYME REGULATION: Inhibited by INK4 proteins (CDKN2C/p18-INK4c), aminopurvalanol, PD0332991, 4-(Pyrazol-4-yl)-pyrimidines and fisetin, a flavonol inhibitor. Activated by Thr-177 phosphorylation and Tyr-24 dephosphorylation (By similarity). Stimulated by cyclin from herpesvirus saimiri (V-cyclin/ECLF2). Rapidly down-regulated prior to cell differentiation (e.g. erythroid and osteoblast). {ECO:0000250, ECO:0000269|PubMed:12833137}.
Q00535	ENZYME REGULATION: Inhibited by 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine (roscovitine), 1-isopropyl-4-aminobenzyl-6-ether-linked benzimidazoles, resveratrol, AT-7519 and olomoucine. Activated by CDK5R1 (p35) and CDK5R2 (p39) during the development of the nervous system; degradation of CDK5R1 (p35) and CDK5R2 (p39) by proteasome result in down regulation of kinase activity, during this process, CDK5 phosphorylates p35 and induces its ubiquitination and subsequent degradation. Kinase activity is mainly determined by the amount of p35 available and subcellular location; reversible association to plasma membrane inhibits activity. Long-term inactivation as well as CDK5R1 (p25)-mediated hyperactivation of CDK5 triggers cell death. The pro-death activity of hyperactivated CDK5 is suppressed by membrane association of CDK5, via myristoylation of p35. Brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor (NGF), retinoic acid, laminin and neuregulin promote activity. Neurotoxicity enhances nuclear activity, thus leading to MEF2 phosphorylation and inhibition prior to apoptosis of cortical neurons. Repression by GSTP1 via p25/p35 translocation prevents neurodegeneration. {ECO:0000269|PubMed:12691662, ECO:0000269|PubMed:15992363, ECO:0000269|PubMed:17611284, ECO:0000269|PubMed:21668448, ECO:0000269|PubMed:9030781}.
Q00536	
Q00537	
Q00577	
Q00587	
Q00597	
Q00604	
Q00610	
Q00613	
Q00653	
Q00688	ENZYME REGULATION: Inhibited preferentially by rapamycin over FK506.
Q00722	
Q00765	
Q00796	
Q00839	
Q00872	
Q00887	
Q00888	
Q00889	
Q008S8	
Q00973	
Q00975	
Q00978	
Q00987	
Q00994	
Q00G26	
Q00LT1	
Q01064	ENZYME REGULATION: Type I PDE are activated by the binding of calmodulin in the presence of Ca(2+).
Q01081	
Q01082	
Q01085	
Q01094	ENZYME REGULATION: BIRC2/c-IAP1 stimulates its transcriptional activity. {ECO:0000269|PubMed:21653699}.
Q01101	
Q01105	
Q01113	
Q01118	
Q01130	
Q01151	
Q01167	
Q01196	
Q01201	
Q01344	
Q01362	
Q01415	
Q01432	
Q01433	
Q01449	
Q01453	
Q01459	
Q01469	
Q01484	
Q01518	
Q01523	
Q01524	
Q01534	
Q01538	
Q01543	
Q01546	
Q01581	
Q01628	
Q01629	
Q01638	
Q01650	
Q01658	
Q01664	
Q01668	
Q01718	
Q01726	
Q01740	
Q01780	
Q01804	
Q01813	ENZYME REGULATION: Allosterically activated by ADP, AMP, or fructose 2,6-bisphosphate, and allosterically inhibited by ATP or citrate. {ECO:0000255|HAMAP-Rule:MF_03184}.
Q01814	
Q01826	
Q01831	
Q01844	
Q01850	
Q01851	
Q01860	
Q01892	
Q01954	
Q01955	
Q01959	
Q01968	
Q01970	
Q01973	
Q01974	
Q01995	
Q02040	
Q02045	
Q02078	
Q02080	
Q02083	ENZYME REGULATION: Stimulated by DTT and Nonidet P-40. {ECO:0000269|PubMed:15655246}.
Q02086	
Q02094	
Q02108	ENZYME REGULATION: Activated by nitric oxide in the presence of magnesium or manganese ions. {ECO:0000269|PubMed:9742212}.
Q02127	
Q02153	ENZYME REGULATION: Activated by nitric oxide in the presence of magnesium or manganese ions. {ECO:0000269|PubMed:1352257}.
Q02156	ENZYME REGULATION: Novel PKCs (PRKCD, PRKCE, PRKCH and PRKCQ) are calcium-insensitive, but activated by diacylglycerol (DAG) and phosphatidylserine. Three specific sites; Thr-566 (activation loop of the kinase domain), Thr-710 (turn motif) and Ser-729 (hydrophobic region), need to be phosphorylated for its full activation.
Q02161	
Q02218	ENZYME REGULATION: Calcium ions and ADP stimulate, whereas ATP and NADH reduce catalytic activity. {ECO:0000269|PubMed:24495017}.
Q02221	
Q02223	
Q02224	
Q02241	
Q02246	
Q02252	
Q02297	
Q02318	
Q02325	
Q02338	ENZYME REGULATION: Requires phosphatidylcholine as an allosteric activator for enzymatic activity. {ECO:0000250|UniProtKB:Q02337}.
Q02363	
Q02383	
Q02386	
Q02388	
Q02410	
Q02413	
Q02446	
Q02447	
Q02487	
Q02505	
Q02509	
Q02535	
Q02539	
Q02543	
Q02548	
Q02556	
Q02575	
Q02577	
Q02641	
Q02643	
Q02742	
Q02747	
Q02750	ENZYME REGULATION: Ras proteins such as HRAS mediate the activation of RAF proteins such as RAF1 or BRAF which in turn activate extracellular signal-regulated kinases (ERK) through MAPK (mitogen-activated protein kinases) and ERK kinases MAP2K1/MEK1 and MAP2K2/MEK2. Activation occurs through phosphorylation of Ser-218 and Ser-222. MAP2K1/MEK1 is also the target of negative feed-back regulation by its substrate kinases, such as MAPK1/ERK2. These phosphorylate MAP2K1/MEK1 on Thr-292, thereby facilitating dephosphorylation of the activating residues Ser-218 and Ser-222. Inhibited by serine/threonine phosphatase 2A (By similarity). Many inhibitors have been identified including pyrrole derivatives, TAK-733 (one of a series of 8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione derivatives), CH4987655 and RDEA119/BAY 869766. {ECO:0000250}.
Q02763	ENZYME REGULATION: Angiopoietin binding leads to receptor dimerization and activation by autophosphorylation at Tyr-992 on the kinase activation loop. Inhibited by staurosporine, K252a, PP2, damnacanthal, SB203580, CEP-11207, CEP-11981 and CE-245677. Inhibited by triazine, thienopyrimidine and thiazolopyrimidine derivatives. {ECO:0000269|PubMed:11080633, ECO:0000269|PubMed:11513602, ECO:0000269|PubMed:17253678, ECO:0000269|PubMed:17350837, ECO:0000269|PubMed:19854647, ECO:0000269|PubMed:20651738}.
Q02779	ENZYME REGULATION: Homodimerization via the leucine zipper domains is required for autophosphorylation and subsequent activation. {ECO:0000250}.
Q02790	ENZYME REGULATION: Inhibited by FK506. {ECO:0000269|PubMed:1279700}.
Q02809	
Q02817	
Q02818	
Q02833	
Q02846	ENZYME REGULATION: Activated by GCAP-1; inhibited by calcium.
Q02878	
Q02880	
Q02928	
Q02930	
Q02952	
Q02962	
Q02978	
Q02985	
Q03001	
Q03013	
Q03014	
Q03052	
Q03060	
Q03111	
Q03112	
Q03113	
Q03135	
Q03154	
Q03164	
Q03167	
Q03169	
Q03181	
Q03188	
Q03252	
Q03393	
Q03395	
Q03403	
Q03405	
Q03426	ENZYME REGULATION: Farnesyl- and geranyl-pyrophosphates are competitive inhibitors.
Q03431	
Q03468	
Q03518	
Q03519	
Q03591	
Q03692	
Q03701	
Q03721	
Q03828	
Q03923	
Q03924	
Q03933	
Q03936	
Q03938	
Q03989	
Q04118	
Q04206	
Q04323	
Q04446	
Q04609	ENZYME REGULATION: The NAALADase activity is inhibited by beta-NAAG, quisqualic acid, 2-(phosphonomethyl) pentanedioic acid (PMPA) and EDTA. Activated by cobalt. {ECO:0000269|PubMed:17567119}.
Q04637	
Q04656	
Q04671	
Q04695	
Q04721	
Q04724	
Q04725	
Q04726	
Q04727	
Q04741	
Q04743	
Q04756	
Q04759	ENZYME REGULATION: Novel PKCs (PRKCD, PRKCE, PRKCH and PRKCQ) are calcium-insensitive, but activated by diacylglycerol (DAG) and phosphatidylserine. Three specific sites; Thr-538 (activation loop of the kinase domain), Ser-676 (turn motif) and Ser-695 (hydrophobic region), need to be phosphorylated for its full activation.
Q04760	ENZYME REGULATION: Regulated by oxidation of Cys-139 in response to the redox state of the cell. Results in the alternative formation of cystine or glutathione-bound cysteine, the latter modification leading to reduced enzyme activity. {ECO:0000269|PubMed:20454679}.
Q04771	
Q04826	
Q04828	ENZYME REGULATION: Inhibited by hexestrol with an IC(50) of 9.5 uM, 1,10-phenanthroline with an IC(50) of 55 uM, 1,7-phenanthroline with an IC(50) of 72 uM, flufenamic acid with an IC(50) of 6.0 uM, indomethacin with an IC(50) of 140 uM, ibuprofen with an IC(50) of 950 uM, lithocholic acid with an IC(50) of 25 uM, ursodeoxycholic acid with an IC(50) of 340 uM and chenodeoxycholic acid with an IC(50) of 570 uM. {ECO:0000269|PubMed:8573067}.
Q04837	
Q04844	
Q04864	
Q04900	
Q04912	ENZYME REGULATION: In its inactive state, the C-terminal tail interacts with the catalytic domain and inhibits the kinase activity. Upon ligand binding, the C-terminal tail is displaced and becomes phosphorylated, thus increasing the kinase activity. {ECO:0000269|PubMed:15632155}.
Q04917	
Q04941	
Q05048	
Q05066	
Q05084	
Q05086	
Q05193	
Q05195	
Q05209	
Q05215	
Q05315	
Q05329	
Q05397	ENZYME REGULATION: Subject to autoinhibition, mediated by interactions between the FERM domain and the kinase domain. Activated by autophosphorylation at Tyr-397. This promotes interaction with SRC and phosphorylation at Tyr-576 and Tyr-577 in the kinase activation loop. Phosphorylation at Tyr-576 and Tyr-577 is required for maximal kinase activity. Inhibited by TAC544, TAE226, PF-573,228 and PF-562,271. {ECO:0000269|PubMed:10655584, ECO:0000269|PubMed:17395594, ECO:0000269|PubMed:17431114, ECO:0000269|PubMed:18006843, ECO:0000269|PubMed:18677107, ECO:0000269|PubMed:20495381}.
Q05469	ENZYME REGULATION: Rapidly activated by cAMP-dependent phosphorylation under the influence of catecholamines. Dephosphorylation and inactivation are controlled by insulin.
Q05481	
Q05513	ENZYME REGULATION: Atypical PKCs (PRKCI and PRKCZ) exhibit an elevated basal enzymatic activity (that may be due to the interaction with SMG1 or SQSTM1) and are not regulated by diacylglycerol, phosphatidylserine, phorbol esters or calcium ions. Two specific sites, Thr-410 (activation loop of the kinase domain) and Thr-560 (turn motif), need to be phosphorylated for its full activation. Phosphatidylinositol 3,4,5-trisphosphate might be a physiological activator (By similarity). {ECO:0000250}.
Q05516	
Q05519	
Q05586	
Q05639	
Q05655	ENZYME REGULATION: Novel PKCs (PRKCD, PRKCE, PRKCH and PRKCQ) are calcium-insensitive, but activated by diacylglycerol (DAG) and phosphatidylserine. Three specific sites; Thr-507 (activation loop of the kinase domain), Ser-645 (turn motif) and Ser-664 (hydrophobic region), need to be phosphorylated for its full activation. Activated by caspase-3 (CASP3) cleavage during apoptosis. After cleavage, the pseudosubstrate motif in the regulatory subunit is released from the substrate recognition site of the catalytic subunit, which enables PRKCD to become constitutively activated. The catalytic subunit which displays properties of a sphingosine-dependent protein kinase is activated by D-erythro-sphingosine (Sph) or N,N-dimethyl-D-erythrosphingosine (DMS) or N,N,N-trimethyl-D-erythrosphingosine (TMS), but not by ceramide or Sph-1-P and is strongly inhibited by phosphatidylserine (By similarity). {ECO:0000250}.
Q05682	
Q05707	
Q05823	ENZYME REGULATION: After binding to 2-5A (5'-phosphorylated 2',5'-linked oligoadenylates) the homodimerization and subsequent activation occurs. Inhibited by RNASEL inhibitor ABCE1/RLI, a cytoplasmic member of the ATP-binding cassette (ABC) transporter family.
Q05901	
Q05923	
Q05925	
Q05932	ENZYME REGULATION: Activated by 10 mM sodium bicarbonate. {ECO:0000269|PubMed:8662720}.
Q05940	
Q05952	
Q05996	
Q05BQ5	
Q05BU3	
Q05BV3	
Q05C16	
Q05D32	
Q05D60	
Q05DH4	
Q06033	
Q06055	
Q06124	
Q06136	
Q06141	
Q06187	ENZYME REGULATION: Activated by phosphorylation. In primary B lymphocytes, is almost always non-phosphorylated and is thus catalytically inactive. Stimulation of TLR8 and TLR9 causes BTK activation. As a negative feedback mechanism to fine-tune BCR signaling, activated PRKCB down-modulates BTK function via direct phosphorylation of BTK at Ser-180, resulting in translocation of BTK back to the cytoplasmic fraction. PIN1, SH3BP5, and IBTK were also identified as BTK activity inhibitors. Interaction with CAV1 leads to dramatic down-regulation of the kinase activity of BTK. LFM-13A is a specific inhibitor of BTK. Dasatinib, a cancer drug acting as a tyrosine kinase inhibitor, also blocks BTK activity. {ECO:0000269|PubMed:10339589, ECO:0000269|PubMed:11577348, ECO:0000269|PubMed:11598012, ECO:0000269|PubMed:11751885, ECO:0000269|PubMed:16415872, ECO:0000269|PubMed:16644721, ECO:0000269|PubMed:17932028, ECO:0000269|PubMed:8630736}.
Q06190	
Q06203	
Q06210	
Q06250	
Q06265	
Q06278	ENZYME REGULATION: Is very potently inhibited by raloxifene (PubMed:26842593). Also inhibited by estradiol, ethinyl estradiol, hydralazine, menadione, isovanillin and thioridazine. Not inhibited by allopurinol, a xanthine dehydrogenase potent inhibitor (PubMed:22031625, PubMed:22522748, PubMed:22996261, PubMed:9224775, PubMed:26322824). {ECO:0000269|PubMed:22031625, ECO:0000269|PubMed:22522748, ECO:0000269|PubMed:22996261, ECO:0000269|PubMed:26322824, ECO:0000269|PubMed:26842593, ECO:0000269|PubMed:9224775}.
Q06323	
Q06330	
Q06413	
Q06416	
Q06418	
Q06432	
Q06455	
Q06481	
Q06495	
Q06520	
Q06546	
Q06547	
Q06587	
Q06609	
Q06643	
Q06710	
Q06730	
Q06732	
Q06787	
Q06828	
Q06830	
Q06889	
Q06945	
Q07000	
Q07001	
Q07002	
Q07011	
Q07020	
Q07021	
Q07065	
Q07075	
Q07092	
Q07108	
Q07157	
Q07283	
Q07325	
Q07326	
Q07343	ENZYME REGULATION: Inhibited by rolipram.
Q07352	
Q07444	
Q07507	
Q075Z2	
Q07617	
Q07627	
Q07654	
Q07666	
Q07687	
Q07699	
Q07812	
Q07817	
Q07820	
Q07837	
Q07864	
Q07866	
Q07869	
Q07889	
Q07890	
Q07912	ENZYME REGULATION: Inhibited by AIM-100 (4-amino-5,6-biaryl-furo[2,3-d]pyrimidine), which suppresses activating phosphorylation at Tyr-284. Repressed by dasatinib. {ECO:0000269|PubMed:20383201, ECO:0000269|PubMed:20623637}.
Q07954	
Q07955	
Q07960	
Q07973	
Q08043	
Q08050	
Q08116	
Q08117	
Q08170	
Q08174	
Q08188	
Q08209	
Q08211	
Q08257	
Q08289	
Q08334	
Q08345	ENZYME REGULATION: Inhibited by the multi-targeted cancer drugs imatinib and ponatinib. {ECO:0000269|PubMed:24768818}.
Q08357	
Q08378	
Q08379	
Q08380	
Q08397	
Q08426	ENZYME REGULATION: Enzyme activity enhanced by acetylation. {ECO:0000269|PubMed:20167786}.
Q08431	
Q08462	ENZYME REGULATION: Activated by forskolin (PubMed:15385642). Is not activated by calmodulin. Inhibited by calcium ions, already at micromolar concentration. Activated by the G protein alpha subunit GNAS. Activated by the G protein beta and gamma subunit complex (By similarity). Phosphorylation by RAF1 results in its activation (PubMed:15385642). Phosphorylation by PKC activates the enzyme (By similarity). {ECO:0000250|UniProtKB:P26769, ECO:0000269|PubMed:15385642}.
Q08477	ENZYME REGULATION: Inhibited by carbon monoxide (CO).
Q08493	ENZYME REGULATION: Inhibited by rolipram.
Q08495	
Q08499	ENZYME REGULATION: Inhibited by rolipram. Activated by phosphatidic acid. {ECO:0000269|PubMed:15131123}.
Q08554	
Q08623	
Q08629	
Q08648	
Q08708	
Q08722	
Q08752	ENZYME REGULATION: Less sensitive to inhibition by cyclosporin A than is CYP-18.
Q08828	ENZYME REGULATION: Activated by calcium/calmodulin. Activated by forskolin. Activated by the G protein alpha subunit GNAS. Inhibited by the G protein beta and gamma subunit complex. Inhibited by the ATP analogs adenosine, 2'-deoxyadenosine and 2'-deoxy-3'-AMP. {ECO:0000250|UniProtKB:P19754}.
Q08830	
Q08881	
Q08945	
Q08999	
Q08AD1	
Q08AE8	
Q08AF3	
Q08AF8	
Q08AG5	
Q08AG7	
Q08AH1	
Q08AH3	
Q08AI6	
Q08AI8	
Q08AM6	
Q08AN1	
Q08E93	
Q08ER8	
Q08ET2	
Q08J23	ENZYME REGULATION: Inhibited by magnesium ions. {ECO:0000269|PubMed:22995836}.
Q09013	ENZYME REGULATION: Coiled-coil-mediated oligomerization enhances the catalytic activity. Proteolytic processing of the C-terminus may release the protein from membranes and constitute a mean to regulate the enzyme. May be regulated by HSPB2, RAC1, RAF1 and G-protein second messengers. {ECO:0000269|PubMed:10869570, ECO:0000269|PubMed:10913253, ECO:0000269|PubMed:12832055, ECO:0000269|PubMed:9490724}.
Q09019	
Q09028	
Q09160	
Q09161	
Q09327	
Q09328	
Q09428	
Q09470	ENZYME REGULATION: Inhibited by 1.1 mM 4-aminopyridine (4-AP) and by 20 mM tetraethylammonium (TEA), but not by charybdotoxin (CTX)(PubMed:19912772). Inhibited by dendrotoxin (DTX) (PubMed:19307729). {ECO:0000269|PubMed:19307729, ECO:0000269|PubMed:19912772}.
Q09472	
Q09666	
Q09FC8	
Q09MP3	
Q0D2H9	
Q0D2I5	
Q0D2J5	
Q0D2K0	
Q0D2K2	
Q0D2K3	
Q0D2K5	
Q0GE19	
Q0IIM8	
Q0IIN9	
Q0JRZ9	
Q0P140	
Q0P5N6	
Q0P5P2	
Q0P641	
Q0P651	
Q0P670	
Q0P6D2	
Q0P6D6	
Q0P6H9	
Q0PNE2	
Q0VAA2	
Q0VAA5	
Q0VAF6	
Q0VAK6	
Q0VAM2	
Q0VAQ4	
Q0VD83	
Q0VD86	
Q0VDD5	
Q0VDD7	
Q0VDD8	
Q0VDE8	
Q0VDF9	
Q0VDG4	
Q0VDI3	
Q0VF49	
Q0VF96	
Q0VFX4	
Q0VFZ6	
Q0VG06	
Q0VG73	
Q0VG99	
Q0VGE8	
Q0VGL1	
Q0WX57	
Q0Z7S8	
Q0ZGT2	
Q0ZLH3	
Q10469	
Q10471	
Q10472	
Q10567	
Q10570	
Q10571	
Q10586	
Q10587	
Q10588	
Q10589	
Q10713	
Q107X0	
Q10981	
Q11128	
Q11130	
Q11201	
Q11203	
Q11206	
Q12756	
Q12765	
Q12766	
Q12767	
Q12768	
Q12769	
Q12770	
Q12772	
Q12774	
Q12778	
Q12788	
Q12789	
Q12791	ENZYME REGULATION: Ethanol and carbon monoxide-bound heme increase channel activation. Heme inhibits channel activation. {ECO:0000269|PubMed:14523450}.
Q12792	
Q12794	
Q12796	
Q12797	
Q12798	
Q12799	
Q12800	
Q12802	
Q12805	
Q12809	
Q12815	
Q12816	
Q12824	
Q12829	
Q12830	
Q12834	
Q12836	
Q12837	
Q12840	
Q12841	
Q12846	
Q12849	
Q12851	ENZYME REGULATION: The tumor necrosis factor (TNF), as well as endotoxins and proinflammatory stimuli such as polyinosine-polycytidine (poly(IC)), lipopolysaccharides (LPS), peptidoglycan (PGN), flagellin, or lipid A activate MAP4K2 by promoting its autophosphorylation. {ECO:0000269|PubMed:15456887, ECO:0000269|PubMed:7477268}.
Q12852	
Q12857	
Q12860	
Q12864	
Q12866	
Q12870	
Q12872	
Q12873	
Q12874	
Q12879	
Q12882	
Q12884	ENZYME REGULATION: Gelatinase activity is inhibited by serine-protease inhibitors, such as phenylmethylsulfonyl fluoride (PMSF), 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride (AEBSF), 4-amidino phenylsulfonyl fluoride (APSF) and diisopropyl fluorophosphate (DFP), N-ethylmaleimide (NEM) and phenylmethylsulfonyl fluoride (PMSF). Dipeptidyl peptidase activity is inhibited by 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid), diisopropylfluorophosphate (DFP). Prolyl endopeptidase activity is inhibited by the boronic acid peptide Ac-Gly-BoroPro, Ac-Gly-Pro-chloromethyl ketone and Thr-Ser-Gly-chloromethyl ketone. {ECO:0000269|PubMed:10593948, ECO:0000269|PubMed:16410248, ECO:0000269|PubMed:16480718, ECO:0000269|PubMed:17381073, ECO:0000269|PubMed:2172980, ECO:0000269|PubMed:9065413}.
Q12887	
Q12888	
Q12889	
Q12891	
Q12893	
Q12894	
Q12899	
Q12901	
Q12904	
Q12905	
Q12906	
Q12907	
Q12908	
Q12912	
Q12913	
Q12918	
Q12923	
Q12926	
Q12929	
Q12931	
Q12933	ENZYME REGULATION: Has very low E3 ubiquitin ligase activity in the absence of sphingosine-1-phosphate. E3 ubiquitin ligase activity is strongly activated by cytoplasmic sphingosine-1-phosphate. {ECO:0000269|PubMed:20577214}.
Q12934	
Q12946	
Q12947	
Q12948	
Q12950	
Q12951	
Q12952	
Q12955	
Q12959	
Q12962	
Q12965	
Q12967	
Q12968	
Q12972	
Q12974	ENZYME REGULATION: Inhibited by sodium orthovanadate and pentamidine. {ECO:0000269|PubMed:12516958, ECO:0000269|PubMed:9018080}.
Q12979	
Q12980	
Q12981	
Q12982	
Q12983	
Q12986	
Q12988	
Q12996	
Q12999	
Q13002	
Q13003	
Q13007	
Q13009	
Q13011	
Q13015	
Q13017	
Q13018	
Q13021	
Q13023	
Q13029	
Q13033	
Q13042	
Q13043	ENZYME REGULATION: Inhibited by the C-terminal non-catalytic region. Activated by caspase-cleavage. Full activation also requires homodimerization and autophosphorylation of Thr-183. Activated by RASSF1 which acts by preventing its dephosphorylation. {ECO:0000269|PubMed:15109305, ECO:0000269|PubMed:21199877, ECO:0000269|PubMed:8702870}.
Q13045	
Q13046	
Q13049	
Q13057	
Q13061	
Q13064	
Q13065	
Q13066	
Q13068	
Q13069	
Q13070	
Q13072	
Q13075	
Q13077	
Q13084	
Q13085	ENZYME REGULATION: By phosphorylation (By similarity). Activity is increased by oligomerization. Citrate and MID1IP1 promote oligomerization. {ECO:0000250, ECO:0000269|PubMed:20952656}.
Q13087	
Q13093	
Q13094	
Q13098	
Q13099	
Q13103	
Q13105	
Q13106	
Q13107	
Q13111	
Q13112	
Q13113	
Q13114	
Q13115	
Q13117	
Q13118	
Q13123	
Q13126	ENZYME REGULATION: Inhibited by 5'-methylthiotubercin and 5'-chloroformycin.
Q13127	
Q13129	
Q13131	ENZYME REGULATION: Activated by phosphorylation on Thr-183. Binding of AMP to non-catalytic gamma subunit (PRKAG1, PRKAG2 or PRKAG3) results in allosteric activation, inducing phosphorylation on Thr-183. AMP-binding to gamma subunit also sustains activity by preventing dephosphorylation of Thr-183. ADP also stimulates Thr-183 phosphorylation, without stimulating already phosphorylated AMPK. ATP promotes dephosphorylation of Thr-183, rendering the enzyme inactive. Under physiological conditions AMPK mainly exists in its inactive form in complex with ATP, which is much more abundant than AMP. AMPK is activated by antihyperglycemic drug metformin, a drug prescribed to patients with type 2 diabetes: in vivo, metformin seems to mainly inhibit liver gluconeogenesis. However, metformin can be used to activate AMPK in muscle and other cells in culture or ex vivo (PubMed:11602624). Selectively inhibited by compound C (6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl)]-3-pyridin-4-yl-pyyrazolo[1,5-a] pyrimidine. Activated by resveratrol, a natural polyphenol present in red wine, and S17834, a synthetic polyphenol. {ECO:0000269|PubMed:11602624, ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15980064, ECO:0000269|PubMed:16054095, ECO:0000269|PubMed:21680840}.
Q13133	
Q13136	
Q13137	
Q13144	
Q13145	
Q13148	
Q13151	
Q13153	ENZYME REGULATION: Phosphorylation of Thr-84 by OXSR1 inhibits activation (By similarity). Activated by binding small G proteins. Binding of GTP-bound CDC42 or RAC1 to the autoregulatory region releases monomers from the autoinhibited dimer, and enables activation by phosphorylation of Thr-423. {ECO:0000250|UniProtKB:P35465, ECO:0000269|PubMed:10995762, ECO:0000269|PubMed:11804587, ECO:0000269|PubMed:15893667, ECO:0000269|PubMed:9032240}.
Q13155	
Q13156	
Q13158	
Q13162	
Q13163	
Q13164	ENZYME REGULATION: Activated by tyrosine and threonine phosphorylation (By similarity). Activated in response to hyperosmolarity, hydrogen peroxide, and epidermal growth factor (EGF). {ECO:0000250, ECO:0000269|PubMed:9384584, ECO:0000269|PubMed:9790194}.
Q13166	
Q13177	ENZYME REGULATION: Activated by binding small G proteins. Binding of GTP-bound CDC42 or RAC1 to the autoregulatory region releases monomers from the autoinhibited dimer, enables phosphorylation of Thr-402 and allows the kinase domain to adopt an active structure (By similarity). Following caspase cleavage, autophosphorylated PAK-2p34 is constitutively active. {ECO:0000250}.
Q13183	
Q13185	
Q13188	ENZYME REGULATION: Inhibited by the C-terminal non-catalytic region. Activated by caspase-cleavage. Full activation also requires homodimerization and autophosphorylation of Thr-180, which are inhibited by the proto-oncogene product RAF1. Activated by RASSF1 which acts by preventing its dephosphorylation. {ECO:0000269|PubMed:15618521, ECO:0000269|PubMed:21199877}.
Q13190	
Q13191	
Q13200	
Q13201	
Q13202	
Q13203	
Q13206	
Q13207	
Q13214	
Q13216	
Q13217	
Q13219	ENZYME REGULATION: Inhibited by complexation with the proform of PRG2. {ECO:0000269|PubMed:10913121}.
Q13224	
Q13227	
Q13228	
Q13231	
Q13232	
Q13233	ENZYME REGULATION: Activated by autophosphorylation on Thr-1400 and Thr-1412 following oligomerization.
Q13237	ENZYME REGULATION: Binding of cGMP results in enzyme activation. {ECO:0000269|PubMed:26769964}.
Q13239	
Q13241	
Q13242	
Q13243	
Q13247	
Q13253	
Q13255	ENZYME REGULATION: Signaling is inhibited by the antagonist LY341495. The LY341495 binding site partially overlaps with the glutamate binding site. Signaling is also inhibited by synthetic allosteric regulators, such as FITM (4-fluoro-N-(4-(6-(isopropylamino)pyrimidin-4-yl)thiazol-2-yl)-N-methylbenzamide) that bind in a pocket between the transmembrane helices. {ECO:0000269|PubMed:24603153}.
Q13257	
Q13258	
Q13261	
Q13263	
Q13268	
Q13275	
Q13277	
Q13278	
Q13283	
Q13285	
Q13286	
Q13287	
Q13291	
Q13296	
Q13303	
Q13304	
Q13308	
Q13309	
Q13310	
Q13315	ENZYME REGULATION: Inhibited by wortmannin. {ECO:0000269|PubMed:9766667}.
Q13316	
Q13319	
Q13322	ENZYME REGULATION: Phosphorylation by mTORC1 stabilizes and activates GRB10 constituting a feedback pathway by which mTORC1 inhibits INSR-dependent signaling. {ECO:0000269|PubMed:21659604}.
Q13323	
Q13324	
Q13325	
Q13326	
Q13330	
Q13332	
Q13336	
Q13342	
Q13347	
Q13349	
Q13351	
Q13352	
Q13356	
Q13360	
Q13361	
Q13362	
Q13363	
Q13367	
Q13368	
Q13370	ENZYME REGULATION: Inhibited by cGMP.
Q13371	
Q13387	
Q13393	ENZYME REGULATION: Stimulated by phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate, activated by the phosphokinase C-alpha, by the ADP-ribosylation factor-1 (ARF-1), and to a lesser extent by GTP-binding proteins: RHO A, RAC-1 and CDC42. Inhibited by oleate.
Q13394	
Q13395	
Q13398	
Q13401	
Q13402	ENZYME REGULATION: ATP hydrolysis is inhibited by Mg(2+), already at a concentration of 0.4 mM. {ECO:0000269|PubMed:21687988}.
Q13404	
Q13405	
Q13409	
Q13410	
Q13415	
Q13416	
Q13418	ENZYME REGULATION: Stimulated rapidly but transiently by both cell fibronectin interactions, as well as by insulin, in a PI3-K-dependent manner, likely via the binding of PtdIns(3,4,5)P3 with a PH-like domain of ILK. The protein kinase activity is stimulated by LIMD2 (PubMed:24590809). {ECO:0000269|PubMed:24590809}.
Q13421	
Q13422	
Q13423	
Q13424	
Q13425	
Q13426	
Q13427	ENZYME REGULATION: Cyclosporin A (CsA)-sensitive.
Q13428	
Q13432	
Q13433	
Q13434	
Q13435	
Q13438	
Q13439	
Q13442	
Q13443	ENZYME REGULATION: Synthesized as an inactive form which is proteolytically cleaved to generate an active enzyme. Processing at the upstream site is particularly important for activation of the proenzyme, whereas processing at the boundary between the pro-domain and the catalytic domain does not appear to be essential. Inhibited by hydroxamic acid-based inhibitors. {ECO:0000250|UniProtKB:Q61072}.
Q13444	ENZYME REGULATION: Inhibited by hydroxamate-type metalloproteinase inhibitors such as marimastat. Inhibited by metalloproteinase inhibitor 2 (TIMP-2) and TIMP-3 at nanomolar concentrations. Not significantly inhibited by TIMP-1 at concentrations of up to 100 nM. Not activated by PMA or ionomycin. {ECO:0000269|PubMed:19207106}.
Q13445	
Q13449	
Q13451	ENZYME REGULATION: Inhibited by FK506 but not cyclosporin.
Q13454	
Q13459	
Q13461	
Q13464	ENZYME REGULATION: Activated by RHOA binding. Inhibited by Y-27632.
Q13467	
Q13469	
Q13470	
Q13472	
Q13474	
Q13477	
Q13478	
Q13480	
Q13485	
Q13487	
Q13488	
Q13489	ENZYME REGULATION: USP19 regulates the stability of BIRC3/c-IAP2 by preventing its ubiquitination. {ECO:0000269|PubMed:21849505}.
Q13490	ENZYME REGULATION: The CARD domain inhibits the activation of E3 ubiquitin ligase activity by preventing RING domain dimerization and E2 ubiquitin donor binding and activation. The CARD domain-mediated autoinhibition of the E3 ubiquitin-protein ligase activity suppresses cell proliferation and migration. USP19 regulates the stability of BIRC2/c-IAP1 by preventing its ubiquitination. {ECO:0000269|PubMed:21549626, ECO:0000269|PubMed:21849505}.
Q13491	
Q13492	
Q13495	
Q13496	ENZYME REGULATION: Allosterically activated by phosphatidylinositol 5-phosphate (PI5P). {ECO:0000269|PubMed:12646134}.
Q13501	
Q13503	
Q13505	
Q13506	
Q13507	
Q13508	
Q13509	
Q13510	
Q13515	
Q13516	
Q13519	
Q13520	
Q13522	
Q13523	
Q13526	
Q13530	
Q13535	ENZYME REGULATION: Serine/threonine-protein kinase activity is directly stimulated by TOPBP1 (PubMed:16530042). ATR kinase activity is also directly activated by ETAA1, independently of TOPBP1 (PubMed:27723720, PubMed:27723717). Activated by DNA and inhibited by BCR-ABL oncogene (PubMed:10597277). Slightly activated by ATRIP (PubMed:14729973). Inhibited by caffeine, wortmannin and LY294002 (PubMed:9766667). {ECO:0000269|PubMed:10597277, ECO:0000269|PubMed:14729973, ECO:0000269|PubMed:16530042, ECO:0000269|PubMed:27723717, ECO:0000269|PubMed:27723720, ECO:0000269|PubMed:9766667}.
Q13536	
Q13541	
Q13542	
Q13546	ENZYME REGULATION: Inhibited by necrostatins, including necrostatin-1, necrostatin-3 and necrostatin-4. {ECO:0000269|PubMed:23473668}.
Q13547	
Q13554	ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of calmodulin results in conformational change that relieves intrasteric autoinhibition and allows autophosphorylation of Thr-287 which turns the kinase in a constitutively active form and confers to the kinase a Ca(2+)-independent activity. {ECO:0000269|PubMed:14722083}.
Q13555	ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of calmodulin results in conformational change that relieves intrasteric autoinhibition and allows autophosphorylation of Thr-287 which turns the kinase in a constitutively active form and confers to the kinase a Ca(2+)-independent activity. {ECO:0000269|PubMed:14722083}.
Q13557	ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of calmodulin results in conformational change that relieves intrasteric autoinhibition and allows autophosphorylation of Thr-287 which turns the kinase in a constitutively active form and confers to the kinase a Ca(2+)-independent activity. {ECO:0000269|PubMed:14722083}.
Q13561	
Q13562	
Q13563	ENZYME REGULATION: Channnel activity is regulated by phosphorylation (PubMed:16551655, PubMed:20881056, PubMed:26269590). Channnel activity is regulated by intracellular Ca(2+) (PubMed:11854751). {ECO:0000269|PubMed:11854751, ECO:0000269|PubMed:16551655, ECO:0000269|PubMed:20881056, ECO:0000269|PubMed:26269590}.
Q13564	ENZYME REGULATION: Binding of TP53BP2 to the regulatory subunit NAE1 decreases neddylation activity.
Q13568	
Q13569	
Q13571	
Q13572	
Q13573	
Q13574	
Q13576	
Q13585	
Q13586	
Q13588	
Q13591	
Q13595	
Q13596	
Q13601	
Q13606	
Q13607	
Q13608	
Q13609	ENZYME REGULATION: Inhibited by zinc. {ECO:0000250|UniProtKB:O89107}.
Q13610	
Q13613	
Q13614	ENZYME REGULATION: Interaction with SBF1 increases phosphatase activity. {ECO:0000269|PubMed:12668758}.
Q13615	
Q13616	
Q13617	
Q13618	
Q13619	
Q13620	
Q13621	ENZYME REGULATION: Activated by WNK3. {ECO:0000269|PubMed:21613606}.
Q13625	
Q13627	ENZYME REGULATION: Inhibited by RANBP9 (PubMed:14500717). Inhibited by harmine, leucettamine B and leucettine L41 (PubMed:22998443). {ECO:0000269|PubMed:14500717, ECO:0000269|PubMed:22998443}.
Q13630	
Q13634	
Q13635	
Q13636	
Q13637	ENZYME REGULATION: Regulated by a guanine nucleotide-exchange factor (GEF) and a GTPase-activating protein (GAP) and alternates between an inactive GDP-bound and an active GTP-bound form. The BLOC-3 complex composed of HPS1 and HPS4 acts as its GEF, promotes the exchange of GDP to GTP, converting it from an inactive GDP-bound form into an active GTP-bound form (By similarity). SGSM2 acts as its GAP and inactivates it by stimulating its GTPase activity (PubMed:21269460). {ECO:0000250|UniProtKB:Q9CZE3}.
Q13639	
Q13641	
Q13642	
Q13643	
Q13651	
Q13670	
Q13671	
Q13683	
Q13685	
Q13686	
Q13698	ENZYME REGULATION: Channel activity is blocked by dihydropyridines (DHP), phenylalkylamines, benzothiazepines, and by omega-agatoxin-IIIA (omega-Aga-IIIA). It is however insensitive to omega-conotoxin-GVIA (omega-CTx-GVIA) and omega-agatoxin-IVA (omega-Aga-IVA). {ECO:0000250|UniProtKB:P07293}.
Q13702	
Q13705	
Q13724	
Q13733	ENZYME REGULATION: Specifically inhibited by an endogenous cardiac glycoside, ouabain. {ECO:0000269|PubMed:16175638}.
Q13740	
Q13748	
Q13751	
Q13753	
Q13761	
Q13765	
Q13769	
Q13772	
Q13790	
Q13794	
Q13795	
Q13796	
Q13797	
Q13813	
Q13822	ENZYME REGULATION: Inhibited by lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P). Inhibited by EDTA and EGTA (Probable). {ECO:0000305|PubMed:15769751, ECO:0000305|PubMed:18175805, ECO:0000305|PubMed:21240271}.
Q13823	
Q13825	
Q13829	
Q13835	
Q13838	
Q13867	
Q13868	
Q13873	
Q13875	
Q13882	ENZYME REGULATION: Activated by EGF, NRG1 and IGF1. Inhibited by SOCS3 to phosphorylate STAT3. Stabilized in the inactive form by an association between the SH3 domain and the SH2-TK linker region. Interaction between Trp-184 within SH2-TK linker region and the catalytic domain appears essential for positive regulation of kinase activity. {ECO:0000269|PubMed:12121988, ECO:0000269|PubMed:15870689, ECO:0000269|PubMed:15961400, ECO:0000269|PubMed:16568091, ECO:0000269|PubMed:17822667}.
Q13884	
Q13885	
Q13886	
Q13887	
Q13888	
Q13889	
Q13895	
Q13901	
Q13905	
Q13907	
Q13936	
Q13938	
Q13939	
Q13946	ENZYME REGULATION: Insensitive to all selective PDE inhibitors.
Q13948	
Q13950	
Q13951	
Q13952	
Q13956	
Q13972	
Q13976	ENZYME REGULATION: In the absence of cGMP, PRKG1 activity is suppressed by autoinhibitory contacts.
Q14002	
Q14003	
Q14004	
Q14005	
Q14008	
Q14011	
Q14012	ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of calmodulin results in conformational change that relieves intrasteric autoinhibition and allows phosphorylation of Thr-177 within the activation loop by CaMKK1 or CaMKK2. Phosphorylation of Thr-177 results in several fold increase in total activity. Unlike CaMK4, is unable to exhibit autonomous activity after Ca(2+)/calmodulin activation. {ECO:0000269|PubMed:23028635, ECO:0000269|PubMed:7641687}.
Q14019	
Q14028	
Q14031	
Q14032	
Q14050	
Q14055	
Q14061	
Q14088	
Q14093	
Q14094	
Q14103	
Q14106	
Q14108	
Q14112	
Q14114	
Q14116	
Q14117	
Q14118	
Q14119	
Q14123	ENZYME REGULATION: Type I PDE are activated by the binding of calmodulin in the presence of Ca(2+).
Q14126	
Q14129	
Q14134	
Q14135	
Q14137	
Q14139	
Q14140	
Q14141	
Q14142	
Q14145	ENZYME REGULATION: Ubiquitination and subsequent degradation of PGAM5 is inhibited by oxidative stress and sulforaphane. Sulforaphane also inhibits ubiquitination of NFE2L2/NRF2. {ECO:0000269|PubMed:15983046, ECO:0000269|PubMed:17046835}.
Q14146	
Q14147	
Q14149	
Q14151	
Q14152	
Q14153	
Q14154	
Q14155	
Q14156	
Q14157	
Q14159	
Q14160	
Q14161	
Q14162	
Q14164	
Q14165	
Q14166	
Q14168	
Q14181	
Q14183	
Q14184	
Q14185	
Q14186	
Q14188	
Q14190	
Q14191	
Q14192	
Q14194	
Q14195	
Q14197	
Q14201	
Q14202	
Q14203	
Q14204	
Q14206	
Q14207	
Q14209	
Q14210	
Q14213	
Q14232	
Q14236	
Q14240	
Q14241	
Q14242	
Q14244	
Q14246	
Q14247	
Q14249	
Q14254	
Q14257	
Q14258	
Q14264	
Q14289	ENZYME REGULATION: Activated in response to stimuli that lead to increased intracellular Ca(2+) levels; this activation is indirect and may be mediated by calcium-mediated production of reactive oxygen species (ROS). Activated by autophosphorylation at Tyr-402; this creates a binding site for SRC family kinases and leads to phosphorylation at additional tyrosine residues. Phosphorylation at Tyr-402, Tyr-579 and Tyr-580 is required for optimal kinase activity. Inhibited by PF-562,271, BIRB796, PF-4618433 and by PF-431396, PF-2318841 and their derivatives. Inhibited by sulfoximine-substituted trifluoromethylpyrimidines. Inhibited by 4-amino and 5-aryl substituted pyridinone compounds. {ECO:0000269|PubMed:18339875, ECO:0000269|PubMed:18951788, ECO:0000269|PubMed:19428251, ECO:0000269|PubMed:19648005}.
Q14296	
Q14314	
Q14315	
Q14318	
Q14320	
Q14324	
Q14330	
Q14331	
Q14332	
Q14344	
Q14353	
Q14376	
Q14390	
Q14392	
Q14393	
Q14397	
Q14406	
Q14409	
Q14410	
Q14416	
Q14432	ENZYME REGULATION: Inhibited by cGMP.
Q14435	
Q14439	
Q14442	
Q14444	
Q14449	
Q14451	
Q14457	
Q14469	
Q14493	
Q14494	
Q14498	
Q14500	
Q14507	
Q14508	
Q14511	
Q14512	
Q14515	
Q14517	
Q14520	
Q14524	
Q14525	
Q14526	
Q14527	
Q14532	
Q14533	
Q14534	
Q14541	
Q14542	
Q14549	
Q14554	
Q14558	
Q14562	
Q14563	
Q14565	
Q14566	
Q14568	
Q14571	
Q14573	
Q14574	
Q14576	
Q14582	
Q14584	
Q14585	
Q14586	
Q14587	
Q14588	
Q14590	
Q14592	
Q14593	
Q14596	
Q14602	
Q14623	
Q14624	
Q14626	
Q14627	
Q14641	
Q14642	
Q14643	
Q14644	
Q14651	
Q14653	ENZYME REGULATION: In the absence of viral infection, maintained as a monomer in an autoinhibited state and phosphorylation disrupts this autoinhibition leading to the liberation of the DNA-binding and dimerization activities and its nuclear localization where it can activate type I IFN and ISG genes.
Q14654	
Q14656	
Q14657	
Q14667	
Q14669	
Q14671	
Q14674	ENZYME REGULATION: Regulated by at least two independent mechanisms. First, it is inactivated via its interaction with securin/PTTG1, which probably covers its active site. The association with PTTG1 is not only inhibitory, since PTTG1 is also required for activating it, the enzyme being inactive in cells in which PTTG1 is absent. PTTG1 degradation at anaphase, liberates it and triggers RAD21 cleavage. Second, phosphorylation at Ser-1126 inactivates it. The complete phosphorylation during mitosis, is removed when cells undergo anaphase. Activation of the enzyme at the metaphase-anaphase transition probably requires the removal of both securin and inhibitory phosphate. {ECO:0000269|PubMed:11747808, ECO:0000269|PubMed:12194817, ECO:0000269|PubMed:12297314}.
Q14676	
Q14677	
Q14678	
Q14679	
Q14680	ENZYME REGULATION: Activated by autophosphorylation of the T-loop at Thr-167 and Ser-171: in contrast to other members of the SNF1 subfamily, phosphorylation at Thr-167 is not mediated by STK11/LKB1 but via autophosphorylation instead. Inhibited by calcium-binding. Kinase activity is also regulated by reducing agents: dithiothreitol (DTT) or reduced glutathione are required for kinase activity in vitro; such dependence is however not due to the presence of disulfide bonds. {ECO:0000269|PubMed:16216881}.
Q14681	
Q14683	
Q14684	
Q14686	
Q14687	
Q14689	
Q14690	
Q14691	
Q14692	
Q14693	ENZYME REGULATION: Potently inhibited by sphingolipids, in particular, the sphingoid bases sphinganine and sphingosine and ceramide-1-phosphate. Inhibited by concentrations of Mg(2+) and Mn(2+) above their optimums and by Ca(2+), Zn(2+), N-ethylmaleimide and propranolol. {ECO:0000269|PubMed:20231281}.
Q14694	ENZYME REGULATION: Specifically inhibited by spautin-1 (specific and potent autophagy inhibitor-1), a derivative of MBCQ that binds to USP10 and inhibits deubiquitinase activity. Regulated by PIK3C3/VPS34-containing complexes. {ECO:0000269|PubMed:21962518}.
Q14695	
Q14696	
Q14697	
Q14699	
Q14703	ENZYME REGULATION: Inhibited by divalent copper and zinc ions, but not by nickel or cobalt. Inhibited by its prosegment, but not smaller fragments thereof.
Q14714	
Q14721	ENZYME REGULATION: Inhibited by 12.7 nM stromatoxin 1 (ScTx1), a spider venom toxin of the tarantula S.calceata (PubMed:14565763). Inhibited by 42 nM hanatoxin 1 (HaTx1), a spider venom toxin of the tarantula G.spatulata (PubMed:14565763). Modestly sensitive to millimolar levels of tetraethylammonium (TEA) (PubMed:8081723, PubMed:1283219). Modestly sensitive to millimolar levels of 4-aminopyridine (4-AP). Completely insensitive to toxins such as dendrotoxin (DTX) and charybdotoxin (CTX) (By similarity). {ECO:0000250|UniProtKB:P15387, ECO:0000269|PubMed:1283219, ECO:0000269|PubMed:14565763, ECO:0000269|PubMed:8081723, ECO:0000305|PubMed:10414301, ECO:0000305|PubMed:15858231}.
Q14722	
Q14728	
Q14738	
Q14739	
Q14746	
Q14749	
Q14761	
Q14764	
Q14765	
Q14766	
Q14767	
Q14773	
Q14774	
Q14781	
Q14789	
Q14790	ENZYME REGULATION: Inhibited by the effector protein NleF that is produced by pathogenic E.coli; this inhibits apoptosis. {ECO:0000269|PubMed:23516580}.
Q147U1	
Q147U7	
Q147X3	
Q14802	
Q14807	
Q14814	
Q14831	
Q14832	
Q14833	
Q14839	
Q14847	
Q14849	
Q14863	
Q14865	
Q14872	
Q14894	
Q14896	
Q14914	
Q14916	
Q14919	
Q14929	
Q14934	
Q14938	
Q14940	
Q14943	
Q14952	
Q14953	
Q14954	
Q14956	
Q14957	
Q14964	
Q14966	
Q14973	
Q14974	
Q14978	
Q14980	
Q14982	
Q14990	
Q14993	
Q14994	
Q14995	ENZYME REGULATION: The heme-bound form can bind gaseous signaling molecules such as CO and nitric oxide (NO) and NO can reverse its transcriptional repressor activity. {ECO:0000269|PubMed:19243223}.
Q14997	
Q14999	
Q149M9	
Q149N8	
Q14BN4	
Q14C86	
Q14C87	
Q14CB8	
Q14CM0	
Q14CN2	
Q14CN4	
Q14CS0	
Q14CW9	
Q14CX5	
Q14CX7	
Q14CZ0	
Q14CZ7	
Q14CZ8	
Q14D04	
Q14D33	
Q14DG7	
Q15003	
Q15004	
Q15005	
Q15006	
Q15007	
Q15008	
Q15011	
Q15012	
Q15013	
Q15014	
Q15018	
Q15019	
Q15020	
Q15021	
Q15022	
Q15024	
Q15025	
Q15027	ENZYME REGULATION: GAP activity stimulated by phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidic acid. {ECO:0000269|PubMed:11062263}.
Q15029	
Q15031	
Q15032	
Q15034	
Q15035	
Q15036	
Q15038	
Q15040	
Q15041	
Q15042	
Q15043	
Q15046	ENZYME REGULATION: Up-regulated by DARS and EEF1A1, but not by AIMP2. {ECO:0000269|PubMed:18029264}.
Q15047	
Q15048	
Q15049	
Q15050	
Q15051	
Q15052	
Q15053	
Q15054	
Q15056	
Q15057	ENZYME REGULATION: GAP activity stimulated by phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidic acid. {ECO:0000269|PubMed:11062263}.
Q15058	
Q15059	
Q15061	
Q15063	
Q15067	
Q15070	
Q15072	
Q15075	
Q15077	
Q15078	
Q15080	
Q15084	
Q15102	
Q15109	
Q15111	
Q15113	
Q15116	
Q15118	ENZYME REGULATION: Activity is enhanced by binding to the pyruvate dehydrogenase subunit DLAT. Inhibited by AZD7545; this compound interferes with DLAT binding and thereby inhibits kinase activity. Inhibited by dichloroacetate and radicicol. {ECO:0000269|PubMed:17683942}.
Q15119	ENZYME REGULATION: Activity is enhanced by binding to the pyruvate dehydrogenase subunit DLAT. Inhibited by ADP and pyruvate; these compounds interfere with DLAT binding and thereby inhibit kinase activity. Inhibited by dichloroacetate. Inhibited by AZD7545; this compound interferes with DLAT binding and thereby inhibits kinase activity. {ECO:0000269|PubMed:15491150, ECO:0000269|PubMed:16517984, ECO:0000269|PubMed:19833728}.
Q15120	ENZYME REGULATION: Activated by interaction with DLAT. Inhibited by AZD7545, dichloroacetate and radicicol. {ECO:0000269|PubMed:10748134, ECO:0000269|PubMed:17683942}.
Q15121	
Q15124	
Q15125	
Q15126	
Q15131	
Q15139	ENZYME REGULATION: Activated by DAG and phorbol esters. Phorbol-ester/DAG-type domain 1 binds DAG with high affinity and appears to play the dominant role in mediating translocation to the cell membrane and trans-Golgi network. Phorbol-ester/DAG-type domain 2 binds phorbol ester with higher affinity. Autophosphorylation of Ser-742 and phosphorylation of Ser-738 by PKC relieves auto-inhibition by the PH domain. Phosphorylation on Tyr-463 by the SRC-ABL1 pathway in response to oxidative stress, is also required for activation. Activated by DAPK1 under oxidative stress. {ECO:0000269|PubMed:12637538, ECO:0000269|PubMed:17703233, ECO:0000269|PubMed:18076381}.
Q15147	
Q15149	
Q15154	
Q15155	
Q15165	
Q15166	
Q15170	
Q15172	
Q15173	
Q15181	
Q15185	
Q15195	
Q15198	
Q15208	ENZYME REGULATION: Activated by binding of S100B which releases autoinhibitory N-lobe interactions, enabling ATP to bind and the autophosphorylation of Ser-281. Thr-444 then undergoes calcium-dependent phosphorylation by STK24/MST3. Interactions between phosphorylated Thr-444 and the N-lobe promote additional structural changes that complete the activation of the kinase. Autoinhibition is also released by the binding of MOB1/MOBKL1A and MOB2/HCCA2 to the N-terminal of STK38. {ECO:0000269|PubMed:12493777, ECO:0000269|PubMed:14661952, ECO:0000269|PubMed:15067004, ECO:0000269|PubMed:15197186}.
Q15223	
Q15233	
Q15238	
Q15256	
Q15257	
Q15262	
Q15269	
Q15270	
Q15274	ENZYME REGULATION: Activity toward QA is slightly repressed by phosphoribosylpyrophosphate (PRPP) in both a competitive and a non-competitive manner. {ECO:0000269|PubMed:17868694}.
Q15276	
Q15283	
Q15286	ENZYME REGULATION: Rab activation is generally mediated by a guanine exchange factor (GEF), while inactivation through hydrolysis of bound GTP is catalyzed by a GTPase activating protein (GAP) (PubMed:20154091). That Rab is activated by the guanine exchange factors DENND1A, DENND1B and DENND1C (PubMed:20154091). {ECO:0000269|PubMed:20154091}.
Q15287	
Q15291	
Q15293	
Q15303	ENZYME REGULATION: Binding of a cognate ligand leads to dimerization and activation by autophosphorylation on tyrosine residues. In vitro kinase activity is increased by Mg(2+). Inhibited by PD153035, lapatinib, gefitinib (iressa, ZD1839), AG1478 and BIBX1382BS. {ECO:0000269|PubMed:11178955, ECO:0000269|PubMed:18334220, ECO:0000269|PubMed:19098003, ECO:0000269|PubMed:21439954, ECO:0000269|PubMed:8617750}.
Q15306	
Q15311	
Q15319	
Q15323	
Q15326	
Q15327	
Q15329	
Q15334	
Q15345	
Q15349	ENZYME REGULATION: Upon extracellular signal or mitogen stimulation, phosphorylated at Thr-570 in the C-terminal kinase domain (CTKD) by MAPK1/ERK2 and MAPK3/ERK1. The activated CTKD then autophosphorylates Ser-377, allowing binding of PDPK1, which in turn phosphorylates Ser-218 in the N-terminal kinase domain (NTDK) leading to the full activation of the protein and subsequent phosphorylation of the substrates by the NTKD. {ECO:0000269|PubMed:10480933}.
Q15361	
Q15363	
Q15365	
Q15366	
Q15369	
Q15370	
Q15375	
Q15382	ENZYME REGULATION: Alternates between an inactive form bound to GDP and an active form bound to GTP. Inactivated by TSC1-TSC2 via the GTPase activating protein (GAP) domain of TSC2.
Q15386	
Q15388	
Q15389	
Q15390	
Q15391	
Q15392	
Q15393	
Q15397	
Q15398	
Q15399	
Q15404	
Q15406	
Q15413	
Q15415	
Q15417	
Q15418	ENZYME REGULATION: Upon extracellular signal or mitogen stimulation, phosphorylated at Thr-573 in the C-terminal kinase domain (CTKD) by MAPK1/ERK2 and MAPK3/ERK1. The activated CTKD then autophosphorylates Ser-380, allowing binding of PDPK1, which in turn phosphorylates Ser-221 in the N-terminal kinase domain (NTDK) leading to the full activation of the protein and subsequent phosphorylation of the substrates by the NTKD. {ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:9430688}.
Q15424	
Q15427	
Q15428	
Q15431	
Q15434	
Q15435	
Q15436	
Q15437	
Q15438	
Q15459	
Q15464	
Q15465	
Q15466	
Q15468	
Q15475	
Q15477	
Q15485	
Q15486	
Q15493	
Q15506	
Q15513	
Q15517	
Q15526	
Q15527	
Q15528	
Q15532	
Q15542	
Q15543	
Q15544	
Q15545	
Q15546	
Q15554	
Q15555	
Q15560	
Q15561	
Q15562	
Q15569	ENZYME REGULATION: Activated by autophosphorylation on Ser-220. Kinase activity is inhibited by SPRED1 (By similarity). {ECO:0000250}.
Q15572	
Q15573	
Q15582	
Q15583	
Q15596	
Q15599	
Q155Q3	
Q15612	
Q15615	
Q15617	
Q15619	
Q15620	
Q15622	
Q15628	
Q15629	
Q15631	
Q15633	
Q15637	
Q15642	
Q15643	
Q15645	
Q15646	
Q15648	
Q15649	
Q15650	
Q15651	
Q15652	
Q15653	
Q15654	
Q15661	
Q15669	
Q15672	
Q15678	
Q15691	
Q15695	
Q15696	
Q15697	
Q15699	
Q156A1	
Q15700	
Q15714	
Q15717	
Q15722	
Q15723	
Q15726	
Q15735	
Q15738	
Q15742	
Q15743	
Q15744	
Q15746	ENZYME REGULATION: Isoform 1 is activated by phosphorylation on Tyr-464 and Tyr-471. Isoforms which lack these tyrosine residues are not regulated in this way. All catalytically active isoforms require binding to calcium and calmodulin for activation. Repressed by organometallic pyridylnaphthalimide complexes, wortmannin, ML-7 (a synthetic naphthalenesulphonyl derivative that inhibits the binding of ATP to MLCK) and ML-9. {ECO:0000269|PubMed:11113114, ECO:0000269|PubMed:11976941, ECO:0000269|PubMed:14741352, ECO:0000269|PubMed:16284075, ECO:0000269|PubMed:16723733, ECO:0000269|PubMed:21918590}.
Q15750	
Q15751	
Q15758	
Q15759	ENZYME REGULATION: Activated by phosphorylation on threonine and tyrosine by MAP2K3/MKK3, MAP2K4/MKK4 and MAP2K6/MKK6. MAP2K3/MKK3 and MAP2K6/MKK6 are both essential for the activation of MAPK11 induced by environmental stress. HDAC3 interacts directly and selectively with MAPK11 to repress ATF2 transcriptional activity, and regulate TNF gene expression in LPS-stimulated cells. Inhibited by SB203580 and pyridinyl-imidazole related compounds. {ECO:0000269|PubMed:11359773, ECO:0000269|PubMed:15356147, ECO:0000269|PubMed:9218798, ECO:0000269|PubMed:9430721}.
Q15760	
Q15761	
Q15762	
Q15768	
Q15771	
Q15772	
Q15773	
Q15776	
Q15777	
Q15782	
Q15784	
Q15785	
Q15788	
Q15796	
Q15797	
Q15800	
Q15811	
Q15813	
Q15814	
Q15818	
Q15819	
Q15822	
Q15825	
Q15828	
Q15831	ENZYME REGULATION: Activated by forming a complex with STRAD (STRADA or STRADB) and CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta): STRADA (or STRADB)-binding promotes a conformational change of STK11/LKB1 in an active conformation, which is stabilized by CAB39/MO25alpha (or CAB39L/MO25beta) interacting with the STK11/LKB1 activation loop. Sequestration in the nucleus by NR4A1 prevents it from phosphorylating and activating cytoplasmic AMPK. {ECO:0000269|PubMed:19892943, ECO:0000269|PubMed:22983157}.
Q15833	
Q15834	
Q15835	ENZYME REGULATION: Inhibited by phosphorylation of Ser-21. {ECO:0000269|PubMed:15946941}.
Q15836	
Q15842	
Q15843	
Q15846	
Q15847	
Q15848	
Q15849	
Q15853	
Q15858	
Q15878	
Q15884	
Q15904	
Q15906	
Q15907	
Q15910	
Q15911	
Q15915	
Q15916	
Q15928	
Q15929	
Q15935	
Q15937	
Q15940	
Q15942	
Q15973	
Q16048	
Q16082	
Q16099	
Q16134	
Q16143	
Q16181	
Q16186	
Q16204	
Q16206	ENZYME REGULATION: Inhibited by the antitumor sulfonylurea LY181984, the vabilloid capsaicin, and retinoids. {ECO:0000269|PubMed:11888291, ECO:0000269|PubMed:9046026, ECO:0000269|PubMed:9932650}.
Q16222	
Q16236	
Q16254	
Q16270	
Q16280	
Q16281	
Q16288	
Q16322	
Q16342	
Q16348	
Q16352	
Q16363	
Q16378	
Q16384	
Q16385	
Q16394	
Q16401	
Q16445	
Q16473	
Q16478	
Q16512	ENZYME REGULATION: Kinase activity is activated upon binding to Rho proteins (RHOA, RHOB and RAC1). Activated by lipids, particularly cardiolipin and to a lesser extent by other acidic phospholipids. Activated by caspase-3 (CASP3) cleavage during apoptosis. Two specific sites, Thr-774 (activation loop of the kinase domain) and Ser-916 (turn motif), need to be phosphorylated for its full activation. {ECO:0000269|PubMed:8571126, ECO:0000269|PubMed:9751706}.
Q16513	ENZYME REGULATION: Kinase activity is activated upon binding to GTP-bound Rhoa/Rac1 GTPases. Activated by caspase-3 (CASP3) cleavage during apoptosis. Activated by lipids, particularly cardiolipin and to a lesser extent by other acidic phospholipids and unsaturated fatty acids. Two specific sites, Thr-816 (activation loop of the kinase domain) and Thr-958 (turn motif), need to be phosphorylated for its full activation. {ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:18835241, ECO:0000269|PubMed:9368003}.
Q16514	
Q16515	
Q16517	
Q16518	
Q16520	
Q16526	ENZYME REGULATION: KL001 (N-[3-(9H-carbazol-9-yl)-2-hydroxypropyl]-N-(2-furanylmethyl)-methanesulfonamide) binds to CRY1 and stabilizes it by inhibiting FBXL3- and ubiquitin-dependent degradation of CRY1 resulting in lengthening of the circadian periods. {ECO:0000269|PubMed:22798407}.
Q16527	
Q16531	
Q16533	
Q16534	
Q16537	
Q16538	
Q16539	ENZYME REGULATION: Activated by cell stresses such as DNA damage, heat shock, osmotic shock, anisomycin and sodium arsenite, as well as pro-inflammatory stimuli such as bacterial lipopolysaccharide (LPS) and interleukin-1. Activation occurs through dual phosphorylation of Thr-180 and Tyr-182 by either of two dual specificity kinases, MAP2K3/MKK3 or MAP2K6/MKK6, and potentially also MAP2K4/MKK4, as well as by TAB1-mediated autophosphorylation. MAPK14 phosphorylated on both Thr-180 and Tyr-182 is 10-20-fold more active than MAPK14 phosphorylated only on Thr-180, whereas MAPK14 phosphorylated on Tyr-182 alone is inactive. whereas Thr-180 is necessary for catalysis, Tyr-182 may be required for auto-activation and substrate recognition. Phosphorylated at Tyr-323 by ZAP70 in an alternative activation pathway in response to TCR signaling in T-cells. This alternative pathway is inhibited by GADD45A. Inhibited by dual specificity phosphatases, such as DUSP1, DUSP10, and DUSP16. Specifically inhibited by the binding of pyridinyl-imidazole compounds, which are cytokine-suppressive anti-inflammatory drugs (CSAID). Isoform Mxi2 is 100-fold less sensitive to these agents than the other isoforms and is not inhibited by DUSP1. Isoform Exip is not activated by MAP2K6. SB203580 is an inhibitor of MAPK14. {ECO:0000269|PubMed:10391943, ECO:0000269|PubMed:10838079, ECO:0000269|PubMed:11278799, ECO:0000269|PubMed:11359773, ECO:0000269|PubMed:11847341, ECO:0000269|PubMed:11866441, ECO:0000269|PubMed:11896401, ECO:0000269|PubMed:12482439, ECO:0000269|PubMed:14561090, ECO:0000269|PubMed:14726206, ECO:0000269|PubMed:15735648, ECO:0000269|PubMed:15735649, ECO:0000269|PubMed:15837335, ECO:0000269|PubMed:16169718, ECO:0000269|PubMed:17003045, ECO:0000269|PubMed:7535770, ECO:0000269|PubMed:8622669, ECO:0000269|PubMed:9430721}.
Q16540	
Q16543	
Q16548	
Q16549	ENZYME REGULATION: Inhibited by zinc and copper. {ECO:0000250}.
Q16552	
Q16553	
Q16555	
Q16557	
Q16558	
Q16559	
Q16560	
Q16563	
Q16566	ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of calmodulin results in conformational change that relieves intrasteric autoinhibition and allows phosphorylation of Thr-200 within the activation loop by CaMKK1 or CaMKK2. Phosphorylation of Thr-200 results in a 10-20-fold increase in total activity to generate Ca(2+)/calmodulin-independent activity. Autophosphorylation of the N-terminus Ser-12 and Ser-13 is required for full activation. Inactivated by protein phosphatase 2A (PPP2CA/PPP2CB) which dephosphorylates Thr-200, thereby terminating autonomous activity and helping to maintain the enzyme in its autoinhibited state. {ECO:0000269|PubMed:15143065, ECO:0000269|PubMed:15769749, ECO:0000269|PubMed:8702940}.
Q16568	
Q16570	
Q16572	
Q16576	
Q16581	
Q16584	ENZYME REGULATION: Homodimerization via the leucine zipper domains is required for autophosphorylation and subsequent activation. {ECO:0000269|PubMed:11053428, ECO:0000269|PubMed:9829970}.
Q16585	
Q16586	
Q16587	
Q16589	
Q16594	
Q16595	
Q16600	
Q16602	
Q16609	
Q16610	
Q16611	
Q16612	
Q16613	
Q16617	
Q16619	
Q16620	ENZYME REGULATION: The neuronal activity and the influx of calcium positively regulate the kinase activity and the internalization of the receptor which are both important for active signaling. Regulated by NGFR that may control the internalization of the receptor. NGFR may also stimulate the activation by BDNF compared to NTF3 and NTF4. SH2D1A inhibits the autophosphorylation of the receptor, and alters the recruitment and activation of downstream effectors and signaling cascades. The formation of active receptors dimers able to fully transduce the ligand-mediated signal, may be negatively regulated by the formation of inactive heterodimers with the non-catalytic isoforms (By similarity). {ECO:0000250|UniProtKB:P15209, ECO:0000250|UniProtKB:Q63604}.
Q16621	
Q16623	
Q16625	
Q16626	
Q16627	
Q16629	
Q16630	
Q16633	
Q16635	
Q16637	
Q16643	
Q16644	ENZYME REGULATION: Activated following phosphorylation by p38-alpha/MAPK14 following various stresses. Inhibited by ligand 5B (2'-[2-(1,3-benzodioxol-5-yl)pyrimidin-4-yl]-5',6'-dihydrospiro[piperidine-4,7'-pyrrolo[3,2-c]pyridin]- 4'(1'h)-one) and ligand P4O (2-[2-(2-fluorophenyl)pyridin-4-yl]-1,5,6,7-tetrahydro- 4h-pyrrolo[3,2-c]pyridin-4-one), 2 ATP-competitive inhibitors.
Q16647	
Q16649	
Q16650	
Q16651	
Q16653	
Q16654	
Q16655	
Q16656	
Q16658	
Q16659	ENZYME REGULATION: Activated by phosphorylation at Ser-189.
Q16661	
Q16663	
Q16665	
Q16666	
Q16667	
Q16670	
Q16671	
Q16674	
Q16676	
Q16678	ENZYME REGULATION: Enzyme activity is increased by liposomes containing anionic phospholipids, phosphatidic acid and cardiolipin. Inhibited by naringenin with an IC(50) of 5 uM. {ECO:0000269|PubMed:22888116, ECO:0000269|PubMed:22935222}.
Q16690	
Q16695	
Q16696	
Q16698	
Q16706	
Q16718	
Q16719	ENZYME REGULATION: Inhibited by o-methoxybenzoylalanine (OMBA). {ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}.
Q16720	
Q16739	
Q16740	
Q16760	ENZYME REGULATION: Partially inhibited by phosphatidylserine.
Q16762	
Q16763	
Q16769	
Q16772	
Q16773	ENZYME REGULATION: Inhibited by tryptophan, indole-3-pyruvic acid, 3-indolepropionic acid, DL-indole-3-lactic acid, indole-3-acetic acid (IAC) and Tris. {ECO:0000269|PubMed:19338303}.
Q16774	
Q16775	
Q16777	
Q16778	
Q16787	
Q16790	ENZYME REGULATION: Inhibited by coumarins, saccharin, sulfonamide derivatives such as acetazolamide (AZA) and Foscarnet (phosphonoformate trisodium salt). {ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.
Q16795	
Q16798	
Q16799	
Q16816	
Q16819	ENZYME REGULATION: Inhibited by several hydroxamate compounds, the most potent inhibitor is actinonin. {ECO:0000269|PubMed:17976009}.
Q16820	ENZYME REGULATION: Strongly inhibited by fetuin-A/AHSG. {ECO:0000269|PubMed:20806899, ECO:0000269|PubMed:22940918}.
Q16821	
Q16822	
Q16825	
Q16827	
Q16828	
Q16829	
Q16831	
Q16832	ENZYME REGULATION: Present in an inactive state in the absence of collagen binding and phosphorylation by SRC. Tyrosine phosphorylation enhances the affinity for ATP and the catalytic activity. {ECO:0000269|PubMed:16186108}.
Q16836	
Q16842	
Q16849	
Q16850	
Q16851	
Q16853	
Q16854	
Q16864	
Q16873	
Q16875	
Q16877	ENZYME REGULATION: The most important regulatory mechanism of these opposing activities is by phosphorylation and dephosphorylation of the enzyme. {ECO:0000250}.
Q16878	
Q16880	
Q16881	
Q16890	
Q16891	
Q17R31	
Q17R55	
Q17R60	
Q17R89	
Q17R98	
Q17RA5	
Q17RB0	
Q17RB8	
Q17RC7	
Q17RD7	
Q17RF5	
Q17RG1	
Q17RH7	
Q17RM4	
Q17RN3	
Q17RP2	
Q17RQ9	
Q17RR3	
Q17RS7	
Q17RW2	
Q17RY0	
Q17RY6	
Q18PE1	
Q19AV6	
Q19T08	
Q1A5X6	
Q1A5X7	
Q1AE95	
Q1ED39	
Q1EHB4	ENZYME REGULATION: Cotransport of monocarboxylates and nicotinate strongly inhibited by ibuprofen, fenoprofen and ketoprofen.
Q1HG43	
Q1HG44	
Q1KMD3	
Q1L5Z9	
Q1L6U9	
Q1MSJ5	
Q1MX18	
Q1RMZ1	
Q1RN00	
Q1T7F1	
Q1W209	
Q1W4C9	
Q1W6H9	
Q1X8D7	
Q1XH10	
Q1ZYL8	
Q1ZZU3	
Q24JP5	
Q24JQ0	
Q27J81	ENZYME REGULATION: Phosphate inhibits both the depolymerization and severing activities.
Q29718	
Q29836	
Q29865	
Q29940	
Q29960	
Q29963	
Q29974	
Q29980	
Q29983	
Q29RF7	
Q2HXU8	
Q2I0M4	
Q2I0M5	
Q2KHM9	
Q2KHN1	
Q2KHR2	
Q2KHR3	
Q2KHT3	
Q2KHT4	
Q2KJY2	
Q2L4Q9	
Q2LD37	
Q2M1K9	
Q2M1P5	
Q2M1V0	
Q2M1Z3	
Q2M218	
Q2M238	
Q2M243	
Q2M296	
Q2M2D7	
Q2M2E3	
Q2M2E5	
Q2M2H8	
Q2M2I3	
Q2M2I5	
Q2M2I8	ENZYME REGULATION: Stimulated by clathrin. {ECO:0000250}.
Q2M2W7	
Q2M2Z5	
Q2M329	
Q2M385	
Q2M389	
Q2M3A8	
Q2M3C6	
Q2M3C7	
Q2M3D2	
Q2M3G0	
Q2M3G4	
Q2M3M2	
Q2M3R5	
Q2M3T9	
Q2M3V2	
Q2M3W8	
Q2M3X9	
Q2M5E4	
Q2MJR0	
Q2MKA7	
Q2MV58	
Q2NKJ3	
Q2NKQ1	
Q2NKX8	
Q2NKX9	
Q2NL67	
Q2NL68	
Q2NL82	
Q2NL98	
Q2PPJ7	
Q2PZI1	
Q2Q1W2	
Q2QD12	
Q2QGD7	
Q2QL34	
Q2T9J0	
Q2T9K0	
Q2T9L4	
Q2TAA2	
Q2TAA5	
Q2TAA8	
Q2TAC2	
Q2TAC6	
Q2TAK8	
Q2TAL5	
Q2TAL6	
Q2TAL8	
Q2TAM9	
Q2TAP0	
Q2TAY7	
Q2TAZ0	
Q2TB10	
Q2TB18	
Q2TB90	
Q2TBA0	
Q2TBC4	
Q2TBE0	
Q2TBF2	
Q2TV78	
Q2UY09	
Q2V2M9	
Q2VIQ3	
Q2VIR3	
Q2VPA4	
Q2VPB7	
Q2VPJ9	
Q2VPK5	
Q2VWA4	
Q2VWP7	
Q2VY69	
Q2VYF4	
Q2WEN9	
Q2WGJ6	
Q2WGJ8	
Q2WGJ9	
Q2WGN9	
Q2Y0W8	ENZYME REGULATION: Activity is inhibited by 4,4'-Di-isothiocyanatostilbene-2,2'-disulfonic acid (DIDS - an inhibitor of several anion channels and transporters).
Q2YD98	
Q30134	
Q30154	
Q30167	
Q30201	
Q309B1	
Q30KP8	
Q30KP9	
Q30KQ1	
Q30KQ4	
Q30KQ5	
Q30KQ6	
Q30KQ7	
Q30KQ8	
Q30KQ9	
Q30KR1	
Q31610	
Q31612	
Q32M45	
Q32M78	
Q32M84	
Q32M88	
Q32M92	
Q32MH5	
Q32MK0	
Q32MQ0	
Q32MZ4	
Q32NB8	ENZYME REGULATION: Activated by calcium and magnesium and inhibited by other bivalent cations. {ECO:0000250}.
Q32NC0	
Q32P28	
Q32P41	
Q32P44	
Q32P51	
Q32Q52	
Q32ZL2	
Q330K2	
Q33E94	
Q38SD2	ENZYME REGULATION: Binding of GTP stimulates kinase activity. {ECO:0000269|PubMed:16243488}.
Q3B726	
Q3B7I2	
Q3B7J2	
Q3B7S5	
Q3B7T1	
Q3B7T3	
Q3B820	
Q3B8N2	
Q3B8N5	
Q3BBV0	
Q3BBV2	
Q3C1V0	
Q3C1V1	
Q3C1V8	
Q3C1V9	
Q3I5F7	
Q3KNS1	
Q3KNS6	
Q3KNT7	
Q3KNT9	
Q3KNV8	
Q3KNW1	
Q3KNW5	
Q3KP22	
Q3KP31	
Q3KP44	
Q3KP66	
Q3KPI0	
Q3KQU3	
Q3KQV3	
Q3KQV9	
Q3KQZ1	
Q3KR16	
Q3KR37	
Q3KRA6	
Q3KRA9	
Q3KRB8	
Q3L8U1	
Q3LFD5	
Q3LHN0	
Q3LHN1	
Q3LHN2	
Q3LI54	
Q3LI58	
Q3LI59	
Q3LI60	
Q3LI61	
Q3LI62	
Q3LI63	
Q3LI64	
Q3LI66	
Q3LI67	
Q3LI68	
Q3LI70	
Q3LI72	
Q3LI73	
Q3LI76	
Q3LI77	
Q3LI81	
Q3LI83	
Q3LIE5	
Q3LXA3	ENZYME REGULATION: Each activity is inhibited by the substrate(s) of the other.
Q3MHD2	
Q3MII6	
Q3MIN7	
Q3MIP1	
Q3MIR4	
Q3MIS6	
Q3MIT2	
Q3MIV0	
Q3MIW9	
Q3MIX3	
Q3MJ13	
Q3MJ16	ENZYME REGULATION: Stimulated by cytosolic Ca(2+). {ECO:0000250}.
Q3MJ40	
Q3MJ62	
Q3MUY2	
Q3SX64	
Q3SXM0	
Q3SXM5	
Q3SXP7	
Q3SXR2	
Q3SXY7	
Q3SXY8	
Q3SXZ3	
Q3SXZ7	
Q3SY00	
Q3SY05	
Q3SY17	
Q3SY46	
Q3SY52	
Q3SY56	
Q3SY69	
Q3SY77	
Q3SY84	
Q3SY89	
Q3SYA9	
Q3SYB3	
Q3SYC2	ENZYME REGULATION: Inhibited by oleic acid and sphingosine, while it is stimulated by phosphatidylcholine, phosphatidylserine and phosphatidic acid. {ECO:0000250}.
Q3SYF9	
Q3SYG4	
Q3T8J9	
Q3T906	
Q3V5L5	
Q3V6T2	
Q3Y452	
Q3YBM2	
Q3YBR2	
Q3YEC7	
Q3ZAQ7	
Q3ZCM7	
Q3ZCN5	
Q3ZCQ2	
Q3ZCQ3	
Q3ZCQ8	
Q3ZCT1	
Q3ZCT8	
Q3ZCU0	
Q3ZCV2	
Q3ZCW2	
Q3ZCX4	
Q3ZLR7	
Q400G9	ENZYME REGULATION: Inhibited by the general metalloprotease inhibitors o-phenanthroline and batimastat. Also significantly inhibited by amastatin, which is an inhibitor of aminopeptidases. Not inhibited by 4-(2-aminoethyl)-benzenesulfonyl fluoride, E-64, and TIMPS (tissue inhibitors of metalloproteinases), which are inhibitors of serine, cysteine, and matrix metalloproteases, respectively. {ECO:0000269|PubMed:15972818}.
Q401N2	
Q460N3	
Q460N5	
Q494R0	
Q494R4	
Q494U1	
Q494V2	
Q494W8	
Q494X1	
Q494X3	
Q495A1	
Q495B1	
Q495C1	
Q495D7	
Q495M3	
Q495M9	
Q495N2	
Q495T6	ENZYME REGULATION: Inhibited by thiorphan and phosphoramidon. {ECO:0000250}.
Q495W5	
Q495X7	
Q495Y7	
Q495Y8	
Q495Z4	
Q496A3	
Q496F6	
Q496H8	
Q496J9	
Q496M5	
Q496Y0	
Q499Y3	
Q499Z3	
Q499Z4	
Q49A17	
Q49A26	
Q49A33	
Q49A88	
Q49A92	
Q49AA0	
Q49AG3	
Q49AH0	
Q49AJ0	
Q49AM1	
Q49AM3	
Q49AN0	ENZYME REGULATION: KL001 (N-[3-(9H-carbazol-9-yl)-2-hydroxypropyl]-N-(2-furanylmethyl)-methanesulfonamide) binds to CRY1 and stabilizes it by inhibiting FBXL3- and ubiquitin-dependent degradation of CRY1 resulting in lengthening of the circadian periods. {ECO:0000269|PubMed:22798407}.
Q49AR2	
Q49AS3	
Q49B96	
Q49MG5	
Q49MI3	
Q49SQ1	
Q4AC94	
Q4AC99	
Q4ADV7	
Q4AE62	
Q4FZB7	
Q4G0A6	
Q4G0F5	
Q4G0G2	
Q4G0G5	
Q4G0I0	
Q4G0J3	
Q4G0M1	
Q4G0N0	
Q4G0N4	ENZYME REGULATION: Inhibited by NADH, NADPH and NADP(+). {ECO:0000269|PubMed:23212377}.
Q4G0N7	
Q4G0N8	
Q4G0P3	
Q4G0S4	
Q4G0S7	
Q4G0T1	
Q4G0U5	
Q4G0W2	
Q4G0X4	
Q4G0X9	
Q4G0Z9	
Q4G112	
Q4G148	
Q4G163	
Q4G176	
Q4G1C9	
Q4J6C6	ENZYME REGULATION: Inhibited by PMSF and Prefabloc, as well as leupeptin at high concentrations. Partially inhibited by TPCK, a chymotrypsin inhibitor, and E64, a cysteine protease inhibitor. Not affected by 4-amidinophenyl-methanesulfonyl fluoride (APMSF), pepstatin or EDTA. {ECO:0000269|PubMed:16385448}.
Q4JDL3	
Q4KMG0	
Q4KMG9	
Q4KMP7	
Q4KMQ1	
Q4KMQ2	ENZYME REGULATION: Exhibits synergistic gating by Ca(2+) and voltage. Inhibited by some non-specific cation channel blockers such as: ruthenium red, 2-aminoethyl diphenylborinate (2APB), gadolinium and cadmium ions (By similarity). {ECO:0000250}.
Q4KMX7	
Q4KMZ1	
Q4KMZ8	
Q4KWH8	
Q4L180	
Q4L235	
Q4LDE5	
Q4LDG9	
Q4LDR2	
Q4LE39	
Q4LEZ3	
Q4QY38	
Q4U2R6	
Q4U2R8	
Q4UJ75	
Q4V321	
Q4V326	
Q4V328	
Q4V339	
Q4V348	
Q4V9L6	
Q4VC05	
Q4VC12	
Q4VC31	
Q4VC39	
Q4VC44	
Q4VCS5	
Q4VNC0	
Q4VNC1	
Q4VX62	
Q4VX76	
Q4VXA5	
Q4VXF1	
Q4VXU2	
Q4W4Y0	
Q4W5G0	
Q4W5N1	
Q4W5P6	
Q4ZG55	
Q4ZHG4	
Q4ZIN3	
Q4ZJI4	
Q502W6	
Q502W7	
Q502X0	
Q504Q3	ENZYME REGULATION: Positively regulated by the regulatory subunit PAN3. {ECO:0000255|HAMAP-Rule:MF_03182}.
Q504T8	
Q504U0	
Q504Y0	
Q504Y2	
Q504Y3	
Q50LG9	
Q52LA3	
Q52LC2	
Q52LD8	
Q52LG2	
Q52LJ0	
Q52LR7	
Q52LW3	
Q52M58	
Q52M75	
Q52M93	
Q52MB2	
Q52WX2	
Q537H7	
Q538Z0	
Q53EL6	
Q53EL9	
Q53EP0	
Q53EQ6	
Q53ET0	
Q53EU6	ENZYME REGULATION: Inhibited by N-ethylmaleimide (NEM). {ECO:0000269|PubMed:17170135}.
Q53EV4	
Q53EZ4	
Q53F19	
Q53F39	
Q53FA7	
Q53FD0	
Q53FE4	
Q53FP2	
Q53FT3	
Q53FV1	
Q53FZ2	
Q53G44	
Q53G59	
Q53GA4	
Q53GD3	
Q53GG5	
Q53GI3	
Q53GL0	
Q53GL7	
Q53GQ0	
Q53GS7	
Q53GS9	
Q53GT1	
Q53H12	
Q53H47	
Q53H54	
Q53H64	
Q53H76	
Q53H80	
Q53H82	
Q53H96	ENZYME REGULATION: Not inhibited by proline. {ECO:0000269|PubMed:23024808}.
Q53HC0	
Q53HC5	
Q53HC9	
Q53HI1	
Q53HL2	
Q53HV7	
Q53LP3	
Q53QV2	
Q53QW1	
Q53QZ3	
Q53R12	
Q53R41	
Q53RD9	
Q53RE8	
Q53RT3	
Q53RY4	
Q53S33	
Q53S58	
Q53S99	
Q53SF7	
Q53SZ7	
Q53T59	
Q53T94	
Q53TN4	
Q53TQ3	
Q53TS8	
Q562E7	
Q562F6	
Q562R1	
Q567U6	
Q567V2	
Q569G3	
Q569H4	
Q569K4	
Q569K6	
Q56A73	
Q56NI9	
Q56P03	
Q56P42	
Q56UN5	
Q56UQ5	
Q56VL3	
Q580R0	
Q587I9	
Q587J7	
Q587J8	
Q58A44	
Q58A45	
Q58DX5	
Q58EX2	
Q58EX7	
Q58F21	
Q58FF3	
Q58FF6	
Q58FF7	
Q58FF8	
Q58FG0	
Q58FG1	
Q58G82	
Q58HT5	
Q58WW2	
Q59EK9	
Q59GN2	
Q59H18	
Q5BIV9	
Q5BJD5	
Q5BJE1	
Q5BJF2	
Q5BJF6	
Q5BJH2	
Q5BJH7	
Q5BKT4	
Q5BKU9	
Q5BKX5	
Q5BKX6	
Q5BKX8	
Q5BKY1	
Q5BKY6	
Q5BKY9	
Q5BKZ1	
Q5BLP8	
Q5BN46	
Q5BVD1	
Q5C9Z4	
Q5CZ79	
Q5CZA5	
Q5CZC0	
Q5D0E6	
Q5D1E8	
Q5D862	
Q5DID0	
Q5DJT8	
Q5DT21	
Q5DX21	
Q5EB52	
Q5EBL2	
Q5EBL4	
Q5EBL8	
Q5EBM0	
Q5EBM4	
Q5EBN2	
Q5EE01	
Q5EG05	
Q5F1R6	
Q5FBB7	
Q5FVE4	
Q5FWE3	
Q5FWF4	
Q5FWF5	
Q5FWF6	
Q5FWF7	
Q5FYA8	
Q5FYB0	
Q5FYB1	
Q5GAN3	
Q5GAN4	
Q5GAN6	
Q5GFL6	
Q5GH70	
Q5GH72	
Q5GH73	
Q5GH76	
Q5GH77	
Q5GJ75	
Q5GLZ8	
Q5H8A3	
Q5H8A4	
Q5H8C1	
Q5H913	
Q5H943	
Q5H9B9	
Q5H9E4	
Q5H9F3	
Q5H9I0	
Q5H9J7	
Q5H9J9	
Q5H9K5	
Q5H9L2	
Q5H9L4	
Q5H9M0	
Q5H9R4	
Q5H9R7	
Q5H9S7	
Q5H9T9	
Q5H9U9	
Q5HY64	
Q5HY92	
Q5HY98	
Q5HYA8	
Q5HYC2	
Q5HYI7	
Q5HYI8	
Q5HYJ1	
Q5HYJ3	
Q5HYK3	
Q5HYK7	
Q5HYK9	
Q5HYL7	
Q5HYM0	
Q5HYN5	
Q5HYR2	
Q5HYW2	
Q5HYW3	
Q5I0G3	
Q5I0X4	
Q5I0X7	
Q5I7T1	
Q5IJ48	
Q5J5C9	
Q5J8M3	
Q5J8X5	
Q5JNZ3	
Q5JNZ5	
Q5JPB2	
Q5JPE7	
Q5JPF3	
Q5JPH6	
Q5JPI3	
Q5JPI9	
Q5JQC4	
Q5JQC9	
Q5JQD4	
Q5JQF7	
Q5JQF8	
Q5JQS5	
Q5JQS6	
Q5JR12	
Q5JR59	
Q5JR98	
Q5JRA6	
Q5JRC9	
Q5JRK9	
Q5JRM2	
Q5JRS4	
Q5JRV8	
Q5JRX3	ENZYME REGULATION: Inhibited by nickel and zinc excess, and slightly activated by manganese. {ECO:0000269|PubMed:19196155}.
Q5JS13	
Q5JS37	
Q5JS54	
Q5JSH3	
Q5JSJ4	
Q5JSL3	
Q5JSP0	
Q5JSQ8	
Q5JSS6	
Q5JST6	
Q5JSZ5	
Q5JT25	
Q5JT78	
Q5JT82	
Q5JTB6	
Q5JTC6	
Q5JTD0	
Q5JTD7	
Q5JTH9	
Q5JTJ3	
Q5JTN6	
Q5JTV8	
Q5JTW2	
Q5JTY5	
Q5JTZ5	
Q5JTZ9	
Q5JU00	
Q5JU67	
Q5JU69	
Q5JU85	
Q5JUK2	
Q5JUK3	
Q5JUK9	
Q5JUQ0	
Q5JUR7	
Q5JUW0	
Q5JUX0	
Q5JV73	
Q5JVF3	
Q5JVG2	
Q5JVG8	
Q5JVL4	
Q5JVS0	
Q5JVX7	
Q5JW98	
Q5JWF2	
Q5JWF8	
Q5JWR5	
Q5JX69	
Q5JX71	
Q5JXA9	
Q5JXB2	
Q5JXC2	
Q5JXM2	
Q5JXX5	
Q5JXX7	
Q5JY77	
Q5JYT7	
Q5JZY3	
Q5K130	
Q5K131	
Q5K4E3	ENZYME REGULATION: Inhibited by serine proteinase inhibitor 4-(2-aminoethyl)-benzenesulfonyl fluoride, but not with EDTA or E-64. {ECO:0000269|PubMed:15536082}.
Q5K4L6	
Q5K651	
Q5KSL6	ENZYME REGULATION: Inhibited in response to H(2)O(2). {ECO:0000269|PubMed:16210324}.
Q5KU26	
Q5M775	
Q5M7Z0	
Q5M8T2	
Q5M9N0	
Q5M9Q1	
Q5MAI5	
Q5MCW4	
Q5MIZ7	
Q5MJ07	
Q5MJ08	
Q5MJ09	
Q5MJ10	
Q5MJ68	
Q5MJ70	
Q5MNV8	
Q5MNZ6	
Q5MNZ9	
Q5MY95	ENZYME REGULATION: Not inhibited by ARL 67156. {ECO:0000269|PubMed:17603550}.
Q5NDL2	
Q5NE16	
Q5NUL3	
Q5PR19	
Q5PRF9	
Q5PSV4	
Q5PT55	
Q5QFB9	
Q5QGS0	
Q5QGT7	
Q5QGZ9	
Q5QJ38	
Q5QJ74	
Q5QJE6	
Q5QJU3	ENZYME REGULATION: Specifically activated by lumenal, but not cytosolic Ca(2+). Inhibited by Zn(2+) or Cu(2+). Mg(2+) or Mn(2+) have no effect on ceramidase activity. {ECO:0000269|PubMed:20089856}.
Q5QNW6	
Q5QP82	
Q5R372	
Q5R387	
Q5R3F8	
Q5R3I4	
Q5R3K3	
Q5RGS3	
Q5RHP9	
Q5RI15	
Q5RIA9	
Q5RKV6	
Q5RL73	
Q5S007	
Q5SGD2	
Q5SNT2	
Q5SNV9	
Q5SQ13	
Q5SQ64	
Q5SQ80	
Q5SQH8	
Q5SQI0	
Q5SQN1	
Q5SQQ9	
Q5SQS7	
Q5SQS8	
Q5SR53	
Q5SR56	
Q5SRD0	
Q5SRD1	
Q5SRE5	
Q5SRE7	ENZYME REGULATION: Activity is increased by ascorbate. Inhibited by myristoyl-CoA. {ECO:0000269|PubMed:21530488}.
Q5SRH9	
Q5SRI9	
Q5SRN2	
Q5SRR4	
Q5SSG8	
Q5SSJ5	
Q5SSQ6	
Q5ST30	
Q5SV17	
Q5SV97	
Q5SVJ3	
Q5SVQ8	
Q5SVS4	
Q5SVZ6	
Q5SW24	
Q5SW79	
Q5SW96	
Q5SWA1	
Q5SWH9	
Q5SWL7	
Q5SWL8	
Q5SWW7	
Q5SWX8	
Q5SXH7	
Q5SXM1	
Q5SXM2	
Q5SXM8	
Q5SY13	
Q5SY16	
Q5SY68	
Q5SY80	
Q5SY85	
Q5SYB0	
Q5SYC1	
Q5SYE7	
Q5SZB4	
Q5SZD1	
Q5SZD4	
Q5SZI1	
Q5SZJ8	
Q5SZK8	
Q5SZL2	
Q5SZQ8	
Q5T011	
Q5T013	
Q5T035	
Q5T036	
Q5T089	
Q5T0B9	
Q5T0D9	
Q5T0F9	
Q5T0J3	
Q5T0J7	
Q5T0L3	
Q5T0N1	
Q5T0N5	
Q5T0T0	
Q5T0U0	
Q5T0W9	
Q5T0Z8	
Q5T124	
Q5T160	
Q5T197	
Q5T1A1	
Q5T1B0	
Q5T1B1	
Q5T1C6	
Q5T1H1	
Q5T1J5	
Q5T1J6	
Q5T1M5	
Q5T1N1	
Q5T1Q4	
Q5T1R4	
Q5T1S8	
Q5T1V6	
Q5T200	
Q5T215	
Q5T230	
Q5T280	
Q5T292	
Q5T2D2	
Q5T2D3	
Q5T2E6	
Q5T2L2	
Q5T2N8	
Q5T2Q4	
Q5T2R2	
Q5T2S8	
Q5T2T1	
Q5T2W1	
Q5T319	
Q5T3F8	
Q5T3I0	
Q5T3J3	
Q5T3U5	
Q5T3Y7	
Q5T440	
Q5T442	
Q5T447	
Q5T481	
Q5T4B2	
Q5T4D3	
Q5T4F4	
Q5T4F7	
Q5T4H9	
Q5T4I8	
Q5T4S7	
Q5T4T1	
Q5T4T6	
Q5T4W7	
Q5T5A4	
Q5T5A8	
Q5T5B0	
Q5T5C0	
Q5T5D7	
Q5T5F5	
Q5T5J6	
Q5T5M9	
Q5T5N4	
Q5T5P2	
Q5T5S1	
Q5T5U3	
Q5T5X7	
Q5T5Y3	
Q5T601	
Q5T619	
Q5T653	
Q5T655	
Q5T681	
Q5T686	
Q5T699	
Q5T6C5	
Q5T6F0	
Q5T6F2	
Q5T6J7	
Q5T6L9	
Q5T6M2	
Q5T6R2	
Q5T6S3	
Q5T6V5	
Q5T6X4	
Q5T6X5	
Q5T700	
Q5T742	
Q5T749	
Q5T750	
Q5T751	
Q5T752	
Q5T753	
Q5T754	
Q5T764	
Q5T7B8	
Q5T7M4	
Q5T7M9	
Q5T7N2	
Q5T7N3	
Q5T7N8	
Q5T7P2	
Q5T7P3	
Q5T7P6	
Q5T7P8	
Q5T7R7	
Q5T7V8	
Q5T7W0	
Q5T7W7	
Q5T848	
Q5T870	
Q5T871	
Q5T890	
Q5T8A7	
Q5T8D3	
Q5T8I3	
Q5T8I9	
Q5T8P6	
Q5T8R8	
Q5T953	
Q5T9A4	
Q5T9C2	
Q5T9C9	
Q5T9G4	
Q5T9L3	
Q5T9S5	
Q5T9Z0	
Q5TA31	
Q5TA45	
Q5TA50	
Q5TA76	
Q5TA77	
Q5TA78	
Q5TA79	
Q5TA81	
Q5TA82	
Q5TA89	
Q5TAA0	
Q5TAB7	
Q5TAG4	
Q5TAH2	
Q5TAP6	
Q5TAQ9	
Q5TAT6	
Q5TAX3	
Q5TB30	
Q5TB80	
Q5TBA9	
Q5TBB1	
Q5TBC7	
Q5TBE3	
Q5TBK1	
Q5TC04	
Q5TC12	
Q5TC63	
Q5TC79	
Q5TC82	
Q5TC84	
Q5TCH4	
Q5TCM9	
Q5TCQ9	
Q5TCS8	
Q5TCX8	ENZYME REGULATION: Homodimerization via the leucine zipper domains is required for autophosphorylation and subsequent activation. {ECO:0000250|UniProtKB:Q16584}.
Q5TCY1	
Q5TCZ1	
Q5TD94	
Q5TD97	
Q5TDH0	
Q5TDP6	
Q5TEA3	
Q5TEA6	
Q5TEC3	
Q5TEJ8	
Q5TEU4	
Q5TEV5	
Q5TEZ4	
Q5TEZ5	
Q5TF21	
Q5TF39	
Q5TF58	
Q5TFE4	
Q5TFG8	
Q5TFQ8	
Q5TG30	
Q5TG53	
Q5TG92	
Q5TGI0	
Q5TGI4	
Q5TGJ6	
Q5TGL8	
Q5TGP6	
Q5TGS1	
Q5TGU0	
Q5TGY1	
Q5TGY3	
Q5TGZ0	
Q5TH69	
Q5TH74	
Q5THJ4	
Q5THK1	
Q5THR3	
Q5TI25	
Q5TIA1	
Q5TID7	
Q5TIE3	
Q5TKA1	
Q5TYM5	
Q5TYW1	
Q5TYW2	
Q5TYX0	
Q5TZ20	
Q5TZA2	
Q5TZF3	
Q5TZJ5	
Q5TZK3	
Q5U3C3	
Q5U4N7	
Q5U4P2	
Q5U5Q3	
Q5U5R9	
Q5U5X0	
Q5U5X8	
Q5U5Z8	ENZYME REGULATION: Inhibited by RARRES1. {ECO:0000269|PubMed:21303978}.
Q5U623	
Q5U649	
Q5U651	
Q5UAW9	
Q5UCC4	
Q5UE93	
Q5UIP0	
Q5VIR6	
Q5VIY5	
Q5VSD8	
Q5VSG8	
Q5VSL9	
Q5VSP4	
Q5VSR9	
Q5VST6	ENZYME REGULATION: Inhibited by palmostatin-B. {ECO:0000269|PubMed:26701913}.
Q5VST9	
Q5VSY0	
Q5VT03	
Q5VT06	
Q5VT25	ENZYME REGULATION: Maintained in an inactive, closed conformation by an interaction between the kinase domain and the negative autoregulatory C-terminal coiled-coil region. Agonist binding to the phorbol ester binding site disrupts this, releasing the kinase domain to allow N-terminus-mediated dimerization and kinase activation by transautophosphorylation. Inhibited by chelerythrine chloride. {ECO:0000269|PubMed:11283256, ECO:0000269|PubMed:21457715}.
Q5VT28	
Q5VT33	
Q5VT40	
Q5VT52	
Q5VT66	
Q5VT79	
Q5VT97	
Q5VT98	
Q5VT99	
Q5VTA0	
Q5VTB9	
Q5VTD9	
Q5VTE0	
Q5VTE6	
Q5VTH2	
Q5VTH9	
Q5VTJ3	
Q5VTL7	
Q5VTL8	
Q5VTM2	
Q5VTQ0	
Q5VTR2	
Q5VTT2	
Q5VTT5	
Q5VTU8	
Q5VTY9	
Q5VU36	
Q5VU43	
Q5VU57	
Q5VU65	
Q5VU69	
Q5VU92	
Q5VU97	
Q5VUA4	
Q5VUB5	
Q5VUD6	
Q5VUE5	
Q5VUG0	
Q5VUJ5	
Q5VUJ6	
Q5VUJ9	
Q5VUM1	
Q5VUR7	
Q5VUY0	
Q5VUY2	
Q5VV11	
Q5VV16	
Q5VV17	
Q5VV41	
Q5VV42	
Q5VV43	
Q5VV52	
Q5VV63	
Q5VV67	
Q5VVB8	
Q5VVC0	
Q5VVH5	
Q5VVJ2	
Q5VVM6	
Q5VVP1	
Q5VVQ6	
Q5VVS0	
Q5VVW2	
Q5VVX9	
Q5VVY1	
Q5VW00	
Q5VW22	
Q5VW32	
Q5VW36	
Q5VW38	
Q5VWC8	
Q5VWG9	
Q5VWI1	
Q5VWJ9	
Q5VWK0	
Q5VWK5	
Q5VWM3	
Q5VWM4	
Q5VWM5	
Q5VWM6	
Q5VWN6	
Q5VWP2	
Q5VWP3	
Q5VWQ0	
Q5VWQ8	
Q5VWT5	
Q5VWW1	
Q5VWX1	
Q5VWZ2	
Q5VX52	
Q5VX71	
Q5VXD3	
Q5VXH4	
Q5VXH5	
Q5VXI9	
Q5VXJ0	
Q5VXM1	
Q5VXT5	
Q5VXU1	
Q5VXU3	
Q5VXU9	
Q5VY09	
Q5VY43	
Q5VY80	
Q5VYJ5	
Q5VYK3	
Q5VYM1	
Q5VYP0	
Q5VYS4	
Q5VYS8	
Q5VYV0	
Q5VYV7	
Q5VYX0	
Q5VYY1	
Q5VYY2	
Q5VZ03	
Q5VZ18	
Q5VZ19	
Q5VZ46	
Q5VZ52	
Q5VZ66	
Q5VZ72	
Q5VZ89	
Q5VZB9	
Q5VZE5	
Q5VZF2	
Q5VZI3	
Q5VZK9	
Q5VZL5	
Q5VZM2	ENZYME REGULATION: The activation of GTP-binding proteins is generally mediated by a guanine exchange factor (GEF), while inactivation through hydrolysis of bound GTP is catalyzed by a GTPase activating protein (GAP). The GATOR1 complex functions as a GAP and stimulates RRAGB GTPase activity to turn it into its inactive GDP-bound form. {ECO:0000269|PubMed:23723238}.
Q5VZP5	
Q5VZQ5	
Q5VZR2	
Q5VZR4	
Q5VZT2	
Q5VZV1	
Q5VZY2	ENZYME REGULATION: Inhibited by N-ethylmaleimide. {ECO:0000269|PubMed:17590538}.
Q5W041	
Q5W064	
Q5W0A0	
Q5W0B1	
Q5W0B7	
Q5W0N0	
Q5W0Q7	
Q5W0U4	
Q5W0V3	
Q5W0Z9	
Q5W111	
Q5W150	
Q5W186	
Q5W188	
Q5W5W9	
Q5W5X9	
Q5XG85	
Q5XG87	
Q5XG92	
Q5XG99	
Q5XKE5	
Q5XKK7	
Q5XKL5	
Q5XKP0	
Q5XKR4	
Q5XKR9	
Q5XLA6	
Q5XPI4	
Q5XUX0	
Q5XUX1	
Q5XX13	
Q5XXA6	ENZYME REGULATION: ATP and calmodulin are essential for its activation. Channel activity is inhibited by CFTR protein and by chloride inhibitors such as niflumic acid (NFA) and 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS). {ECO:0000269|PubMed:22178883}.
Q5Y7A7	
Q5YKI7	
Q5ZPR3	
Q60I27	
Q629K1	
Q63HK3	
Q63HK5	
Q63HM1	
Q63HM2	
Q63HM9	
Q63HN1	
Q63HN8	
Q63HQ0	
Q63HQ2	
Q63HR2	
Q63ZE4	
Q63ZY3	
Q63ZY6	
Q641Q2	
Q641Q3	
Q643R3	
Q64ET8	
Q64LD2	
Q658K8	
Q658L1	
Q658N2	
Q658P3	
Q658T7	
Q658Y4	
Q659A1	
Q659C4	
Q66GS9	
Q66K14	
Q66K41	
Q66K64	
Q66K66	
Q66K74	
Q66K79	ENZYME REGULATION: Inhibited by 2-mercaptomethyl-3-guanidinoethylthiopropanoic acid (MGTA) and guanidinoethylmercaptosuccinic acid (GEMSA). Inhibited by chelating agents such as EDTA and EGTA. {ECO:0000269|PubMed:9099699}.
Q66K80	
Q66K89	
Q66LE6	
Q66PJ3	
Q674R7	
Q674X7	
Q676U5	
Q67FW5	
Q684P5	
Q685J3	
Q687X5	
Q68BL7	
Q68BL8	
Q68CJ6	
Q68CJ9	
Q68CK6	ENZYME REGULATION: Activated by monovalent cations, such as potassium, rubidium or ammonium. {ECO:0000269|PubMed:10434065}.
Q68CL5	
Q68CP4	
Q68CP9	
Q68CQ1	
Q68CQ4	
Q68CQ7	
Q68CR1	
Q68CR7	
Q68CZ1	
Q68CZ2	
Q68CZ6	
Q68D06	
Q68D10	
Q68D20	
Q68D42	
Q68D51	
Q68D85	
Q68D86	
Q68D91	
Q68DA7	
Q68DC2	
Q68DD2	ENZYME REGULATION: Stimulated by cytosolic Ca(2+). {ECO:0000250}.
Q68DE3	
Q68DH5	
Q68DI1	
Q68DK2	
Q68DK7	
Q68DL7	
Q68DN1	
Q68DQ2	
Q68DU8	
Q68DV7	
Q68DX3	
Q68DY1	
Q68DY9	
Q68E01	
Q68EA5	
Q68EM7	
Q68EN5	
Q68G74	
Q68G75	
Q68J44	
Q69383	
Q69384	
Q693B1	
Q695T7	
Q69YG0	
Q69YH5	
Q69YI7	
Q69YL0	
Q69YN2	
Q69YN4	
Q69YQ0	
Q69YU3	
Q69YU5	
Q69YW2	
Q69YZ2	
Q6A162	
Q6A163	
Q6A1A2	
Q6A555	
Q6AHZ1	
Q6AI08	
Q6AI12	
Q6AI14	
Q6AI39	
Q6AW86	
Q6AWC2	
Q6AWC8	
Q6AZW8	
Q6AZY7	
Q6AZZ1	
Q6B0B8	
Q6B0I6	
Q6B0K9	
Q6B8I1	ENZYME REGULATION: Inhibited by vanadate. {ECO:0000269|PubMed:15252030}.
Q6B9Z1	
Q6BAA4	
Q6BCY4	
Q6BDI9	
Q6BDS2	
Q6BEB4	
Q6DCA0	
Q6DD87	
Q6DD88	
Q6DHV5	
Q6DHV7	
Q6DHY5	
Q6DJT9	
Q6DKI1	
Q6DKI2	
Q6DKI7	
Q6DKJ4	
Q6DKK2	
Q6DN03	
Q6DN12	
Q6DN14	
Q6DN72	
Q6DN90	
Q6DRA6	
Q6DT37	ENZYME REGULATION: Maintained in an inactive, closed conformation by an interaction between the kinase domain and the negative autoregulatory C-terminal coiled-coil region. Agonist binding to the phorbol ester binding site disrupts this, releasing the kinase domain to allow N-terminus-mediated dimerization and kinase activation by transautophosphorylation (By similarity). {ECO:0000250|UniProtKB:Q5VT25}.
Q6DWJ6	
Q6E0U4	
Q6E213	
Q6EBC2	
Q6ECI4	
Q6EEV4	
Q6EEV6	
Q6EIG7	
Q6EKJ0	
Q6EMB2	
Q6EMK4	
Q6F5E7	
Q6F5E8	
Q6FHJ7	
Q6FI13	
Q6FI81	
Q6FIF0	
Q6GMR7	ENZYME REGULATION: Inhibited by O-aryl carbamates and alpha-keto heterocytes. {ECO:0000269|PubMed:17015445}.
Q6GMV1	
Q6GMV2	
Q6GMV3	
Q6GPH4	
Q6GPH6	
Q6GPI1	
Q6GQQ9	ENZYME REGULATION: Deubiquitinase activity is inhibited following interaction with PARK7. {ECO:0000269|PubMed:21097510}.
Q6GTS8	
Q6GTX8	
Q6GV28	
Q6GYQ0	
Q6H3X3	
Q6H8Q1	
Q6H9L7	
Q6HA08	ENZYME REGULATION: Inhibited by wide spectrum metalloproteinase inhibitor batimastat (BB-94). Also inhibited by EDTA. {ECO:0000269|PubMed:15087446}.
Q6I9Y2	
Q6IA17	
Q6IA69	
Q6IA86	
Q6IAA8	
Q6IAN0	
Q6IB77	
Q6IBS0	
Q6IBW4	
Q6IC83	
Q6IC98	
Q6ICB0	
Q6ICB4	
Q6ICC9	
Q6ICG6	
Q6ICG8	
Q6ICH7	
Q6ICI0	
Q6ICL3	
Q6ICL7	
Q6IE36	
Q6IE37	
Q6IE38	
Q6IE81	
Q6IED9	
Q6IEE7	
Q6IEE8	
Q6IEG0	
Q6IEU7	
Q6IEV9	
Q6IEY1	
Q6IEZ7	
Q6IF00	
Q6IF36	
Q6IF42	
Q6IF63	
Q6IF82	
Q6IF99	
Q6IFG1	
Q6IFH4	
Q6IFN5	
Q6IMI4	
Q6IMI6	
Q6IMN6	
Q6IN84	
Q6IN85	
Q6IN97	
Q6IPM2	
Q6IPR1	
Q6IPR3	
Q6IPT2	
Q6IPT4	
Q6IPU0	
Q6IPW1	
Q6IPX1	
Q6IPX3	
Q6IQ16	
Q6IQ19	
Q6IQ20	ENZYME REGULATION: Activity is stimulated by divalent cations. {ECO:0000250}.
Q6IQ21	
Q6IQ22	ENZYME REGULATION: Rab activation is generally mediated by a guanine exchange factor (GEF), while inactivation through hydrolysis of bound GTP is catalyzed by a GTPase activating protein (GAP) (By similarity). That Rab is activated by DENND3, a guanine exchange factor. {ECO:0000250, ECO:0000269|PubMed:20937701}.
Q6IQ23	
Q6IQ26	
Q6IQ32	
Q6IQ49	
Q6IQ55	
Q6IS14	
Q6IS24	
Q6ISB3	
Q6ISS4	
Q6ISU1	
Q6IV72	
Q6IWH7	
Q6J272	
Q6J4K2	ENZYME REGULATION: Inhibited by the sodium/calcium exchanger inhibitor CGP-37157 (PubMed:24898248). Strongly inhibited by zinc (PubMed:15060069). {ECO:0000269|PubMed:15060069, ECO:0000269|PubMed:24898248}.
Q6J9G0	
Q6JBY9	
Q6JEL2	
Q6JQN1	
Q6JVE5	
Q6JVE6	
Q6JVE9	
Q6K0P9	
Q6KB66	
Q6KC79	
Q6KCM7	
Q6KF10	
Q6L8G4	
Q6L8G5	
Q6L8G8	
Q6L8G9	
Q6L8H1	
Q6L8H2	
Q6L8H4	
Q6L8Q7	
Q6L9T8	
Q6L9W6	
Q6MZM0	
Q6MZM9	
Q6MZN7	
Q6MZP7	
Q6MZQ0	
Q6MZT1	
Q6MZW2	
Q6MZZ7	
Q6N021	
Q6N022	
Q6N043	
Q6N063	
Q6N069	
Q6N075	
Q6NS38	ENZYME REGULATION: Activated by ascorbate and magnesium ions. {ECO:0000269|PubMed:12486230, ECO:0000269|PubMed:18519673}.
Q6NSI1	
Q6NSI3	
Q6NSI4	
Q6NSI8	
Q6NSJ0	
Q6NSJ2	
Q6NSJ5	
Q6NSW5	
Q6NSW7	
Q6NSX1	
Q6NSZ9	
Q6NT04	
Q6NT16	
Q6NT32	
Q6NT46	
Q6NT52	
Q6NT55	
Q6NT76	
Q6NT89	
Q6NTE8	
Q6NTF7	ENZYME REGULATION: Antiviral activity is neutralized by the HIV-1 virion infectivity factor (VIF), that prevents its incorporation into progeny virions by both inhibiting its translation and/or by inducing its ubiquitination and subsequent degradation by the 26S proteasome. {ECO:0000269|PubMed:21835787}.
Q6NTF9	
Q6NUI1	
Q6NUI2	ENZYME REGULATION: Inhibited by N-ethylmaleimide (NEM). {ECO:0000250|UniProtKB:Q14DK4}.
Q6NUI6	
Q6NUJ1	
Q6NUJ2	
Q6NUJ5	
Q6NUK1	
Q6NUK4	
Q6NUM6	
Q6NUM9	
Q6NUN0	
Q6NUN7	
Q6NUN9	
Q6NUP7	
Q6NUQ1	
Q6NUQ4	
Q6NUR6	
Q6NUS6	
Q6NUS8	
Q6NUT2	
Q6NUT3	
Q6NV74	
Q6NV75	
Q6NVH7	
Q6NVU6	
Q6NVV0	
Q6NVV1	
Q6NVV3	
Q6NVV7	
Q6NVV9	
Q6NVY1	
Q6NW29	
Q6NW34	
Q6NW40	
Q6NWY9	
Q6NX45	
Q6NX49	
Q6NXE6	
Q6NXG1	
Q6NXN4	
Q6NXP0	
Q6NXP2	
Q6NXP6	
Q6NXR0	
Q6NXR4	
Q6NXS1	
Q6NXT1	
Q6NXT2	
Q6NXT4	
Q6NXT6	
Q6NY19	
Q6NYC1	
Q6NYC8	
Q6NZ36	
Q6NZ63	
Q6NZ67	
Q6NZI2	
Q6NZY4	
Q6NZY7	
Q6P047	
Q6P050	
Q6P087	
Q6P093	
Q6P0A1	
Q6P0N0	
Q6P0Q8	
Q6P158	
Q6P161	
Q6P179	
Q6P1A2	ENZYME REGULATION: Activity is inhibited by thimerosal.
Q6P1J6	ENZYME REGULATION: Inhibited by diisopropyl fluorophosphate. {ECO:0000250}.
Q6P1J9	
Q6P1K1	
Q6P1K2	
Q6P1K8	
Q6P1L5	
Q6P1L6	
Q6P1L8	
Q6P1M0	
Q6P1M3	
Q6P1M9	
Q6P1N0	
Q6P1N9	
Q6P1Q0	
Q6P1Q9	
Q6P1R3	
Q6P1R4	
Q6P1S2	
Q6P1W5	
Q6P1X5	
Q6P1X6	
Q6P280	
Q6P2C0	
Q6P2C8	
Q6P2D0	
Q6P2D8	
Q6P2E9	
Q6P2H3	
Q6P2H8	
Q6P2I3	
Q6P2I7	
Q6P2M8	ENZYME REGULATION: Activated by Ca(2+)/calmodulin. {ECO:0000250}.
Q6P2P2	
Q6P2Q9	
Q6P2S7	
Q6P387	
Q6P3R8	
Q6P3S1	
Q6P3S6	
Q6P3V2	
Q6P3W2	
Q6P3W6	
Q6P3W7	
Q6P3X3	
Q6P3X8	
Q6P435	
Q6P444	
Q6P461	
Q6P474	
Q6P499	
Q6P4A7	
Q6P4A8	
Q6P4D5	
Q6P4E1	
Q6P4F1	
Q6P4F2	
Q6P4F7	
Q6P4H8	
Q6P4I2	
Q6P4Q7	
Q6P4R8	
Q6P531	
Q6P575	
Q6P582	
Q6P587	
Q6P589	
Q6P597	
Q6P5Q4	
Q6P5R6	
Q6P5S2	
Q6P5S7	
Q6P5W5	
Q6P5X5	
Q6P5X7	
Q6P5Z2	ENZYME REGULATION: Two specific sites, Thr-718 (activation loop of the kinase domain) and Thr-860 (turn motif), need to be phosphorylated for its full activation. {ECO:0000250}.
Q6P656	
Q6P6B1	
Q6P6B7	
Q6P6C2	
Q6P7N7	
Q6P988	
Q6P995	
Q6P996	
Q6P9A1	
Q6P9A2	
Q6P9A3	
Q6P9B6	
Q6P9B9	
Q6P9F0	
Q6P9F5	
Q6P9F7	
Q6P9G0	
Q6P9G4	
Q6P9G9	
Q6P9H4	
Q6P9H5	
Q6PB30	
Q6PCB0	
Q6PCB5	
Q6PCB6	ENZYME REGULATION: Inhibited by palmostatin-B. {ECO:0000269|PubMed:26701913}.
Q6PCB7	
Q6PCB8	
Q6PCD5	
Q6PCE3	
Q6PCT2	
Q6PD62	
Q6PD74	
Q6PDA7	
Q6PDB4	
Q6PEV8	
Q6PEW0	
Q6PEW1	
Q6PEX3	
Q6PEX7	
Q6PEY0	
Q6PEY1	
Q6PEY2	
Q6PEZ8	
Q6PF04	
Q6PF05	
Q6PF06	
Q6PF15	
Q6PF18	
Q6PFW1	
Q6PG37	
Q6PGN9	
Q6PGP7	
Q6PGQ1	
Q6PGQ7	
Q6PH81	
Q6PH85	
Q6PHR2	
Q6PHW0	
Q6PI25	
Q6PI26	
Q6PI47	
Q6PI48	
Q6PI73	
Q6PI77	
Q6PI78	
Q6PI97	
Q6PI98	
Q6PID6	
Q6PID8	
Q6PIF2	
Q6PIF6	
Q6PII3	
Q6PII5	
Q6PIJ6	
Q6PIL6	
Q6PIS1	
Q6PIU1	
Q6PIU2	
Q6PIV2	
Q6PIV7	
Q6PIW4	
Q6PIY5	
Q6PIY7	
Q6PIZ9	
Q6PJ21	
Q6PJ61	
Q6PJ69	
Q6PJE2	
Q6PJF5	
Q6PJG2	
Q6PJG6	
Q6PJG9	
Q6PJI9	
Q6PJP8	
Q6PJQ5	
Q6PJT7	
Q6PJW8	
Q6PK04	
Q6PK18	
Q6PK57	
Q6PK81	
Q6PKC3	
Q6PKG0	
Q6PKH6	
Q6PKX4	
Q6PL18	
Q6PL24	
Q6PL45	
Q6PML9	
Q6PP77	
Q6PRD1	
Q6PRD7	
Q6PUV4	
Q6PXP3	
Q6Q0C0	
Q6Q0C1	
Q6Q4G3	ENZYME REGULATION: Inhibited by bestatin. {ECO:0000269|PubMed:17525158}.
Q6Q6R5	
Q6Q759	
Q6Q788	
Q6Q795	
Q6Q8B3	
Q6QAJ8	
Q6QEF8	
Q6QHC5	
Q6QHF9	
Q6QHK4	
Q6QN14	
Q6QNK2	
Q6QNY0	
Q6QNY1	
Q6R2W3	
Q6R327	
Q6R6M4	
Q6RFH5	
Q6RFH8	
Q6RI45	
Q6RSH7	
Q6RUI8	
Q6RVD6	
Q6RW13	
Q6S545	
Q6S5H5	
Q6S5L8	
Q6S8J3	
Q6S8J7	
Q6S9Z5	
Q6SA08	ENZYME REGULATION: Activated by phosphorylation on Thr-197, potentially by autophosphorylation. {ECO:0000250}.
Q6SJ93	
Q6SJ96	
Q6SPF0	
Q6STE5	
Q6SZW1	
Q6T310	
Q6T311	
Q6T423	
Q6T4P5	
Q6T4R5	
Q6TCH4	
Q6TCH7	
Q6TDP4	
Q6TDU7	
Q6TFL3	
Q6TFL4	
Q6TGC4	
Q6U736	
Q6U7Q0	
Q6U841	
Q6U949	
Q6UB28	
Q6UB35	
Q6UB98	
Q6UB99	
Q6UDR6	
Q6UE05	
Q6ULP2	
Q6UN15	
Q6UQ28	
Q6URK8	
Q6UUV7	
Q6UUV9	
Q6UVJ0	
Q6UVK1	
Q6UVM3	
Q6UVW9	
Q6UVY6	
Q6UW01	
Q6UW02	
Q6UW10	
Q6UW15	
Q6UW32	
Q6UW49	
Q6UW56	
Q6UW60	
Q6UW63	
Q6UW68	
Q6UW78	
Q6UW88	
Q6UWB1	
Q6UWB4	
Q6UWD8	
Q6UWE0	
Q6UWE3	
Q6UWF3	
Q6UWF5	
Q6UWF7	
Q6UWF9	
Q6UWH4	
Q6UWH6	
Q6UWI2	
Q6UWI4	
Q6UWJ1	
Q6UWJ8	
Q6UWK7	
Q6UWL2	
Q6UWL6	
Q6UWM5	
Q6UWM7	
Q6UWM9	
Q6UWN0	
Q6UWN5	
Q6UWN8	
Q6UWP2	ENZYME REGULATION: Inhibited by flavonoids including apigenin, luteolin, genistein, kaempferol and quercetin and also by carbenoxolone, zearalenone, glycyrrhetinic, curcumin and flufenamic acid. {ECO:0000269|PubMed:26920053}.
Q6UWP7	
Q6UWP8	
Q6UWQ5	
Q6UWQ7	
Q6UWR7	ENZYME REGULATION: Inhibited by EDTA and EGTA in vitro. {ECO:0000269|PubMed:15788404}.
Q6UWS5	
Q6UWT2	
Q6UWT4	
Q6UWU2	
Q6UWU4	
Q6UWV2	
Q6UWV6	ENZYME REGULATION: Inhibited in a dose dependent manner by ATP, imidazole, orthovanadate and zinc ion. Not inhibited by ADP, AMP and EDTA. {ECO:0000269|PubMed:12885774}.
Q6UWV7	
Q6UWW0	
Q6UWW8	
Q6UWW9	
Q6UWX4	
Q6UWY0	
Q6UWY2	ENZYME REGULATION: Inhibited by SERPINA1, SERPINC1 and SERPING1. {ECO:0000269|PubMed:22474388}.
Q6UWY5	
Q6UWZ7	
Q6UX01	
Q6UX04	
Q6UX06	
Q6UX07	
Q6UX15	
Q6UX27	
Q6UX34	
Q6UX39	
Q6UX40	
Q6UX41	
Q6UX46	
Q6UX52	
Q6UX53	
Q6UX65	
Q6UX68	
Q6UX71	
Q6UX72	
Q6UX73	
Q6UX82	
Q6UX98	
Q6UXA7	
Q6UXB0	
Q6UXB1	
Q6UXB2	
Q6UXB3	
Q6UXB4	
Q6UXB8	
Q6UXC1	
Q6UXD1	
Q6UXD5	
Q6UXD7	
Q6UXE8	
Q6UXF1	
Q6UXF7	
Q6UXG2	
Q6UXG3	
Q6UXG8	
Q6UXH0	
Q6UXH1	
Q6UXH8	
Q6UXH9	
Q6UXI7	
Q6UXI9	
Q6UXK2	
Q6UXK5	
Q6UXL0	
Q6UXM1	
Q6UXN2	
Q6UXN7	
Q6UXN8	
Q6UXN9	
Q6UXP3	
Q6UXP7	
Q6UXP9	
Q6UXQ4	
Q6UXQ8	
Q6UXR4	
Q6UXR6	
Q6UXR8	
Q6UXS0	
Q6UXS9	
Q6UXT8	
Q6UXT9	
Q6UXU0	
Q6UXU4	
Q6UXU6	
Q6UXV0	
Q6UXV1	
Q6UXV3	
Q6UXV4	
Q6UXX5	
Q6UXX9	
Q6UXY1	
Q6UXY8	
Q6UXZ0	
Q6UXZ3	
Q6UXZ4	
Q6UY01	
Q6UY09	
Q6UY11	
Q6UY13	
Q6UY14	
Q6UY18	
Q6UY27	
Q6UYE1	
Q6V0I7	
Q6V0L0	
Q6V1P9	
Q6V1X1	ENZYME REGULATION: Inhibited by zinc. Inhibited by the serine proteinase inhibitor 4-(2-aminoethyl)benzenesulphonyl fluoride (AEBSF), and by di-isopropylfuorophosphate. Specifically inhibited by isoindoline derivatives. {ECO:0000269|PubMed:11012666, ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15664838}.
Q6V702	
Q6V9R5	
Q6VAB6	ENZYME REGULATION: Kinase activity is inhibited by ASC24. {ECO:0000269|PubMed:21441910}.
Q6VB84	
Q6VEQ5	
Q6VMQ6	
Q6VN20	
Q6VUC0	
Q6VVB1	
Q6VVX0	
Q6VY07	
Q6W0C5	
Q6W2J9	
Q6W349	
Q6W3E5	
Q6W4X9	
Q6W5P4	
Q6WBX8	
Q6WCQ1	
Q6WKZ4	
Q6WN34	
Q6WQI6	
Q6WRI0	
Q6WRX3	
Q6X4T0	
Q6X4U4	
Q6X4W1	
Q6X784	
Q6X9E4	
Q6XCG6	
Q6XD76	
Q6XE24	
Q6XE38	
Q6XLA1	
Q6XPR3	
Q6XPS3	
Q6XQN6	
Q6XR72	
Q6XUX3	
Q6XXX2	
Q6XYB7	
Q6XYQ8	
Q6XZB0	ENZYME REGULATION: Inhibited by sodium vanadate. {ECO:0000269|PubMed:12963729}.
Q6XZF7	
Q6Y1H2	
Q6Y288	
Q6Y2X3	
Q6Y7W6	
Q6YBV0	
Q6YFQ2	
Q6YHK3	
Q6YHU6	
Q6YI46	
Q6YN16	
Q6YP21	
Q6ZMB0	
Q6ZMB5	
Q6ZMC9	
Q6ZMD2	
Q6ZMG9	
Q6ZMH5	
Q6ZMI0	
Q6ZMI3	
Q6ZMJ2	
Q6ZMJ4	
Q6ZMK1	
Q6ZMM2	
Q6ZMN7	
Q6ZMN8	
Q6ZMP0	
Q6ZMQ8	
Q6ZMR3	
Q6ZMR5	
Q6ZMS4	
Q6ZMS7	
Q6ZMT1	
Q6ZMT4	
Q6ZMT9	
Q6ZMU1	
Q6ZMU5	
Q6ZMV5	
Q6ZMV7	
Q6ZMV8	
Q6ZMV9	
Q6ZMW2	
Q6ZMW3	
Q6ZMY3	
Q6ZMY6	
Q6ZMY9	
Q6ZMZ0	
Q6ZMZ3	
Q6ZN01	
Q6ZN03	
Q6ZN04	
Q6ZN06	
Q6ZN08	
Q6ZN11	
Q6ZN16	ENZYME REGULATION: Contains an N-terminal autoinhibitory domain. Activated by phosphorylation at Thr-812, inhibited by phosphorylation at Ser-924 and Ser-994 (By similarity). {ECO:0000250}.
Q6ZN17	
Q6ZN18	
Q6ZN19	
Q6ZN28	
Q6ZN30	
Q6ZN32	
Q6ZN44	
Q6ZN54	
Q6ZN55	
Q6ZN57	
Q6ZN66	
Q6ZN68	
Q6ZN79	
Q6ZN84	
Q6ZN92	
Q6ZNA1	
Q6ZNA4	ENZYME REGULATION: Binds free ubiquitin non-covalently via its RING-type zinc finger. Ubiquitin-binding leads to enhance the E3 ubiquitin-protein ligase activity by stabilizing the ubiquitin-conjugating enzyme E2 (donor ubiquitin) in the 'closed' conformation and activating ubiquitin transfer. {ECO:0000250|UniProtKB:Q6ZSG1}.
Q6ZNA5	
Q6ZNB5	
Q6ZNB6	
Q6ZNB7	
Q6ZNC4	
Q6ZNC8	ENZYME REGULATION: Partially inhibited by thimerosal.
Q6ZNE5	
Q6ZNE9	
Q6ZNF0	
Q6ZNG0	
Q6ZNG1	
Q6ZNG2	
Q6ZNG9	
Q6ZNH5	
Q6ZNI0	
Q6ZNJ1	
Q6ZNK6	
Q6ZNL6	
Q6ZNM6	
Q6ZNQ3	
Q6ZNR0	
Q6ZNW5	
Q6ZNX1	
Q6ZP01	
Q6ZP29	
Q6ZP65	
Q6ZP68	
Q6ZP80	
Q6ZP82	
Q6ZP98	
Q6ZPA2	
Q6ZPB5	
Q6ZPD8	
Q6ZPD9	
Q6ZQN5	
Q6ZQN7	
Q6ZQQ2	
Q6ZQQ6	
Q6ZQR2	
Q6ZQT0	
Q6ZQT7	
Q6ZQV5	
Q6ZQW0	ENZYME REGULATION: Activity is inhibited by D-1MT (1-methyl-D-tryptophan) and MTH-trp (methylthiohydantoin-DL-tryptophan) but not L-1MT (1-methyl-L-tryptophan). {ECO:0000269|PubMed:17671174}.
Q6ZQX7	
Q6ZQY2	
Q6ZQY3	
Q6ZQY7	
Q6ZR03	
Q6ZR08	
Q6ZR37	
Q6ZR52	
Q6ZR54	
Q6ZR62	
Q6ZR85	
Q6ZRC1	
Q6ZRF7	
Q6ZRF8	
Q6ZRG5	
Q6ZRH7	
Q6ZRI0	
Q6ZRI6	
Q6ZRI8	
Q6ZRK6	
Q6ZRM9	
Q6ZRN7	
Q6ZRP0	
Q6ZRP5	
Q6ZRP7	
Q6ZRQ5	
Q6ZRR5	
Q6ZRR7	
Q6ZRR9	
Q6ZRS2	
Q6ZRS4	
Q6ZRT6	
Q6ZRU5	
Q6ZRV2	
Q6ZRV3	
Q6ZRX8	
Q6ZRY4	
Q6ZRZ4	
Q6ZS02	
Q6ZS10	
Q6ZS11	
Q6ZS17	
Q6ZS27	
Q6ZS30	
Q6ZS46	
Q6ZS49	
Q6ZS52	
Q6ZS62	
Q6ZS72	
Q6ZS81	
Q6ZS82	
Q6ZS86	
Q6ZS92	
Q6ZS94	
Q6ZSA7	
Q6ZSA8	
Q6ZSB3	
Q6ZSB9	
Q6ZSC3	
Q6ZSG1	ENZYME REGULATION: Binds free ubiquitin non-covalently via its RING-type zinc finger. Ubiquitin-binding leads to enhance the E3 ubiquitin-protein ligase activity by stabilizing the ubiquitin-conjugating enzyme E2 (donor ubiquitin) in the 'closed' conformation and activating ubiquitin transfer (PubMed:26656854).
Q6ZSG2	
Q6ZSI9	
Q6ZSJ8	
Q6ZSJ9	
Q6ZSK4	
Q6ZSM3	
Q6ZSN1	
Q6ZSR3	
Q6ZSR6	
Q6ZSR9	
Q6ZSS3	
Q6ZSS7	
Q6ZST2	
Q6ZST4	
Q6ZSU1	
Q6ZSV7	
Q6ZSY5	
Q6ZSZ5	
Q6ZSZ6	
Q6ZT07	
Q6ZT12	
Q6ZT21	
Q6ZT52	
Q6ZT62	
Q6ZT77	
Q6ZT83	
Q6ZT89	
Q6ZT98	
Q6ZTA4	
Q6ZTB9	
Q6ZTC4	
Q6ZTI0	
Q6ZTI6	
Q6ZTK2	
Q6ZTN6	
Q6ZTQ3	
Q6ZTQ4	
Q6ZTR5	
Q6ZTR6	
Q6ZTR7	
Q6ZTU2	
Q6ZTW0	
Q6ZTY9	
Q6ZTZ1	
Q6ZU15	
Q6ZU35	
Q6ZU45	
Q6ZU52	
Q6ZU64	
Q6ZU65	
Q6ZU67	
Q6ZU69	
Q6ZU80	
Q6ZUA9	
Q6ZUB0	
Q6ZUB1	
Q6ZUF6	
Q6ZUG5	
Q6ZUI0	
Q6ZUJ4	
Q6ZUJ8	
Q6ZUK4	
Q6ZUL3	
Q6ZUM4	
Q6ZUS5	
Q6ZUS6	
Q6ZUT1	
Q6ZUT3	
Q6ZUT4	
Q6ZUT6	
Q6ZUT9	
Q6ZUU3	
Q6ZUV0	
Q6ZUX3	
Q6ZUX7	
Q6ZV29	
Q6ZV50	
Q6ZV56	
Q6ZV60	
Q6ZV65	
Q6ZV70	
Q6ZV73	
Q6ZV77	
Q6ZV80	
Q6ZV89	
Q6ZVC0	
Q6ZVD7	
Q6ZVD8	ENZYME REGULATION: Inhibited by AKT1, AKT2 and AKT3. Activated by oleic acid and arachidonic acid (PubMed:24892992). {ECO:0000269|PubMed:24892992, ECO:0000305}.
Q6ZVE7	
Q6ZVF9	
Q6ZVH6	
Q6ZVH7	
Q6ZVK1	
Q6ZVK8	
Q6ZVL6	
Q6ZVL8	
Q6ZVM7	
Q6ZVN7	
Q6ZVN8	
Q6ZVQ6	
Q6ZVS7	
Q6ZVT0	
Q6ZVT6	
Q6ZVU0	
Q6ZVW7	
Q6ZVX7	
Q6ZVX9	
Q6ZVZ8	
Q6ZW05	
Q6ZW13	
Q6ZW31	
Q6ZW33	
Q6ZW35	
Q6ZW49	
Q6ZW61	
Q6ZW76	
Q6ZWB6	
Q6ZWC4	
Q6ZWE6	
Q6ZWH5	
Q6ZWI9	
Q6ZWJ1	
Q6ZWJ8	
Q6ZWK4	
Q6ZWK6	
Q6ZWL3	ENZYME REGULATION: Inhibited by N-hydroxy-N'-(4-n-butyl-2-methylphenyl formamidine)(HET0016) with an IC(50) of 38 nM. {ECO:0000269|PubMed:19661213}.
Q6ZWT7	ENZYME REGULATION: Partially inhibited by thimerosal.
Q6ZXV5	
Q6ZYL4	
Q701N2	
Q701N4	
Q702N8	
Q709C8	
Q709F0	
Q70CQ1	
Q70CQ2	
Q70CQ3	ENZYME REGULATION: Inhibited by the diterpenoid derivative 15-oxospiramilactone (S3). {ECO:0000250|UniProtKB:Q3UN04}.
Q70CQ4	
Q70E73	
Q70EK8	
Q70EK9	
Q70EL1	
Q70EL2	
Q70EL3	
Q70EL4	
Q70HW3	ENZYME REGULATION: Strongly inhibited by tannic acid and Bromocresol Purple. {ECO:0000269|PubMed:14674884}.
Q70IA6	
Q70IA8	
Q70J99	
Q70JA7	
Q70SY1	
Q70UQ0	
Q70YC4	
Q70YC5	
Q70Z35	
Q70Z44	
Q70Z53	
Q711Q0	
Q712K3	
Q717R9	
Q719H9	
Q719I0	
Q71DI3	
Q71F23	
Q71F56	
Q71F78	
Q71H61	
Q71RC2	
Q71RC9	
Q71RG4	
Q71RG6	
Q71RH2	
Q71RS6	
Q71SY5	
Q71U36	
Q71UI9	
Q71UM5	
Q75L30	
Q75LS8	
Q75MW2	
Q75N03	
Q75N90	
Q75NE6	
Q75QN2	
Q75T13	
Q75V66	
Q75VX8	
Q75WM6	
Q765I0	
Q765P7	
Q76B58	
Q76EJ3	
Q76FK4	
Q76G19	
Q76I76	
Q76KD6	
Q76KP1	
Q76KX8	
Q76L83	
Q76LX8	ENZYME REGULATION: Zinc and calcium ions cooperatively modulate enzyme activity. The cleavage of the pro-domain is not required for protease activity. Dependence on calcium for proteolytic activity is mediated by the high affinity site. {ECO:0000269|PubMed:12975358, ECO:0000269|PubMed:16286459, ECO:0000269|PubMed:19047683}.
Q76M96	
Q76MJ5	ENZYME REGULATION: The kinase domain is activated by trans-autophosphorylation. Kinase activity is required for activation of the endoribonuclease domain (By similarity). {ECO:0000250|UniProtKB:O75460}.
Q76N32	
Q76N89	
Q76NI1	
Q7KYR7	
Q7KZ85	
Q7KZF4	
Q7KZI7	ENZYME REGULATION: Inhibited by PAK5; inhibition is independent of the kinase activity of PAK5 (By similarity). Activated by phosphorylation on Thr-208. Inhibited by phosphorylation at Ser-212 and Thr-596. Inhibited by hymenialdisine. Specifically inhibited by the H.pylori CagA peptide FPLKRHDKVDDLSK that mimics host substrates and binds to the kinase substrate-binding site. {ECO:0000250, ECO:0000269|PubMed:12429843, ECO:0000269|PubMed:14976552}.
Q7KZN9	
Q7L014	
Q7L099	
Q7L0J3	
Q7L0L9	
Q7L0Q8	
Q7L0R7	
Q7L0X0	
Q7L0X2	
Q7L0Y3	
Q7L190	
Q7L1I2	
Q7L1Q6	
Q7L1S5	
Q7L1T6	
Q7L1V2	
Q7L1W4	
Q7L211	
Q7L266	ENZYME REGULATION: Glycine accelerates autocleavage into an alpha and beta chain. {ECO:0000269|PubMed:22861376}.
Q7L273	
Q7L2E3	
Q7L2H7	
Q7L2J0	
Q7L2K0	
Q7L2R6	
Q7L2Z9	
Q7L311	
Q7L3B6	
Q7L3S4	
Q7L3T8	
Q7L3V2	
Q7L4E1	
Q7L4I2	
Q7L4P6	
Q7L4S7	
Q7L513	
Q7L523	ENZYME REGULATION: The activation of GTP-binding proteins is generally mediated by a guanine exchange factor (GEF), while inactivation through hydrolysis of bound GTP is catalyzed by a GTPase activating protein (GAP) (PubMed:25936802). The GATOR1 complex functions as a GAP and stimulates RRAGA GTPase activity to turn it into its inactive GDP-bound form (PubMed:25936802, PubMed:23723238). {ECO:0000269|PubMed:23723238, ECO:0000303|PubMed:25936802}.
Q7L576	
Q7L590	
Q7L591	
Q7L592	
Q7L5A3	
Q7L5A8	
Q7L5D6	
Q7L5L3	
Q7L5N1	
Q7L5N7	ENZYME REGULATION: Acetyltransferase activity is increased following acute inflammatory stimulation by lipopolysaccharide (LPS). Acyltransferase activity is unchanged (By similarity). {ECO:0000250}.
Q7L5Y1	
Q7L5Y6	
Q7L5Y9	
Q7L622	
Q7L775	
Q7L7L0	
Q7L7V1	
Q7L7X3	ENZYME REGULATION: Serine/threonine-protein kinase activity is inhibited by SPRED1.
Q7L804	
Q7L8A9	
Q7L8C5	
Q7L8J4	
Q7L8L6	
Q7L8S5	
Q7L8W6	
Q7L945	
Q7L985	
Q7L9B9	
Q7L9L4	
Q7LBC6	
Q7LBE3	
Q7LBR1	
Q7LC44	
Q7LDG7	ENZYME REGULATION: Isoform 1 and isoform 2 are differently regulated by calcium and DAG. {ECO:0000269|PubMed:10918068}.
Q7LDI9	
Q7LFL8	
Q7LFX5	ENZYME REGULATION: Inhibited by phenyl beta-GalNAc(4,6-SO(4)). {ECO:0000269|PubMed:16024005}.
Q7LG56	
Q7LGA3	
Q7LGC8	
Q7M4L6	
Q7RTM1	
Q7RTN6	
Q7RTP0	
Q7RTP6	
Q7RTR0	
Q7RTR2	
Q7RTR8	
Q7RTS1	
Q7RTS3	
Q7RTS5	
Q7RTS6	
Q7RTS7	
Q7RTS9	
Q7RTT3	
Q7RTT4	
Q7RTT5	
Q7RTT6	
Q7RTT9	
Q7RTU0	
Q7RTU1	
Q7RTU3	
Q7RTU4	
Q7RTU5	
Q7RTU7	
Q7RTU9	
Q7RTV0	
Q7RTV2	
Q7RTV3	
Q7RTV5	
Q7RTW8	
Q7RTX0	
Q7RTX1	
Q7RTX7	ENZYME REGULATION: The CatSper calcium channel is indirectly activated by extracellular progesterone and prostaglandins following the sequence: progesterone > PGF1-alpha = PGE1 > PGA1 > PGE2 >> PGD2 (PubMed:21412338, PubMed:21412339, PubMed:26989199). The CatSper calcium channel is directly inhibited by endocannabinoid 2-arachidonoylglycerol (2AG) (PubMed:26989199). Indirect activation by progesterone takes place via the following mechanism: progesterone binds and activates the acylglycerol lipase ABHD2, which in turn mediates hydrolysis of 2AG inhibitor, relieving inhibition of the CatSper channel (PubMed:26989199). The primary effect of progesterone activation is to shift voltage dependence towards more physiological, negative membrane potentials; it is not mediated by metabotropic receptors and second messengers (PubMed:21412338, PubMed:21412339). Sperm capacitation enhances the effect of progesterone by providing additional negative shift. Also activated by the elevation of intracellular pH (PubMed:21412338, PubMed:21412339). {ECO:0000269|PubMed:21412338, ECO:0000269|PubMed:21412339, ECO:0000269|PubMed:26989199}.
Q7RTX9	
Q7RTY0	
Q7RTY1	
Q7RTY3	
Q7RTY5	
Q7RTY7	
Q7RTY8	
Q7RTY9	
Q7RTZ1	
Q7RTZ2	
Q7Z2D5	
Q7Z2E3	
Q7Z2F6	
Q7Z2G1	
Q7Z2H8	
Q7Z2K6	
Q7Z2K8	
Q7Z2Q7	
Q7Z2R9	
Q7Z2T5	
Q7Z2V1	
Q7Z2W4	
Q7Z2W7	
Q7Z2W9	
Q7Z2X4	
Q7Z2X7	
Q7Z2Y5	
Q7Z2Y8	
Q7Z2Z1	
Q7Z2Z2	
Q7Z304	
Q7Z309	
Q7Z333	
Q7Z340	
Q7Z353	
Q7Z388	
Q7Z392	
Q7Z398	
Q7Z3B0	
Q7Z3B1	
Q7Z3B3	
Q7Z3B4	
Q7Z3C6	
Q7Z3D4	
Q7Z3D6	
Q7Z3E1	
Q7Z3E2	
Q7Z3E5	
Q7Z3F1	
Q7Z3G6	
Q7Z3H0	
Q7Z3H4	
Q7Z3I7	
Q7Z3J2	
Q7Z3J3	
Q7Z3K3	
Q7Z3K6	
Q7Z3Q1	
Q7Z3S7	
Q7Z3S9	
Q7Z3T1	
Q7Z3T8	
Q7Z3U7	
Q7Z3V4	
Q7Z3V5	
Q7Z3Y7	
Q7Z3Y8	
Q7Z3Y9	
Q7Z3Z0	
Q7Z3Z2	
Q7Z3Z3	
Q7Z3Z4	
Q7Z401	
Q7Z402	
Q7Z403	
Q7Z404	
Q7Z406	
Q7Z407	
Q7Z408	
Q7Z410	ENZYME REGULATION: Inhibited by serine protease inhibitors PMSF and 4-(2-aminoethyl)benzenesulfonyl fluoride, but not by EDTA. {ECO:0000269|PubMed:12886014}.
Q7Z412	
Q7Z417	
Q7Z418	
Q7Z419	
Q7Z422	
Q7Z429	
Q7Z434	
Q7Z442	
Q7Z443	ENZYME REGULATION: The calcium channel is gated following an off-response property by acid: gated open after the removal of acid stimulus, but not during acid application. {ECO:0000269|PubMed:18535624, ECO:0000269|PubMed:19464260, ECO:0000269|PubMed:22420714}.
Q7Z444	ENZYME REGULATION: Alternates between an inactive form bound to GDP and an active form bound to GTP. Activated by a guanine nucleotide-exchange factor (GEF) and inactivated by a GTPase-activating protein (GAP).
Q7Z449	
Q7Z460	
Q7Z465	
Q7Z478	
Q7Z494	
Q7Z4B0	
Q7Z4F1	
Q7Z4G1	
Q7Z4G4	
Q7Z4H3	
Q7Z4H4	
Q7Z4H7	
Q7Z4H8	
Q7Z4H9	
Q7Z4I7	
Q7Z4J2	
Q7Z4K8	
Q7Z4L0	
Q7Z4L5	
Q7Z4L9	
Q7Z4M0	
Q7Z4N2	
Q7Z4N8	
Q7Z4P5	
Q7Z4Q2	
Q7Z4R8	
Q7Z4S6	
Q7Z4S9	
Q7Z4T8	
Q7Z4T9	
Q7Z4U5	
Q7Z4V0	
Q7Z4V5	
Q7Z4W1	
Q7Z4W2	
Q7Z4W3	
Q7Z4Y8	
Q7Z553	
Q7Z569	
Q7Z570	
Q7Z572	
Q7Z589	
Q7Z591	
Q7Z5A4	
Q7Z5A7	
Q7Z5A8	
Q7Z5A9	
Q7Z5B4	
Q7Z5D8	
Q7Z5G4	
Q7Z5H3	
Q7Z5H4	
Q7Z5H5	
Q7Z5J1	
Q7Z5J4	
Q7Z5J8	
Q7Z5K2	
Q7Z5L0	
Q7Z5L2	
Q7Z5L3	
Q7Z5L4	
Q7Z5L7	
Q7Z5L9	
Q7Z5M5	
Q7Z5M8	
Q7Z5N4	
Q7Z5P4	
Q7Z5P9	
Q7Z5Q1	
Q7Z5Q5	ENZYME REGULATION: Inhibited by ddTTP. {ECO:0000269|PubMed:16787914}.
Q7Z5R6	
Q7Z5S9	
Q7Z5U6	
Q7Z5V6	
Q7Z5W3	
Q7Z5Y6	
Q7Z5Y7	
Q7Z601	
Q7Z602	
Q7Z614	
Q7Z624	
Q7Z628	
Q7Z692	
Q7Z695	
Q7Z698	
Q7Z699	
Q7Z6A9	
Q7Z6B0	
Q7Z6B7	
Q7Z6E9	
Q7Z6G3	
Q7Z6G8	
Q7Z6I5	
Q7Z6I6	
Q7Z6I8	
Q7Z6J0	
Q7Z6J2	
Q7Z6J4	
Q7Z6J6	
Q7Z6J8	
Q7Z6J9	
Q7Z6K1	
Q7Z6K3	
Q7Z6K4	
Q7Z6K5	
Q7Z6L0	
Q7Z6L1	
Q7Z6M1	
Q7Z6M2	
Q7Z6M3	
Q7Z6M4	
Q7Z6P3	
Q7Z6R9	
Q7Z6V5	
Q7Z6W1	
Q7Z6W7	
Q7Z6Z6	
Q7Z6Z7	
Q7Z713	
Q7Z736	
Q7Z739	
Q7Z745	
Q7Z769	
Q7Z794	
Q7Z7A1	
Q7Z7A3	
Q7Z7A4	
Q7Z7B0	
Q7Z7B1	
Q7Z7B7	
Q7Z7B8	
Q7Z7C7	
Q7Z7C8	
Q7Z7D3	
Q7Z7E8	
Q7Z7F0	
Q7Z7F7	
Q7Z7G0	
Q7Z7G1	
Q7Z7G2	
Q7Z7G8	
Q7Z7H3	
Q7Z7H5	
Q7Z7H8	
Q7Z7J5	
Q7Z7J7	
Q7Z7J9	
Q7Z7K0	
Q7Z7K2	
Q7Z7K6	
Q7Z7L1	
Q7Z7L7	
Q7Z7L8	
Q7Z7L9	
Q7Z7M0	
Q7Z7M1	
Q7Z7M8	
Q7Z7M9	
Q7Z7N9	
Q86SE5	
Q86SE8	
Q86SE9	
Q86SF2	
Q86SG2	
Q86SG3	
Q86SG4	
Q86SG5	
Q86SG6	
Q86SG7	
Q86SH2	
Q86SH4	
Q86SI9	
Q86SJ2	
Q86SJ6	
Q86SK9	
Q86SM5	
Q86SM8	
Q86SP6	
Q86SQ0	
Q86SQ3	
Q86SQ4	
Q86SQ6	
Q86SQ7	
Q86SQ9	
Q86SR1	
Q86SS6	
Q86SU0	
Q86SX3	
Q86SX6	
Q86SY8	
Q86SZ2	
Q86T03	
Q86T13	
Q86T20	
Q86T23	
Q86T24	
Q86T26	ENZYME REGULATION: Inhibited by aprotinin, leupeptin, benzamidine, SERPINA1, SPINT1 and SPINT2. {ECO:0000269|PubMed:24498351}.
Q86T29	
Q86T65	
Q86T75	
Q86T82	
Q86T90	
Q86T96	
Q86TA1	
Q86TA4	
Q86TB3	
Q86TB9	
Q86TC9	
Q86TD4	
Q86TE4	
Q86TG1	
Q86TG7	
Q86TH1	
Q86TI0	
Q86TI2	ENZYME REGULATION: Inhibited by the serine proteinase inhibitor 4-(2-aminoethyl)benzenesulphonyl fluoride (AEBSF), and by di-isopropylfuorophosphate. {ECO:0000269|PubMed:12662155}.
Q86TI4	
Q86TJ2	
Q86TJ5	
Q86TL0	ENZYME REGULATION: Inhibited by N-ethylmaleimide.
Q86TL2	
Q86TM3	
Q86TM6	
Q86TN4	
Q86TP1	ENZYME REGULATION: Activated by magnesium ions and inhibited by manganese ions. Inhibited by dipyridamole, moderately sensitive to IBMX and inhibited by vinpocetine. {ECO:0000269|PubMed:14998490}.
Q86TS7	
Q86TS9	
Q86TU6	
Q86TU7	
Q86TV6	
Q86TW2	
Q86TX2	
Q86TY3	
Q86TZ1	
Q86U02	
Q86U06	
Q86U10	
Q86U17	
Q86U28	
Q86U37	
Q86U38	
Q86U42	
Q86U44	ENZYME REGULATION: Methyltransferase activity is regulated by miRNAs via a sequence pairing mechanism. {ECO:0000250|UniProtKB:Q8C3P7}.
Q86U70	
Q86U86	
Q86U90	
Q86UA1	
Q86UA6	
Q86UB2	
Q86UB9	
Q86UC2	
Q86UD0	
Q86UD1	
Q86UD3	
Q86UD4	
Q86UD5	
Q86UD7	
Q86UE3	
Q86UE4	
Q86UE6	
Q86UE8	ENZYME REGULATION: Cell cycle-regulated, with maximal activity in the S-phase. Rapidly and transiently inhibited by phosphorylation following the generation of DNA double-stranded breaks during S-phase, probably by CHEK1, possibly at Ser-750. This inhibition is cell cycle checkpoint- and ATM-dependent. {ECO:0000269|PubMed:10523312, ECO:0000269|PubMed:12660173, ECO:0000269|PubMed:12955071, ECO:0000269|PubMed:20016786}.
Q86UF1	
Q86UF2	
Q86UF4	
Q86UG4	
Q86UK0	
Q86UK5	
Q86UK7	
Q86UL3	ENZYME REGULATION: Inhibited by N-ethylmaleimide (NEM). {ECO:0000269|PubMed:18238778}.
Q86UL8	
Q86UN2	
Q86UN3	
Q86UN6	
Q86UP0	
Q86UP2	
Q86UP3	
Q86UP6	
Q86UP8	
Q86UP9	
Q86UQ0	
Q86UQ4	
Q86UQ5	
Q86UQ8	
Q86UR1	
Q86UR5	
Q86US8	
Q86UT5	
Q86UT6	
Q86UT8	
Q86UU0	
Q86UU1	
Q86UU5	
Q86UU9	
Q86UV5	
Q86UV6	
Q86UV7	
Q86UW1	
Q86UW2	
Q86UW6	
Q86UW7	
Q86UW8	
Q86UW9	
Q86UX2	
Q86UX6	
Q86UX7	
Q86UY5	
Q86UY6	
Q86UY8	
Q86UZ6	
Q86V15	
Q86V20	
Q86V21	
Q86V24	
Q86V25	
Q86V35	
Q86V40	
Q86V42	
Q86V48	
Q86V59	
Q86V71	
Q86V81	
Q86V85	
Q86V86	
Q86V87	
Q86V88	ENZYME REGULATION: Inhibited by vanadate and zinc, and slightly by calcium. {ECO:0000250}.
Q86V97	
Q86VB7	
Q86VD1	
Q86VD7	
Q86VD9	
Q86VE0	
Q86VE3	
Q86VE9	
Q86VF2	
Q86VF5	
Q86VF7	
Q86VG3	
Q86VH2	
Q86VH4	
Q86VH5	
Q86VI1	
Q86VI3	
Q86VI4	
Q86VK4	
Q86VL8	
Q86VM9	
Q86VN1	
Q86VP1	
Q86VP3	
Q86VP6	
Q86VQ0	
Q86VQ1	
Q86VQ3	
Q86VQ6	
Q86VR2	
Q86VR7	
Q86VR8	
Q86VS3	
Q86VS8	
Q86VU5	
Q86VV4	
Q86VV8	
Q86VW0	
Q86VW1	
Q86VW2	
Q86VX2	
Q86VX9	
Q86VY4	
Q86VY9	
Q86VZ1	
Q86VZ2	
Q86VZ4	
Q86VZ5	ENZYME REGULATION: Inhibited by bacterial PC-phospholipase C inhibitor D609. {ECO:0000269|PubMed:14685263}.
Q86VZ6	
Q86W10	
Q86W11	
Q86W24	
Q86W25	
Q86W26	
Q86W28	
Q86W33	
Q86W34	ENZYME REGULATION: Inhibited by the general metalloprotease inhibitors o-phenanthroline and batimastat. Also significantly inhibited by amastatin, which is an inhibitor of aminopeptidases. Not inhibited by 4-(2-aminoethyl)-benzenesulfonyl fluoride, E-64, and TIMPS (tissue inhibitors of metalloproteinases), which are inhibitors of serine, cysteine, and matrix metalloproteases, respectively. {ECO:0000269|PubMed:15972818}.
Q86W42	
Q86W47	
Q86W50	
Q86W54	
Q86W56	
Q86W67	
Q86W74	
Q86W92	
Q86WA6	
Q86WA8	
Q86WA9	
Q86WB0	
Q86WB7	
Q86WC4	
Q86WC6	
Q86WD7	
Q86WG3	
Q86WG5	
Q86WH2	
Q86WI0	
Q86WI1	
Q86WI3	
Q86WJ1	
Q86WK6	
Q86WK7	
Q86WK9	
Q86WN1	
Q86WN2	
Q86WP2	
Q86WQ0	
Q86WR0	
Q86WR6	
Q86WR7	
Q86WS3	
Q86WS4	
Q86WS5	
Q86WT1	
Q86WT6	
Q86WU2	
Q86WV1	
Q86WV5	
Q86WV6	
Q86WW8	
Q86WX3	
Q86WZ0	
Q86WZ6	
Q86X02	
Q86X10	
Q86X19	
Q86X24	
Q86X27	
Q86X29	
Q86X40	
Q86X45	
Q86X51	
Q86X52	
Q86X53	
Q86X55	ENZYME REGULATION: Methylation of H3R17 (H3R17me) by CARM1 is stimulated by preacetylation of H3 'Lys-18' (H3K18ac) H3 'Lys-23' (H3K23ac) by EP300 and blocked by citrullination of H3 'Arg-17' (H3R17ci) by PADI4. {ECO:0000250}.
Q86X59	
Q86X60	
Q86X67	
Q86X76	
Q86X83	
Q86X95	
Q86XA0	
Q86XA9	
Q86XD5	
Q86XD8	
Q86XE0	
Q86XE3	
Q86XE5	ENZYME REGULATION: Inhibited by divalent cations. {ECO:0000250}.
Q86XF0	
Q86XF7	
Q86XG9	
Q86XH1	
Q86XI2	
Q86XI6	
Q86XI8	
Q86XJ0	
Q86XJ1	
Q86XK2	
Q86XK3	
Q86XK7	
Q86XL3	
Q86XM0	
Q86XN6	
Q86XN7	
Q86XN8	
Q86XP0	ENZYME REGULATION: Stimulated by cytosolic Ca(2+). {ECO:0000269|PubMed:14709560}.
Q86XP1	
Q86XP3	
Q86XP6	
Q86XQ3	ENZYME REGULATION: The CatSper calcium channel is indirectly activated by extracellular progesterone and prostaglandins following the sequence: progesterone > PGF1-alpha = PGE1 > PGA1 > PGE2 >> PGD2 (PubMed:21412338, PubMed:21412339, PubMed:26989199). The CatSper calcium channel is directly inhibited by endocannabinoid 2-arachidonoylglycerol (2AG) (PubMed:26989199). Indirect activation by progesterone takes place via the following mechanism: progesterone binds and activates the acylglycerol lipase ABHD2, which in turn mediates hydrolysis of 2AG inhibitor, relieving inhibition of the CatSper channel (PubMed:26989199). The primary effect of progesterone activation is to shift voltage dependence towards more physiological, negative membrane potentials; it is not mediated by metabotropic receptors and second messengers (PubMed:21412338, PubMed:21412339). Sperm capacitation enhances the effect of progesterone by providing additional negative shift. Also activated by the elevation of intracellular pH (PubMed:21412338, PubMed:21412339). {ECO:0000269|PubMed:21412338, ECO:0000269|PubMed:21412339, ECO:0000269|PubMed:26989199}.
Q86XR2	
Q86XR5	
Q86XR7	
Q86XR8	
Q86XS5	
Q86XS8	
Q86XT2	
Q86XT4	
Q86XT9	
Q86XU0	
Q86XW9	
Q86XX4	
Q86XZ4	
Q86Y01	
Q86Y07	ENZYME REGULATION: RAN inhibits its autophosphorylation and its ability to phosphorylate histone H3. {ECO:0000269|PubMed:18617507}.
Q86Y13	
Q86Y22	
Q86Y25	
Q86Y26	
Q86Y27	
Q86Y28	
Q86Y29	
Q86Y30	
Q86Y33	
Q86Y34	
Q86Y37	
Q86Y38	
Q86Y39	
Q86Y46	
Q86Y56	
Q86Y78	
Q86Y79	
Q86Y82	
Q86Y91	
Q86Y97	
Q86YA3	
Q86YB7	
Q86YB8	ENZYME REGULATION: Glutathione may be required to regulate its activity in the endoplasmic reticulum. {ECO:0000269|PubMed:15161913}.
Q86YC2	
Q86YC3	
Q86YD1	
Q86YD3	
Q86YD5	
Q86YD7	
Q86YE8	
Q86YF9	
Q86YG4	
Q86YH2	
Q86YH6	
Q86YI8	
Q86YJ5	
Q86YJ6	
Q86YJ7	
Q86YL5	
Q86YL7	
Q86YM7	
Q86YN1	
Q86YN6	
Q86YP4	
Q86YQ2	
Q86YQ8	
Q86YR5	
Q86YR6	
Q86YR7	
Q86YS3	
Q86YS6	
Q86YS7	
Q86YT5	
Q86YT6	
Q86YT9	
Q86YV0	
Q86YV5	
Q86YV6	
Q86YV9	
Q86YW0	
Q86YW5	
Q86YW7	
Q86YW9	
Q86YZ3	
Q86Z02	
Q86Z14	
Q86Z20	
Q86Z23	
Q8HWS3	
Q8IU53	
Q8IU54	
Q8IU57	
Q8IU60	
Q8IU68	
Q8IU80	
Q8IU81	
Q8IU85	ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of calmodulin results in conformational change that relieves intrasteric autoinhibition and allows phosphorylation of Thr-180 within the activation loop by CaMKK1 or CaMKK2. Phosphorylation of Thr-180 results in several fold increase in total activity. Unlike CaMK4, may be unable to exhibit autonomous activity after Ca(2+)/calmodulin activation. {ECO:0000269|PubMed:11050006, ECO:0000269|PubMed:12935886}.
Q8IU89	
Q8IU99	ENZYME REGULATION: Inhibited by Gd(3+), Ruthenium Red, and Zn(2+) and partially inhibited by 2-aminoethoxydiphenyl borate. {ECO:0000269|PubMed:22711817}.
Q8IUA0	
Q8IUA7	
Q8IUB2	
Q8IUB3	
Q8IUB5	
Q8IUB9	
Q8IUC0	
Q8IUC1	
Q8IUC2	
Q8IUC3	
Q8IUC4	
Q8IUC6	
Q8IUC8	
Q8IUD2	
Q8IUD6	
Q8IUE0	
Q8IUE1	
Q8IUE6	
Q8IUF1	
Q8IUF8	
Q8IUG1	
Q8IUG5	
Q8IUH2	
Q8IUH3	
Q8IUH4	
Q8IUH5	
Q8IUH8	
Q8IUI4	
Q8IUI8	
Q8IUK5	
Q8IUK8	
Q8IUL8	
Q8IUM7	
Q8IUN9	
Q8IUQ0	
Q8IUQ4	ENZYME REGULATION: Inhibited by interaction with SNCAIP (isoform 2, but not isoform 1). May be inhibited by interaction with PEG10. {ECO:0000269|PubMed:19224863}.
Q8IUR0	
Q8IUR5	
Q8IUR6	
Q8IUR7	
Q8IUS5	
Q8IUW3	
Q8IUW5	
Q8IUX1	
Q8IUX4	ENZYME REGULATION: Antiviral activity is neutralized by the HIV-1 virion infectivity factor (VIF), that prevents its incorporation into progeny virions by both inhibiting its translation and/or by inducing its ubiquitination and subsequent degradation by the 26S proteasome. {ECO:0000269|PubMed:21835787}.
Q8IUX7	
Q8IUX8	
Q8IUY3	
Q8IUZ0	
Q8IUZ5	
Q8IV01	
Q8IV03	
Q8IV04	
Q8IV08	
Q8IV13	
Q8IV16	
Q8IV20	
Q8IV31	
Q8IV32	
Q8IV33	
Q8IV35	
Q8IV36	
Q8IV38	
Q8IV42	
Q8IV45	
Q8IV48	ENZYME REGULATION: Although it can bind simultaneously with SLBP to the 3'-end of histone mRNA, the presence of SLBP prevents the exonuclease activity. {ECO:0000269|PubMed:14536070}.
Q8IV50	
Q8IV53	
Q8IV56	
Q8IV61	
Q8IV63	
Q8IV76	
Q8IV77	ENZYME REGULATION: Calcium-calmodulin exerts its inhibitory effect in cAMP sensitivity by binding to IQ-like motif of CNGA4 and preferably binds to the channel in the closed state. Inhibition by PIP3 of the CNG channel probably occurs via CGNA2 binding. {ECO:0000269|PubMed:17032767}.
Q8IVA1	
Q8IVB4	
Q8IVB5	
Q8IVC4	
Q8IVD9	
Q8IVE0	
Q8IVE3	
Q8IVF1	
Q8IVF2	
Q8IVF4	
Q8IVF5	
Q8IVF6	
Q8IVF7	
Q8IVG5	
Q8IVG9	
Q8IVH2	
Q8IVH4	ENZYME REGULATION: GTPase activity is stimulated by MUT. {ECO:0000269|PubMed:20876572, ECO:0000269|PubMed:28497574}.
Q8IVH8	
Q8IVI9	
Q8IVJ1	
Q8IVJ8	
Q8IVK1	
Q8IVL0	
Q8IVL1	
Q8IVL5	ENZYME REGULATION: Inhibited by pyridine 2,4-dicarboxylate, an analog of 2-oxoglutarate. {ECO:0000269|PubMed:18487197}.
Q8IVL6	
Q8IVL8	ENZYME REGULATION: Strongly inhibited by potato carboxypeptidase inhibitor, and the chelating agents EDTA and 1,10-phenanthroline. Also inhibited by compounds with multiple carboxylic acid groups such as citrate and succinate, and to a lesser exent the amino acids aspartate and glutamate. Not significantly inhibited by benzylsuccinic acid. {ECO:0000269|PubMed:21921028}.
Q8IVM0	
Q8IVM7	
Q8IVM8	
Q8IVN3	
Q8IVN8	
Q8IVP5	
Q8IVP9	
Q8IVQ6	
Q8IVS2	
Q8IVS8	
Q8IVT2	
Q8IVT5	
Q8IVU1	
Q8IVU3	
Q8IVU9	
Q8IVV2	
Q8IVV7	
Q8IVV8	
Q8IVW1	
Q8IVW4	
Q8IVW6	
Q8IVW8	
Q8IVY1	
Q8IW00	
Q8IW03	
Q8IW19	
Q8IW35	
Q8IW36	
Q8IW40	
Q8IW41	ENZYME REGULATION: Activated following phosphorylation at Thr-182 by p38-alpha/MAPK14, p38-beta/MAPK11, ERK2/MAPK1, ERK3/MAPK6, and ERK4/MAPK4. Activated by stress-related extracellular stimuli; such as H(2)O(2), arsenite, anisomycin TNF alpha and also PMA and the calcium ionophore A23187; but to a lesser extent. In vitro, activated by SQSTM1. Inhibited by diterpenoid alkaloid noroxoaconitine. {ECO:0000269|PubMed:10708586, ECO:0000269|PubMed:9628874}.
Q8IW45	
Q8IW50	
Q8IW52	
Q8IW70	
Q8IW75	
Q8IW92	
Q8IW93	
Q8IWA0	
Q8IWA4	
Q8IWA5	
Q8IWA6	
Q8IWB1	
Q8IWB4	
Q8IWB6	
Q8IWB7	
Q8IWB9	
Q8IWC1	
Q8IWD4	
Q8IWD5	
Q8IWE2	
Q8IWE4	
Q8IWE5	
Q8IWF2	
Q8IWF6	
Q8IWF7	
Q8IWF9	
Q8IWG1	
Q8IWI9	
Q8IWJ2	
Q8IWK6	
Q8IWL1	
Q8IWL2	
Q8IWL3	
Q8IWL8	
Q8IWN6	
Q8IWN7	
Q8IWP9	
Q8IWQ3	ENZYME REGULATION: Activated by phosphorylation on Thr-174 by STK11/LKB1. {ECO:0000269|PubMed:14976552}.
Q8IWR0	
Q8IWR1	
Q8IWS0	
Q8IWT0	
Q8IWT1	
Q8IWT3	
Q8IWT6	
Q8IWU2	
Q8IWU4	
Q8IWU5	
Q8IWU6	
Q8IWU9	
Q8IWV1	
Q8IWV2	
Q8IWV7	
Q8IWV8	
Q8IWW6	
Q8IWW8	
Q8IWX5	
Q8IWX7	
Q8IWX8	
Q8IWY4	
Q8IWY8	
Q8IWY9	
Q8IWZ3	
Q8IWZ4	
Q8IWZ5	
Q8IWZ6	
Q8IWZ8	
Q8IX01	
Q8IX03	
Q8IX04	
Q8IX05	
Q8IX06	
Q8IX07	
Q8IX12	
Q8IX15	
Q8IX18	
Q8IX19	
Q8IX21	
Q8IX29	
Q8IX30	
Q8IX90	
Q8IX94	
Q8IX95	
Q8IXA5	
Q8IXB1	
Q8IXB3	
Q8IXE1	
Q8IXF0	
Q8IXF9	
Q8IXH6	
Q8IXH7	
Q8IXH8	
Q8IXI1	
Q8IXI2	
Q8IXJ6	ENZYME REGULATION: Inhibited by Sirtinol, A3 and M15 small molecules (PubMed:11483616). Inhibited by nicotinamide. Inhibited by a macrocyclic peptide inhibitor S2iL5 (PubMed:24389023). Inhibited by EP300-induced acetylation (PubMed:18722353). {ECO:0000269|PubMed:11483616, ECO:0000269|PubMed:18722353, ECO:0000269|PubMed:24389023}.
Q8IXJ9	
Q8IXK0	
Q8IXK2	
Q8IXL6	ENZYME REGULATION: Serine/threonine protein kinase activity is increased upon interaction with FAM20A. {ECO:0000269|PubMed:25789606}.
Q8IXL7	
Q8IXL9	
Q8IXM2	
Q8IXM3	
Q8IXM6	
Q8IXM7	
Q8IXN7	
Q8IXP5	
Q8IXQ3	
Q8IXQ4	
Q8IXQ5	
Q8IXQ6	ENZYME REGULATION: Binding to poly(ADP-ribose) does not affect its activity. {ECO:0000269|PubMed:28525742}.
Q8IXQ8	
Q8IXQ9	
Q8IXR5	
Q8IXR9	
Q8IXS0	
Q8IXS2	
Q8IXS6	
Q8IXS8	
Q8IXT1	
Q8IXT2	
Q8IXT5	
Q8IXU6	
Q8IXV7	
Q8IXW0	
Q8IXW5	
Q8IXX5	
Q8IXY8	
Q8IXZ2	
Q8IXZ3	
Q8IY17	ENZYME REGULATION: Inhibited by a series a OPs such as mipafox (MPX), phenyl saligenin phosphate (PSP), phenyl dipentyl phosphinate (PDPP), diisopropyl fluorophosphate and paraoxon. {ECO:0000269|PubMed:15044461}.
Q8IY18	
Q8IY21	
Q8IY22	
Q8IY26	
Q8IY31	
Q8IY33	
Q8IY34	
Q8IY37	
Q8IY42	
Q8IY45	
Q8IY47	
Q8IY49	
Q8IY50	
Q8IY51	
Q8IY57	
Q8IY63	
Q8IY67	
Q8IY81	
Q8IY82	
Q8IY84	ENZYME REGULATION: Activated by phosphorylation at Thr-229, probably by autophosphorylation. {ECO:0000269|PubMed:15733851}.
Q8IY85	
Q8IY92	
Q8IY95	
Q8IYA2	
Q8IYA6	
Q8IYA7	
Q8IYA8	
Q8IYB0	
Q8IYB1	
Q8IYB3	
Q8IYB4	
Q8IYB5	
Q8IYB7	
Q8IYB8	ENZYME REGULATION: Helicase activity toward DNA substrate is inhibited by micromolar concentrations of 5,6-dichloro-1-(beta-D-ribofuranosyl)benzotriazole (DRBT) and 4,5,6,7-tetrabromobenzotriazole (TBBT). Helicase activity toward RNA substrate is inhibited by elevated concentrations of TBBT. Inhibited by some ring-expanded nucleoside analogs. {ECO:0000269|PubMed:12694177, ECO:0000269|PubMed:14561097}.
Q8IYB9	
Q8IYD1	
Q8IYD2	
Q8IYD8	
Q8IYD9	
Q8IYE0	
Q8IYE1	
Q8IYF1	
Q8IYF3	
Q8IYG6	
Q8IYH5	
Q8IYI0	
Q8IYI6	
Q8IYI8	
Q8IYJ0	
Q8IYJ1	
Q8IYJ2	
Q8IYJ3	
Q8IYK2	
Q8IYK4	
Q8IYK8	
Q8IYL2	
Q8IYL3	
Q8IYL9	
Q8IYM0	
Q8IYM1	
Q8IYM2	
Q8IYM9	
Q8IYN0	
Q8IYN2	
Q8IYN6	
Q8IYP2	
Q8IYP9	
Q8IYQ7	
Q8IYR0	
Q8IYR2	
Q8IYR6	
Q8IYS0	
Q8IYS1	
Q8IYS2	
Q8IYS4	
Q8IYS5	
Q8IYS8	
Q8IYT1	
Q8IYT2	
Q8IYT3	
Q8IYT4	
Q8IYT8	
Q8IYU2	
Q8IYU4	
Q8IYU8	
Q8IYV9	
Q8IYW2	
Q8IYW4	
Q8IYW5	
Q8IYX0	
Q8IYX1	
Q8IYX3	
Q8IYX4	
Q8IYX7	
Q8IYX8	
Q8IYY4	
Q8IZ02	
Q8IZ07	
Q8IZ08	
Q8IZ13	
Q8IZ16	
Q8IZ20	
Q8IZ21	
Q8IZ26	
Q8IZ40	
Q8IZ41	
Q8IZ52	
Q8IZ57	
Q8IZ63	
Q8IZ69	
Q8IZ73	
Q8IZ81	
Q8IZ83	
Q8IZ96	
Q8IZA0	
Q8IZA3	
Q8IZC4	
Q8IZC6	
Q8IZC7	
Q8IZD0	
Q8IZD2	
Q8IZD4	
Q8IZD6	
Q8IZD9	
Q8IZE3	
Q8IZF0	
Q8IZF2	
Q8IZF3	
Q8IZF4	
Q8IZF5	
Q8IZF6	
Q8IZF7	
Q8IZH2	
Q8IZI9	
Q8IZJ0	
Q8IZJ1	
Q8IZJ3	
Q8IZJ4	
Q8IZJ6	
Q8IZK6	ENZYME REGULATION: Channel activity is reduced by low extracellular/lumenal pH level (PubMed:19940139). {ECO:0000269|PubMed:19940139, ECO:0000305}.
Q8IZL2	
Q8IZL8	
Q8IZL9	
Q8IZM0	
Q8IZM8	
Q8IZM9	
Q8IZN3	
Q8IZN7	
Q8IZP0	
Q8IZP1	
Q8IZP2	
Q8IZP6	
Q8IZP7	
Q8IZP9	
Q8IZQ1	
Q8IZQ5	
Q8IZQ8	
Q8IZR5	
Q8IZS5	
Q8IZS6	
Q8IZS7	
Q8IZS8	
Q8IZT6	
Q8IZT8	
Q8IZT9	
Q8IZU0	
Q8IZU1	
Q8IZU2	
Q8IZU3	
Q8IZU8	
Q8IZU9	
Q8IZV2	
Q8IZV5	
Q8IZW8	
Q8IZX4	
Q8IZY2	
Q8IZY5	
Q8J025	
Q8MH63	
Q8N0S2	
Q8N0S6	
Q8N0T1	
Q8N0U2	
Q8N0U4	
Q8N0U6	
Q8N0U7	
Q8N0U8	ENZYME REGULATION: Inhibited by warfarin (coumadin). {ECO:0000269|PubMed:21367861, ECO:0000269|PubMed:23928358, ECO:0000269|PubMed:24532791}.
Q8N0V1	
Q8N0V3	
Q8N0V4	
Q8N0V5	
Q8N0W3	
Q8N0W4	
Q8N0W5	
Q8N0W7	
Q8N0X2	
Q8N0X4	
Q8N0X7	
Q8N0Y2	
Q8N0Y3	
Q8N0Y5	
Q8N0Y7	
Q8N0Z2	
Q8N0Z3	
Q8N0Z6	
Q8N0Z8	
Q8N0Z9	
Q8N100	
Q8N103	
Q8N104	
Q8N108	
Q8N109	
Q8N111	
Q8N112	
Q8N114	
Q8N118	
Q8N119	
Q8N122	
Q8N123	
Q8N126	
Q8N127	
Q8N128	
Q8N129	
Q8N130	
Q8N131	
Q8N135	
Q8N136	
Q8N137	
Q8N138	
Q8N139	
Q8N140	
Q8N141	
Q8N142	
Q8N143	
Q8N144	
Q8N145	
Q8N146	
Q8N148	
Q8N149	
Q8N157	
Q8N158	
Q8N159	ENZYME REGULATION: Increased by L-arginine. {ECO:0000269|PubMed:12459178, ECO:0000269|PubMed:23894642}.
Q8N162	
Q8N163	
Q8N165	
Q8N183	
Q8N184	
Q8N187	
Q8N196	
Q8N1A0	
Q8N1A6	
Q8N1B3	
Q8N1B4	
Q8N1C3	
Q8N1D0	
Q8N1D5	
Q8N1E2	
Q8N1E6	
Q8N1F1	
Q8N1F7	
Q8N1F8	
Q8N1G0	
Q8N1G1	
Q8N1G2	
Q8N1G4	
Q8N1H7	
Q8N1I0	
Q8N1I8	
Q8N1K5	
Q8N1L1	
Q8N1L4	
Q8N1L9	
Q8N1M1	
Q8N1N0	
Q8N1N2	
Q8N1N4	
Q8N1N5	
Q8N1P7	
Q8N1Q1	ENZYME REGULATION: Inhibited by acetazolamide. {ECO:0000269|PubMed:18618712}.
Q8N1Q8	
Q8N1S5	
Q8N1T3	
Q8N1V2	
Q8N1V8	
Q8N1W1	
Q8N1W2	
Q8N1X5	
Q8N1Y9	
Q8N201	
Q8N205	
Q8N228	
Q8N239	
Q8N257	
Q8N264	
Q8N268	
Q8N271	
Q8N283	
Q8N292	
Q8N2A0	
Q8N2A8	ENZYME REGULATION: SsDNA hydrolase activity does not depend upon, but it stimulated by, the presence of Ca(2+) and Mn(2+). {ECO:0000250|UniProtKB:Q5SWZ9}.
Q8N2B8	
Q8N2C3	
Q8N2C7	
Q8N2C9	
Q8N2E2	
Q8N2E6	
Q8N2F6	
Q8N2G4	
Q8N2G6	
Q8N2G8	
Q8N2H3	
Q8N2H4	
Q8N2H9	
Q8N2I2	
Q8N2I9	
Q8N2K0	
Q8N2K1	
Q8N2M4	
Q8N2M8	
Q8N2N9	
Q8N2Q7	
Q8N2R0	
Q8N2R8	
Q8N2S1	
Q8N2U0	
Q8N2U9	
Q8N2W9	
Q8N2X6	
Q8N2Y8	
Q8N2Z9	
Q8N300	
Q8N302	
Q8N307	
Q8N309	
Q8N319	
Q8N323	
Q8N326	
Q8N328	
Q8N335	
Q8N336	
Q8N339	
Q8N344	
Q8N349	
Q8N350	
Q8N357	
Q8N365	
Q8N370	
Q8N371	
Q8N377	
Q8N386	
Q8N387	
Q8N392	
Q8N393	
Q8N394	
Q8N398	
Q8N3A8	
Q8N3C0	
Q8N3C7	
Q8N3D4	
Q8N3E9	ENZYME REGULATION: Strongly activated by phosphatidic acid. Inhibited by phosphatidylethanolamine (PtdEtn), phosphatidylcholine (PtdCho), sphingomyelin and phosphatidylserine (PtdSer). {ECO:0000269|PubMed:10336610, ECO:0000269|PubMed:9799116}.
Q8N3F0	
Q8N3F8	
Q8N3F9	
Q8N3G9	
Q8N3H0	
Q8N3I7	
Q8N3J2	
Q8N3J3	
Q8N3J5	
Q8N3J6	
Q8N3J9	
Q8N3K9	
Q8N3L3	
Q8N3P4	
Q8N3R3	
Q8N3R9	
Q8N3S3	
Q8N3T1	
Q8N3T6	
Q8N3U1	
Q8N3U4	
Q8N3V7	
Q8N3X1	
Q8N3X6	
Q8N3Y1	
Q8N3Y3	
Q8N3Y7	
Q8N3Z0	
Q8N3Z3	
Q8N3Z6	
Q8N402	
Q8N412	
Q8N413	
Q8N414	
Q8N423	
Q8N427	
Q8N428	
Q8N431	
Q8N434	
Q8N436	
Q8N441	
Q8N442	
Q8N443	
Q8N446	
Q8N448	
Q8N456	
Q8N461	
Q8N465	ENZYME REGULATION: Activated by zinc and cobalt. {ECO:0000269|PubMed:15070399}.
Q8N468	
Q8N474	
Q8N475	
Q8N485	
Q8N488	
Q8N490	
Q8N4A0	
Q8N4B1	
Q8N4B4	
Q8N4B5	
Q8N4C0	
Q8N4C6	
Q8N4C7	
Q8N4C8	
Q8N4C9	
Q8N4E4	
Q8N4E7	
Q8N4F0	
Q8N4F4	
Q8N4F7	
Q8N4G2	
Q8N4H0	
Q8N4H5	
Q8N4J0	
Q8N4K4	
Q8N4L1	
Q8N4L2	
Q8N4L4	
Q8N4L8	
Q8N4M1	
Q8N4M7	
Q8N4N3	
Q8N4N8	
Q8N4P2	
Q8N4P3	
Q8N4P6	
Q8N4Q0	
Q8N4Q1	
Q8N4S0	
Q8N4S7	
Q8N4S9	
Q8N4T0	
Q8N4T4	
Q8N4T8	
Q8N4U5	
Q8N4V1	
Q8N4V2	
Q8N4W6	
Q8N4W9	
Q8N4X5	
Q8N4Y2	
Q8N4Z0	
Q8N511	
Q8N531	
Q8N535	
Q8N539	
Q8N543	
Q8N554	
Q8N556	
Q8N565	
Q8N567	
Q8N568	
Q8N573	
Q8N584	
Q8N587	
Q8N594	
Q8N5A5	
Q8N5B7	
Q8N5C1	
Q8N5C6	
Q8N5C7	
Q8N5C8	
Q8N5D0	
Q8N5D6	
Q8N5F7	
Q8N5G0	
Q8N5G2	
Q8N5H3	
Q8N5H7	
Q8N5I2	
Q8N5I3	
Q8N5I4	
Q8N5I9	
Q8N5J2	
Q8N5J4	
Q8N5K1	
Q8N5L8	
Q8N5M1	
Q8N5M4	
Q8N5M9	
Q8N5N4	
Q8N5N7	
Q8N5P1	
Q8N5Q1	
Q8N5R6	
Q8N5S1	
Q8N5S3	
Q8N5S9	ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of calmodulin may relieve intrasteric autoinhibition. Partially inhibited upon phosphorylation by PRCAKA/PKA (By similarity). May be regulated through phosphorylation by CAMK1 and CAMK4. {ECO:0000250}.
Q8N5T2	
Q8N5U0	
Q8N5U1	
Q8N5U6	
Q8N5V2	
Q8N5W8	
Q8N5W9	
Q8N5X7	
Q8N5Y2	
Q8N5Y8	
Q8N5Z0	ENZYME REGULATION: Kynurenine transaminase activity is competitively inhibited by aminoadipate, asparagine, glutamate, histidine, cysteine, lysine, 3-hydroxy-kynurenine and phenylalanine. {ECO:0000269|PubMed:18620547}.
Q8N5Z5	
Q8N608	
Q8N609	
Q8N612	
Q8N614	
Q8N616	
Q8N628	
Q8N635	
Q8N653	
Q8N660	
Q8N661	ENZYME REGULATION: Competitively inhibited by lysophosphatidic acid. {ECO:0000269|PubMed:21515882}.
Q8N668	
Q8N680	
Q8N682	
Q8N684	
Q8N687	
Q8N688	
Q8N690	
Q8N693	
Q8N695	
Q8N697	
Q8N699	
Q8N6C5	
Q8N6C7	
Q8N6C8	
Q8N6D2	
Q8N6D5	
Q8N6F1	
Q8N6F7	
Q8N6F8	
Q8N6G1	
Q8N6G2	
Q8N6G5	
Q8N6G6	
Q8N6H7	
Q8N6I1	
Q8N6I4	
Q8N6K0	
Q8N6K4	
Q8N6K7	
Q8N6L0	
Q8N6L1	
Q8N6L7	
Q8N6M0	
Q8N6M3	
Q8N6M5	
Q8N6M6	ENZYME REGULATION: Strongly inhibited by ophenanthroline, a metalloprotease inhibitor. Inhibited by arphamenine A, a potent inhibitor of aminopeptidases. Not affected by AEBSF and E-64, which are common inhibitors of serine- and cysteine-proteases, respectively. {ECO:0000269|PubMed:15687497}.
Q8N6M8	
Q8N6M9	
Q8N6N2	
Q8N6N3	
Q8N6N6	
Q8N6N7	
Q8N6P7	
Q8N6Q1	
Q8N6Q3	
Q8N6Q8	
Q8N6R0	
Q8N6R1	
Q8N6S4	
Q8N6S5	
Q8N6T0	
Q8N6T3	
Q8N6T7	
Q8N6U2	
Q8N6U8	
Q8N6V4	
Q8N6V9	
Q8N6W0	
Q8N6Y0	
Q8N6Y1	
Q8N6Y2	
Q8N715	
Q8N720	
Q8N726	
Q8N729	
Q8N743	
Q8N752	
Q8N755	
Q8N766	
Q8N769	
Q8N782	
Q8N7A1	
Q8N7B1	
Q8N7B6	
Q8N7B9	
Q8N7C0	
Q8N7C3	
Q8N7C4	
Q8N7C7	
Q8N7E2	
Q8N7F7	
Q8N7G0	
Q8N7H1	
Q8N7H5	
Q8N7I0	
Q8N7J2	
Q8N7K0	
Q8N7L0	
Q8N7M0	
Q8N7M2	
Q8N7N1	
Q8N7P1	
Q8N7P3	
Q8N7P7	
Q8N7Q2	
Q8N7Q3	
Q8N7R0	
Q8N7R1	
Q8N7R7	
Q8N7S2	
Q8N7S6	
Q8N7U6	
Q8N7U7	
Q8N7U9	
Q8N7W2	
Q8N7X0	
Q8N7X1	
Q8N7X2	
Q8N7X4	
Q8N7X8	
Q8N7Y1	
Q8N7Z2	
Q8N7Z5	
Q8N801	
Q8N806	
Q8N807	
Q8N808	
Q8N812	
Q8N813	
Q8N814	
Q8N815	
Q8N816	
Q8N819	
Q8N823	
Q8N831	
Q8N841	
Q8N859	
Q8N865	
Q8N878	
Q8N883	
Q8N884	ENZYME REGULATION: The enzyme activity is strongly increased by double-stranded DNA, but not by single-stranded DNA or RNA (PubMed:23258413, PubMed:23707061, PubMed:26300263). The enzyme activity is impaired by the cleavage at Asp-140 and Asp-157 produced by CASP1 (PubMed:28314590). {ECO:0000269|PubMed:23258413, ECO:0000269|PubMed:23707061, ECO:0000269|PubMed:26300263, ECO:0000269|PubMed:28314590}.
Q8N888	
Q8N895	
Q8N8A2	
Q8N8A6	
Q8N8A8	
Q8N8B7	
Q8N8C0	
Q8N8D1	
Q8N8D7	
Q8N8D9	
Q8N8E1	
Q8N8E2	
Q8N8E3	
Q8N8F6	
Q8N8F7	
Q8N8G2	
Q8N8G6	
Q8N8H1	
Q8N8I0	
Q8N8I6	
Q8N8J0	
Q8N8J6	
Q8N8J7	
Q8N8K9	
Q8N8L2	
Q8N8L6	
Q8N8M0	
Q8N8N0	
Q8N8N7	
Q8N8P6	
Q8N8P7	
Q8N8Q1	
Q8N8Q3	
Q8N8Q8	
Q8N8Q9	
Q8N8R3	
Q8N8R5	
Q8N8R7	
Q8N8S7	
Q8N8U2	
Q8N8U3	
Q8N8U9	
Q8N8V2	
Q8N8V4	
Q8N8V8	
Q8N8W4	
Q8N8X9	
Q8N8Y2	
Q8N8Y5	
Q8N8Z3	
Q8N8Z6	
Q8N8Z8	
Q8N907	
Q8N910	
Q8N912	
Q8N944	
Q8N945	
Q8N954	
Q8N957	
Q8N960	
Q8N961	
Q8N966	
Q8N967	
Q8N972	
Q8N976	
Q8N983	
Q8N987	
Q8N988	
Q8N998	
Q8N999	
Q8N9A8	
Q8N9B4	
Q8N9B5	
Q8N9B8	
Q8N9C0	
Q8N9E0	
Q8N9F0	ENZYME REGULATION: Aminooxyacetic acid (AOAA) blocks its activity in both cytoplasm and mitochondria. {ECO:0000269|PubMed:20385109}.
Q8N9F7	
Q8N9F8	
Q8N9G6	
Q8N9H6	
Q8N9H8	
Q8N9H9	
Q8N9I0	
Q8N9I5	
Q8N9I9	
Q8N9K5	
Q8N9L1	
Q8N9L7	
Q8N9L9	
Q8N9M1	
Q8N9M5	
Q8N9N2	
Q8N9N5	
Q8N9N7	
Q8N9N8	
Q8N9P0	
Q8N9P6	
Q8N9Q2	
Q8N9R0	
Q8N9R6	
Q8N9R8	
Q8N9S9	
Q8N9T2	
Q8N9T8	
Q8N9U0	
Q8N9U9	
Q8N9V2	
Q8N9V3	
Q8N9V6	
Q8N9V7	
Q8N9W4	
Q8N9W5	
Q8N9W6	
Q8N9W7	
Q8N9W8	
Q8N9X3	
Q8N9X5	
Q8N9Y4	
Q8N9Z0	
Q8N9Z2	
Q8N9Z9	
Q8NA03	
Q8NA19	
Q8NA23	
Q8NA29	
Q8NA31	
Q8NA42	
Q8NA47	
Q8NA54	
Q8NA56	
Q8NA57	
Q8NA58	
Q8NA61	
Q8NA66	
Q8NA69	
Q8NA70	
Q8NA72	
Q8NA75	
Q8NA77	
Q8NA82	
Q8NA92	
Q8NA96	
Q8NA97	
Q8NAA4	
Q8NAA5	
Q8NAA6	
Q8NAB2	
Q8NAC3	
Q8NAE3	
Q8NAF0	
Q8NAG6	
Q8NAJ2	
Q8NAM6	
Q8NAN2	
Q8NAP1	
Q8NAP3	
Q8NAP8	
Q8NAQ8	
Q8NAS9	
Q8NAT1	
Q8NAT2	
Q8NAU1	
Q8NAV1	
Q8NAV2	
Q8NAX2	
Q8NB12	
Q8NB14	
Q8NB15	
Q8NB16	ENZYME REGULATION: Inhibited by necrosulfonamide, a specific inhibitor of necroptosis that targets Cys-86. {ECO:0000269|PubMed:22265413}.
Q8NB25	
Q8NB37	
Q8NB42	
Q8NB46	
Q8NB49	
Q8NB50	
Q8NB59	
Q8NB66	
Q8NB78	ENZYME REGULATION: Histone H3K4me1 and H3K4me2 demethylase activity is enhanced by GLYR1. {ECO:0000269|PubMed:23260659}.
Q8NB90	
Q8NB91	
Q8NBA8	
Q8NBB2	
Q8NBB4	
Q8NBC4	
Q8NBD8	
Q8NBE8	
Q8NBF1	
Q8NBF2	
Q8NBF4	
Q8NBF6	
Q8NBH2	
Q8NBI2	
Q8NBI3	
Q8NBI5	
Q8NBI6	
Q8NBJ4	
Q8NBJ5	
Q8NBJ7	
Q8NBJ9	
Q8NBK3	
Q8NBL1	
Q8NBL3	
Q8NBM4	
Q8NBM8	
Q8NBN3	
Q8NBN7	
Q8NBP0	
Q8NBP5	
Q8NBP7	ENZYME REGULATION: Its proteolytic activity is autoinhibited by the non-covalent binding of the propeptide to the catalytic domain. Inhibited by EGTA.
Q8NBQ5	
Q8NBQ7	
Q8NBR0	
Q8NBR6	
Q8NBR9	
Q8NBS3	
Q8NBS9	
Q8NBT0	
Q8NBT2	
Q8NBT3	
Q8NBU5	
Q8NBV4	
Q8NBV8	
Q8NBW4	
Q8NBX0	
Q8NBZ0	
Q8NBZ7	
Q8NBZ9	
Q8NC01	
Q8NC06	
Q8NC24	
Q8NC26	
Q8NC38	
Q8NC42	
Q8NC44	
Q8NC51	
Q8NC54	
Q8NC56	
Q8NC60	
Q8NC67	
Q8NC69	
Q8NC74	
Q8NC96	
Q8NCA5	
Q8NCA9	
Q8NCB2	
Q8NCC3	
Q8NCC5	
Q8NCD3	
Q8NCE0	
Q8NCE2	
Q8NCF0	
Q8NCF5	
Q8NCG5	
Q8NCG7	ENZYME REGULATION: Inhibited by p-hydroxy-mercuri-benzoate and HgCl(2), but not to PMSF. Also inhibited by RHC80267, a drug that blocks 2-AG formation. {ECO:0000269|PubMed:14610053}.
Q8NCH0	
Q8NCI6	
Q8NCJ5	
Q8NCK3	
Q8NCK7	
Q8NCL4	
Q8NCL8	
Q8NCL9	
Q8NCM2	
Q8NCM8	
Q8NCN2	
Q8NCN4	
Q8NCN5	
Q8NCP5	
Q8NCQ2	
Q8NCQ3	
Q8NCQ5	
Q8NCQ7	
Q8NCR0	
Q8NCR3	
Q8NCR6	
Q8NCR9	
Q8NCS4	
Q8NCS7	
Q8NCT1	
Q8NCT3	
Q8NCU1	
Q8NCU4	
Q8NCU7	
Q8NCU8	
Q8NCV1	
Q8NCW0	
Q8NCW5	
Q8NCW6	
Q8NCX0	
Q8NCY6	
Q8ND04	
Q8ND07	
Q8ND23	
Q8ND24	
Q8ND25	
Q8ND30	
Q8ND56	
Q8ND61	
Q8ND71	
Q8ND76	
Q8ND82	
Q8ND83	
Q8ND90	
Q8ND94	
Q8NDA2	
Q8NDA8	
Q8NDB2	
Q8NDB6	
Q8NDC0	
Q8NDC4	
Q8NDD1	
Q8NDF8	
Q8NDG6	
Q8NDH2	
Q8NDH3	
Q8NDH6	
Q8NDI1	
Q8NDL9	
Q8NDM7	
Q8NDN9	
Q8NDP4	
Q8NDQ6	
Q8NDT2	
Q8NDV1	
Q8NDV2	
Q8NDV3	
Q8NDV7	
Q8NDW4	
Q8NDW8	
Q8NDX1	
Q8NDX2	
Q8NDX5	
Q8NDX6	
Q8NDX9	
Q8NDY3	
Q8NDY4	
Q8NDY6	
Q8NDY8	
Q8NDZ0	
Q8NDZ2	
Q8NDZ4	
Q8NDZ6	
Q8NDZ9	
Q8NE00	
Q8NE01	
Q8NE09	
Q8NE18	
Q8NE22	
Q8NE28	
Q8NE31	
Q8NE35	
Q8NE62	
Q8NE63	
Q8NE65	
Q8NE71	
Q8NE79	
Q8NE86	ENZYME REGULATION: Inhibited by ruthenium red or its derivative Ru360. {ECO:0000269|PubMed:23755363}.
Q8NEA4	
Q8NEA5	
Q8NEA6	
Q8NEA9	
Q8NEB5	ENZYME REGULATION: Inhibited by N-ethylmaleimide. {ECO:0000269|PubMed:17590538}.
Q8NEB7	
Q8NEB9	
Q8NEC5	ENZYME REGULATION: The CatSper calcium channel is indirectly activated by extracellular progesterone and prostaglandins following the sequence: progesterone > PGF1-alpha = PGE1 > PGA1 > PGE2 >> PGD2 (PubMed:21412338, PubMed:21412339, PubMed:26989199). The CatSper calcium channel is directly inhibited by endocannabinoid 2-arachidonoylglycerol (2AG) (PubMed:26989199). Indirect activation by progesterone takes place via the following mechanism: progesterone binds and activates the acylglycerol lipase ABHD2, which in turn mediates hydrolysis of 2AG inhibitor, relieving inhibition of the CatSper channel (PubMed:26989199). The primary effect of progesterone activation is to shift voltage dependence towards more physiological, negative membrane potentials; it is not mediated by metabotropic receptors and second messengers (PubMed:21412338, PubMed:21412339). Sperm capacitation enhances the effect of progesterone by providing additional negative shift. Also activated by the elevation of intracellular pH (PubMed:21412338, PubMed:21412339). {ECO:0000269|PubMed:21412338, ECO:0000269|PubMed:21412339, ECO:0000269|PubMed:26989199}.
Q8NEC7	
Q8NEE0	
Q8NEE6	
Q8NEE8	
Q8NEF3	
Q8NEF9	
Q8NEG0	
Q8NEG2	
Q8NEG4	
Q8NEG5	
Q8NEG7	
Q8NEH6	
Q8NEJ0	ENZYME REGULATION: Activated by manganese ions, inhibited by iodoaretic acid. {ECO:0000269|PubMed:12591617}.
Q8NEJ9	
Q8NEK5	
Q8NEK8	
Q8NEL0	
Q8NEL9	
Q8NEM0	
Q8NEM1	
Q8NEM2	
Q8NEM7	
Q8NEM8	
Q8NEN0	
Q8NEN9	
Q8NEP3	
Q8NEP4	
Q8NEP7	
Q8NEP9	
Q8NEQ5	
Q8NEQ6	
Q8NER1	ENZYME REGULATION: Channel activity is activated via the interaction with PIRT and phosphatidylinositol 4,5-bisphosphate (PIP2). Both PIRT and PIP2 are required to activate channel activity (By similarity). The channel is sensitized by ATP binding. Repeated stimulation with capsaicin gives rise to progressively smaller responses, due to desensitization. This desensitization is triggered by the influx of calcium ions and is inhibited by elevated ATP levels. Ca(2+) and CALM displace ATP from its binding site and trigger a conformation change that leads to a closed, desensitized channel. Intracellular PIP2 inhibits desensitization. The double-knot toxin (DkTx) from the Chinese earth tiger tarantula activates the channel and traps it in an open conformation (By similarity). The Scolopendra mutilans RhTx toxin potentiates the heat activation pathway mediated by this channel by binding to the charge-rich outer pore region (in an activated state) (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q704Y3}.
Q8NER5	
Q8NES3	
Q8NES8	
Q8NET1	
Q8NET4	
Q8NET5	
Q8NET6	
Q8NET8	
Q8NEU8	
Q8NEV1	
Q8NEV4	
Q8NEV8	
Q8NEV9	
Q8NEW0	
Q8NEW7	
Q8NEX5	
Q8NEX6	
Q8NEX9	
Q8NEY1	
Q8NEY3	
Q8NEY4	
Q8NEY8	
Q8NEZ2	
Q8NEZ3	
Q8NEZ4	
Q8NEZ5	
Q8NF37	ENZYME REGULATION: Not activated by inflammatory stimulation. Inhibited by Cu(2+) and Fe(2+). Activity is not affected by Co(2+), Mg(2+) or Mn(2+) (By similarity). {ECO:0000250}.
Q8NF50	
Q8NF64	
Q8NF67	
Q8NF86	
Q8NF91	
Q8NF99	
Q8NFA0	
Q8NFA2	
Q8NFB2	
Q8NFC6	
Q8NFD2	
Q8NFD4	
Q8NFD5	
Q8NFF2	
Q8NFF5	
Q8NFG4	
Q8NFH3	
Q8NFH4	
Q8NFH5	
Q8NFH8	
Q8NFI3	
Q8NFI4	
Q8NFJ5	
Q8NFJ6	
Q8NFJ8	
Q8NFJ9	
Q8NFK1	
Q8NFL0	
Q8NFM4	ENZYME REGULATION: Activated by forskolin. Insensitive to calcium/calmodulin. Stimulated by GNAS and by the G-protein beta and gamma subunit complex. {ECO:0000250|UniProtKB:P26770}.
Q8NFM7	
Q8NFN8	
Q8NFP0	
Q8NFP4	
Q8NFP7	
Q8NFP9	
Q8NFQ5	
Q8NFQ6	
Q8NFQ8	
Q8NFR3	
Q8NFR7	
Q8NFR9	
Q8NFT2	
Q8NFT6	
Q8NFT8	
Q8NFU0	
Q8NFU1	
Q8NFU3	ENZYME REGULATION: GSS(-) is a potent inhibitor of TSTD1, since the presence of the sulfur dioxygenase (SDO) strongly increases the TSTD1 catalytic activity (PubMed:24981631). {ECO:0000269|PubMed:24981631}.
Q8NFU4	
Q8NFU5	
Q8NFU7	
Q8NFV4	
Q8NFV5	
Q8NFW1	
Q8NFW5	
Q8NFW8	
Q8NFW9	
Q8NFX7	
Q8NFY4	
Q8NFY9	
Q8NFZ0	
Q8NFZ3	
Q8NFZ4	
Q8NFZ5	
Q8NFZ6	
Q8NFZ8	
Q8NG04	
Q8NG06	
Q8NG08	ENZYME REGULATION: Inhibited by salt concentration greater than 100 mM. Uses either magnesium or manganese ions to support helicase activity. Binds strongly to single-stranded DNA in the absence of ATP but dissociates readily in the presence of 1 mM ATP. {ECO:0000269|PubMed:12181327}.
Q8NG11	
Q8NG27	
Q8NG31	
Q8NG35	
Q8NG41	
Q8NG48	
Q8NG50	
Q8NG57	
Q8NG66	ENZYME REGULATION: Autorepressed by intramolecular binding of the C-terminus which dissociates following phosphorylation by NEK2 isoform 1 in G1/S-arrested cells. NEK2 isoform 2 is largely not present in the nucleolus, and does not appear to phosphorylate NEK11. Activated in response to DNA damage. Inhibited by zinc. {ECO:0000269|PubMed:12154088, ECO:0000269|PubMed:15161910}.
Q8NG68	
Q8NG75	
Q8NG76	
Q8NG77	
Q8NG78	
Q8NG80	
Q8NG81	
Q8NG83	
Q8NG84	
Q8NG85	
Q8NG92	
Q8NG94	
Q8NG95	
Q8NG97	
Q8NG98	
Q8NG99	
Q8NGA0	
Q8NGA1	
Q8NGA2	
Q8NGA4	
Q8NGA5	
Q8NGA6	
Q8NGA8	
Q8NGB2	
Q8NGB4	
Q8NGB6	
Q8NGB8	
Q8NGB9	
Q8NGC0	
Q8NGC1	
Q8NGC2	
Q8NGC3	
Q8NGC4	
Q8NGC5	
Q8NGC6	
Q8NGC7	
Q8NGC8	
Q8NGC9	
Q8NGD0	
Q8NGD1	
Q8NGD2	
Q8NGD3	
Q8NGD4	
Q8NGD5	
Q8NGE0	
Q8NGE1	
Q8NGE2	
Q8NGE3	
Q8NGE5	
Q8NGE7	
Q8NGE8	
Q8NGE9	
Q8NGF0	
Q8NGF1	
Q8NGF3	
Q8NGF4	
Q8NGF6	
Q8NGF7	
Q8NGF8	
Q8NGF9	
Q8NGG0	
Q8NGG1	
Q8NGG2	
Q8NGG3	
Q8NGG4	
Q8NGG5	
Q8NGG6	
Q8NGG7	
Q8NGG8	
Q8NGH3	
Q8NGH5	
Q8NGH6	
Q8NGH7	
Q8NGH8	
Q8NGH9	
Q8NGI0	
Q8NGI1	
Q8NGI2	
Q8NGI3	
Q8NGI4	
Q8NGI6	
Q8NGI7	
Q8NGI8	
Q8NGI9	
Q8NGJ0	
Q8NGJ1	
Q8NGJ2	
Q8NGJ3	
Q8NGJ4	
Q8NGJ5	
Q8NGJ6	
Q8NGJ7	
Q8NGJ8	
Q8NGJ9	
Q8NGK0	
Q8NGK1	
Q8NGK2	
Q8NGK3	
Q8NGK4	
Q8NGK5	
Q8NGK6	
Q8NGK9	
Q8NGL0	
Q8NGL1	
Q8NGL2	
Q8NGL3	
Q8NGL4	
Q8NGL6	
Q8NGL7	
Q8NGL9	
Q8NGM1	
Q8NGM8	
Q8NGM9	
Q8NGN0	
Q8NGN1	
Q8NGN2	
Q8NGN3	
Q8NGN4	
Q8NGN5	
Q8NGN6	
Q8NGN7	
Q8NGN8	
Q8NGP0	
Q8NGP2	
Q8NGP3	
Q8NGP4	
Q8NGP6	
Q8NGP8	
Q8NGP9	
Q8NGQ1	
Q8NGQ2	
Q8NGQ3	
Q8NGQ4	
Q8NGQ5	
Q8NGQ6	
Q8NGR1	
Q8NGR2	
Q8NGR3	
Q8NGR4	
Q8NGR5	
Q8NGR6	
Q8NGR8	
Q8NGR9	
Q8NGS0	
Q8NGS1	
Q8NGS2	
Q8NGS3	
Q8NGS4	
Q8NGS5	
Q8NGS6	
Q8NGS7	
Q8NGS8	
Q8NGS9	
Q8NGT0	
Q8NGT1	
Q8NGT2	
Q8NGT5	
Q8NGT7	
Q8NGT9	
Q8NGU1	
Q8NGU2	
Q8NGU4	
Q8NGU9	
Q8NGV0	
Q8NGV5	
Q8NGV6	
Q8NGV7	
Q8NGW1	
Q8NGW6	
Q8NGX0	
Q8NGX1	
Q8NGX2	
Q8NGX3	
Q8NGX5	
Q8NGX6	
Q8NGX8	
Q8NGX9	
Q8NGY0	
Q8NGY1	
Q8NGY2	
Q8NGY3	
Q8NGY5	
Q8NGY6	
Q8NGY7	
Q8NGY9	
Q8NGZ0	
Q8NGZ2	
Q8NGZ3	
Q8NGZ4	
Q8NGZ5	
Q8NGZ6	
Q8NGZ9	
Q8NH00	
Q8NH01	
Q8NH02	
Q8NH03	
Q8NH04	
Q8NH05	
Q8NH06	
Q8NH07	
Q8NH08	
Q8NH09	
Q8NH10	
Q8NH16	
Q8NH18	
Q8NH19	
Q8NH21	
Q8NH37	
Q8NH40	
Q8NH41	
Q8NH42	
Q8NH43	
Q8NH48	
Q8NH49	
Q8NH50	
Q8NH51	
Q8NH53	
Q8NH54	
Q8NH55	
Q8NH56	
Q8NH57	
Q8NH59	
Q8NH60	
Q8NH61	
Q8NH63	
Q8NH64	
Q8NH67	
Q8NH69	
Q8NH70	
Q8NH72	
Q8NH73	
Q8NH74	
Q8NH76	
Q8NH79	
Q8NH80	
Q8NH81	
Q8NH83	
Q8NH85	
Q8NH87	
Q8NH89	
Q8NH90	
Q8NH92	
Q8NH93	
Q8NH94	
Q8NH95	
Q8NHA4	
Q8NHA6	
Q8NHA8	
Q8NHB1	
Q8NHB7	
Q8NHB8	
Q8NHC4	
Q8NHC5	
Q8NHC6	
Q8NHC7	
Q8NHC8	
Q8NHE4	
Q8NHG7	
Q8NHG8	
Q8NHH1	
Q8NHH9	
Q8NHJ6	
Q8NHK3	
Q8NHL6	
Q8NHM4	
Q8NHM5	
Q8NHP1	
Q8NHP6	
Q8NHP7	
Q8NHP8	
Q8NHQ1	
Q8NHQ8	
Q8NHQ9	
Q8NHR7	
Q8NHR9	
Q8NHS0	
Q8NHS1	
Q8NHS2	
Q8NHS3	
Q8NHS4	
Q8NHS9	
Q8NHU0	
Q8NHU2	
Q8NHU3	ENZYME REGULATION: Inhibited by bacterial PC-phospholipase C inhibitor D609. {ECO:0000269|PubMed:14685263}.
Q8NHU6	
Q8NHV1	
Q8NHV4	
Q8NHV5	
Q8NHV9	
Q8NHW3	
Q8NHW4	
Q8NHW5	
Q8NHW6	
Q8NHX4	
Q8NHX9	
Q8NHY0	
Q8NHY2	ENZYME REGULATION: TRIB1 competes with substrates for RFWD2 binding. {ECO:0000269|PubMed:27041596}.
Q8NHY3	
Q8NHY5	
Q8NHY6	
Q8NHZ7	
Q8NHZ8	
Q8NI08	
Q8NI17	
Q8NI22	
Q8NI27	
Q8NI28	
Q8NI29	
Q8NI32	
Q8NI35	
Q8NI36	
Q8NI37	
Q8NI38	
Q8NI51	
Q8NI60	ENZYME REGULATION: Autoinhibited by the N-terminal domain, containing the KxGQ motif, that completely occludes the typical substrate binding pocket. Nucleotide-binding relieves inhibition (PubMed:27499294). {ECO:0000269|PubMed:25498144, ECO:0000269|PubMed:27499294}.
Q8NI77	
Q8NI99	
Q8TA86	
Q8TA94	
Q8TAA1	
Q8TAA3	
Q8TAA5	
Q8TAA9	
Q8TAB3	
Q8TAB5	
Q8TAB7	
Q8TAC1	
Q8TAC2	
Q8TAC9	
Q8TAD2	
Q8TAD4	
Q8TAD7	
Q8TAD8	
Q8TAE6	
Q8TAE7	
Q8TAE8	
Q8TAF3	
Q8TAF5	
Q8TAF7	
Q8TAF8	
Q8TAG5	
Q8TAG6	
Q8TAG9	
Q8TAI1	
Q8TAI7	
Q8TAK5	
Q8TAK6	
Q8TAL5	
Q8TAL6	
Q8TAM1	
Q8TAM2	
Q8TAM6	
Q8TAP4	
Q8TAP6	
Q8TAP8	
Q8TAP9	
Q8TAQ2	
Q8TAQ5	
Q8TAQ9	
Q8TAS1	
Q8TAT2	
Q8TAT5	
Q8TAT6	
Q8TAT8	
Q8TAU0	
Q8TAU3	
Q8TAV0	
Q8TAV3	
Q8TAV4	
Q8TAV5	
Q8TAW3	
Q8TAX0	
Q8TAX7	
Q8TAX9	
Q8TAY7	
Q8TAZ6	
Q8TB03	
Q8TB05	
Q8TB22	
Q8TB24	
Q8TB33	
Q8TB36	
Q8TB37	
Q8TB40	
Q8TB45	
Q8TB52	
Q8TB61	
Q8TB68	
Q8TB69	
Q8TB72	
Q8TB73	
Q8TB92	
Q8TB96	
Q8TBA6	
Q8TBB0	
Q8TBB1	
Q8TBB5	
Q8TBB6	
Q8TBC3	
Q8TBC4	ENZYME REGULATION: Binding of TP53BP2 to the regulatory subunit NAE1 decreases activity.
Q8TBC5	
Q8TBE0	
Q8TBE1	
Q8TBE3	
Q8TBE7	
Q8TBE9	ENZYME REGULATION: Inhibited by vanadate and calcium. {ECO:0000269|PubMed:16237198}.
Q8TBF2	
Q8TBF4	
Q8TBF5	
Q8TBF8	
Q8TBG4	
Q8TBG9	
Q8TBH0	
Q8TBJ4	
Q8TBJ5	
Q8TBK2	
Q8TBK6	
Q8TBM7	
Q8TBM8	
Q8TBN0	
Q8TBP0	
Q8TBP5	
Q8TBP6	
Q8TBQ9	
Q8TBR4	
Q8TBR5	
Q8TBR7	
Q8TBX8	
Q8TBY0	
Q8TBY8	
Q8TBY9	
Q8TBZ0	
Q8TBZ2	
Q8TBZ3	
Q8TBZ5	
Q8TBZ6	
Q8TBZ8	
Q8TBZ9	
Q8TC05	
Q8TC07	
Q8TC12	
Q8TC17	
Q8TC20	
Q8TC21	
Q8TC26	
Q8TC27	
Q8TC29	
Q8TC36	
Q8TC41	
Q8TC44	
Q8TC56	
Q8TC57	
Q8TC59	
Q8TC71	
Q8TC76	
Q8TC84	
Q8TC90	
Q8TC92	ENZYME REGULATION: Not inhibited by the antitumor sulfonylurea LY181984, the vabilloid capsaicin, and retinoids. {ECO:0000269|PubMed:11360993, ECO:0000269|PubMed:12565167}.
Q8TC94	
Q8TC99	
Q8TCA0	
Q8TCB0	
Q8TCB6	
Q8TCB7	
Q8TCC3	
Q8TCC7	
Q8TCD1	
Q8TCD5	
Q8TCD6	
Q8TCE6	
Q8TCE9	
Q8TCF1	
Q8TCG1	
Q8TCG2	ENZYME REGULATION: Recruited and activated by membrane association. Binding to the microsomal membrane has been shown to enhance its activity. {ECO:0000269|PubMed:12324459}.
Q8TCG5	
Q8TCH9	
Q8TCI5	
Q8TCJ0	
Q8TCJ2	
Q8TCN5	
Q8TCP9	
Q8TCQ1	
Q8TCS8	
Q8TCT0	ENZYME REGULATION: Inhibited by sulfatide. {ECO:0000269|PubMed:19168031}.
Q8TCT1	
Q8TCT6	ENZYME REGULATION: Its proteolytic activity is blocked by a signal peptide peptidase (SPP) inhibitor, (ZLL)2-ketone (ZLL) or a gamma-secretase inhibitor, LY411,575 (PubMed:16873890). However, is not inhibited by ZLL and LY411,575 for activity on simian foamy virus envelope glycoprotein gp130 (PubMed:23132852). {ECO:0000269|PubMed:16873890, ECO:0000269|PubMed:23132852}.
Q8TCT7	
Q8TCT8	
Q8TCT9	
Q8TCU3	
Q8TCU4	
Q8TCU5	
Q8TCU6	
Q8TCV5	
Q8TCW7	
Q8TCW9	
Q8TCX1	
Q8TCX5	
Q8TCY0	
Q8TCY5	
Q8TCY9	
Q8TCZ2	
Q8TCZ7	
Q8TD06	
Q8TD07	
Q8TD08	ENZYME REGULATION: Activated by threonine and tyrosine phosphorylation. Inhibited by dual specificity phosphatases, such as DUSP1 (By similarity). {ECO:0000250}.
Q8TD10	
Q8TD16	
Q8TD17	
Q8TD19	ENZYME REGULATION: Activated during mitosis by intramolecular autophosphorylation. Activity and autophosphorylation is activated by manganese >> magnesium ions. Sensitive to increasing concentration of detergents. It is not cell-cycle regulated but activity is higher in G0-arrested cells.
Q8TD20	
Q8TD22	
Q8TD23	
Q8TD26	
Q8TD30	
Q8TD31	
Q8TD33	
Q8TD35	
Q8TD43	ENZYME REGULATION: Gating is voltage-dependent and repressed by decavanadate (PubMed:15331675, PubMed:29211723). Calmodulin-binding confers the Ca(2+) sensitivity (PubMed:15590641). ATP is able to restore Ca(2+) sensitivity after desensitization (PubMed:15590641). ATP inhibits channel activity (PubMed:15331675, PubMed:14758478, PubMed:29211723). Phosphatidylinositol 4,5-bisphosphate (PIP2)-binding strongly enhances activity, by increasing the channel's Ca(2+) sensitivity and shifting its voltage dependence of activation towards negative potentials (PubMed:16186107, PubMed:16424899). Activity is also enhanced by 3,5-bis(trifluoromethyl)pyrazole derivative (BTP2) (PubMed:16407466). {ECO:0000269|PubMed:14758478, ECO:0000269|PubMed:15331675, ECO:0000269|PubMed:15590641, ECO:0000269|PubMed:16186107, ECO:0000269|PubMed:16407466, ECO:0000269|PubMed:16424899, ECO:0000269|PubMed:29211723}.
Q8TD46	
Q8TD47	
Q8TD55	
Q8TD57	
Q8TD84	
Q8TD86	
Q8TD90	
Q8TD91	
Q8TD94	
Q8TDB4	
Q8TDB6	ENZYME REGULATION: Binding to PARP9 enhances DTX3L catalytic activity. {ECO:0000269|PubMed:28525742}.
Q8TDB8	
Q8TDC0	
Q8TDC3	ENZYME REGULATION: Activated by phosphorylation on Thr-189 by STK11/LKB1. {ECO:0000269|PubMed:14976552}.
Q8TDD1	
Q8TDD2	
Q8TDD5	ENZYME REGULATION: Inhibited by lumenal H(+) and Na(+) (PubMed:18369318, PubMed:29106414). The channel pore shows dynamic behavior and undergoes spontaneous, Ca(2+)-dependent modulation when conducting Ca(2+) (PubMed:20378547). {ECO:0000269|PubMed:18369318, ECO:0000269|PubMed:20378547, ECO:0000269|PubMed:29106414}.
Q8TDE3	
Q8TDF5	
Q8TDF6	
Q8TDG2	
Q8TDG4	
Q8TDH9	
Q8TDI0	
Q8TDI7	
Q8TDI8	
Q8TDJ6	
Q8TDL5	
Q8TDM0	
Q8TDM5	
Q8TDM6	
Q8TDN1	
Q8TDN2	
Q8TDN4	
Q8TDN6	
Q8TDN7	ENZYME REGULATION: Inhibited by sphingosine. {ECO:0000250}.
Q8TDP1	
Q8TDQ0	
Q8TDQ1	
Q8TDQ7	
Q8TDR0	
Q8TDR2	
Q8TDR4	
Q8TDS4	
Q8TDS5	
Q8TDS7	
Q8TDT2	
Q8TDU5	
Q8TDU6	
Q8TDU9	
Q8TDV0	
Q8TDV2	
Q8TDV5	
Q8TDW0	
Q8TDW4	
Q8TDW5	
Q8TDW7	
Q8TDX5	
Q8TDX6	
Q8TDX7	ENZYME REGULATION: Binding to NEK9 stimulates its activity by releasing the autoinhibitory function of Tyr-97. {ECO:0000269|PubMed:19941817}.
Q8TDX9	
Q8TDY2	
Q8TDY3	
Q8TDY4	
Q8TDY8	
Q8TDZ2	
Q8TE02	
Q8TE04	ENZYME REGULATION: Regulated by feedback inhibition by CoA and its thioesters. Strongly inhibited by acetyl-CoA and by manyl-CoA and also inhibited by high concentration of non-esterified CoA (CoASH) (By similarity). {ECO:0000250}.
Q8TE12	
Q8TE23	
Q8TE49	
Q8TE54	
Q8TE56	
Q8TE57	
Q8TE58	
Q8TE59	
Q8TE60	
Q8TE67	
Q8TE68	
Q8TE69	
Q8TE73	
Q8TE76	
Q8TE77	
Q8TE82	
Q8TE85	
Q8TE96	
Q8TE99	
Q8TEA1	
Q8TEA7	
Q8TEA8	
Q8TEB1	
Q8TEB7	
Q8TEB9	ENZYME REGULATION: Inhibited by aprotinin. {ECO:0000269|PubMed:18953687}.
Q8TEC5	
Q8TED0	
Q8TED1	
Q8TED4	ENZYME REGULATION: Inhibited by vanadate but not by chlorogenic acid. {ECO:0000269|PubMed:21949678}.
Q8TED9	
Q8TEE9	
Q8TEF2	
Q8TEH3	ENZYME REGULATION: The guanine nucleotide exchange factor (GEF) activity is autoinhibited. Autoinhibition may be the result of intramolecular interaction between the DENN domain and the C-terminus, which is disrupted upon phosphorylation. Activation is regulated by Akt activation. {ECO:0000269|PubMed:26055712}.
Q8TEJ3	
Q8TEK3	
Q8TEL6	
Q8TEM1	
Q8TEP8	
Q8TEQ0	
Q8TEQ6	
Q8TEQ8	
Q8TER0	
Q8TER5	
Q8TES7	
Q8TET4	
Q8TEU7	
Q8TEU8	
Q8TEV8	
Q8TEV9	
Q8TEW0	
Q8TEW6	
Q8TEW8	
Q8TEX9	
Q8TEY5	
Q8TEY7	
Q8TEZ7	
Q8TF01	
Q8TF05	
Q8TF08	
Q8TF09	
Q8TF17	
Q8TF20	
Q8TF21	
Q8TF27	
Q8TF30	
Q8TF32	
Q8TF39	
Q8TF40	
Q8TF42	
Q8TF44	
Q8TF45	
Q8TF46	
Q8TF47	
Q8TF50	
Q8TF61	
Q8TF62	
Q8TF63	
Q8TF64	
Q8TF65	
Q8TF66	
Q8TF68	
Q8TF71	
Q8TF72	
Q8TF74	
Q8TF76	ENZYME REGULATION: Constitutive activity that does not require phosphorylation. Specifically inhibited by 3-(1H-indazol-5-yl)-N-propylimidazo[1,2-b]pyridazin-6-amine (CHR-6494). {ECO:0000269|PubMed:19918057, ECO:0000269|PubMed:21658950, ECO:0000269|PubMed:21804608}.
Q8WTP8	
Q8WTP9	
Q8WTQ1	
Q8WTQ4	
Q8WTQ7	ENZYME REGULATION: Inhibited by phosphorylation of Ser-36. {ECO:0000250}.
Q8WTR2	
Q8WTR4	
Q8WTR7	
Q8WTR8	
Q8WTS1	
Q8WTS6	
Q8WTT0	
Q8WTT2	
Q8WTU0	ENZYME REGULATION: Inhibited by the proteinase inhibitors amprenavir, indinavir, lopinavir, isovaleryl pepstatin, ritonavir and saquinavir. {ECO:0000269|PubMed:21266539}.
Q8WTU2	
Q8WTV0	
Q8WTV1	
Q8WTW3	
Q8WTW4	
Q8WTX7	
Q8WTX9	
Q8WTZ3	
Q8WTZ4	
Q8WU03	
Q8WU08	
Q8WU10	
Q8WU17	
Q8WU20	
Q8WU39	
Q8WU43	
Q8WU49	
Q8WU58	
Q8WU66	
Q8WU67	
Q8WU68	
Q8WU76	
Q8WU79	
Q8WU90	
Q8WUA2	
Q8WUA4	
Q8WUA7	
Q8WUA8	
Q8WUB2	
Q8WUB8	
Q8WUD1	
Q8WUD4	
Q8WUD6	
Q8WUE5	
Q8WUF5	
Q8WUF8	
Q8WUG5	
Q8WUH1	
Q8WUH2	
Q8WUH6	
Q8WUI4	
Q8WUJ0	
Q8WUJ1	
Q8WUJ3	ENZYME REGULATION: Activity is up-regulated by histamine. {ECO:0000269|PubMed:23509262}.
Q8WUK0	
Q8WUM0	
Q8WUM4	
Q8WUM9	
Q8WUN7	
Q8WUP2	
Q8WUQ7	
Q8WUR7	
Q8WUS8	
Q8WUT4	
Q8WUT9	
Q8WUU4	
Q8WUU5	
Q8WUU8	
Q8WUW1	
Q8WUX1	ENZYME REGULATION: Not inhibited by lithium. {ECO:0000269|PubMed:11243884}.
Q8WUX2	
Q8WUX9	
Q8WUY1	
Q8WUY3	
Q8WUY8	
Q8WUY9	
Q8WUZ0	
Q8WV07	
Q8WV15	
Q8WV16	
Q8WV19	
Q8WV22	
Q8WV24	
Q8WV28	
Q8WV35	
Q8WV37	
Q8WV41	
Q8WV44	
Q8WV48	
Q8WV60	
Q8WV74	
Q8WV83	
Q8WV92	
Q8WV93	
Q8WV99	
Q8WVB3	ENZYME REGULATION: Inhibited by O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino N-phenylcarbamate (PUGNAc). {ECO:0000250}.
Q8WVB6	
Q8WVC0	
Q8WVC6	
Q8WVD3	
Q8WVD5	
Q8WVE0	
Q8WVE6	
Q8WVE7	
Q8WVF1	
Q8WVF2	
Q8WVF5	
Q8WVH0	
Q8WVI0	
Q8WVI7	
Q8WVJ2	
Q8WVJ9	
Q8WVK2	
Q8WVK7	
Q8WVL7	
Q8WVM0	
Q8WVM7	
Q8WVM8	
Q8WVN6	
Q8WVN8	
Q8WVP5	
Q8WVP7	
Q8WVQ1	
Q8WVR3	
Q8WVS4	
Q8WVT3	
Q8WVV4	
Q8WVV5	
Q8WVV9	
Q8WVX3	
Q8WVX9	
Q8WVY7	
Q8WVZ1	
Q8WVZ7	
Q8WVZ9	
Q8WW01	
Q8WW12	
Q8WW14	
Q8WW18	
Q8WW22	
Q8WW24	
Q8WW27	
Q8WW32	
Q8WW33	
Q8WW34	
Q8WW35	
Q8WW36	
Q8WW38	
Q8WW43	
Q8WW52	
Q8WW59	
Q8WW62	
Q8WWA0	
Q8WWA1	
Q8WWB3	
Q8WWB5	
Q8WWB7	
Q8WWC4	
Q8WWF1	
Q8WWF3	
Q8WWF5	
Q8WWF6	
Q8WWF8	
Q8WWG1	
Q8WWG9	
Q8WWH4	
Q8WWH5	
Q8WWI1	
Q8WWI5	
Q8WWK9	
Q8WWL2	
Q8WWL7	
Q8WWM1	
Q8WWM7	
Q8WWM9	
Q8WWN8	
Q8WWN9	
Q8WWP7	
Q8WWQ0	
Q8WWQ2	
Q8WWQ8	
Q8WWR8	
Q8WWR9	
Q8WWT9	
Q8WWU5	
Q8WWU7	
Q8WWV3	
Q8WWV6	
Q8WWW0	
Q8WWW8	
Q8WWX0	
Q8WWX8	
Q8WWX9	
Q8WWY3	
Q8WWY6	
Q8WWY7	
Q8WWY8	ENZYME REGULATION: Inhibited by sodium vanadate. {ECO:0000269|PubMed:12963729}.
Q8WWZ1	
Q8WWZ3	
Q8WWZ4	
Q8WWZ7	
Q8WWZ8	
Q8WX39	
Q8WX77	
Q8WX92	
Q8WX93	
Q8WX94	
Q8WXA2	
Q8WXA3	
Q8WXA8	
Q8WXA9	
Q8WXB1	
Q8WXB4	
Q8WXC3	
Q8WXC6	
Q8WXD0	
Q8WXD2	
Q8WXD5	
Q8WXD9	
Q8WXE0	
Q8WXE1	
Q8WXE9	
Q8WXF0	
Q8WXF1	
Q8WXF3	
Q8WXF5	
Q8WXF7	
Q8WXF8	
Q8WXG1	
Q8WXG6	
Q8WXG8	
Q8WXG9	
Q8WXH0	
Q8WXH2	
Q8WXH4	
Q8WXH5	
Q8WXH6	
Q8WXI2	
Q8WXI3	
Q8WXI4	
Q8WXI7	
Q8WXI8	
Q8WXI9	
Q8WXJ9	
Q8WXK1	
Q8WXK3	
Q8WXK4	
Q8WXQ3	
Q8WXQ8	
Q8WXR4	
Q8WXS3	
Q8WXS4	
Q8WXS5	
Q8WXS8	
Q8WXT5	
Q8WXU2	
Q8WXW3	
Q8WXX0	
Q8WXX5	
Q8WXX7	
Q8WY07	
Q8WY21	
Q8WY22	
Q8WY36	
Q8WY41	
Q8WY50	
Q8WY54	
Q8WY64	ENZYME REGULATION: Can bind 1 iron ion per dimer. Iron binding seems to decrease LDLR degradation activity. {ECO:0000269|PubMed:21685362}.
Q8WY91	
Q8WY98	
Q8WYA0	
Q8WYA1	
Q8WYA6	
Q8WYB5	
Q8WYH8	
Q8WYJ6	
Q8WYK0	ENZYME REGULATION: Inhibited by ADP. Active in the presence of ATP. {ECO:0000269|PubMed:16951743}.
Q8WYK1	
Q8WYK2	
Q8WYL5	
Q8WYN0	ENZYME REGULATION: Inhibited by N-ethylmaleimide. Redox-regulated during autophagy since reducing conditions activate ATG4A whereas an oxidizing environment such as the presence of H(2)O(2) inhibits its activity. {ECO:0000269|PubMed:12473658, ECO:0000269|PubMed:17347651}.
Q8WYN3	
Q8WYP3	
Q8WYP5	
Q8WYQ3	
Q8WYQ4	
Q8WYQ5	
Q8WYQ9	
Q8WYR1	ENZYME REGULATION: Greatly activated by G gamma proteins. {ECO:0000250}.
Q8WYR4	
Q8WZ04	
Q8WZ19	
Q8WZ26	
Q8WZ33	
Q8WZ42	ENZYME REGULATION: Full activation of the protein kinase domain requires both phosphorylation of Tyr-32341, preventing it from blocking the catalytic aspartate residue, and binding of Ca/CALM to the C-terminal regulatory tail of the molecule which results in ATP binding to the kinase. {ECO:0000269|PubMed:9804419}.
Q8WZ55	
Q8WZ59	
Q8WZ60	
Q8WZ64	
Q8WZ69	
Q8WZ71	
Q8WZ73	
Q8WZ74	
Q8WZ75	
Q8WZ79	
Q8WZ82	
Q8WZ84	
Q8WZ92	
Q8WZ94	
Q8WZA0	
Q8WZA1	
Q8WZA2	
Q8WZA6	
Q8WZA8	
Q8WZA9	
Q8WZB0	
Q902F8	
Q902F9	
Q92185	
Q92186	
Q92187	
Q92466	
Q92478	
Q92481	
Q92482	
Q92484	ENZYME REGULATION: Requires micromolar levels of Zn(2+) for activity (PubMed:26783088). Inhibited by millimolar levels of Zn(2+) (PubMed:25288789, PubMed:26783088). {ECO:0000269|PubMed:25288789, ECO:0000269|PubMed:26783088}.
Q92485	
Q92496	
Q92499	
Q92502	
Q92503	
Q92504	
Q92506	
Q92508	
Q92519	
Q92520	
Q92521	
Q92522	
Q92523	
Q92526	
Q92527	
Q92529	
Q92530	
Q92535	
Q92536	ENZYME REGULATION: Arginine transport is strongly inhibited by lysine, glutamate, leucine, glutamine, methionine and histidine, in the presence of Na(+). Also inhibited by protein kinase C (PKC) and treatment with phorbol-12-myristate-13-acetate (PMA). Mutual inhibition is observed when leucine or glutamine is used as substrate. Inhibition of arginine and leucine uptake also occurs when SLC3A2/4F2hc is either truncated at its C-terminus or mutated at critical residues within the terminal 15 amino acids.
Q92537	
Q92538	ENZYME REGULATION: Inhibited by brefeldin A (BFA) (PubMed:15616190). Inhibited by golgicide A (GCA) (By similarity). {ECO:0000250|UniProtKB:Q9R1D7, ECO:0000269|PubMed:15616190}.
Q92539	ENZYME REGULATION: Inhibited by N-ethylmaleimide. {ECO:0000250}.
Q92540	
Q92541	
Q92542	
Q92543	
Q92544	
Q92545	
Q92546	
Q92547	
Q92551	
Q92552	
Q92556	
Q92558	
Q92560	
Q92561	
Q92562	
Q92563	
Q92564	
Q92565	
Q92567	
Q92569	
Q92570	
Q92572	
Q92574	
Q92575	
Q92576	
Q92581	
Q92583	
Q92585	
Q92597	
Q92598	
Q92599	
Q92600	
Q92604	
Q92608	
Q92609	
Q92610	
Q92611	
Q92613	
Q92614	
Q92615	
Q92616	
Q92617	
Q92618	
Q92619	
Q92620	
Q92621	
Q92622	
Q92623	
Q92624	
Q92625	
Q92626	
Q92628	
Q92629	
Q92630	ENZYME REGULATION: Activated by autophosphorylation on the second tyrosine residue in the Tyr-X-Tyr motif in the activation loop. Inhibited by acridine analogs, purvalanol, and barely by harmine. Inhibited by leucettine and leucettine derivatives. {ECO:0000269|PubMed:16611631, ECO:0000269|PubMed:19796173, ECO:0000269|PubMed:20836251, ECO:0000269|PubMed:22998443}.
Q92633	
Q92636	
Q92637	
Q92643	
Q92664	
Q92665	
Q92667	
Q92670	
Q92673	
Q92674	
Q92681	
Q92685	
Q92686	
Q92688	
Q92692	
Q92696	ENZYME REGULATION: The enzymatic reaction requires the aid of a Rab escort protein (also called component A), such as CHM.
Q92698	
Q92729	
Q92730	
Q92731	
Q92733	
Q92734	
Q92736	ENZYME REGULATION: Channel activity is modulated by the alkaloid ryanodine that binds to the open Ca-release channel with high affinity. At low concentrations, ryanodine maintains the channel in an open conformation. High ryanodine concentrations inhibit channel activity. Channel activity is regulated by calmodulin (CALM). The calcium release is activated by increased cytoplasmic calcium levels, by nitric oxyde (NO), caffeine and ATP. Channel activity is inhibited by magnesium ions, possibly by competition for calcium binding sites. {ECO:0000250|UniProtKB:P11716}.
Q92737	
Q92738	
Q92743	
Q92747	
Q92748	
Q92750	
Q92752	
Q92753	
Q92754	
Q92759	
Q92764	
Q92765	
Q92766	
Q92769	
Q92771	
Q92772	
Q92777	
Q92781	ENZYME REGULATION: Inhibited by 9-cis-, 13-cis- and all-trans-retinoic acids, with the most potent inhibitor being 13-cis-retinoic acid. Weakly inhibited by oleic acid. {ECO:0000269|PubMed:10588954}.
Q92782	
Q92783	
Q92784	
Q92785	
Q92786	
Q92791	
Q92793	
Q92794	
Q92796	
Q92797	
Q92800	
Q92802	
Q92804	
Q92805	
Q92806	
Q92813	
Q92817	
Q92819	
Q92820	
Q92823	
Q92824	
Q92826	
Q92828	
Q92830	
Q92831	
Q92832	
Q92833	
Q92834	
Q92835	ENZYME REGULATION: Activated upon translocation to the sites of synthesis of PtdIns(3,4,5)P3 in the membrane. {ECO:0000250}.
Q92837	
Q92838	
Q92839	
Q92841	
Q92843	
Q92844	
Q92845	
Q92847	
Q92851	
Q92854	
Q92858	
Q92859	
Q92870	
Q92871	ENZYME REGULATION: IMP, a metabolite whose concentration is elevated in anoxia, inhibits phosphomannomutase and phosphoglucomutase activities and strongly enhances glucose-1,6-bisphosphatase activity. {ECO:0000250}.
Q92874	
Q92876	ENZYME REGULATION: Inhibited by a range of serine protease inhibitors including soybean trypsin inhibitor, benzamidine and serpins. Activated by a range of glycosaminoglycans including chondroitin sulfate, dermatan sulfate, heparan sulfate and heparin. {ECO:0000269|PubMed:12878203, ECO:0000269|PubMed:16321973}.
Q92878	
Q92879	
Q92882	
Q92886	
Q92887	
Q92888	
Q92889	
Q92890	
Q92896	
Q92900	
Q92901	
Q92902	
Q92903	
Q92904	
Q92905	
Q92908	
Q92911	
Q92913	
Q92914	
Q92915	
Q92917	
Q92918	
Q92922	
Q92925	
Q92928	
Q92930	
Q92932	
Q92934	
Q92935	
Q92945	
Q92947	ENZYME REGULATION: Strongly inhibited by MCPA-CoA, a metabolite of hypoglycin which is present in unripened fruit of the ackee tree. {ECO:0000269|PubMed:6423663}.
Q92949	
Q92952	
Q92953	ENZYME REGULATION: Inhibited by quinine at micromolar levels. Modestly sensitive to millimolar levels of tetraethylammonium (TEA) and 4-aminopyridine (4-AP). {ECO:0000250|UniProtKB:Q63099, ECO:0000250|UniProtKB:Q95167, ECO:0000305|PubMed:10414301}.
Q92954	
Q92956	
Q92959	
Q92963	ENZYME REGULATION: Alternates between an inactive form bound to GDP and an active form bound to GTP.
Q92966	
Q92968	
Q92973	
Q92974	
Q92979	
Q92982	
Q92985	ENZYME REGULATION: In the absence of viral infection, maintained as a monomer in an autoinhibited state and phosphorylation disrupts this autoinhibition leading to the liberation of the DNA-binding and dimerization activities and its nuclear localization where it can activate type I IFN and ISG genes.
Q92988	
Q92989	
Q92990	
Q92993	
Q92994	
Q92995	ENZYME REGULATION: Specifically inhibited by spautin-1 (specific and potent autophagy inhibitor-1), a derivative of MBCQ that binds to USP13 and inhibits deubiquitinase activity. Regulated by PIK3C3/VPS34-containing complexes. The weak deubiquitinase activity in vitro suggests the existence of some mechanism that activates the enzyme. {ECO:0000269|PubMed:21962518}.
Q92997	
Q93008	
Q93009	ENZYME REGULATION: Inhibited by N-ethyl-maleimide (NEM) and divalent cations. Tolerates high concentrations of NaCl but is inhibited at concentrations of 195 mM and higher. {ECO:0000269|PubMed:14506283}.
Q93015	
Q93033	
Q93034	
Q93038	
Q93045	
Q93050	
Q93052	
Q93062	
Q93063	
Q93070	
Q93073	
Q93074	
Q93075	
Q93077	
Q93079	
Q93083	
Q93084	ENZYME REGULATION: Inhibited by sarcolipin (SLN), phospholamban (PLN) and myoregulin (MRLN) (By similarity). Enhanced by DWORF; DWORF increases activity by displacing sarcolipin (SLN), phospholamban (PLN) and myoregulin (MRLN) (By similarity). {ECO:0000250|UniProtKB:P04191, ECO:0000250|UniProtKB:Q8R429}.
Q93086	
Q93088	
Q93091	
Q93096	ENZYME REGULATION: Inhibited by sodium orthovanadate and pentamidine. {ECO:0000269|PubMed:12516958}.
Q93097	
Q93098	
Q93099	
Q93100	ENZYME REGULATION: By phosphorylation of various serine residues. {ECO:0000250}.
Q95365	
Q95460	
Q95604	
Q95IE3	
Q969D9	
Q969E1	
Q969E2	
Q969E3	
Q969E4	
Q969E8	
Q969F0	
Q969F1	
Q969F2	
Q969F8	
Q969F9	
Q969G2	
Q969G3	
Q969G5	
Q969G6	
Q969G9	
Q969H0	
Q969H4	
Q969H6	
Q969H8	
Q969H9	
Q969I3	
Q969I6	
Q969J2	
Q969J3	
Q969J5	
Q969K3	
Q969K4	
Q969K7	
Q969L2	
Q969L4	
Q969M1	
Q969M2	
Q969M3	
Q969M7	
Q969N2	
Q969N4	
Q969P0	
Q969P5	
Q969P6	
Q969Q0	
Q969Q1	
Q969Q4	
Q969Q5	
Q969Q6	
Q969R2	
Q969R5	
Q969R8	
Q969S0	
Q969S2	ENZYME REGULATION: Acetylation of Lys-50 leads to loss of DNA nicking activity. Acetylation of Lys-154 has no effect.
Q969S3	
Q969S6	
Q969S8	
Q969S9	
Q969T3	
Q969T4	
Q969T7	
Q969T9	
Q969U6	
Q969U7	
Q969V1	
Q969V3	
Q969V4	
Q969V5	
Q969V6	
Q969W0	
Q969W1	
Q969W3	
Q969W8	
Q969W9	
Q969X0	
Q969X1	
Q969X2	
Q969X5	
Q969X6	
Q969Y0	
Q969Y2	
Q969Z0	
Q969Z3	
Q969Z4	
Q96A00	
Q96A04	
Q96A05	
Q96A08	
Q96A09	
Q96A11	
Q96A19	
Q96A22	
Q96A23	
Q96A25	
Q96A26	
Q96A28	
Q96A29	
Q96A32	
Q96A33	
Q96A35	
Q96A37	
Q96A44	
Q96A46	
Q96A47	
Q96A49	
Q96A54	
Q96A56	
Q96A57	
Q96A58	
Q96A59	
Q96A61	
Q96A65	
Q96A70	
Q96A72	
Q96A73	
Q96A83	
Q96A84	
Q96A98	
Q96A99	
Q96AA3	
Q96AA8	
Q96AB3	
Q96AB6	ENZYME REGULATION: Inhibited by micromolar concentrations of copper and zinc ions. {ECO:0000269|PubMed:21375249}.
Q96AC1	
Q96AC6	
Q96AD5	ENZYME REGULATION: Inhibited by BEL ((E)-6-(bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2-one), a suicide substrate inhibitor. No differences in enzymatic activity that uses (1,2-dilinoleoyl)-phosphatidylcholine as substrate was detected in the presence or absence of ATP. Activated by ABHD5 and SERPINF1. {ECO:0000269|PubMed:15364929, ECO:0000269|PubMed:17032652}.
Q96AE4	
Q96AE7	
Q96AG3	
Q96AG4	
Q96AH0	
Q96AH8	
Q96AJ1	
Q96AJ9	
Q96AK3	ENZYME REGULATION: Antiviral activity is neutralized by the HIV-1 virion infectivity factor (VIF), that prevents its incorporation into progeny virions by both inhibiting its translation and/or by inducing its ubiquitination and subsequent degradation by the 26S proteasome. {ECO:0000269|PubMed:21835787}.
Q96AM1	
Q96AN5	
Q96AP0	
Q96AP4	
Q96AP7	
Q96AQ1	
Q96AQ2	
Q96AQ6	
Q96AQ7	
Q96AQ8	
Q96AQ9	
Q96AT1	
Q96AT9	
Q96AV8	
Q96AW1	
Q96AX1	
Q96AX2	
Q96AX9	
Q96AY2	
Q96AY3	ENZYME REGULATION: Inhibited by both FK506 and rapamycin, but not by cyclosporin A. {ECO:0000250}.
Q96AY4	
Q96AZ1	
Q96AZ6	
Q96B01	
Q96B02	
Q96B18	
Q96B21	
Q96B23	
Q96B26	
Q96B33	
Q96B36	
Q96B42	
Q96B45	
Q96B49	
Q96B54	
Q96B67	
Q96B70	
Q96B77	
Q96B86	
Q96B96	
Q96B97	
Q96BA8	
Q96BD0	
Q96BD5	
Q96BD6	
Q96BD8	
Q96BF3	
Q96BF6	
Q96BH1	
Q96BH3	
Q96BI1	
Q96BI3	
Q96BJ3	
Q96BJ8	
Q96BK5	
Q96BM0	
Q96BM1	
Q96BM9	
Q96BN2	
Q96BN6	
Q96BN8	
Q96BP2	
Q96BP3	
Q96BQ1	
Q96BQ3	
Q96BQ5	
Q96BR1	ENZYME REGULATION: Two specific sites, one in the kinase domain (Thr-320) and the other in the C-terminal regulatory region (Ser-486), need to be phosphorylated for its full activation.
Q96BR5	
Q96BR6	
Q96BR9	
Q96BS2	
Q96BT1	
Q96BT3	
Q96BT7	
Q96BU1	
Q96BV0	
Q96BW1	
Q96BW5	
Q96BW9	
Q96BX8	
Q96BY2	
Q96BY6	
Q96BY7	
Q96BY9	
Q96BZ4	
Q96BZ8	
Q96BZ9	
Q96C00	
Q96C01	
Q96C03	
Q96C10	
Q96C11	
Q96C12	
Q96C19	
Q96C23	
Q96C24	
Q96C28	
Q96C34	
Q96C36	ENZYME REGULATION: Subject to competitive inhibition by NADP. Not inhibited by proline. {ECO:0000269|PubMed:2722838, ECO:0000269|PubMed:6894153}.
Q96C45	
Q96C55	
Q96C57	
Q96C74	
Q96C86	ENZYME REGULATION: The hydrolytic product 7-methylguanosine diphosphate (m7GDP) efficiently inhibits the decapping scavenger activity and acts as a competitive inhibitor in vitro. Inhibited by 2,4-diaminoquinazoline. {ECO:0000269|PubMed:18839960, ECO:0000269|PubMed:22985415}.
Q96C90	
Q96C92	
Q96CA5	
Q96CB5	
Q96CB8	
Q96CB9	
Q96CC6	
Q96CD0	
Q96CD2	
Q96CE8	
Q96CF2	
Q96CG3	
Q96CG8	
Q96CH1	
Q96CJ1	
Q96CK0	
Q96CM3	
Q96CM4	
Q96CM8	
Q96CN4	
Q96CN5	
Q96CN7	
Q96CN9	
Q96CP2	
Q96CP6	
Q96CP7	
Q96CQ1	
Q96CS2	
Q96CS3	
Q96CS4	
Q96CS7	
Q96CT2	
Q96CT7	
Q96CU9	
Q96CV9	
Q96CW1	
Q96CW5	
Q96CW6	
Q96CW9	
Q96CX2	
Q96CX3	
Q96CX6	
Q96D03	
Q96D05	
Q96D09	
Q96D15	
Q96D21	
Q96D31	
Q96D42	
Q96D46	
Q96D53	ENZYME REGULATION: Autoinhibited by the N-terminal domain, containing the KxGQ motif, that completely occludes the typical substrate binding pocket. Nucleotide-binding relieves inhibition. {ECO:0000250|UniProtKB:Q8NI60}.
Q96D59	
Q96D70	
Q96D71	
Q96D96	ENZYME REGULATION: The dimers display cooperative channel gating (By similarity). The channel activity is inhibited by zinc ions. {ECO:0000250, ECO:0000269|PubMed:16554753, ECO:0000269|PubMed:22020278}.
Q96D98	
Q96DA0	
Q96DA2	
Q96DA6	
Q96DB2	
Q96DB5	
Q96DB9	
Q96DC7	
Q96DC8	
Q96DC9	
Q96DD0	
Q96DD7	
Q96DE0	ENZYME REGULATION: The phosphatase activity is inhibited by the product IMP. {ECO:0000269|PubMed:26121039}.
Q96DE5	
Q96DE9	
Q96DF8	
Q96DG6	ENZYME REGULATION: Strongly inhibited by p-chloromercuribenzoate (PCMB). Partially inhibited by bis-p-nitrophenylphosphate (BNPP). Not inhibited by DFP, PMSF, eserine or EDTA.
Q96DH6	
Q96DI7	
Q96DL1	
Q96DM1	
Q96DM3	
Q96DN0	
Q96DN2	
Q96DN5	
Q96DN6	
Q96DP5	
Q96DR4	
Q96DR5	
Q96DR7	
Q96DR8	
Q96DS6	
Q96DT0	
Q96DT5	
Q96DT6	ENZYME REGULATION: Inhibited by N-ethylmaleimide.
Q96DT7	
Q96DU3	
Q96DU7	ENZYME REGULATION: Activated by calcium/calmodulin. Inhibited by high concentrations of the substrate Ins(1,2,4)P3, and allosterically activated by the product Ins(1,3,4,5)P4. {ECO:0000269|PubMed:11085927}.
Q96DU9	
Q96DV4	
Q96DW6	
Q96DX4	
Q96DX5	
Q96DX7	
Q96DX8	
Q96DY2	
Q96DY7	
Q96DZ1	
Q96DZ5	
Q96DZ7	
Q96DZ9	
Q96E09	
Q96E11	
Q96E14	
Q96E16	
Q96E17	
Q96E22	
Q96E29	
Q96E35	
Q96E39	
Q96E40	
Q96E52	
Q96E66	
Q96E93	
Q96EA4	
Q96EB1	
Q96EB6	ENZYME REGULATION: Inhibited by nicotinamide. Activated by resveratrol (3,5,4'-trihydroxy-trans-stilbene), butein (3,4,2',4'-tetrahydroxychalcone), piceatannol (3,5,3',4'-tetrahydroxy-trans-stilbene), Isoliquiritigenin (4,2',4'-trihydroxychalcone), fisetin (3,7,3',4'-tetrahydroxyflavone) and quercetin (3,5,7,3',4'-pentahydroxyflavone). MAPK8/JNK1 and RPS19BP1/AROS act as positive regulators of deacetylation activity. Negatively regulated by CCAR2. {ECO:0000269|PubMed:12297502, ECO:0000269|PubMed:12939617, ECO:0000269|PubMed:18235501, ECO:0000269|PubMed:18235502}.
Q96EC8	
Q96ED9	
Q96EE3	
Q96EE4	
Q96EF0	
Q96EF6	
Q96EF9	
Q96EG1	ENZYME REGULATION: Inhibited by phosphate. The phosphate forms a covalent bond with the active site 3-oxoalanine.
Q96EG3	
Q96EH3	
Q96EH5	
Q96EH8	
Q96EI5	
Q96EK2	
Q96EK4	
Q96EK5	
Q96EK6	
Q96EK7	
Q96EK9	
Q96EL1	
Q96EL2	
Q96EL3	
Q96EM0	
Q96EN8	
Q96EN9	
Q96EP0	
Q96EP1	
Q96EP5	
Q96EP9	
Q96EQ0	
Q96EQ8	
Q96ER3	
Q96ER9	
Q96ES6	
Q96ES7	
Q96ET8	
Q96EU6	
Q96EU7	
Q96EV2	
Q96EV8	
Q96EW2	
Q96EX1	
Q96EX2	
Q96EX3	
Q96EY1	
Q96EY4	
Q96EY5	
Q96EY7	
Q96EY8	
Q96EY9	
Q96EZ4	
Q96EZ8	
Q96F05	
Q96F07	
Q96F10	
Q96F15	
Q96F24	
Q96F25	
Q96F44	
Q96F45	
Q96F46	
Q96F63	
Q96F81	
Q96F83	
Q96F85	
Q96F86	
Q96FA3	
Q96FA7	
Q96FB5	
Q96FC7	
Q96FC9	ENZYME REGULATION: ATPase activity is stimulated by high magnesium salt levels (up to a 0.1 M), and potassium salts (glutamate, chloride or acetate) are more effective than the corresponding sodium salts (PubMed:10648783, PubMed:18499658). ATPase activity is enhanced by the long non-coding RNA (lncRNA) cohesion regulator noncoding RNA (CONCR) (PubMed:27477908). Double-stranded DNA helicase activity is maximal with magnesium ions at low concentrations (0.5-1 mM) whereas is markedly inhibited at higher levels (5 mM and above) (PubMed:10648783, PubMed:18499658). Double-stranded DNA helicase activity is stimulated by 25-50 mM potassium acetate, stimulated to a lesser extent by 25 mM of ammonium acetate, and markedly inhibited by sodium acetate (PubMed:18499658). {ECO:0000269|PubMed:10648783, ECO:0000269|PubMed:18499658, ECO:0000269|PubMed:27477908}.
Q96FE5	
Q96FE7	
Q96FF7	
Q96FF9	
Q96FG2	
Q96FH0	
Q96FI4	
Q96FJ0	
Q96FJ2	
Q96FK6	
Q96FL8	
Q96FL9	
Q96FM1	
Q96FN4	
Q96FN5	
Q96FN9	
Q96FQ6	
Q96FQ7	
Q96FS4	
Q96FT7	
Q96FT9	
Q96FV0	
Q96FV2	
Q96FV3	
Q96FV9	
Q96FW1	ENZYME REGULATION: By free ubiquitin: binding of free ubiquitin triggers conformational changes in the OTU domain and formation of a ubiquitin-binding helix in the N-terminus, promoting binding of the conjugated donor ubiquitin in UBE2N/UBC13 to OTUB1. {ECO:0000269|PubMed:22325355, ECO:0000269|PubMed:22367539}.
Q96FX2	
Q96FX7	
Q96FX8	
Q96FZ2	
Q96FZ5	
Q96FZ7	
Q96G01	
Q96G03	
Q96G04	
Q96G21	
Q96G23	
Q96G25	
Q96G27	
Q96G28	
Q96G30	
Q96G42	
Q96G46	
Q96G61	
Q96G74	ENZYME REGULATION: Inhibited by N-ethyl-maleimide (NEM).
Q96G75	
Q96G79	
Q96G91	
Q96G97	
Q96GA3	
Q96GA7	
Q96GC5	
Q96GC6	
Q96GC9	
Q96GD0	ENZYME REGULATION: Inhibited by NaF, Zn(2+), Ca(2+), Mn(2+) and EDTA. {ECO:0000269|PubMed:15580268}.
Q96GD3	
Q96GD4	ENZYME REGULATION: Activity is greatly increased when AURKB is within the CPC complex. In particular, AURKB-phosphorylated INCENP acts as an activator of AURKB. Positive feedback between HASPIN and AURKB contributes to CPC localization. {ECO:0000269|PubMed:12925766, ECO:0000269|PubMed:14722118, ECO:0000269|PubMed:15249581}.
Q96GE4	
Q96GE5	
Q96GE6	
Q96GE9	
Q96GF1	
Q96GG9	
Q96GI7	
Q96GJ1	
Q96GK7	
Q96GL9	
Q96GM1	
Q96GM5	
Q96GM8	
Q96GN5	
Q96GP6	
Q96GQ5	
Q96GQ7	
Q96GR2	
Q96GR4	
Q96GS4	
Q96GS6	ENZYME REGULATION: Inhibited by palmostatin-B. {ECO:0000269|PubMed:26701913}.
Q96GT9	
Q96GU1	
Q96GV9	
Q96GW7	
Q96GW9	
Q96GX1	
Q96GX2	
Q96GX5	
Q96GX8	
Q96GX9	
Q96GY0	
Q96GY3	
Q96GZ6	
Q96H12	
Q96H15	
Q96H20	
Q96H22	
Q96H35	
Q96H40	
Q96H55	
Q96H72	
Q96H78	
Q96H79	
Q96H86	
Q96H96	
Q96HA1	
Q96HA4	
Q96HA7	
Q96HA8	
Q96HA9	
Q96HB5	
Q96HC4	
Q96HD1	
Q96HD9	
Q96HE7	ENZYME REGULATION: Enzyme activity is tightly regulated to prevent the accumulation of reactive oxygen species in the endoplasmic reticulum. Reversibly down-regulated by the formation of disulfide bonds between the active site Cys-94 and Cys-131, and between Cys-99 and Cys-104. Glutathione may be required to regulate its activity in the endoplasmic reticulum. {ECO:0000269|PubMed:15161913, ECO:0000269|PubMed:18833192, ECO:0000269|PubMed:18971943}.
Q96HE8	
Q96HE9	
Q96HF1	
Q96HG1	
Q96HH4	
Q96HH6	
Q96HH9	
Q96HI0	
Q96HJ3	
Q96HJ5	
Q96HJ9	
Q96HL8	
Q96HM7	
Q96HN2	
Q96HP0	
Q96HP4	
Q96HP8	
Q96HQ0	
Q96HQ2	
Q96HR3	
Q96HR8	
Q96HR9	
Q96HS1	
Q96HT8	
Q96HU1	
Q96HU8	
Q96HV5	
Q96HW7	
Q96HY6	
Q96HY7	
Q96HZ4	
Q96HZ7	
Q96I13	
Q96I15	
Q96I23	
Q96I24	
Q96I25	
Q96I27	
Q96I34	
Q96I36	
Q96I45	
Q96I51	
Q96I59	
Q96I76	
Q96I82	
Q96I85	
Q96I99	
Q96IC2	
Q96ID5	
Q96IF1	
Q96IG2	
Q96II8	
Q96IJ6	
Q96IK0	
Q96IK1	
Q96IK5	
Q96IL0	
Q96IM9	
Q96IP4	
Q96IQ7	
Q96IQ9	
Q96IR2	
Q96IR3	
Q96IR7	
Q96IS3	
Q96IT1	
Q96IT6	
Q96IU2	
Q96IU4	
Q96IV0	ENZYME REGULATION: Inhibited by Z-VAD-fmk, a well-known caspase inhibitor, which inhibits enzyme activity through covalent binding of the carbohydrate to the single Cys-306 residue. {ECO:0000269|PubMed:15610852}.
Q96IV6	
Q96IW2	
Q96IW7	
Q96IX5	
Q96IX9	
Q96IY1	
Q96IY4	ENZYME REGULATION: TAFI/CPB2 is unique among carboxypeptidases in that it spontaneously inactivates with a short half-life, a property that is crucial for its role in controlling blood clot lysis. The zymogen is stabilized by interactions with the activation peptide. Release of the activation peptide increases a dynamic flap mobility and in time this leads to conformational changes that disrupt the catalytic site and expose a cryptic thrombin-cleavage site present at Arg-324. {ECO:0000269|PubMed:18559974}.
Q96IZ0	
Q96IZ2	
Q96IZ5	
Q96IZ6	
Q96IZ7	
Q96J01	
Q96J02	ENZYME REGULATION: Activated by NDFIP1- and NDFIP2-binding (PubMed:25631046). Activated by PI4K2A-binding (PubMed:23146885). Inhibited by DTX3L-binding (PubMed:24790097). Inhibited by N4BP1 binding (By similarity). {ECO:0000250|UniProtKB:Q8C863, ECO:0000269|PubMed:23146885, ECO:0000269|PubMed:24790097, ECO:0000269|PubMed:25631046}.
Q96J42	
Q96J65	
Q96J66	
Q96J77	
Q96J84	
Q96J86	
Q96J87	
Q96J88	
Q96J92	ENZYME REGULATION: Activation requires autophosphorylation of Ser-335. Phosphorylation of Ser-331 also promotes increased activity (By similarity). {ECO:0000250|UniProtKB:Q9JIH7}.
Q96J94	
Q96JA1	
Q96JA3	
Q96JA4	
Q96JB1	
Q96JB2	
Q96JB3	
Q96JB5	
Q96JB6	
Q96JB8	
Q96JC1	
Q96JC4	
Q96JC9	
Q96JD6	ENZYME REGULATION: Inhibited by p-chloromercuribenzoic acid and alkyliodines. {ECO:0000250|UniProtKB:P82125}.
Q96JE7	
Q96JE9	
Q96JF0	
Q96JF6	
Q96JG6	
Q96JG8	
Q96JG9	
Q96JH7	
Q96JH8	
Q96JI7	
Q96JJ3	
Q96JJ6	
Q96JJ7	
Q96JK2	
Q96JK4	
Q96JK9	
Q96JL9	
Q96JM2	
Q96JM3	
Q96JM4	
Q96JM7	
Q96JN0	
Q96JN2	
Q96JN8	
Q96JP0	
Q96JP2	
Q96JP5	
Q96JP9	
Q96JQ0	
Q96JQ2	
Q96JQ5	
Q96JS3	
Q96JT2	
Q96JW4	
Q96JX3	
Q96JY0	
Q96JY6	
Q96JZ2	
Q96K12	
Q96K17	
Q96K19	
Q96K21	
Q96K30	
Q96K31	
Q96K37	
Q96K49	
Q96K58	
Q96K62	
Q96K75	
Q96K76	
Q96K78	
Q96K80	
Q96K83	
Q96KA5	
Q96KB5	ENZYME REGULATION: Activated by phosphorylation. {ECO:0000250}.
Q96KC2	
Q96KC8	
Q96KC9	
Q96KD3	
Q96KE9	
Q96KF2	
Q96KF7	
Q96KG7	
Q96KG9	
Q96KH6	
Q96KJ4	
Q96KJ9	
Q96KK3	
Q96KK4	
Q96KK5	
Q96KM6	
Q96KN1	
Q96KN2	ENZYME REGULATION: Inhibited by the metal chelator 1,10-o-phenantrolin. The inhibitory concentration 50% (IC(50)) is 5 uM.
Q96KN3	
Q96KN4	
Q96KN7	
Q96KN8	
Q96KN9	
Q96KP1	
Q96KP4	ENZYME REGULATION: Inhibited by p-hydroxymercurybenzoate. The inhibitory concentration 50% (IC(50)) is 13 uM. Inhibited by bestatin. The inhibitory concentration 50% (IC(50)) is 7 nM at pH 9.5. {ECO:0000269|PubMed:12473676}.
Q96KP6	
Q96KQ4	
Q96KQ7	
Q96KR1	
Q96KR4	
Q96KR6	
Q96KR7	
Q96KS0	
Q96KS9	
Q96KT0	
Q96KT6	
Q96KT7	
Q96KV6	
Q96KV7	
Q96KW2	
Q96KW9	
Q96KX0	
Q96KX1	
Q96KX2	
Q96L03	
Q96L08	
Q96L11	
Q96L12	
Q96L14	
Q96L15	
Q96L21	
Q96L33	
Q96L34	ENZYME REGULATION: Activated by phosphorylation on Thr-214. {ECO:0000269|PubMed:14976552}.
Q96L42	
Q96L46	
Q96L50	
Q96L58	
Q96L73	
Q96L91	
Q96L92	
Q96L93	
Q96L94	
Q96L96	
Q96LA5	
Q96LA6	
Q96LA8	
Q96LA9	
Q96LB0	
Q96LB1	
Q96LB2	
Q96LB3	
Q96LB4	
Q96LB8	
Q96LB9	
Q96LC7	
Q96LC9	
Q96LD1	
Q96LD4	
Q96LD8	
Q96LI5	
Q96LI6	
Q96LI9	
Q96LJ7	
Q96LJ8	
Q96LK0	
Q96LK8	
Q96LL3	
Q96LL4	
Q96LL9	
Q96LM1	
Q96LM5	
Q96LM6	
Q96LM9	
Q96LP2	
Q96LP6	
Q96LQ0	
Q96LR2	
Q96LR4	
Q96LR5	
Q96LR7	
Q96LR9	
Q96LS8	
Q96LT4	
Q96LT6	
Q96LT7	
Q96LT9	
Q96LU5	
Q96LU7	
Q96LW1	
Q96LW2	
Q96LW4	
Q96LW7	
Q96LW9	
Q96LX7	
Q96LX8	
Q96LY2	
Q96LZ2	
Q96LZ3	
Q96LZ7	
Q96M02	
Q96M11	
Q96M15	
Q96M19	
Q96M20	
Q96M27	
Q96M29	
Q96M32	
Q96M34	
Q96M42	
Q96M43	
Q96M53	
Q96M60	
Q96M61	
Q96M63	
Q96M66	
Q96M69	
Q96M78	
Q96M83	
Q96M85	
Q96M86	
Q96M89	
Q96M91	
Q96M93	
Q96M94	
Q96M95	
Q96M96	
Q96M98	
Q96MA1	
Q96MA6	
Q96MB7	
Q96MC2	
Q96MC4	
Q96MC5	
Q96MC6	
Q96MC9	
Q96MD2	
Q96MD7	
Q96ME1	
Q96ME7	
Q96MF0	
Q96MF2	
Q96MF4	
Q96MF6	
Q96MF7	
Q96MG2	
Q96MG7	
Q96MG8	
Q96MH2	
Q96MH6	
Q96MH7	
Q96MI6	
Q96MI9	
Q96MK2	
Q96MK3	
Q96MM3	
Q96MM6	
Q96MM7	
Q96MN2	
Q96MN5	
Q96MN9	
Q96MP5	
Q96MP8	
Q96MR6	
Q96MR7	
Q96MR9	
Q96MS0	
Q96MS3	
Q96MT0	
Q96MT1	
Q96MT3	
Q96MT4	
Q96MT7	
Q96MT8	
Q96MU5	
Q96MU6	
Q96MU7	
Q96MU8	
Q96MV1	
Q96MV8	
Q96MW1	
Q96MW5	
Q96MW7	
Q96MX0	
Q96MX3	
Q96MX6	
Q96MY1	
Q96MY7	
Q96MZ0	
Q96MZ4	
Q96N03	
Q96N06	
Q96N11	
Q96N16	
Q96N19	
Q96N20	
Q96N21	
Q96N22	
Q96N23	
Q96N28	
Q96N35	
Q96N38	
Q96N46	
Q96N53	
Q96N58	
Q96N64	
Q96N66	ENZYME REGULATION: Activity is inhibited by thimerosal.
Q96N67	
Q96N68	
Q96N76	
Q96N77	
Q96N87	
Q96N95	
Q96N96	ENZYME REGULATION: Both the ABR and the SH3 domains contribute to maintaining the protein in an inhibited conformation by associating with the C-terminal tail. Binding of these domains to the C-terminal tail inhibits the activity of the protein by blocking a region that is required for its GEF activity. {ECO:0000269|PubMed:17145773}.
Q96NA2	
Q96NA8	
Q96NB1	
Q96NB2	
Q96NB3	
Q96NC0	
Q96ND0	
Q96ND8	
Q96NE9	
Q96NF6	
Q96NG3	
Q96NG5	
Q96NG8	
Q96NH3	
Q96NI6	
Q96NI8	
Q96NJ1	
Q96NJ3	
Q96NJ5	
Q96NJ6	
Q96NK8	
Q96NL0	
Q96NL1	
Q96NL3	
Q96NL6	
Q96NL8	
Q96NM4	
Q96NN9	
Q96NR2	
Q96NR3	
Q96NR7	
Q96NR8	
Q96NS1	
Q96NS5	
Q96NS8	
Q96NT0	
Q96NT1	
Q96NT3	
Q96NT5	
Q96NU0	
Q96NU1	
Q96NU7	
Q96NW4	
Q96NW7	
Q96NX5	ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of calmodulin is thought to result in a conformational change and leads to activation through phosphorylation by CAMKK1 (By similarity). {ECO:0000250}.
Q96NX9	
Q96NY7	
Q96NY8	
Q96NY9	
Q96NZ1	
Q96NZ8	
Q96NZ9	
Q96P09	
Q96P11	
Q96P15	
Q96P16	
Q96P20	
Q96P26	ENZYME REGULATION: Activated by ADP. {ECO:0000250}.
Q96P31	
Q96P44	
Q96P47	ENZYME REGULATION: GTPase activity is stimulated by oxidative stress. {ECO:0000269|PubMed:16461359}.
Q96P48	
Q96P50	
Q96P53	
Q96P56	ENZYME REGULATION: The CatSper calcium channel is indirectly activated by extracellular progesterone and prostaglandins following the sequence: progesterone > PGF1-alpha = PGE1 > PGA1 > PGE2 >> PGD2 (PubMed:21412338, PubMed:21412339, PubMed:26989199). The CatSper calcium channel is directly inhibited by endocannabinoid 2-arachidonoylglycerol (2AG) (PubMed:26989199). Indirect activation by progesterone takes place via the following mechanism: progesterone binds and activates the acylglycerol lipase ABHD2, which in turn mediates hydrolysis of 2AG inhibitor, relieving inhibition of the CatSper channel (PubMed:26989199). The primary effect of progesterone activation is to shift voltage dependence towards more physiological, negative membrane potentials; it is not mediated by metabotropic receptors and second messengers (PubMed:21412338, PubMed:21412339). Sperm capacitation enhances the effect of progesterone by providing additional negative shift. Also activated by the elevation of intracellular pH (PubMed:21412338, PubMed:21412339). {ECO:0000269|PubMed:21412338, ECO:0000269|PubMed:21412339, ECO:0000269|PubMed:26989199}.
Q96P63	
Q96P64	
Q96P65	
Q96P66	
Q96P67	
Q96P68	
Q96P69	
Q96P70	
Q96P71	
Q96P88	
Q96PB1	
Q96PB7	
Q96PB8	
Q96PC2	
Q96PC3	
Q96PC5	
Q96PD2	
Q96PD4	
Q96PD5	
Q96PD6	
Q96PD7	ENZYME REGULATION: Inhibited by niacin. {ECO:0000250}.
Q96PE1	
Q96PE2	
Q96PE3	
Q96PE5	
Q96PE6	
Q96PE7	
Q96PF1	
Q96PF2	ENZYME REGULATION: Activated by phosphorylation on Thr-174, potentially by autophosphorylation. {ECO:0000250}.
Q96PG1	
Q96PG2	
Q96PG8	
Q96PH1	ENZYME REGULATION: Activated by calcium which induces conformational changes and interaction between the N-terminal regulatory region and the C-terminal catalytic region. Inhibited by diphenylene iodonium. {ECO:0000269|PubMed:14982937}.
Q96PH6	
Q96PI1	
Q96PJ5	
Q96PK6	
Q96PL1	
Q96PL2	
Q96PL5	
Q96PM5	
Q96PM9	
Q96PN6	ENZYME REGULATION: Activated by manganese or magnesium ions (PubMed:12609998, PubMed:24616449). In the presence of magnesium ions, the enzyme is activated by bicarbonate (PubMed:12609998, PubMed:15659711, PubMed:24567411). In the presence of manganese ions, the enzyme is inhibited by bicarbonate (PubMed:15659711). In the absence of magnesium and bicarbonate, the enzyme is weakly activated by calcium (PubMed:15659711). Calcium mildly increases the enzyme activity, also in the presence of magnesium ions (PubMed:15659711, PubMed:25040695). {ECO:0000269|PubMed:12609998, ECO:0000269|PubMed:15659711, ECO:0000269|PubMed:24567411, ECO:0000269|PubMed:24616449, ECO:0000269|PubMed:25040695}.
Q96PN7	
Q96PN8	ENZYME REGULATION: Activated by phosphorylation on Thr-168, potentially by autophosphorylation. {ECO:0000250}.
Q96PP4	
Q96PP8	
Q96PP9	
Q96PQ0	
Q96PQ1	
Q96PQ5	
Q96PQ6	
Q96PQ7	
Q96PR1	ENZYME REGULATION: Inhibited by Stichodactyla helianthus peptide ShK (PubMed:15709110). Inhibited by millimolar levels of tetraethylammonium (TEA). Contrary to other channels, inhibited only by millimolar levels of 4-aminopyridine (4-AP) (By similarity). {ECO:0000250|UniProtKB:P22462, ECO:0000269|PubMed:15709110, ECO:0000305|PubMed:10414303}.
Q96PS1	
Q96PS6	
Q96PS8	
Q96PT3	
Q96PT4	
Q96PU4	
Q96PU5	ENZYME REGULATION: Activated by NDFIP1- and NDFIP2-binding.
Q96PU8	
Q96PU9	
Q96PV0	
Q96PV4	
Q96PV6	
Q96PV7	
Q96PX1	
Q96PX6	
Q96PX8	
Q96PX9	
Q96PY0	
Q96PY5	
Q96PY6	
Q96PZ0	
Q96PZ2	
Q96PZ7	
Q96Q04	
Q96Q05	
Q96Q06	
Q96Q07	
Q96Q11	
Q96Q15	ENZYME REGULATION: Inhibited by caffeine, LY294002 and wortmannin. {ECO:0000269|PubMed:11331269, ECO:0000269|PubMed:11544179, ECO:0000269|PubMed:15175154}.
Q96Q27	
Q96Q35	
Q96Q40	
Q96Q42	
Q96Q45	
Q96Q77	
Q96Q80	
Q96Q83	ENZYME REGULATION: Activated by ascorbate. {ECO:0000269|PubMed:12486230}.
Q96Q89	
Q96Q91	
Q96QA5	
Q96QA6	
Q96QB1	
Q96QC0	
Q96QD5	
Q96QD8	ENZYME REGULATION: Inhibited by N-methyl-D-glucamine and probably choline. {ECO:0000269|PubMed:10930503}.
Q96QD9	
Q96QE2	
Q96QE3	
Q96QE4	
Q96QE5	
Q96QF0	
Q96QF7	
Q96QG7	
Q96QH2	
Q96QH8	
Q96QI5	
Q96QK1	
Q96QK8	
Q96QP1	
Q96QR1	
Q96QR8	
Q96QS1	
Q96QS3	
Q96QS6	
Q96QT4	
Q96QT6	
Q96QU1	
Q96QU4	
Q96QU6	
Q96QU8	
Q96QV1	
Q96QV6	
Q96QZ0	
Q96QZ7	
Q96R05	
Q96R06	
Q96R08	
Q96R09	
Q96R27	
Q96R28	
Q96R30	
Q96R45	
Q96R47	
Q96R48	
Q96R54	
Q96R67	
Q96R69	
Q96R72	
Q96R84	
Q96RA2	
Q96RB7	
Q96RC9	
Q96RD0	
Q96RD1	
Q96RD2	
Q96RD3	
Q96RD6	
Q96RD7	
Q96RD9	
Q96RE7	
Q96RE9	
Q96RF0	
Q96RG2	ENZYME REGULATION: Protein kinase activity is inhibited by the first PAS domain: binding of an unidentified ligand desinhibits the protein kinase activity. May be activated by autophosphorylation on Thr-1161 and Thr-1165 (PubMed:11459942). The activating role of autophosphorylation at Thr-1161 is unclear: according to a report, autophosphorylation at Thr-1161 does not play a major role in activation (PubMed:20943661). Autophosphorylation is enhanced upon phosphatidylinositol monophosphate (phosphatidylinositol 4-phosphate) binding and inhibited upon phosphatidylinositol bi- and tri-phosphate binding. In contrast, phosphorylation of target proteins is inhibited upon all phosphatidylinositol-binding (phosphatidylinositol mono- bi- and tri-phosphate). {ECO:0000269|PubMed:11459942, ECO:0000269|PubMed:20943661, ECO:0000269|PubMed:21418524}.
Q96RI0	
Q96RI1	
Q96RI8	
Q96RI9	
Q96RJ0	
Q96RJ3	
Q96RJ6	
Q96RK0	
Q96RK1	
Q96RK4	
Q96RL1	
Q96RL6	
Q96RL7	
Q96RM1	
Q96RN1	ENZYME REGULATION: Activity is inhibited by 4,4'-Di-isothiocyanatostilbene-2,2'-disulfonic acid (DIDS - an inhibitor of several anion channels and transporters), gluconate, and by thiosulfate.
Q96RN5	
Q96RP3	
Q96RP7	
Q96RP8	
Q96RP9	
Q96RQ1	
Q96RQ3	
Q96RQ9	
Q96RR1	
Q96RR4	ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of calmodulin may relieve intrasteric autoinhibition. Autophosphorylation does not alter activity or regulation by Ca(2+)/calmodulin. In part, activity is independent on Ca(2+)/calmodulin (By similarity). {ECO:0000250}.
Q96RS0	
Q96RS6	
Q96RT1	
Q96RT6	
Q96RT7	
Q96RT8	
Q96RU2	
Q96RU3	
Q96RU7	
Q96RU8	
Q96RV3	
Q96RW7	
Q96RY5	
Q96RY7	
Q96S06	
Q96S07	
Q96S15	
Q96S16	
Q96S19	
Q96S21	
Q96S37	
Q96S38	
Q96S42	
Q96S44	
Q96S52	
Q96S53	ENZYME REGULATION: Activated by autophosphorylation on Ser-219. {ECO:0000250}.
Q96S55	
Q96S59	
Q96S65	
Q96S66	
Q96S79	
Q96S82	
Q96S86	
Q96S90	
Q96S94	
Q96S95	
Q96S96	
Q96S97	
Q96S99	
Q96SA4	
Q96SB3	
Q96SB4	ENZYME REGULATION: Activated by phosphorylation on Ser-51 and Ser-555. {ECO:0000269|PubMed:12565829}.
Q96SB8	
Q96SC8	
Q96SD1	
Q96SE0	
Q96SE7	
Q96SF2	
Q96SF7	
Q96SI1	
Q96SI9	
Q96SJ8	
Q96SK2	
Q96SK3	
Q96SL1	
Q96SL4	
Q96SL8	
Q96SM3	
Q96SN7	
Q96SN8	
Q96SQ5	
Q96SQ7	
Q96SQ9	
Q96SR6	
Q96ST2	
Q96ST3	
Q96ST8	
Q96SU4	
Q96SW2	
Q96SY0	
Q96SZ4	
Q96SZ5	
Q96SZ6	
Q96T17	
Q96T21	
Q96T23	
Q96T25	
Q96T37	
Q96T49	
Q96T51	
Q96T52	
Q96T53	
Q96T54	
Q96T55	
Q96T58	
Q96T59	
Q96T60	
Q96T66	ENZYME REGULATION: Activity is strongly inhibited by galotannin. Inhibited by P1-(adenosine-5')-P4-(nicotinic-acid-riboside-5')-tetraphosphate (Nap4AD). {ECO:0000269|PubMed:17402747}.
Q96T68	
Q96T75	
Q96T76	
Q96T83	
Q96T88	
Q96T91	
Q96T92	
Q96TA0	
Q96TA1	
Q96TA2	
Q96TC7	
Q99062	
Q99075	
Q99081	
Q99102	
Q99217	
Q99218	
Q99250	
Q99259	
Q99417	
Q99418	
Q99424	
Q99426	
Q99435	
Q99436	
Q99437	
Q99439	
Q99440	
Q99442	
Q99445	
Q99447	
Q99453	
Q99456	
Q99457	
Q99459	
Q99460	
Q99463	
Q99466	
Q99467	
Q99469	
Q99470	
Q99471	
Q99487	ENZYME REGULATION: Inhibited by phenylmethanesulfonyl fluoride, 3,4,dichloroisocoumarin, diisopropyl fluorophosphate (DFP) and diethyl p-nitrophenyl phosphate (DENP). {ECO:0000269|PubMed:9494101}.
Q99489	
Q99490	ENZYME REGULATION: GAP activity is stimulated by phosphatidylinositol 4,5-bisphosphate (PIP2) and, to a lesser extent, by phosphatidylinositol 3,4,5-trisphosphate (PIP3). Phosphatidic acid potentiates PIP2 stimulation.
Q99496	
Q99497	
Q99500	
Q99501	
Q99502	
Q99504	
Q99518	
Q99519	
Q99523	
Q99525	
Q99527	
Q99536	
Q99538	
Q99541	
Q99542	ENZYME REGULATION: Strongly inhibited by TIMP-2, TIMP-3 and TIMP-4, while TIMP-1 is less efficient.
Q99543	
Q99547	
Q99549	
Q99550	
Q99551	
Q99558	
Q99567	
Q99569	
Q99570	
Q99571	
Q99572	
Q99574	
Q99575	
Q99576	
Q99578	
Q99581	
Q99583	
Q99584	
Q99590	
Q99592	
Q99593	
Q99594	
Q99595	
Q99598	
Q99607	
Q99608	
Q99611	
Q99612	
Q99613	
Q99614	
Q99615	
Q99616	
Q99618	
Q99619	
Q99622	
Q99623	
Q99624	
Q99626	
Q99627	
Q99633	
Q99638	
Q99640	ENZYME REGULATION: Negatively regulated by hyperphosphorylation during mitosis. The hyperphosphorylated form does not associate with CCNB1-CDC2 complexes. The PLK1 protein kinase may be required for mitotic phosphorylation. {ECO:0000269|PubMed:9268380}.
Q99643	
Q99645	
Q99650	
Q99653	
Q99661	
Q99665	
Q99666	
Q99674	
Q99675	
Q99676	
Q99677	
Q99678	
Q99679	
Q99680	
Q99683	ENZYME REGULATION: Activated by various stressors, including oxidative stress, endoplasmic reticulum stress, and calcium overload, as well as by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF) and lipopolysaccharide (LPS). Homophilic association of MAP3K5/ASK1 through the C-terminal coiled-coil domains and the heteromeric complex formation of MAP3K5/ASK1 with the reduced form of thioredoxin (TXN), constitutes an inactive form of the kinase (PubMed:17210579, PubMed:9564042). Upon ROS-induced dissociation of TXN from MAP3K5/ASK1, TRAF2 and TRAF6 are reciprocally recruited to MAP3K5/ASK1 and form the active MAP3K5/ASK1 signalosome, in which TRAF2 and TRAF6 appear to facilitate the active configuration of MAP3K5/ASK1 (PubMed:9774977, PubMed:10688666, PubMed:11920685). MAP3K5/ASK1 activity is also regulated through several phosphorylation and dephosphorylation events. Thr-838 is an activating phosphorylation site that is autophosphorylated and phosphorylated by MAP3K6/ASK2 and dephosphorylated by PPP5C (PubMed:11689443). Ser-83 and Ser-1033 are inactivating phosphorylation sites, the former of which is phosphorylated by AKT1 and AKT2 (PubMed:11154276, PubMed:12697749, PubMed:15094778). Phosphorylation of Ser-966 induces association of MAP3K5/ASK1 with the 14-3-3 family proteins, which suppresses MAP3K5/ASK1 activity (PubMed:10411906, PubMed:14688258). Calcium/calmodulin-activated protein phosphatase calcineurin (PPP3CA) has been shown to directly dephosphorylate this site (PubMed:14749717). SOCS1 binds to ASK1 by recognizing phosphorylation of Tyr-718 and induces MAP3K5/ASK1 degradation in endothelial cells (PubMed:16407264). Also dephosphorylated and activated by PGAM5. Contains an N-terminal autoinhibitory domain. Once activated targeted for proteosomal degradation by RC3H2-mediated ubiquitination (PubMed:24448648). {ECO:0000269|PubMed:10411906, ECO:0000269|PubMed:10688666, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11689443, ECO:0000269|PubMed:11920685, ECO:0000269|PubMed:12556535, ECO:0000269|PubMed:12697749, ECO:0000269|PubMed:14688258, ECO:0000269|PubMed:14749717, ECO:0000269|PubMed:15094778, ECO:0000269|PubMed:16407264, ECO:0000269|PubMed:17210579, ECO:0000269|PubMed:24448648, ECO:0000269|PubMed:9564042, ECO:0000269|PubMed:9774977}.
Q99684	
Q99685	
Q99687	
Q99689	
Q99697	
Q99698	
Q99700	
Q99704	
Q99705	
Q99706	
Q99707	
Q99708	
Q99712	
Q99714	
Q99715	
Q99717	
Q99719	
Q99720	
Q99726	
Q99727	
Q99728	
Q99729	
Q99731	
Q99732	
Q99733	
Q99735	
Q99741	
Q99742	
Q99743	ENZYME REGULATION: Carbon monoxide (CO) and the redox state of the cell can modulate the transcriptional activity of the NPAS2-ARNTL/BMAL1 heterodimer. NADH and NADPH enhance the DNA-binding activity of the heterodimer whereas CO binds the heme group in NPAS2 and inhibits the DNA-binding activity of the heterodimer. {ECO:0000250|UniProtKB:P97460}.
Q99747	
Q99748	
Q99750	
Q99755	
Q99757	
Q99758	
Q99759	ENZYME REGULATION: Activated by phosphorylation on Thr-530. {ECO:0000250}.
Q99766	
Q99767	
Q99784	
Q99788	
Q99795	
Q99797	ENZYME REGULATION: Activity is divalent cation-dependent. It is stimulated by manganese, magnesium or calcium ions and reversibly inhibited by zinc, cobalt and iron (By similarity). {ECO:0000250}.
Q99798	
Q99801	
Q99805	
Q99807	
Q99808	
Q99811	
Q99814	
Q99816	
Q99819	
Q99828	
Q99829	
Q99832	
Q99835	
Q99836	
Q99848	
Q99853	
Q99856	
Q99865	
Q99871	
Q99873	ENZYME REGULATION: By BTG1, BTG2 and ILF3.
Q99877	
Q99878	
Q99879	
Q99880	
Q99884	
Q99895	
Q99909	
Q99928	
Q99929	
Q99932	
Q99933	
Q99935	
Q99941	
Q99942	
Q99943	
Q99944	
Q99946	
Q99952	
Q99954	
Q99956	
Q99958	
Q99959	
Q99961	
Q99962	
Q99963	
Q99965	
Q99966	
Q99967	
Q99969	
Q99972	
Q99973	
Q99983	
Q99985	
Q99986	ENZYME REGULATION: Active in presence of Mn(2+), Mg(2+) and Zn(2+), but is not functional with Ca(2+) or Cu(2+). Has a higher affinity for Mn(2+) than for Mg(2+). RAN inhibits its autophosphorylation and its ability to phosphorylate histone H3. {ECO:0000269|PubMed:11883897, ECO:0000269|PubMed:18617507}.
Q99988	
Q99990	
Q99996	
Q99999	
Q9BPU6	
Q9BPU9	
Q9BPV8	
Q9BPW4	
Q9BPW5	
Q9BPW8	
Q9BPW9	
Q9BPX1	
Q9BPX3	
Q9BPX5	
Q9BPX6	
Q9BPX7	
Q9BPY3	
Q9BPY8	
Q9BPZ2	
Q9BPZ3	
Q9BPZ7	
Q9BQ04	
Q9BQ08	
Q9BQ13	
Q9BQ15	
Q9BQ16	
Q9BQ24	
Q9BQ31	
Q9BQ39	
Q9BQ48	
Q9BQ49	
Q9BQ50	
Q9BQ51	
Q9BQ52	
Q9BQ61	ENZYME REGULATION: Zn(2+) inhibits the RNase activity while Mg(2+), Ca(2+), Mn(2+), K(+), Na(+), EDTA and EGTA show little effect on the exoribonuclease activity (PubMed:28322335). {ECO:0000269|PubMed:28322335}.
Q9BQ65	
Q9BQ66	
Q9BQ67	
Q9BQ69	ENZYME REGULATION: Subject to competitive inhibition by the product ADP-ribose. {ECO:0000269|PubMed:21257746}.
Q9BQ70	
Q9BQ75	
Q9BQ83	
Q9BQ87	
Q9BQ89	
Q9BQ90	
Q9BQ95	
Q9BQA1	
Q9BQA5	
Q9BQA9	
Q9BQB4	
Q9BQB6	ENZYME REGULATION: Inhibited by warfarin (coumadin). {ECO:0000269|PubMed:15879509, ECO:0000269|PubMed:16270630, ECO:0000269|PubMed:22923610}.
Q9BQC3	
Q9BQC6	
Q9BQD1	
Q9BQD3	
Q9BQD7	
Q9BQE3	
Q9BQE4	
Q9BQE5	
Q9BQE6	
Q9BQE9	
Q9BQF6	
Q9BQG0	
Q9BQG1	
Q9BQG2	
Q9BQI0	
Q9BQI3	ENZYME REGULATION: Induced by acute heme depletion, that not only increases EIF2AK1 protein levels, but also stimulates kinase activity by autophosphorylation. Inhibited by the heme-degradation products biliverdin and bilirubin. Induced by oxidative stress generated by arsenite treatment. Binding of nitric oxide (NO) to the heme iron in the N-terminal heme-binding domain activates the kinase activity, while binding of carbon monoxide (CO) suppresses kinase activity (By similarity). {ECO:0000250}.
Q9BQI4	
Q9BQI5	
Q9BQI6	
Q9BQI7	
Q9BQI9	
Q9BQJ4	
Q9BQK8	ENZYME REGULATION: Inhibited by N-ethylmaleimide. {ECO:0000250}.
Q9BQL6	
Q9BQM9	
Q9BQN1	
Q9BQP7	
Q9BQP9	
Q9BQQ3	
Q9BQQ7	
Q9BQR3	
Q9BQS2	
Q9BQS6	
Q9BQS7	
Q9BQS8	
Q9BQT8	
Q9BQT9	
Q9BQW3	
Q9BQY4	
Q9BQY6	
Q9BQY9	
Q9BR01	
Q9BR09	
Q9BR10	
Q9BR11	
Q9BR26	
Q9BR39	
Q9BR46	
Q9BR61	
Q9BR76	
Q9BR77	
Q9BR84	
Q9BRA0	
Q9BRA2	
Q9BRB3	
Q9BRC7	
Q9BRD0	
Q9BRF8	
Q9BRG1	
Q9BRG2	
Q9BRH9	
Q9BRI3	
Q9BRJ2	
Q9BRJ6	
Q9BRJ7	
Q9BRJ9	
Q9BRK0	
Q9BRK3	
Q9BRK4	
Q9BRK5	
Q9BRL6	
Q9BRL7	
Q9BRN9	
Q9BRP0	
Q9BRP1	
Q9BRP4	
Q9BRP7	
Q9BRP8	
Q9BRP9	
Q9BRQ0	
Q9BRQ3	
Q9BRQ4	
Q9BRQ5	
Q9BRQ6	
Q9BRQ8	
Q9BRR0	
Q9BRR3	
Q9BRR6	
Q9BRR8	
Q9BRR9	
Q9BRS2	
Q9BRS8	
Q9BRT2	
Q9BRT3	
Q9BRT6	
Q9BRT7	
Q9BRT8	
Q9BRT9	
Q9BRU2	
Q9BRU9	
Q9BRV3	
Q9BRV8	
Q9BRX2	
Q9BRX5	
Q9BRX8	
Q9BRX9	
Q9BRY0	
Q9BRZ2	
Q9BS16	
Q9BS18	
Q9BS26	
Q9BS31	
Q9BS34	
Q9BS40	
Q9BS86	
Q9BS91	
Q9BS92	
Q9BSA4	
Q9BSA9	
Q9BSB4	
Q9BSC4	
Q9BSD3	
Q9BSD7	
Q9BSE2	
Q9BSE4	
Q9BSE5	
Q9BSF0	
Q9BSF4	
Q9BSF8	
Q9BSG0	
Q9BSG1	
Q9BSG5	
Q9BSH3	
Q9BSH4	
Q9BSH5	
Q9BSI4	
Q9BSJ1	
Q9BSJ2	
Q9BSJ5	
Q9BSJ6	
Q9BSJ8	
Q9BSK0	
Q9BSK1	
Q9BSK2	
Q9BSK4	
Q9BSL1	
Q9BSM1	
Q9BSN7	
Q9BSQ5	
Q9BSR8	
Q9BST9	
Q9BSU1	
Q9BSU3	
Q9BSV6	
Q9BSW2	
Q9BSW7	
Q9BSY4	
Q9BSY9	
Q9BT04	
Q9BT09	
Q9BT17	
Q9BT22	
Q9BT23	
Q9BT25	
Q9BT30	
Q9BT40	
Q9BT43	
Q9BT49	
Q9BT56	
Q9BT67	
Q9BT73	
Q9BT76	
Q9BT78	
Q9BT81	
Q9BT88	
Q9BT92	
Q9BTA0	
Q9BTA9	
Q9BTC0	
Q9BTC8	
Q9BTD1	
Q9BTD3	
Q9BTD8	
Q9BTE0	
Q9BTE1	
Q9BTE3	
Q9BTE6	
Q9BTE7	
Q9BTF0	
Q9BTK2	
Q9BTK6	
Q9BTL3	
Q9BTL4	
Q9BTM1	
Q9BTM9	
Q9BTN0	
Q9BTP6	
Q9BTP7	
Q9BTT0	
Q9BTT4	
Q9BTT6	
Q9BTU6	
Q9BTV4	
Q9BTV5	
Q9BTV6	
Q9BTV7	
Q9BTW9	
Q9BTX1	
Q9BTX3	
Q9BTX7	
Q9BTY2	
Q9BTY7	
Q9BTZ2	
Q9BU02	
Q9BU19	
Q9BU20	
Q9BU23	
Q9BU40	
Q9BU61	
Q9BU64	
Q9BU68	
Q9BU70	
Q9BU76	
Q9BU79	
Q9BU89	
Q9BUA3	
Q9BUA6	
Q9BUB4	
Q9BUB5	ENZYME REGULATION: Phosphorylated and activated by the p38 kinases and kinases in the Erk pathway. {ECO:0000269|PubMed:9155018}.
Q9BUB7	
Q9BUD6	
Q9BUE0	
Q9BUE6	
Q9BUF5	
Q9BUF7	
Q9BUG6	
Q9BUH6	
Q9BUH8	
Q9BUI4	
Q9BUJ0	
Q9BUJ2	
Q9BUK0	
Q9BUK6	
Q9BUL5	
Q9BUL8	
Q9BUL9	
Q9BUM1	ENZYME REGULATION: Inhibited by vanadate. {ECO:0000269|PubMed:13129915}.
Q9BUN1	
Q9BUN5	
Q9BUN8	
Q9BUP0	
Q9BUP3	
Q9BUQ8	
Q9BUR4	
Q9BUR5	
Q9BUT1	
Q9BUT9	
Q9BUU2	
Q9BUV0	
Q9BUV8	
Q9BUW7	
Q9BUX1	
Q9BUY5	
Q9BUY7	
Q9BUZ4	
Q9BV10	
Q9BV19	
Q9BV20	
Q9BV23	
Q9BV29	
Q9BV35	
Q9BV36	
Q9BV38	
Q9BV40	
Q9BV44	
Q9BV47	
Q9BV57	
Q9BV68	
Q9BV73	
Q9BV79	
Q9BV81	
Q9BV86	
Q9BV87	
Q9BV90	
Q9BV94	
Q9BV97	
Q9BV99	
Q9BVA0	
Q9BVA1	
Q9BVA6	ENZYME REGULATION: The side chain of Glu-234 determines which of the two opposing activities (AMPylase or de-AMPylase) will take place. In response to endoplasmic reticulum stress, mediates de-AMPylase activity (By similarity). Adenylyltransferase activity is inhibited by the inhibitory helix present at the N-terminus: Glu-234 binds ATP and competes with ATP-binding at Arg-374, thereby preventing adenylyltransferase activity (PubMed:22266942, PubMed:25435325). In unstressed cells, disengagement of Glu-234 promotes adenylyltransferase activity (By similarity). Activation dissociates ATP-binding from Glu-234, allowing ordered binding of the entire ATP moiety with the alpha-phosphate in an orientation that is productive for accepting an incoming target hydroxyl side chain (PubMed:22266942, PubMed:25435325). {ECO:0000250|UniProtKB:A0A061I403, ECO:0000269|PubMed:22266942, ECO:0000269|PubMed:25435325}.
Q9BVC3	
Q9BVC4	
Q9BVC5	
Q9BVC6	
Q9BVG3	
Q9BVG4	
Q9BVG8	
Q9BVG9	ENZYME REGULATION: Inhibited in both the MAM and the ER per se by ethanolamine. Requires calcium ions. {ECO:0000269|PubMed:19014349}.
Q9BVH7	
Q9BVI0	
Q9BVI4	
Q9BVJ6	
Q9BVJ7	
Q9BVK2	
Q9BVK6	
Q9BVK8	
Q9BVL2	
Q9BVL4	
Q9BVM2	
Q9BVM4	
Q9BVN2	
Q9BVP2	
Q9BVQ7	
Q9BVR0	
Q9BVS4	
Q9BVS5	
Q9BVT8	
Q9BVV2	
Q9BVV6	
Q9BVV7	
Q9BVV8	
Q9BVW5	
Q9BVW6	
Q9BVX2	
Q9BW04	
Q9BW11	
Q9BW19	
Q9BW27	
Q9BW30	
Q9BW60	
Q9BW61	
Q9BW62	
Q9BW66	
Q9BW71	
Q9BW72	
Q9BW83	
Q9BW85	
Q9BW91	
Q9BW92	
Q9BWC9	
Q9BWD1	
Q9BWD3	
Q9BWE0	
Q9BWF2	
Q9BWF3	
Q9BWG4	
Q9BWG6	
Q9BWH2	
Q9BWH6	
Q9BWJ2	
Q9BWJ5	
Q9BWK5	
Q9BWL3	
Q9BWM5	
Q9BWM7	
Q9BWN1	
Q9BWP8	
Q9BWQ6	
Q9BWQ8	
Q9BWS9	
Q9BWT1	
Q9BWT3	
Q9BWT6	
Q9BWT7	
Q9BWU0	
Q9BWU1	
Q9BWV1	
Q9BWV2	
Q9BWV3	
Q9BWV7	
Q9BWW4	
Q9BWW7	
Q9BWW8	
Q9BWW9	
Q9BWX1	
Q9BWX5	
Q9BX10	
Q9BX26	
Q9BX40	
Q9BX46	
Q9BX51	
Q9BX59	
Q9BX63	
Q9BX66	
Q9BX67	
Q9BX68	
Q9BX69	
Q9BX70	
Q9BX73	
Q9BX74	
Q9BX79	
Q9BX82	
Q9BX84	
Q9BX93	
Q9BX95	
Q9BX97	
Q9BXA5	
Q9BXA6	
Q9BXA7	ENZYME REGULATION: Kinase activity is specifically inhibited by 2 classes of compounds: biphenyl compounds (1,1'-(biphenyl-4,4'-diyl)bis(2,2-dihydroxyethanone)) and 1,2,7-trialky-1H-imidazo[4,5-g]quinoxalin-6-one. Activated by phosphorylation on Thr-174 and potentially by autophosphorylation. {ECO:0000269|PubMed:15733851, ECO:0000269|PubMed:19530700}.
Q9BXA9	
Q9BXB1	
Q9BXB4	
Q9BXB5	
Q9BXB7	
Q9BXC0	
Q9BXC1	
Q9BXC9	
Q9BXD5	
Q9BXE9	
Q9BXF3	
Q9BXF6	
Q9BXF9	
Q9BXG8	
Q9BXH1	
Q9BXI2	
Q9BXI3	ENZYME REGULATION: Activated by ADP.
Q9BXI6	
Q9BXI9	
Q9BXJ0	
Q9BXJ1	
Q9BXJ2	
Q9BXJ3	
Q9BXJ4	
Q9BXJ5	
Q9BXJ7	
Q9BXJ8	
Q9BXJ9	
Q9BXK1	
Q9BXK5	
Q9BXL5	
Q9BXL6	
Q9BXL7	
Q9BXL8	
Q9BXM0	
Q9BXM7	
Q9BXM9	
Q9BXN1	
Q9BXN2	
Q9BXN6	
Q9BXP2	
Q9BXP5	
Q9BXP8	
Q9BXQ6	
Q9BXR0	
Q9BXR3	
Q9BXR5	
Q9BXR6	
Q9BXS0	
Q9BXS1	
Q9BXS4	
Q9BXS5	
Q9BXS6	
Q9BXS9	ENZYME REGULATION: Apical membrane chloride-formate exchange activity in the proximal tubules of the kidney and oxalate secretion in the duodenum are inhibited by 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS - an inhibitor of several anion channels and transporters) (By similarity). Apical membrane chloride-bicarbonate exchange activity of the pancreatic duct is inhibited by 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS - an inhibitor of several anion channels and transporters). Isoform 4, isoform 5 and isoform 6 chloride, bicarbonate and sulfate transport activities are inhibited by DIDS. {ECO:0000250, ECO:0000269|PubMed:12444019, ECO:0000269|PubMed:15990874, ECO:0000269|PubMed:20501439}.
Q9BXT2	
Q9BXT4	
Q9BXT5	
Q9BXT6	
Q9BXT8	
Q9BXU0	
Q9BXU1	
Q9BXU2	
Q9BXU3	
Q9BXU7	
Q9BXU8	
Q9BXU9	
Q9BXV9	
Q9BXW3	
Q9BXW4	
Q9BXW6	
Q9BXW7	
Q9BXW9	
Q9BXX0	
Q9BXX2	
Q9BXX3	
Q9BXY0	
Q9BXY4	
Q9BXY5	
Q9BXY8	
Q9BY07	ENZYME REGULATION: Activity is inhibited by 4,4'-di-isothiocyanatostilbene-2,2'-disulfonic acid (DIDS - an inhibitor of several anion channels and transporters).
Q9BY08	
Q9BY10	
Q9BY11	
Q9BY12	
Q9BY14	
Q9BY15	
Q9BY19	
Q9BY21	
Q9BY27	
Q9BY31	
Q9BY32	
Q9BY41	ENZYME REGULATION: Its activity is inhibited by trichostatin A (TSA), suberoylanilide hydroxamic acid (SAHA), 3-(1-methyl-4-phenylacetyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide (APHA), 4-dimethylamino-N-(6-hydroxycarbamoyethyl)benzamide-N-hydroxy-7-(4-dimethylaminobenzoyl)aminoheptanamide (MS-344), 5-(4-methyl-benzoylamino)-biphenyl-3,4'-dicarboxylic acid 3-dimethylamide 4'-hydroxyamide (CRA-A) and butyrate. {ECO:0000269|PubMed:15242608}.
Q9BY42	
Q9BY43	
Q9BY44	
Q9BY49	
Q9BY50	
Q9BY60	
Q9BY64	
Q9BY65	
Q9BY66	
Q9BY67	
Q9BY71	
Q9BY76	
Q9BY77	
Q9BY78	
Q9BY79	
Q9BY84	
Q9BY89	
Q9BYB0	
Q9BYB4	
Q9BYC2	
Q9BYC5	
Q9BYC8	
Q9BYC9	
Q9BYD1	
Q9BYD2	
Q9BYD3	
Q9BYD5	
Q9BYD6	
Q9BYD9	
Q9BYE0	
Q9BYE2	
Q9BYE3	
Q9BYE4	
Q9BYE7	
Q9BYE9	
Q9BYF1	ENZYME REGULATION: Activated by chloride and fluoride, but not bromide. Inhibited by MLN-4760, cFP_Leu, and EDTA, but not by the ACE inhibitors linosipril, captopril and enalaprilat. {ECO:0000269|PubMed:10924499, ECO:0000269|PubMed:10969042, ECO:0000269|PubMed:11815627, ECO:0000269|PubMed:15231706}.
Q9BYG0	
Q9BYG3	
Q9BYG4	
Q9BYG5	
Q9BYG7	
Q9BYG8	
Q9BYH1	
Q9BYH8	
Q9BYI3	
Q9BYJ0	
Q9BYJ1	
Q9BYJ4	
Q9BYJ9	
Q9BYK8	
Q9BYL1	
Q9BYM8	
Q9BYN0	
Q9BYN7	
Q9BYN8	
Q9BYP7	ENZYME REGULATION: Activation requires autophosphorylation of Ser-308. Phosphorylation of Ser-304 also promotes increased activity (By similarity). Kinase activity is inhibited by WNK4. {ECO:0000250|UniProtKB:Q9JIH7, ECO:0000269|PubMed:17975670}.
Q9BYP8	
Q9BYP9	
Q9BYQ0	
Q9BYQ2	
Q9BYQ3	
Q9BYQ4	
Q9BYQ5	
Q9BYQ6	
Q9BYQ7	
Q9BYQ8	
Q9BYQ9	
Q9BYR0	
Q9BYR2	
Q9BYR3	
Q9BYR4	
Q9BYR5	
Q9BYR6	
Q9BYR7	
Q9BYR8	
Q9BYR9	
Q9BYS1	
Q9BYS8	
Q9BYT1	
Q9BYT3	
Q9BYT5	
Q9BYT8	
Q9BYT9	
Q9BYU1	
Q9BYU5	
Q9BYV1	
Q9BYV2	
Q9BYV6	
Q9BYV7	
Q9BYV8	
Q9BYV9	
Q9BYW1	
Q9BYW2	ENZYME REGULATION: Specifically inhibited by sinefungin derivatives. N-propyl sinefungin (Pr-SNF) interacts preferentially with SETD2. {ECO:0000269|PubMed:23043551}.
Q9BYW3	
Q9BYX2	
Q9BYX4	
Q9BYX7	
Q9BYZ2	
Q9BYZ6	
Q9BYZ8	
Q9BZ11	
Q9BZ19	
Q9BZ23	ENZYME REGULATION: Regulated by feedback inhibition by CoA and its thioesters.
Q9BZ29	
Q9BZ67	
Q9BZ68	
Q9BZ71	
Q9BZ72	
Q9BZ76	
Q9BZ81	
Q9BZ95	
Q9BZ97	
Q9BZ98	
Q9BZA0	
Q9BZA5	
Q9BZA7	
Q9BZA8	
Q9BZB8	
Q9BZC1	
Q9BZC7	
Q9BZD2	
Q9BZD3	
Q9BZD4	
Q9BZD6	
Q9BZD7	
Q9BZE0	
Q9BZE1	
Q9BZE2	
Q9BZE3	
Q9BZE4	
Q9BZE7	
Q9BZE9	
Q9BZF1	
Q9BZF2	
Q9BZF3	
Q9BZF9	
Q9BZG1	
Q9BZG2	
Q9BZG8	
Q9BZH6	
Q9BZI1	
Q9BZI7	
Q9BZJ0	
Q9BZJ3	
Q9BZJ4	
Q9BZJ6	
Q9BZJ7	
Q9BZJ8	
Q9BZK3	
Q9BZK7	
Q9BZK8	
Q9BZL1	
Q9BZL3	
Q9BZL4	
Q9BZL6	ENZYME REGULATION: Activated by DAG and phorbol esters (PubMed:12058027, PubMed:17962809, PubMed:28428613). Phorbol-ester/DAG-type domains bind DAG, mediating translocation to membranes (PubMed:17962809). Autophosphorylation of Ser-710 and phosphorylation of Ser-706 by PKC relieves auto-inhibition by the PH domain (PubMed:17962809). Catalytic activity is further increased by phosphorylation at Tyr-717 in response to oxidative stress (PubMed:28428613). {ECO:0000269|PubMed:12058027, ECO:0000269|PubMed:17962809, ECO:0000269|PubMed:28428613}.
Q9BZM1	
Q9BZM2	
Q9BZM3	
Q9BZM4	
Q9BZM5	
Q9BZM6	
Q9BZP3	
Q9BZP6	
Q9BZQ2	
Q9BZQ4	ENZYME REGULATION: Inhibited by P1-(adenosine-5')-P3-(nicotinamide-riboside-5')-triphosphate (Np3AD) and P1-(adenosine-5')-P4-(nicotinamide-riboside-5')-tetraphosphate (Np4AD). {ECO:0000269|PubMed:17402747}.
Q9BZQ6	
Q9BZQ8	
Q9BZR6	
Q9BZR8	
Q9BZR9	
Q9BZS1	
Q9BZS9	
Q9BZV1	
Q9BZV2	
Q9BZV3	
Q9BZW2	
Q9BZW4	
Q9BZW5	
Q9BZW7	
Q9BZW8	
Q9BZX2	
Q9BZX4	
Q9BZY9	
Q9BZZ2	
Q9BZZ5	
Q9C000	
Q9C002	
Q9C004	
Q9C005	
Q9C009	
Q9C010	
Q9C019	
Q9C026	
Q9C029	
Q9C030	
Q9C035	
Q9C037	
Q9C040	
Q9C056	
Q9C073	
Q9C075	
Q9C086	
Q9C091	
Q9C093	
Q9C098	
Q9C099	
Q9C0A0	
Q9C0A1	
Q9C0A6	
Q9C0B0	
Q9C0B1	ENZYME REGULATION: Activated by ascorbate. Inhibited by N-oxalylglycine, fumarate and succinate (By similarity). {ECO:0000250}.
Q9C0B2	
Q9C0B5	
Q9C0B6	
Q9C0B7	
Q9C0B9	
Q9C0C2	
Q9C0C4	
Q9C0C6	
Q9C0C7	
Q9C0C9	ENZYME REGULATION: inhibited by phenylarsine oxide (PAO). {ECO:0000269|PubMed:24703950}.
Q9C0D0	
Q9C0D2	
Q9C0D3	
Q9C0D4	
Q9C0D5	
Q9C0D6	
Q9C0D7	
Q9C0D9	
Q9C0E2	
Q9C0E4	
Q9C0E8	
Q9C0F0	
Q9C0F1	
Q9C0F3	
Q9C0G0	
Q9C0G6	
Q9C0H2	
Q9C0H5	
Q9C0H6	
Q9C0H9	
Q9C0I1	
Q9C0I3	
Q9C0I4	
Q9C0I9	
Q9C0J1	
Q9C0J8	
Q9C0J9	
Q9C0K0	
Q9C0K1	
Q9C0K3	
Q9C0K7	
Q9GIP4	
Q9GIY3	
Q9GZK3	
Q9GZK4	
Q9GZK6	
Q9GZK7	
Q9GZL7	
Q9GZL8	
Q9GZM3	
Q9GZM5	
Q9GZM6	
Q9GZM7	
Q9GZM8	
Q9GZN0	
Q9GZN1	
Q9GZN2	
Q9GZN4	
Q9GZN6	
Q9GZN7	
Q9GZN8	
Q9GZP0	
Q9GZP1	
Q9GZP4	
Q9GZP7	
Q9GZP8	
Q9GZP9	
Q9GZQ3	
Q9GZQ4	
Q9GZQ6	
Q9GZQ8	
Q9GZR1	
Q9GZR2	
Q9GZR5	
Q9GZR7	
Q9GZS0	
Q9GZS1	
Q9GZS3	
Q9GZS9	
Q9GZT3	
Q9GZT4	ENZYME REGULATION: Allosterically activated by magnesium, and possibly also other divalent metal cations. Allosterically activated by ATP, ADP or GTP. Competitively inhibited by malonate.
Q9GZT5	
Q9GZT6	
Q9GZT8	
Q9GZT9	ENZYME REGULATION: Following exposure to hypoxia, activated in HeLa cells but not in cardiovascular cells. {ECO:0000269|PubMed:12670503, ECO:0000269|PubMed:20840591}.
Q9GZU0	
Q9GZU1	ENZYME REGULATION: Channel activity is controlled by multiple regulatory mechanisms in different subcellular compartments. Channel function is transiently modulated by changes in Ca(2+), and inhibited by a reduction of pH; pH changes modify the aggregation state of unitary channels; a negative cooperativity between extracellular/lumenal Ca(2+) and H(+) is suggested (PubMed:12459486, PubMed:28112729). Regulated by phosphoinositides in a compartment-specific manner: in lysosomes activated by PtdIns(3,5)P2 (Phosphatidylinositol 3,5-bisphosphate) and at the plasma membrane inhibited by PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) (PubMed:22733759, PubMed:29019983). {ECO:0000269|PubMed:12459486, ECO:0000269|PubMed:22733759, ECO:0000269|PubMed:28112729, ECO:0000269|PubMed:29019983}.
Q9GZU2	
Q9GZU3	
Q9GZU5	
Q9GZU7	ENZYME REGULATION: Stimulated by GTF2F1. Inhibited by beryllofluoride anions. {ECO:0000269|PubMed:12721286}.
Q9GZU8	
Q9GZV1	
Q9GZV3	
Q9GZV4	
Q9GZV5	
Q9GZV7	
Q9GZV8	
Q9GZV9	
Q9GZW5	
Q9GZW8	
Q9GZX3	
Q9GZX5	
Q9GZX6	
Q9GZX7	
Q9GZX9	
Q9GZY0	
Q9GZY1	
Q9GZY4	
Q9GZY6	
Q9GZY8	
Q9GZZ0	
Q9GZZ1	
Q9GZZ6	
Q9GZZ7	
Q9GZZ8	
Q9GZZ9	
Q9H000	
Q9H008	
Q9H009	
Q9H013	
Q9H015	
Q9H019	
Q9H040	
Q9H061	
Q9H063	
Q9H069	
Q9H074	
Q9H078	
Q9H079	
Q9H081	
Q9H082	ENZYME REGULATION: Regulated by a guanine nucleotide-exchange factor (GEF) and a GTPase-activating protein (GAP) and alternates between an inactive GDP-bound and an active GTP-bound form. In vitro, SGSM2 acts as its GAP and inactivates it by stimulating its GTPase activity. {ECO:0000269|PubMed:21808068}.
Q9H089	
Q9H091	
Q9H093	ENZYME REGULATION: Activated by phosphorylation on Thr-208. {ECO:0000269|PubMed:14976552}.
Q9H094	
Q9H095	
Q9H098	
Q9H0A0	
Q9H0A3	
Q9H0A6	
Q9H0A8	
Q9H0A9	
Q9H0B3	
Q9H0B6	
Q9H0B8	
Q9H0C1	
Q9H0C2	
Q9H0C3	
Q9H0C5	
Q9H0C8	ENZYME REGULATION: Inhibited rather than stimulated by magnesium.
Q9H0D2	
Q9H0D6	
Q9H0E2	
Q9H0E3	
Q9H0E7	
Q9H0E9	
Q9H0F5	
Q9H0F6	
Q9H0F7	
Q9H0G5	
Q9H0H0	
Q9H0H3	
Q9H0H5	
Q9H0H9	
Q9H0I2	
Q9H0I3	
Q9H0I9	
Q9H0J4	
Q9H0J9	
Q9H0K1	ENZYME REGULATION: Activated by phosphorylation on Thr-175. {ECO:0000269|PubMed:14976552}.
Q9H0K4	
Q9H0K6	
Q9H0L4	
Q9H0M0	ENZYME REGULATION: Activated by NDFIP1- and NDFIP2-binding.
Q9H0M4	
Q9H0M5	
Q9H0N0	
Q9H0N5	
Q9H0P0	
Q9H0P7	
Q9H0Q0	
Q9H0Q3	
Q9H0R1	
Q9H0R3	
Q9H0R4	
Q9H0R5	
Q9H0R6	
Q9H0R8	
Q9H0S4	
Q9H0T7	
Q9H0U3	
Q9H0U4	ENZYME REGULATION: Rab activation is generally mediated by a guanine exchange factor (GEF), while inactivation through hydrolysis of bound GTP is catalyzed by a GTPase activating protein (GAP). {ECO:0000305}.
Q9H0U6	
Q9H0U9	
Q9H0V1	
Q9H0V9	
Q9H0W5	
Q9H0W7	
Q9H0W8	
Q9H0W9	
Q9H0X4	
Q9H0X6	
Q9H0X9	
Q9H0Y0	
Q9H0Z9	
Q9H106	
Q9H112	
Q9H114	
Q9H115	
Q9H116	
Q9H147	
Q9H156	
Q9H158	
Q9H159	
Q9H160	
Q9H161	
Q9H165	
Q9H169	
Q9H171	
Q9H172	
Q9H173	
Q9H175	
Q9H190	
Q9H195	
Q9H1A3	
Q9H1A4	
Q9H1A7	
Q9H1B4	
Q9H1B5	
Q9H1B7	
Q9H1C0	
Q9H1C3	
Q9H1C4	
Q9H1C7	
Q9H1D0	
Q9H1D9	
Q9H1E1	
Q9H1E3	
Q9H1E5	
Q9H1F0	
Q9H1H1	
Q9H1H9	
Q9H1I8	
Q9H1J1	
Q9H1J5	
Q9H1J7	
Q9H1K0	
Q9H1K1	
Q9H1K4	
Q9H1K6	
Q9H1L0	
Q9H1M0	
Q9H1M3	
Q9H1M4	
Q9H1N7	
Q9H1P3	
Q9H1P6	
Q9H1Q7	
Q9H1R2	
Q9H1R3	
Q9H1U4	
Q9H1U9	
Q9H1V8	
Q9H1X1	
Q9H1X3	
Q9H1Y0	
Q9H1Y3	
Q9H1Z4	
Q9H1Z8	
Q9H1Z9	
Q9H201	
Q9H204	
Q9H205	
Q9H207	
Q9H208	
Q9H209	
Q9H210	
Q9H211	
Q9H213	
Q9H221	ENZYME REGULATION: The ATPase activity of the heterodimer is stimulated by cholate. Taurocholate, glycocholate, taurochenodeoxycholate, glycochenodeoxycholate and taurodeoxycholate also stimulate ATPase activity, but to a lower degree. Glycodeoxycholate has no significant effect on ATPase activity. ATPase activity is inhibited by vanadate and by berillium fluoride. {ECO:0000269|PubMed:20210363, ECO:0000269|PubMed:27144356}.
Q9H222	ENZYME REGULATION: The ATPase activity of the heterodimer is stimulated by cholate. Taurocholate, glycocholate, taurochenodeoxycholate, glycochenodeoxycholate and taurodeoxycholate also stimulate ATPase activity, but to a lower degree. Glycodeoxycholate has no significant effect on ATPase activity. ATPase activity is inhibited by vanadate and by berillium fluoride. {ECO:0000269|PubMed:20210363, ECO:0000269|PubMed:27144356}.
Q9H223	
Q9H227	ENZYME REGULATION: Inhibited by 2,4-dinitrophenyl-2-fluoro-2-deoxy-beta-D-glucopyranoside and sodium taurocholate. {ECO:0000269|PubMed:11389701, ECO:0000269|PubMed:11784319}.
Q9H228	
Q9H237	
Q9H239	
Q9H244	
Q9H246	
Q9H251	
Q9H252	
Q9H254	
Q9H255	
Q9H257	
Q9H267	
Q9H269	
Q9H270	
Q9H293	
Q9H295	
Q9H299	
Q9H2A2	
Q9H2A3	
Q9H2A7	
Q9H2A9	
Q9H2B2	
Q9H2B4	
Q9H2C0	
Q9H2C1	
Q9H2C2	
Q9H2C5	
Q9H2C8	
Q9H2D1	
Q9H2D6	
Q9H2E6	
Q9H2F3	
Q9H2F5	
Q9H2F9	
Q9H2G2	
Q9H2G4	
Q9H2G9	
Q9H2H0	
Q9H2H8	
Q9H2H9	ENZYME REGULATION: Inhibited by potassium, choline ions and 2-methylamino-isobutyric acid (MeAIB) (By similarity). Inhibited by lithium and N-methyl-D-glucamine. {ECO:0000250, ECO:0000269|PubMed:10891391}.
Q9H2I8	
Q9H2J1	
Q9H2J4	
Q9H2J7	
Q9H2K0	
Q9H2K2	ENZYME REGULATION: Specifically inhibited by XAV939, a small molecule, leading to inhibit the Wnt signaling pathway by stabilizing AXIN1 and AXIN2. {ECO:0000269|PubMed:19759537}.
Q9H2K8	
Q9H2L4	
Q9H2L5	
Q9H2M3	
Q9H2M9	
Q9H2P0	
Q9H2P9	
Q9H2Q1	
Q9H2R5	
Q9H2S1	
Q9H2S5	
Q9H2S6	
Q9H2S9	
Q9H2T7	
Q9H2U1	
Q9H2U2	
Q9H2U6	
Q9H2U9	
Q9H2V7	
Q9H2W1	
Q9H2W2	
Q9H2W6	
Q9H2X0	
Q9H2X3	
Q9H2X6	
Q9H2X8	
Q9H2X9	ENZYME REGULATION: Inhibited by WNK3. {ECO:0000269|PubMed:21613606}.
Q9H2Y7	
Q9H2Y9	
Q9H2Z4	
Q9H300	
Q9H305	
Q9H306	
Q9H307	
Q9H310	
Q9H313	
Q9H320	
Q9H321	
Q9H322	
Q9H324	
Q9H329	
Q9H330	
Q9H334	
Q9H336	
Q9H339	
Q9H340	
Q9H341	
Q9H342	
Q9H343	
Q9H344	
Q9H346	
Q9H347	
Q9H354	
Q9H361	
Q9H379	
Q9H3C7	
Q9H3D4	
Q9H3E2	
Q9H3F6	
Q9H3G5	
Q9H3H1	
Q9H3H3	
Q9H3H5	
Q9H3H9	
Q9H3J6	
Q9H3K2	
Q9H3K6	
Q9H3L0	
Q9H3M0	
Q9H3M7	
Q9H3M9	
Q9H3N1	
Q9H3N8	
Q9H3P2	
Q9H3P7	
Q9H3Q1	
Q9H3Q3	ENZYME REGULATION: Strongly inhibited by Cu(2+) and Zn(2+). {ECO:0000269|PubMed:11029462}.
Q9H3R0	
Q9H3R1	
Q9H3R2	
Q9H3R5	
Q9H3S1	
Q9H3S3	
Q9H3S4	
Q9H3S5	
Q9H3S7	
Q9H3T2	
Q9H3T3	
Q9H3U1	
Q9H3U5	
Q9H3U7	
Q9H3V2	
Q9H3W5	
Q9H3Y0	
Q9H3Y6	
Q9H3Y8	
Q9H3Z4	
Q9H3Z7	
Q9H400	
Q9H410	
Q9H422	
Q9H425	
Q9H426	
Q9H427	
Q9H444	
Q9H446	
Q9H461	
Q9H467	
Q9H469	
Q9H477	ENZYME REGULATION: Activated by a monovalent cation that binds near, but not in, the active site. The most likely occupant of the site in vivo is potassium. Ion binding induces a conformational change that may alter substrate affinity (By similarity). Competitively inhibited by phosphonoacetic acid, etidronate, 2-carboxethylphosphonic acid, N-(phosphonomethyl)glycine, N-(phosphonomethyl)iminodiacetic acid and clodronate (PubMed:17585908). {ECO:0000255|HAMAP-Rule:MF_03215, ECO:0000269|PubMed:17585908}.
Q9H478	
Q9H479	
Q9H488	
Q9H489	
Q9H490	
Q9H492	
Q9H496	
Q9H497	
Q9H4A3	ENZYME REGULATION: By hypertonicity. Activation requires autophosphorylation of Ser-382, that may be regulated by calcium. Phosphorylation of Ser-378 also promotes increased activity. {ECO:0000250|UniProtKB:Q9JIH7}.
Q9H4A4	
Q9H4A5	
Q9H4A6	
Q9H4A9	ENZYME REGULATION: Inhibited by L-penicillamine. {ECO:0000250}.
Q9H4B0	
Q9H4B4	
Q9H4B6	
Q9H4B7	
Q9H4B8	ENZYME REGULATION: Inhibited by L-penicillamine. {ECO:0000250}.
Q9H4D0	
Q9H4D5	
Q9H4E5	
Q9H4E7	
Q9H4F1	
Q9H4F8	
Q9H4G0	
Q9H4G1	
Q9H4G4	
Q9H4G8	
Q9H4H8	
Q9H4I0	
Q9H4I2	
Q9H4I3	
Q9H4I8	
Q9H4I9	
Q9H4K1	
Q9H4K7	
Q9H4L4	ENZYME REGULATION: On oxidative stress, SENP3 degradation is blocked by inhibition of its ubiquitination, which stabilizes it as it accumulates in the nucleoplasm. {ECO:0000269|PubMed:19680224}.
Q9H4L5	
Q9H4L7	
Q9H4M3	
Q9H4M7	
Q9H4M9	
Q9H4P4	
Q9H4Q3	
Q9H4Q4	
Q9H4R4	
Q9H4S2	
Q9H4T2	
Q9H4W6	
Q9H4X1	
Q9H4Y5	
Q9H4Z2	
Q9H4Z3	
Q9H501	
Q9H503	
Q9H511	
Q9H521	
Q9H553	
Q9H560	
Q9H568	
Q9H579	
Q9H582	
Q9H583	
Q9H596	
Q9H598	
Q9H5F2	
Q9H5H4	
Q9H5I1	
Q9H5I5	
Q9H5J0	
Q9H5J4	
Q9H5J8	
Q9H5K3	
Q9H5L6	
Q9H5L9	
Q9H5N1	
Q9H5P4	
Q9H5Q4	
Q9H5U6	
Q9H5V7	
Q9H5V8	
Q9H5V9	
Q9H5X1	
Q9H5Y7	
Q9H5Z1	
Q9H5Z6	
Q9H606	
Q9H607	
Q9H609	
Q9H611	
Q9H628	
Q9H633	
Q9H649	
Q9H665	
Q9H668	
Q9H672	
Q9H693	
Q9H694	
Q9H6A0	
Q9H6A9	
Q9H6B1	
Q9H6B4	
Q9H6B9	ENZYME REGULATION: Inhibited by 1-(1-acetylpiperidin-4-yl)-3-(4-(trifl uoromethoxy)phenyl)urea (TPAU), 1-cyclohexyl-3-dodecylurea (CDU), 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA), 1-((3S, 5S, 7S)-adamantan-1-yl)-3-(5-(2-(2-ethoxyethoxy) ethoxy)pentyl)urea (AEPU) and to a lesser extent by 8-(3-((3S, 5S, 7S)-adamantan-1-yl)ureido) octanoic acid (AUOA). {ECO:0000269|PubMed:22798687}.
Q9H6D3	
Q9H6D7	
Q9H6D8	
Q9H6E4	
Q9H6E5	ENZYME REGULATION: Adenylyltransferase activity is specifically phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). {ECO:0000269|PubMed:18288197}.
Q9H6F2	
Q9H6F5	
Q9H6H4	
Q9H6I2	
Q9H6J7	
Q9H6K1	
Q9H6K4	
Q9H6K5	
Q9H6L2	
Q9H6L4	
Q9H6L5	
Q9H6N6	
Q9H6P5	
Q9H6Q3	
Q9H6Q4	
Q9H6R0	
Q9H6R3	
Q9H6R4	
Q9H6R6	
Q9H6R7	
Q9H6S0	
Q9H6S1	
Q9H6S3	
Q9H6T0	
Q9H6T3	
Q9H6U6	
Q9H6U8	
Q9H6V9	
Q9H6W3	
Q9H6X2	
Q9H6X4	
Q9H6X5	
Q9H6Y2	
Q9H6Y5	
Q9H6Y7	
Q9H6Z4	
Q9H6Z9	ENZYME REGULATION: Activated in cardiovascular cells and Hela cells following exposure to hypoxia. Inhibited by polynitrogen compounds probably by chelation to Fe(2+) ions. {ECO:0000269|PubMed:11595184, ECO:0000269|PubMed:12670503, ECO:0000269|PubMed:21421125}.
Q9H706	
Q9H707	
Q9H714	
Q9H720	
Q9H741	
Q9H756	
Q9H765	
Q9H772	
Q9H773	ENZYME REGULATION: Inhibited by the reaction end product PPi. Inhibited by dCDP. Inhibited by triptolide. {ECO:0000269|PubMed:24467396}.
Q9H777	
Q9H788	
Q9H790	
Q9H792	
Q9H799	
Q9H7B2	
Q9H7B4	ENZYME REGULATION: Histone methyltransferase activity strongly stimulated by HSPCA. {ECO:0000269|PubMed:15235609}.
Q9H7B7	
Q9H7C4	
Q9H7C9	
Q9H7D0	
Q9H7D7	
Q9H7E2	
Q9H7E9	
Q9H7F0	
Q9H7F4	
Q9H7H0	
Q9H7J1	
Q9H7L2	
Q9H7L9	
Q9H7M6	
Q9H7M9	
Q9H7N4	
Q9H7P6	
Q9H7P9	
Q9H7R0	
Q9H7R5	
Q9H7S9	
Q9H7T0	
Q9H7T3	
Q9H7T9	
Q9H7U1	
Q9H7V2	
Q9H7X0	
Q9H7X2	
Q9H7X3	
Q9H7X7	
Q9H7Y0	
Q9H7Z3	
Q9H7Z6	
Q9H7Z7	ENZYME REGULATION: Isomerase activity is increased by sulfhydril compounds. Dithiothreitol (DTT) is most effective, followed by dihydrolipoic acid, glutathione (GSH) and 2-mercaptoethanol. {ECO:0000269|PubMed:12804604}.
Q9H808	
Q9H813	
Q9H814	
Q9H816	
Q9H819	
Q9H825	
Q9H832	
Q9H840	
Q9H841	
Q9H845	
Q9H853	
Q9H857	
Q9H867	
Q9H869	
Q9H871	
Q9H875	
Q9H892	
Q9H898	
Q9H8E8	
Q9H8G1	
Q9H8G2	
Q9H8H0	
Q9H8H2	
Q9H8H3	
Q9H8J5	
Q9H8K7	
Q9H8L6	
Q9H8M1	
Q9H8M2	
Q9H8M5	
Q9H8M7	
Q9H8M9	
Q9H8N7	
Q9H8P0	
Q9H8Q6	
Q9H8S5	
Q9H8S9	
Q9H8T0	
Q9H8U3	
Q9H8V3	
Q9H8V8	
Q9H8W2	
Q9H8W3	
Q9H8W4	
Q9H8W5	
Q9H8X2	
Q9H8X3	
Q9H8X9	
Q9H8Y1	
Q9H8Y5	
Q9H8Y8	
Q9H900	
Q9H902	
Q9H903	
Q9H910	
Q9H920	
Q9H930	
Q9H936	
Q9H939	
Q9H944	
Q9H963	
Q9H967	
Q9H972	
Q9H974	
Q9H977	
Q9H981	
Q9H987	
Q9H992	
Q9H993	
Q9H999	ENZYME REGULATION: Regulated by feedback inhibition by CoA and its thioesters. {ECO:0000250}.
Q9H9A5	
Q9H9A6	
Q9H9A7	
Q9H9B1	ENZYME REGULATION: Methyltransferase activity is inhibited by BIX-01294. Efficiently inhibited by compound E72, a BIX-01294 derivative in which the diazepane ring and the benzyl are replaced with a 3-dimethylaminopropyl and a 5-aminopentyl group at sites B and C, respectively. {ECO:0000269|PubMed:20434463}.
Q9H9B4	
Q9H9C1	
Q9H9D4	
Q9H9E1	
Q9H9E3	
Q9H9F9	
Q9H9G7	
Q9H9H4	
Q9H9H5	
Q9H9J2	
Q9H9J4	
Q9H9K5	
Q9H9L3	
Q9H9L4	
Q9H9L7	
Q9H9P2	
Q9H9P5	
Q9H9P8	
Q9H9Q2	
Q9H9Q4	
Q9H9R9	
Q9H9S0	
Q9H9S3	
Q9H9S4	
Q9H9S5	
Q9H9T3	
Q9H9V4	
Q9H9V9	
Q9H9Y2	
Q9H9Y4	
Q9H9Y6	
Q9H9Z2	
Q9HA38	
Q9HA47	
Q9HA64	
Q9HA65	
Q9HA72	
Q9HA77	
Q9HA82	
Q9HA90	
Q9HA92	
Q9HAA7	
Q9HAB3	
Q9HAB8	
Q9HAC7	
Q9HAC8	
Q9HAD4	
Q9HAE3	
Q9HAF1	
Q9HAH1	
Q9HAH7	
Q9HAI6	
Q9HAJ7	
Q9HAK2	
Q9HAN9	ENZYME REGULATION: Activity is strongly inhibited by galotannin. Inhibited by P1-(adenosine-5')-P4-(nicotinic-acid-riboside-5')-tetraphosphate (Nap4AD). {ECO:0000269|PubMed:17402747}.
Q9HAP2	
Q9HAP6	
Q9HAQ2	
Q9HAR2	
Q9HAS0	
Q9HAS3	
Q9HAT0	
Q9HAT1	
Q9HAT2	
Q9HAT8	
Q9HAU0	
Q9HAU4	ENZYME REGULATION: Activated by NDFIP1- and NDFIP2-binding.
Q9HAU5	
Q9HAU6	
Q9HAU8	ENZYME REGULATION: Inhibited by calcium but not affected by chloride ions. Inhibited by amastatin and to a lower extent by bestatin. Weakly inhibited by puromycin. {ECO:0000269|PubMed:19508204}.
Q9HAV0	
Q9HAV4	
Q9HAV5	
Q9HAV7	
Q9HAW0	
Q9HAW4	
Q9HAW7	
Q9HAW8	
Q9HAW9	
Q9HAY2	
Q9HAY6	
Q9HAZ1	ENZYME REGULATION: TG003 inhibits its kinase activity and affects the regulation of alternative splicing mediated by phosphorylation of SR proteins. {ECO:0000250}.
Q9HAZ2	
Q9HB03	
Q9HB07	
Q9HB09	
Q9HB14	
Q9HB15	
Q9HB19	
Q9HB20	
Q9HB21	
Q9HB29	
Q9HB31	
Q9HB40	
Q9HB55	
Q9HB58	
Q9HB63	
Q9HB65	
Q9HB71	
Q9HB75	
Q9HB89	
Q9HB90	
Q9HB96	
Q9HBA0	ENZYME REGULATION: Channel activation is inhibited by binding to phosphatidylinositol-4,5-bisphosphate, and to a much lesser degree by phosphatidylinositol-3,4,5-trisphosphate. Not inhibited by phosphatidylinositol-3,4-bisphosphate and phosphatidylinositol-3,5-bisphosphate. {ECO:0000269|PubMed:25256292}.
Q9HBA9	
Q9HBB8	
Q9HBD1	
Q9HBE1	
Q9HBE4	
Q9HBE5	
Q9HBF4	
Q9HBF5	
Q9HBG4	
Q9HBG6	
Q9HBG7	
Q9HBH0	
Q9HBH1	
Q9HBH5	
Q9HBH7	
Q9HBH9	ENZYME REGULATION: Inhibited by CGP57380 and staurosporine. Activated by phosphorylation in a negative-feedback regulatory manner in response to chemotherapy (e.g. cytarabine) and thus impairs the generation of antileukemic responses. {ECO:0000269|PubMed:11154262, ECO:0000269|PubMed:16111636, ECO:0000269|PubMed:16917500, ECO:0000269|PubMed:20664001, ECO:0000269|PubMed:20722422, ECO:0000269|PubMed:20927323}.
Q9HBI0	
Q9HBI1	
Q9HBI5	
Q9HBI6	
Q9HBJ0	
Q9HBJ7	
Q9HBJ8	
Q9HBK9	
Q9HBL0	
Q9HBL6	
Q9HBL7	
Q9HBL8	
Q9HBM0	
Q9HBM1	
Q9HBM6	
Q9HBQ8	
Q9HBR0	
Q9HBT6	
Q9HBT7	
Q9HBT8	
Q9HBU1	
Q9HBU6	
Q9HBU9	
Q9HBV1	
Q9HBV2	
Q9HBW0	
Q9HBW1	
Q9HBW9	
Q9HBX3	
Q9HBX8	
Q9HBX9	
Q9HBY0	ENZYME REGULATION: Activated by the ototoxic drug cisplatin (By similarity). Activated by NOXO1. Cooperatively activated by NCF1 and NCF2 or NOXA1 in a phorbol 12-myristate 13-acetate (PMA)-dependent manner. Inhibited by diphenyleneiodonium chloride. {ECO:0000250, ECO:0000269|PubMed:15181005, ECO:0000269|PubMed:15824103}.
Q9HBY8	ENZYME REGULATION: Two specific sites, one in the kinase domain (Thr-253) and the other in the C-terminal regulatory region (Ser-416), need to be phosphorylated for its full activation.
Q9HBZ2	
Q9HC07	
Q9HC10	
Q9HC16	ENZYME REGULATION: Assembly into ribonucleoprotein complexes of high-molecular-mass (HMM) inhibits its enzymatic activity. Antiviral activity is neutralized by the HIV-1 virion infectivity factor (VIF), that prevents its incorporation into progeny HIV-1 virions by both inhibiting its translation and/or by inducing its ubiquitination and subsequent degradation by the 26S proteasome. Can also be neutralized by simian immunodeficiency virus sooty mangabey monkey virus (SIV-sm) and chimpanzee immunodeficiency virus (SIV-cpz) VIF. {ECO:0000269|PubMed:21835787}.
Q9HC21	
Q9HC23	
Q9HC24	
Q9HC29	
Q9HC35	
Q9HC36	
Q9HC38	
Q9HC44	
Q9HC47	
Q9HC52	
Q9HC56	
Q9HC57	
Q9HC58	
Q9HC62	
Q9HC73	
Q9HC77	
Q9HC78	
Q9HC84	
Q9HC96	
Q9HC97	
Q9HC98	ENZYME REGULATION: Binding to NEK9 stimulates its activity by releasing the autoinhibitory function of Tyr-108. {ECO:0000269|PubMed:19941817}.
Q9HCB6	
Q9HCC0	
Q9HCC6	
Q9HCC8	
Q9HCC9	
Q9HCD5	
Q9HCD6	
Q9HCE0	
Q9HCE1	
Q9HCE3	
Q9HCE5	
Q9HCE6	
Q9HCE7	
Q9HCE9	
Q9HCF6	
Q9HCG1	
Q9HCG7	ENZYME REGULATION: Enzymatic activity is dependent on membrane association and requires the presence of lipids. {ECO:0000250}.
Q9HCG8	
Q9HCH0	
Q9HCH3	
Q9HCH5	
Q9HCI5	
Q9HCI6	
Q9HCI7	
Q9HCJ0	
Q9HCJ1	
Q9HCJ2	
Q9HCJ3	
Q9HCJ5	
Q9HCJ6	
Q9HCK0	
Q9HCK1	
Q9HCK4	
Q9HCK5	
Q9HCK8	
Q9HCL0	
Q9HCL2	
Q9HCL3	
Q9HCM1	
Q9HCM2	
Q9HCM3	
Q9HCM4	
Q9HCM7	
Q9HCM9	
Q9HCN2	
Q9HCN3	
Q9HCN4	
Q9HCN6	
Q9HCN8	
Q9HCP0	ENZYME REGULATION: Repressed by 2-(2-hydroxyethylamino)-6-(3-chloroanilino)-9-isopropylpurine (DB08325).
Q9HCP6	
Q9HCQ5	
Q9HCQ7	
Q9HCR9	ENZYME REGULATION: Inhibited by 3-isobutyl-1-methylxanthine (IBMX), zaprinast and dipyridamole. cGMP acts as an allosteric activator. Weakly inhibited by Sildenafil (Viagra) and Tadalafil (Cialis); however, the fact that the protein is probably absent from testis, suggests that it is not biologically relevant and is not related with erectile dysfunction. {ECO:0000269|PubMed:10725373, ECO:0000269|PubMed:11050148, ECO:0000269|PubMed:16079899, ECO:0000269|PubMed:16330539}.
Q9HCS2	
Q9HCS4	
Q9HCS5	
Q9HCS7	
Q9HCT0	
Q9HCU0	
Q9HCU4	
Q9HCU5	
Q9HCU8	
Q9HCU9	
Q9HCX3	
Q9HCX4	
Q9HCY8	
Q9HCZ1	
Q9HD15	
Q9HD20	
Q9HD23	
Q9HD26	
Q9HD33	
Q9HD34	
Q9HD36	
Q9HD40	
Q9HD42	
Q9HD43	ENZYME REGULATION: Regulated by reversible dimerization. Dimerization reduces its catalytic activity. {ECO:0000269|PubMed:15850787}.
Q9HD45	
Q9HD47	
Q9HD64	
Q9HD67	
Q9HD87	
Q9HD89	
Q9HD90	
Q9HDB5	
Q9HDB8	
Q9HDB9	
Q9HDC5	
Q9HDC9	
Q9HDD0	
Q9N2J8	
Q9N2K0	
Q9NNW5	
Q9NNW7	
Q9NNX1	
Q9NNX6	
Q9NNX9	
Q9NNZ3	
Q9NNZ6	
Q9NP08	
Q9NP31	
Q9NP50	
Q9NP55	
Q9NP56	ENZYME REGULATION: Inhibited by dipyridamole, IBMX and SCH 51866. Insensitive to zaprinast, rolipram, and milrinone.
Q9NP58	
Q9NP59	
Q9NP60	
Q9NP61	ENZYME REGULATION: GAP activity stimulated by phosphatidylinositol 4,5-bisphosphate (PIP2). {ECO:0000269|PubMed:11172815}.
Q9NP62	
Q9NP64	
Q9NP66	
Q9NP70	
Q9NP71	
Q9NP72	
Q9NP73	
Q9NP74	
Q9NP77	
Q9NP78	
Q9NP79	
Q9NP80	ENZYME REGULATION: Inhibited by E-6-bromomethylene-3-1-naphthalenyl-2H-tetrahydropyran-2-one (BEL).
Q9NP81	
Q9NP84	
Q9NP85	
Q9NP86	
Q9NP87	
Q9NP90	
Q9NP91	
Q9NP92	
Q9NP94	
Q9NP95	
Q9NP97	
Q9NP98	
Q9NP99	
Q9NPA0	
Q9NPA1	
Q9NPA2	
Q9NPA3	
Q9NPA5	
Q9NPA8	
Q9NPB0	
Q9NPB1	
Q9NPB3	
Q9NPB6	
Q9NPB8	
Q9NPB9	
Q9NPC1	
Q9NPC2	
Q9NPC3	
Q9NPC4	
Q9NPC6	
Q9NPC7	
Q9NPC8	
Q9NPD3	
Q9NPD5	
Q9NPD7	
Q9NPD8	
Q9NPE2	
Q9NPE3	
Q9NPE6	
Q9NPF0	
Q9NPF2	
Q9NPF4	
Q9NPF5	
Q9NPF7	
Q9NPF8	
Q9NPG1	
Q9NPG2	
Q9NPG3	
Q9NPG4	
Q9NPG8	
Q9NPH0	
Q9NPH2	ENZYME REGULATION: Inhibited by mood-stabilizing drugs such as valproate (VPA) and lithium. {ECO:0000269|PubMed:17901568, ECO:0000269|PubMed:17988368}.
Q9NPH3	
Q9NPH5	ENZYME REGULATION: Inhibited by plumbagin (By similarity). Activated by phorbol 12-myristate 13-acetate (PMA). Activated by insulin. Inhibited by diphenylene iodonium. {ECO:0000250, ECO:0000269|PubMed:14966267, ECO:0000269|PubMed:15572675, ECO:0000269|PubMed:16019190, ECO:0000269|PubMed:16324151}.
Q9NPH6	
Q9NPH9	
Q9NPI0	
Q9NPI1	
Q9NPI5	
Q9NPI6	
Q9NPI7	
Q9NPI8	
Q9NPI9	
Q9NPJ1	
Q9NPJ3	
Q9NPJ4	
Q9NPJ6	
Q9NPJ8	
Q9NPL8	
Q9NPP4	
Q9NPQ8	
Q9NPR2	
Q9NPR9	
Q9NPU4	
Q9NPY3	
Q9NPZ5	
Q9NQ03	
Q9NQ11	
Q9NQ25	
Q9NQ29	
Q9NQ30	
Q9NQ31	
Q9NQ32	
Q9NQ33	
Q9NQ34	
Q9NQ35	
Q9NQ36	
Q9NQ38	
Q9NQ39	
Q9NQ40	
Q9NQ48	
Q9NQ50	
Q9NQ55	
Q9NQ60	
Q9NQ66	
Q9NQ69	
Q9NQ75	
Q9NQ76	
Q9NQ79	
Q9NQ84	
Q9NQ86	
Q9NQ87	
Q9NQ88	
Q9NQ89	
Q9NQ90	ENZYME REGULATION: Channel activity is repressed by chloride inhibitors; strongly by niflumic acid (NFA), partially by flufenamic acid (FFA), and only slightly by meclofenamic acid (MFA), 5-Nitro-2-(3-phenylpropylamino)benzoic acid (NPPB), 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate (SITS), and 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS). {ECO:0000250}.
Q9NQ92	
Q9NQ94	
Q9NQA3	
Q9NQA5	ENZYME REGULATION: Activated by WNK3. {ECO:0000269|PubMed:18768590}.
Q9NQB0	
Q9NQC1	
Q9NQC3	
Q9NQC7	ENZYME REGULATION: Inhibited by phosphorylation at serine residues. {ECO:0000269|PubMed:15870263}.
Q9NQC8	
Q9NQE7	
Q9NQE9	
Q9NQF3	
Q9NQG1	
Q9NQG5	
Q9NQG6	
Q9NQG7	
Q9NQH7	
Q9NQI0	
Q9NQL2	
Q9NQL9	
Q9NQM4	
Q9NQN1	
Q9NQP4	
Q9NQQ7	
Q9NQR1	
Q9NQR4	
Q9NQR7	
Q9NQR9	
Q9NQS1	
Q9NQS3	
Q9NQS5	
Q9NQS7	
Q9NQT4	
Q9NQT5	
Q9NQT6	
Q9NQT8	
Q9NQU5	
Q9NQV5	
Q9NQV6	
Q9NQV7	
Q9NQV8	
Q9NQW1	
Q9NQW5	
Q9NQW6	
Q9NQW7	ENZYME REGULATION: Inhibited by apstatin and the metal ion chelators EDTA and 1,10-phenanthroline. Partially inhibited by dithiothreitol. Not inhibited by enalaprilat or amastatin. {ECO:0000269|PubMed:11106490}.
Q9NQW8	
Q9NQX0	
Q9NQX1	
Q9NQX3	ENZYME REGULATION: Inhibited by copper and tungsten. {ECO:0000250}.
Q9NQX4	
Q9NQX5	
Q9NQX6	
Q9NQX7	
Q9NQY0	
Q9NQZ2	
Q9NQZ3	
Q9NQZ5	
Q9NQZ6	
Q9NQZ7	
Q9NQZ8	
Q9NR00	
Q9NR09	ENZYME REGULATION: Inhibited by DIABLO/SMAC, HTRA2, CASP3, CASP6, CASP7 and CASP9. {ECO:0000269|PubMed:15200957}.
Q9NR11	
Q9NR12	
Q9NR16	
Q9NR19	
Q9NR20	
Q9NR21	
Q9NR22	
Q9NR23	
Q9NR28	
Q9NR30	
Q9NR31	
Q9NR33	
Q9NR34	ENZYME REGULATION: Inhibited by both 1-deoxymannojirimycin and kifunensine.
Q9NR45	
Q9NR46	
Q9NR48	
Q9NR50	
Q9NR55	
Q9NR56	
Q9NR61	
Q9NR63	
Q9NR64	
Q9NR71	ENZYME REGULATION: Inhibited by dithiothreitol (DTT), 2-mercaptoethanol, Zn(2+), Cu(2+) and Fe(2+). Enhanced by Na(+) and Ca(2+), and at lower level Mg(2+) and Mn(2+).
Q9NR77	
Q9NR80	
Q9NR81	
Q9NR82	
Q9NR83	
Q9NR90	
Q9NR96	
Q9NR97	
Q9NR99	
Q9NRA0	ENZYME REGULATION: Inhibited by sulfatide. {ECO:0000269|PubMed:19168031}.
Q9NRA1	
Q9NRA2	
Q9NRA8	
Q9NRB3	
Q9NRC1	
Q9NRC6	
Q9NRC8	
Q9NRC9	
Q9NRD0	
Q9NRD1	
Q9NRD5	
Q9NRD8	ENZYME REGULATION: Peroxidase activity is inhibited by aminobenzohydrazide (By similarity). The NADPH oxidase activity is calcium-dependent. {ECO:0000250, ECO:0000269|PubMed:15972824}.
Q9NRD9	ENZYME REGULATION: The NADPH oxidase activity is calcium-dependent. Peroxidase activity is inhibited by aminobenzohydrazide. {ECO:0000269|PubMed:11514595, ECO:0000269|PubMed:15972824}.
Q9NRE1	
Q9NRE2	
Q9NRF2	
Q9NRF8	
Q9NRF9	
Q9NRG0	
Q9NRG1	
Q9NRG4	
Q9NRG7	
Q9NRG9	
Q9NRH1	
Q9NRH2	ENZYME REGULATION: Activated by phosphorylation on Thr-173. {ECO:0000269|PubMed:15733851}.
Q9NRH3	
Q9NRI5	
Q9NRI6	
Q9NRI7	
Q9NRJ1	
Q9NRJ2	
Q9NRJ3	
Q9NRJ4	
Q9NRJ5	
Q9NRJ7	
Q9NRK6	
Q9NRL2	
Q9NRL3	
Q9NRM0	
Q9NRM1	
Q9NRM2	
Q9NRM6	
Q9NRM7	
Q9NRN5	
Q9NRN7	
Q9NRN9	
Q9NRP0	
Q9NRP2	
Q9NRP4	
Q9NRP7	
Q9NRQ2	
Q9NRQ5	
Q9NRR1	
Q9NRR2	
Q9NRR3	
Q9NRR4	
Q9NRR5	
Q9NRR6	ENZYME REGULATION: Active in the presence of octyl-glucoside or Triton X-100, but completely inhibited by CTAB. {ECO:0000269|PubMed:10764818}.
Q9NRR8	
Q9NRS4	
Q9NRS6	
Q9NRU3	
Q9NRV9	
Q9NRW1	
Q9NRW3	
Q9NRW4	
Q9NRW7	
Q9NRX1	
Q9NRX2	
Q9NRX3	
Q9NRX4	
Q9NRX5	
Q9NRX6	
Q9NRY2	
Q9NRY4	ENZYME REGULATION: Binding of acidic phospholipids inhibits the Rho GAP activity and promotes the Rac GAP activity. {ECO:0000269|PubMed:19673492}.
Q9NRY5	
Q9NRY6	
Q9NRY7	
Q9NRZ5	
Q9NRZ7	
Q9NRZ9	
Q9NS00	
Q9NS15	
Q9NS18	ENZYME REGULATION: The 2Fe-2S present in the homodimer leads to inactivation of the enzyme. The 2Fe-2S may serve as a redox sensor: the presence of one-electron oxidants or reductants leading to the loss of the 2Fe-2S cluster, subsequent monomerization and activation of the enzyme. Unlike other glutaredoxins, it is not inhibited by oxidation of structural Cys residues. {ECO:0000269|PubMed:15917333}.
Q9NS23	
Q9NS25	
Q9NS26	
Q9NS28	
Q9NS37	
Q9NS39	
Q9NS40	
Q9NS56	
Q9NS61	
Q9NS62	
Q9NS64	
Q9NS66	
Q9NS67	
Q9NS68	
Q9NS69	
Q9NS71	
Q9NS73	
Q9NS75	
Q9NS82	
Q9NS84	
Q9NS85	
Q9NS86	
Q9NS87	
Q9NS91	
Q9NS93	
Q9NS98	
Q9NSA0	
Q9NSA1	
Q9NSA2	
Q9NSA3	
Q9NSB2	
Q9NSB4	
Q9NSB8	
Q9NSC2	
Q9NSC5	
Q9NSC7	
Q9NSD4	
Q9NSD5	
Q9NSD7	
Q9NSD9	
Q9NSE2	
Q9NSE4	
Q9NSE7	
Q9NSG2	
Q9NSI2	
Q9NSI5	
Q9NSI6	
Q9NSI8	
Q9NSJ1	
Q9NSK0	
Q9NSK7	
Q9NSN8	
Q9NSP4	
Q9NSQ0	
Q9NST1	
Q9NSU2	
Q9NSV4	
Q9NSY0	
Q9NSY1	
Q9NSY2	
Q9NT22	
Q9NT62	
Q9NT68	
Q9NT99	
Q9NTG1	
Q9NTG7	
Q9NTI2	ENZYME REGULATION: ATPase activity is stimulated by phosphatidylserine (PS) and minimally by phosphatidylethanolamine (PE). ATPase activity is inhibited by N-ethylmaleimide (NEM) and vanadate. Flippase activity is inhibited by NEM and 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) (By similarity). {ECO:0000250}.
Q9NTI5	
Q9NTI7	
Q9NTJ3	
Q9NTJ4	ENZYME REGULATION: Strongly inhibited by swainsonine. Also inhibited to a lesser extent by deoxymannojirimycin (DMM). {ECO:0000269|PubMed:16848760}.
Q9NTJ5	
Q9NTK1	
Q9NTK5	
Q9NTM9	
Q9NTN3	
Q9NTN9	
Q9NTQ9	
Q9NTU4	
Q9NTU7	
Q9NTW7	
Q9NTX5	
Q9NTX7	
Q9NTX9	
Q9NTZ6	
Q9NU02	
Q9NU19	
Q9NU22	
Q9NU23	
Q9NU39	
Q9NU53	
Q9NU63	
Q9NUA8	
Q9NUB1	ENZYME REGULATION: Inhibited by acetylation at Lys-642 and activated by deacetylation. {ECO:0000269|PubMed:16788062}.
Q9NUB4	
Q9NUC0	
Q9NUD5	
Q9NUD7	
Q9NUD9	
Q9NUE0	
Q9NUG4	
Q9NUG6	
Q9NUH8	
Q9NUI1	
Q9NUJ1	
Q9NUJ3	
Q9NUJ7	
Q9NUK0	
Q9NUL3	
Q9NUL5	
Q9NUL7	
Q9NUM3	
Q9NUM4	
Q9NUN5	
Q9NUN7	ENZYME REGULATION: Activated by Ca(2+) and inhibited by Zn(2+).
Q9NUP1	
Q9NUP7	
Q9NUP9	
Q9NUQ2	
Q9NUQ3	
Q9NUQ6	
Q9NUQ7	
Q9NUQ8	
Q9NUQ9	
Q9NUR3	
Q9NUS5	
Q9NUT2	
Q9NUU6	
Q9NUU7	
Q9NUV7	
Q9NUV9	
Q9NUW8	
Q9NUX5	
Q9NUY8	
Q9NUZ1	
Q9NV06	
Q9NV12	
Q9NV23	
Q9NV29	
Q9NV31	
Q9NV35	
Q9NV39	
Q9NV44	
Q9NV56	
Q9NV58	
Q9NV64	
Q9NV66	
Q9NV70	
Q9NV72	
Q9NV79	
Q9NV88	
Q9NV92	
Q9NV96	
Q9NVA1	
Q9NVA2	
Q9NVA4	
Q9NVC3	
Q9NVC6	
Q9NVD3	
Q9NVD7	
Q9NVE4	
Q9NVE5	
Q9NVE7	ENZYME REGULATION: Regulated by feedback inhibition by CoA and its thioesters. {ECO:0000250}.
Q9NVF7	
Q9NVF9	
Q9NVG8	
Q9NVH0	
Q9NVH1	
Q9NVH2	
Q9NVH6	
Q9NVI1	
Q9NVI7	
Q9NVJ2	
Q9NVK5	
Q9NVL1	
Q9NVL8	
Q9NVM1	
Q9NVM4	
Q9NVM6	
Q9NVM9	
Q9NVN3	
Q9NVN8	
Q9NVP1	
Q9NVP2	
Q9NVP4	
Q9NVQ4	
Q9NVR0	
Q9NVR2	
Q9NVR5	
Q9NVR7	
Q9NVS2	
Q9NVS9	
Q9NVT9	
Q9NVU0	
Q9NVU7	
Q9NVV0	
Q9NVV2	
Q9NVV4	
Q9NVV5	
Q9NVV9	
Q9NVW2	
Q9NVX0	
Q9NVX2	
Q9NVX7	
Q9NVZ3	
Q9NW07	
Q9NW08	
Q9NW13	
Q9NW15	
Q9NW38	
Q9NW61	
Q9NW64	
Q9NW68	
Q9NW75	
Q9NW81	
Q9NW82	
Q9NW97	
Q9NWA0	
Q9NWB1	
Q9NWB6	
Q9NWB7	
Q9NWC5	
Q9NWD8	
Q9NWD9	
Q9NWF4	
Q9NWF9	
Q9NWH2	
Q9NWH7	
Q9NWH9	
Q9NWK9	
Q9NWL6	
Q9NWM0	ENZYME REGULATION: Inhibited at more than 90% by SL-11144, SL-11150 and SL-11158, at concentrations less than 1 uM.
Q9NWM3	
Q9NWM8	
Q9NWN3	
Q9NWQ4	
Q9NWQ8	
Q9NWQ9	
Q9NWR8	
Q9NWS0	
Q9NWS1	
Q9NWS6	
Q9NWS8	
Q9NWS9	
Q9NWT1	
Q9NWT6	
Q9NWT8	
Q9NWU1	ENZYME REGULATION: Inhibited by cerulenin. {ECO:0000269|PubMed:15668256}.
Q9NWU2	
Q9NWU5	
Q9NWV4	
Q9NWV8	
Q9NWW0	
Q9NWW5	
Q9NWW6	
Q9NWW7	
Q9NWW9	
Q9NWX5	
Q9NWX6	
Q9NWY4	
Q9NWZ3	
Q9NWZ5	
Q9NWZ8	
Q9NX00	
Q9NX01	
Q9NX02	
Q9NX04	
Q9NX05	
Q9NX07	
Q9NX08	
Q9NX09	
Q9NX14	
Q9NX18	
Q9NX20	
Q9NX24	
Q9NX31	
Q9NX36	
Q9NX38	
Q9NX40	
Q9NX45	
Q9NX46	ENZYME REGULATION: Activity is enhanced by magnesium. {ECO:0000269|PubMed:16278211}.
Q9NX47	
Q9NX52	
Q9NX55	
Q9NX57	
Q9NX58	
Q9NX61	
Q9NX62	ENZYME REGULATION: Strongly inhibited by lithium. {ECO:0000250}.
Q9NX63	
Q9NX65	
Q9NX70	
Q9NX74	
Q9NX76	
Q9NX77	
Q9NX78	
Q9NX94	
Q9NX95	
Q9NXA8	ENZYME REGULATION: Inhibited by suramin. NAD-dependent lysine desuccinylase activity is inhibited by physiological nicotinamide concentrations, while deacetylase activity is not. In contrast, resveratrol activates deacetylase activity, while inhibiting desuccinylase activity. {ECO:0000269|PubMed:17355872, ECO:0000269|PubMed:23028781, ECO:0000269|PubMed:23185430}.
Q9NXB0	
Q9NXB9	
Q9NXC2	
Q9NXC5	
Q9NXD2	
Q9NXE4	ENZYME REGULATION: Activated by phosphatidylserine and tumor necrosis factor (TNF). Inhibited by scyphostatin. {ECO:0000269|PubMed:16517606}.
Q9NXE8	
Q9NXF1	
Q9NXF7	
Q9NXF8	
Q9NXG0	
Q9NXG2	
Q9NXG6	
Q9NXH3	
Q9NXH8	
Q9NXH9	
Q9NXI6	
Q9NXJ0	
Q9NXJ5	ENZYME REGULATION: Inhibited by transition metal ions including Ni(2+), Zn(2+), and Cu(2+) and by sulfhydryl-blocking agents. {ECO:0000269|PubMed:12651114}.
Q9NXK6	
Q9NXK8	
Q9NXL2	
Q9NXL6	
Q9NXL9	
Q9NXN4	
Q9NXP7	
Q9NXR1	
Q9NXR5	
Q9NXR7	
Q9NXR8	
Q9NXS2	
Q9NXS3	
Q9NXT0	
Q9NXU5	
Q9NXV2	
Q9NXV6	
Q9NXW2	
Q9NXW9	
Q9NXX6	
Q9NXZ1	
Q9NXZ2	
Q9NY12	
Q9NY15	
Q9NY25	
Q9NY26	
Q9NY27	
Q9NY28	
Q9NY30	
Q9NY33	ENZYME REGULATION: Activated by Co(2+). Inhibited by EDTA and o-phenanthroline (in vitro). {ECO:0000269|PubMed:11209758, ECO:0000269|PubMed:1515063, ECO:0000269|PubMed:3233187, ECO:0000269|PubMed:9425109}.
Q9NY35	
Q9NY37	
Q9NY43	
Q9NY46	
Q9NY47	
Q9NY56	
Q9NY57	
Q9NY59	ENZYME REGULATION: Activated by unsaturated fatty acids and phosphatidylserine. {ECO:0000269|PubMed:10823942}.
Q9NY61	
Q9NY64	
Q9NY65	
Q9NY72	
Q9NY74	
Q9NY84	
Q9NY87	
Q9NY91	ENZYME REGULATION: Inhibited by phlorizin. {ECO:0000269|PubMed:13130073, ECO:0000269|PubMed:17110502, ECO:0000269|PubMed:22766068}.
Q9NY93	
Q9NY97	
Q9NY99	
Q9NYA1	
Q9NYA3	
Q9NYA4	
Q9NYB0	
Q9NYB5	
Q9NYB9	
Q9NYC9	
Q9NYD6	
Q9NYF0	
Q9NYF3	
Q9NYF5	
Q9NYF8	
Q9NYG2	
Q9NYG5	
Q9NYG8	ENZYME REGULATION: Activated by arachidonic acid. {ECO:0000269|PubMed:22282805, ECO:0000269|PubMed:25500157}.
Q9NYH9	
Q9NYI0	
Q9NYJ1	
Q9NYJ7	
Q9NYJ8	
Q9NYK1	
Q9NYK5	
Q9NYK6	
Q9NYL2	ENZYME REGULATION: Activated by phosphorylation by PKN1 and autophosphorylation on Thr-161 and Ser-165. {ECO:0000269|PubMed:11042189, ECO:0000269|PubMed:12761180, ECO:0000269|PubMed:15342622}.
Q9NYL4	
Q9NYL5	
Q9NYL9	
Q9NYM4	
Q9NYM9	
Q9NYN1	
Q9NYP3	
Q9NYP7	
Q9NYP8	
Q9NYP9	
Q9NYQ3	
Q9NYQ6	
Q9NYQ7	
Q9NYQ8	
Q9NYR8	
Q9NYR9	
Q9NYS0	
Q9NYS7	
Q9NYT0	
Q9NYT6	
Q9NYU1	
Q9NYU2	
Q9NYV4	ENZYME REGULATION: Inhibited by the ATP analog flavopiridol, purvalanol A, purvalanol B, staurosporine and CR8. {ECO:0000269|PubMed:24662513}.
Q9NYV6	
Q9NYV7	
Q9NYV8	
Q9NYV9	
Q9NYW0	
Q9NYW1	
Q9NYW2	
Q9NYW3	
Q9NYW4	
Q9NYW5	
Q9NYW6	
Q9NYW7	
Q9NYW8	
Q9NYX4	
Q9NYY1	
Q9NYY3	ENZYME REGULATION: Activated by phosphorylation of Thr-239. Once activated, activity is stimulated by binding target proteins (By similarity). {ECO:0000250}.
Q9NYY8	
Q9NYZ1	
Q9NYZ2	
Q9NYZ3	
Q9NYZ4	
Q9NZ01	
Q9NZ08	
Q9NZ09	
Q9NZ20	ENZYME REGULATION: Arachidonic acid release is markedly increased by glypican, a glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan.
Q9NZ32	
Q9NZ38	
Q9NZ42	
Q9NZ43	
Q9NZ45	
Q9NZ52	
Q9NZ53	
Q9NZ56	
Q9NZ63	
Q9NZ71	
Q9NZ72	
Q9NZ81	
Q9NZ94	
Q9NZA1	
Q9NZB2	
Q9NZB8	
Q9NZC2	
Q9NZC3	
Q9NZC4	
Q9NZC7	
Q9NZC9	
Q9NZD1	
Q9NZD2	
Q9NZD4	
Q9NZD8	
Q9NZE8	
Q9NZF1	
Q9NZG7	
Q9NZH0	
Q9NZH4	
Q9NZH5	
Q9NZH6	
Q9NZH7	
Q9NZH8	
Q9NZI2	
Q9NZI5	
Q9NZI6	
Q9NZI7	
Q9NZI8	
Q9NZJ0	
Q9NZJ4	
Q9NZJ5	ENZYME REGULATION: Perturbation in protein folding in the endoplasmic reticulum (ER) promotes reversible dissociation from HSPA5/BIP and oligomerization, resulting in transautophosphorylation and kinase activity induction. {ECO:0000250}.
Q9NZJ6	
Q9NZJ7	
Q9NZJ9	
Q9NZK5	
Q9NZK7	
Q9NZL3	
Q9NZL4	
Q9NZL6	
Q9NZL9	
Q9NZM1	
Q9NZM3	
Q9NZM4	
Q9NZM5	
Q9NZM6	
Q9NZN1	
Q9NZN3	
Q9NZN4	ENZYME REGULATION: The very low intrinsic ATPase activity is increased upon interaction with liposomes. {ECO:0000250|UniProtKB:Q8BH64}.
Q9NZN5	
Q9NZN8	
Q9NZN9	
Q9NZP0	
Q9NZP2	
Q9NZP5	
Q9NZP6	
Q9NZP8	
Q9NZQ0	
Q9NZQ3	
Q9NZQ7	
Q9NZQ8	
Q9NZQ9	
Q9NZR1	
Q9NZR2	
Q9NZR4	
Q9NZS2	
Q9NZS9	
Q9NZT1	
Q9NZT2	
Q9NZU0	
Q9NZU1	
Q9NZU5	
Q9NZU7	
Q9NZV1	
Q9NZV5	
Q9NZV6	
Q9NZV7	
Q9NZV8	
Q9NZW4	
Q9NZW5	
Q9NZY2	
Q9NZZ3	
Q9P000	
Q9P003	
Q9P013	
Q9P015	
Q9P016	
Q9P021	
Q9P031	
Q9P032	
Q9P035	
Q9P055	
Q9P086	
Q9P0B6	
Q9P0G3	ENZYME REGULATION: Inhibited by SERPINA1, SERPINC1, SERPINE1, SERPINF2, aprotinin, soybean, trypsin inhibitor and leupeptin. Inhibited by serine protease inhibitor SPINK5. Has an autoproteolytic activity which may have a regulatory effect. Activated by citrate and inhibited by zinc and to a lower extent by manganese. {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:17110383, ECO:0000269|PubMed:17158887}.
Q9P0I2	
Q9P0J0	
Q9P0J1	
Q9P0J6	
Q9P0J7	
Q9P0K1	
Q9P0K7	
Q9P0K8	
Q9P0K9	
Q9P0L0	
Q9P0L1	
Q9P0L2	ENZYME REGULATION: Inhibited by phosphorylation at Ser-219 (By similarity). Activated by phosphorylation on Thr-215. {ECO:0000250, ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:17573348}.
Q9P0L9	ENZYME REGULATION: The calcium channel is gated following an off-response property by acid: gated open after the removal of acid stimulus, but not during acid application. {ECO:0000269|PubMed:18535624, ECO:0000269|PubMed:19464260, ECO:0000269|PubMed:22420714}.
Q9P0M2	
Q9P0M4	
Q9P0M6	
Q9P0M9	
Q9P0N5	
Q9P0N8	
Q9P0N9	
Q9P0P0	
Q9P0P8	
Q9P0R6	
Q9P0S2	
Q9P0S3	
Q9P0S9	
Q9P0T4	
Q9P0T7	
Q9P0U1	
Q9P0U3	
Q9P0U4	
Q9P0V3	
Q9P0V8	
Q9P0V9	
Q9P0W0	
Q9P0W2	
Q9P0W8	
Q9P0X4	
Q9P0Z9	
Q9P104	
Q9P107	
Q9P109	
Q9P121	
Q9P126	
Q9P127	
Q9P1A2	
Q9P1A6	
Q9P1C3	
Q9P1D8	
Q9P1F3	
Q9P1G2	
Q9P1J3	
Q9P1P4	
Q9P1P5	
Q9P1Q0	
Q9P1Q5	
Q9P1T7	
Q9P1U0	
Q9P1U1	
Q9P1V8	
Q9P1W3	ENZYME REGULATION: Activated by hyperosmotic shock after mannitol treatment. {ECO:0000269|PubMed:24503647}.
Q9P1W8	
Q9P1W9	
Q9P1Y5	
Q9P1Y6	
Q9P1Z0	
Q9P1Z2	
Q9P1Z3	ENZYME REGULATION: Inhibited by Cs(1+) and ZD7288. Is apparently not activated by cAMP. {ECO:0000269|PubMed:16043489}.
Q9P1Z9	
Q9P202	
Q9P203	
Q9P206	
Q9P209	
Q9P212	ENZYME REGULATION: Activated by the heterotrimeric G-protein subunits GNA12, GNA13 and GNB1-GNG2. Activated by HRAS, RAP1A, RHOA, RHOB, RHOC, RRAS and RRAS2. Activated by the G(s)-coupled GPCRs ADRB2, PTGER1 and CHRM3 through cyclic-AMP formation and RAP2B activation. Inhibited by G(i)-coupled GPCRs. {ECO:0000269|PubMed:11022047, ECO:0000269|PubMed:11022048, ECO:0000269|PubMed:11715024, ECO:0000269|PubMed:11877431, ECO:0000269|PubMed:15157671, ECO:0000269|PubMed:16537651}.
Q9P215	
Q9P217	
Q9P218	
Q9P219	
Q9P225	
Q9P227	
Q9P232	
Q9P241	
Q9P242	
Q9P243	
Q9P244	
Q9P246	
Q9P253	
Q9P255	
Q9P258	
Q9P260	
Q9P265	
Q9P266	
Q9P267	
Q9P270	
Q9P272	
Q9P273	
Q9P275	
Q9P278	
Q9P281	
Q9P283	
Q9P286	
Q9P287	
Q9P289	ENZYME REGULATION: Interaction with Golgi matrix protein GOLGA2 leads to autophosphorylation on Thr-178, possibly as a consequence of stabilization of dimer formation. May also be activated by C-terminal cleavage. {ECO:0000269|PubMed:15037601}.
Q9P291	
Q9P296	
Q9P298	
Q9P299	
Q9P2A4	
Q9P2B2	
Q9P2B4	
Q9P2B7	
Q9P2C4	
Q9P2D0	
Q9P2D1	
Q9P2D3	
Q9P2D6	
Q9P2D7	
Q9P2D8	
Q9P2E2	
Q9P2E3	
Q9P2E5	
Q9P2E7	
Q9P2E8	
Q9P2E9	
Q9P2F5	
Q9P2F6	
Q9P2F8	
Q9P2F9	
Q9P2G1	
Q9P2G3	
Q9P2G4	
Q9P2G9	
Q9P2H0	
Q9P2H3	
Q9P2H5	
Q9P2I0	
Q9P2J2	
Q9P2J3	
Q9P2J5	ENZYME REGULATION: 5-fluoro-1,3-dihydro-1-hydroxy-1,2-benzoxaborole inhibits LARS by forming a covalent adduct with the 3' adenosine of tRNA(Leu) at the editing site, thus locking the enzyme in an inactive conformation.
Q9P2J8	
Q9P2J9	
Q9P2K1	
Q9P2K2	
Q9P2K3	
Q9P2K5	
Q9P2K6	
Q9P2K8	
Q9P2K9	
Q9P2L0	
Q9P2M1	
Q9P2M4	
Q9P2M7	
Q9P2N2	
Q9P2N4	
Q9P2N5	
Q9P2N6	
Q9P2N7	
Q9P2P1	
Q9P2P5	
Q9P2P6	
Q9P2Q2	
Q9P2R3	
Q9P2R6	
Q9P2R7	
Q9P2S2	
Q9P2S5	
Q9P2S6	
Q9P2T0	
Q9P2T1	
Q9P2U7	
Q9P2U8	
Q9P2V4	
Q9P2W1	
Q9P2W3	
Q9P2W6	
Q9P2W7	
Q9P2W9	
Q9P2X0	
Q9P2X3	
Q9P2X7	
Q9P2X8	
Q9P2Y4	
Q9P2Y5	
Q9P2Z0	
Q9QC07	
Q9TNN7	
Q9TQE0	
Q9UBA6	
Q9UBB4	
Q9UBB5	
Q9UBB6	
Q9UBB9	
Q9UBC0	
Q9UBC1	
Q9UBC2	
Q9UBC3	ENZYME REGULATION: Activated by binding to the regulatory factor DNMT3L. {ECO:0000250}.
Q9UBC5	
Q9UBC7	
Q9UBC9	
Q9UBD0	
Q9UBD3	
Q9UBD5	
Q9UBD6	
Q9UBD9	
Q9UBE0	
Q9UBE8	ENZYME REGULATION: Activated by dimerization and subsequent intermolecular autophosphorylation on Thr-298 (By similarity). Activated by the non-canonical Wnt signaling pathway, in which WNT5A treatment leads to activation of MAP3K7/TAK1 and HIPK2, which subsequently phosphorylates and activates this protein. Other cytokines such as IL6 may also activate this regulatory circuit. {ECO:0000250, ECO:0000269|PubMed:12482967, ECO:0000269|PubMed:15004007}.
Q9UBF1	
Q9UBF2	
Q9UBF6	
Q9UBF8	ENZYME REGULATION: Inhibited by wortmannin. Increased kinase activity upon interaction with NCS1/FREQ (By similarity). {ECO:0000250}.
Q9UBF9	
Q9UBG0	
Q9UBG3	
Q9UBG7	
Q9UBH0	
Q9UBH6	
Q9UBI1	
Q9UBI4	
Q9UBI6	
Q9UBI9	
Q9UBJ2	
Q9UBK2	
Q9UBK5	
Q9UBK7	
Q9UBK8	
Q9UBK9	
Q9UBL0	
Q9UBL3	
Q9UBL6	
Q9UBL9	
Q9UBM1	ENZYME REGULATION: The first methylation is rate-limiting.
Q9UBM4	
Q9UBM7	
Q9UBM8	
Q9UBN1	
Q9UBN4	
Q9UBN6	
Q9UBN7	
Q9UBP0	ENZYME REGULATION: Allosteric enzyme with a cooperative mechanism; at least two neighbor subunits influence each other strongly in spastin hexamers (PubMed:22637577). Microtubule binding promotes cooperative interactions among spastin subunits (PubMed:22637577). ATP-bound enzyme interacts strongly and cooperatively with microtubules; this interaction stimulates ATP hydrolysis (PubMed:23745751). {ECO:0000255|HAMAP-Rule:MF_03021, ECO:0000269|PubMed:22637577, ECO:0000269|PubMed:23745751}.
Q9UBP4	
Q9UBP5	
Q9UBP6	
Q9UBP8	
Q9UBP9	
Q9UBQ0	
Q9UBQ5	
Q9UBQ6	
Q9UBQ7	
Q9UBR1	ENZYME REGULATION: Allosteric enzyme with positive cooperativity toward the substrate N-carbamoyl-beta-alanine. {ECO:0000250}.
Q9UBR2	
Q9UBR4	
Q9UBR5	
Q9UBS0	
Q9UBS3	
Q9UBS4	
Q9UBS5	
Q9UBS8	
Q9UBS9	
Q9UBT2	
Q9UBT3	
Q9UBT6	
Q9UBT7	
Q9UBU2	
Q9UBU3	
Q9UBU6	
Q9UBU7	
Q9UBU8	
Q9UBU9	
Q9UBV2	
Q9UBV4	
Q9UBV7	
Q9UBV8	
Q9UBW5	
Q9UBW7	
Q9UBW8	
Q9UBX0	
Q9UBX1	
Q9UBX2	
Q9UBX3	
Q9UBX5	
Q9UBX7	
Q9UBX8	ENZYME REGULATION: Inhibited by EDTA. {ECO:0000250}.
Q9UBY0	
Q9UBY5	
Q9UBY8	
Q9UBY9	
Q9UBZ4	ENZYME REGULATION: 3'-5' exonuclease activity is activated by sodium and manganese. 3'-5' exonuclease and 3'-phosphodiesterase activities are stimulated in presence of PCNA.
Q9UBZ9	
Q9UC06	
Q9UC07	
Q9UD57	
Q9UD71	
Q9UDR5	
Q9UDT6	
Q9UDV6	
Q9UDV7	
Q9UDW1	
Q9UDW3	
Q9UDX3	
Q9UDX4	
Q9UDX5	
Q9UDY2	
Q9UDY4	
Q9UDY6	
Q9UDY8	
Q9UEE5	ENZYME REGULATION: Inhibited by thiazolidinedione-type compounds: inhibited by furan- and pyridone- thiazolidinediones. {ECO:0000269|PubMed:21802008}.
Q9UEE9	
Q9UEF7	
Q9UEG4	
Q9UER7	
Q9UET6	
Q9UEU0	
Q9UEU5	
Q9UEW3	
Q9UEW8	
Q9UEY8	
Q9UF02	
Q9UF11	
Q9UF12	ENZYME REGULATION: Hydroproxyproline dehydrogenase activity is inhibited by THFA,(1R,3R)3-OH-cyclopentane-COOH and 5-OH-1H-pyrazole-3-COOH. {ECO:0000269|PubMed:25697095}.
Q9UF33	
Q9UF47	
Q9UF56	
Q9UF72	
Q9UF83	
Q9UFB7	
Q9UFC0	
Q9UFD9	
Q9UFE4	
Q9UFF9	
Q9UFG5	
Q9UFH2	
Q9UFN0	
Q9UFP1	
Q9UFV1	
Q9UFV3	
Q9UFW8	
Q9UG01	
Q9UG22	
Q9UG56	
Q9UG63	
Q9UGB4	
Q9UGB7	
Q9UGC6	
Q9UGC7	
Q9UGF5	
Q9UGF6	
Q9UGF7	
Q9UGH3	
Q9UGI0	
Q9UGI6	
Q9UGI8	
Q9UGI9	
Q9UGJ0	
Q9UGJ1	
Q9UGK3	
Q9UGK8	
Q9UGL1	ENZYME REGULATION: Several specific inhibitors are being developed and tested (PubMed:27214403, PubMed:26741168). The inhibitor KDOAM-25 inhibits its demethylase activity, resulting to cell cycle arrest in myeloma cells (PubMed:28262558). {ECO:0000269|PubMed:26741168, ECO:0000269|PubMed:27214403, ECO:0000269|PubMed:28262558}.
Q9UGL9	
Q9UGM1	
Q9UGM3	
Q9UGM5	
Q9UGM6	
Q9UGN4	
Q9UGN5	
Q9UGP4	
Q9UGP5	
Q9UGP8	
Q9UGQ2	
Q9UGQ3	
Q9UGR2	
Q9UGT4	
Q9UGU0	
Q9UGU5	
Q9UGV2	
Q9UGY1	
Q9UH03	
Q9UH17	
Q9UH36	
Q9UH62	
Q9UH64	
Q9UH65	
Q9UH73	
Q9UH77	
Q9UH90	
Q9UH92	
Q9UH99	
Q9UHA2	
Q9UHA3	
Q9UHA4	
Q9UHA7	
Q9UHB4	
Q9UHB6	
Q9UHB7	
Q9UHB9	
Q9UHC1	
Q9UHC3	
Q9UHC6	
Q9UHC7	
Q9UHC9	
Q9UHD0	
Q9UHD1	
Q9UHD2	
Q9UHD4	
Q9UHD8	
Q9UHD9	
Q9UHE5	
Q9UHE8	
Q9UHF0	
Q9UHF1	
Q9UHF3	
Q9UHF4	
Q9UHF5	
Q9UHF7	
Q9UHG0	
Q9UHG2	
Q9UHG3	
Q9UHH9	
Q9UHI5	
Q9UHI6	
Q9UHI7	
Q9UHI8	
Q9UHJ3	
Q9UHJ6	
Q9UHJ9	
Q9UHK0	
Q9UHK6	
Q9UHL0	
Q9UHL3	
Q9UHL4	
Q9UHL9	
Q9UHM6	
Q9UHN1	
Q9UHN6	
Q9UHP3	
Q9UHP6	
Q9UHP7	
Q9UHP9	
Q9UHQ1	
Q9UHQ4	
Q9UHQ7	
Q9UHQ9	
Q9UHR4	
Q9UHR5	
Q9UHR6	
Q9UHT4	
Q9UHU1	
Q9UHV2	
Q9UHV5	
Q9UHV7	
Q9UHV8	
Q9UHV9	
Q9UHW5	
Q9UHW9	ENZYME REGULATION: Activated by N-ethylmaleimide (NEM). Inhibited by DIOA, bumetanide and furosemide. Inhibited by WNK3. {ECO:0000269|PubMed:21613606}.
Q9UHX1	
Q9UHX3	
Q9UHY1	
Q9UHY7	
Q9UHY8	
Q9UI08	
Q9UI09	
Q9UI10	
Q9UI12	
Q9UI14	
Q9UI15	
Q9UI17	
Q9UI25	
Q9UI26	
Q9UI30	
Q9UI32	
Q9UI33	
Q9UI36	
Q9UI38	
Q9UI40	
Q9UI42	ENZYME REGULATION: Inhibited by interaction with the metallocarboxypeptidase inhibitor (MCPI) from N.versicolor that binds to the catalytic zinc ion. {ECO:0000269|PubMed:22294694}.
Q9UI43	
Q9UI46	
Q9UI47	
Q9UI54	
Q9UI72	
Q9UI95	
Q9UIA0	
Q9UIA9	
Q9UIB8	
Q9UIC8	
Q9UID3	
Q9UID6	
Q9UIE0	
Q9UIF3	
Q9UIF7	
Q9UIF8	
Q9UIF9	
Q9UIG0	
Q9UIG4	
Q9UIG5	
Q9UIG8	
Q9UIH9	
Q9UII2	
Q9UII4	
Q9UII5	
Q9UII6	
Q9UIJ5	
Q9UIJ7	
Q9UIK4	ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Regulated by a double locking mechanism, involving autophosphorylation at Ser-318, calmodulin binding, and dimerization. In the inactive state, Ser-318 is phosphorylated, and the kinase is dimeric. Activation involves: dephosphorylation at Ser-318, release-of-autoinhibition mechanism where calmodulin binding induces a conformational change that relieves the steric block of the active site by the autoinhibitory domain, and generation of the monomeric active form of the kinase. {ECO:0000269|PubMed:10376525}.
Q9UIK5	
Q9UIL1	
Q9UIL4	
Q9UIL8	
Q9UIM3	
Q9UIQ6	
Q9UIR0	
Q9UIS9	
Q9UIU6	
Q9UIV1	
Q9UIV8	
Q9UIW0	
Q9UIW2	
Q9UIX4	
Q9UIY3	
Q9UJ04	
Q9UJ14	
Q9UJ37	
Q9UJ41	
Q9UJ42	
Q9UJ55	
Q9UJ68	
Q9UJ70	
Q9UJ71	
Q9UJ72	
Q9UJ78	
Q9UJ83	
Q9UJ90	
Q9UJ94	
Q9UJ96	
Q9UJ98	
Q9UJ99	
Q9UJA2	
Q9UJA3	
Q9UJA5	
Q9UJA9	
Q9UJC3	
Q9UJC5	
Q9UJD0	
Q9UJF2	
Q9UJG1	
Q9UJH8	
Q9UJJ7	
Q9UJJ9	
Q9UJK0	
Q9UJL9	
Q9UJM3	
Q9UJM8	
Q9UJN7	
Q9UJP4	
Q9UJQ1	
Q9UJQ4	
Q9UJQ7	
Q9UJS0	
Q9UJT0	
Q9UJT1	
Q9UJT2	
Q9UJT9	
Q9UJU2	
Q9UJU3	
Q9UJU5	
Q9UJU6	
Q9UJV3	
Q9UJV8	
Q9UJV9	
Q9UJW0	
Q9UJW2	
Q9UJW3	
Q9UJW7	
Q9UJW8	
Q9UJW9	
Q9UJX0	
Q9UJX2	
Q9UJX3	
Q9UJX4	
Q9UJX5	
Q9UJX6	
Q9UJY1	
Q9UJY4	
Q9UJY5	
Q9UJZ1	
Q9UK00	
Q9UK05	
Q9UK08	
Q9UK10	
Q9UK11	
Q9UK12	
Q9UK13	
Q9UK17	
Q9UK22	
Q9UK23	
Q9UK28	
Q9UK32	ENZYME REGULATION: Constitutively activated by phosphorylation at Ser-232, Ser-372, and Ser-389 in serum-starved cells. Does not require growth factor stimulation for significant kinase activity. {ECO:0000269|PubMed:15632195}.
Q9UK33	
Q9UK39	
Q9UK41	
Q9UK45	
Q9UK53	
Q9UK55	
Q9UK58	
Q9UK59	
Q9UK61	
Q9UK73	
Q9UK76	
Q9UK80	
Q9UK85	
Q9UK96	
Q9UK97	
Q9UK99	
Q9UKA1	
Q9UKA2	
Q9UKA4	
Q9UKA8	
Q9UKA9	
Q9UKB1	
Q9UKB3	
Q9UKB5	
Q9UKC9	
Q9UKD1	
Q9UKD2	
Q9UKE5	
Q9UKF2	
Q9UKF5	
Q9UKF6	
Q9UKF7	
Q9UKG1	
Q9UKG4	
Q9UKG9	
Q9UKH3	
Q9UKI2	
Q9UKI3	
Q9UKI8	ENZYME REGULATION: Cell-cycle regulated, maximal activity in S-phase. Inactivated by phosphorylation at Ser-743, potentially by CHEK1. {ECO:0000269|PubMed:10523312, ECO:0000269|PubMed:12660173}.
Q9UKI9	
Q9UKJ0	
Q9UKJ1	
Q9UKJ3	
Q9UKJ5	
Q9UKJ8	
Q9UKK3	
Q9UKK6	
Q9UKK9	
Q9UKL0	
Q9UKL2	
Q9UKL3	
Q9UKL4	
Q9UKL6	
Q9UKM7	ENZYME REGULATION: Inhibited by both 1-deoxymannojirimycin (dMNJ) and kifunensine. {ECO:0000269|PubMed:10409699}.
Q9UKM9	
Q9UKN1	
Q9UKN5	
Q9UKN7	
Q9UKN8	
Q9UKP3	
Q9UKP4	
Q9UKP5	
Q9UKP6	
Q9UKQ2	
Q9UKQ9	
Q9UKR0	
Q9UKR3	
Q9UKR5	
Q9UKR8	
Q9UKS6	
Q9UKS7	
Q9UKT4	
Q9UKT5	
Q9UKT6	
Q9UKT7	
Q9UKT8	
Q9UKT9	
Q9UKU0	
Q9UKU6	
Q9UKU7	
Q9UKU9	
Q9UKV0	ENZYME REGULATION: Inhibited by Trichostatin A (TSA) and suberoylanilide hydroxamic acid. {ECO:0000269|PubMed:11535832}.
Q9UKV3	
Q9UKV5	
Q9UKV8	ENZYME REGULATION: Inhibited by EDTA. {ECO:0000269|PubMed:15284456}.
Q9UKW4	
Q9UKW6	
Q9UKX2	
Q9UKX3	
Q9UKX5	
Q9UKX7	
Q9UKY0	
Q9UKY1	
Q9UKY3	
Q9UKY4	ENZYME REGULATION: Slightly activated by Mg(2+) and inhibited by both Ca(+) and Mn(2+). EDTA ha no effect on activity in vitro. {ECO:0000269|PubMed:14699049}.
Q9UKY7	
Q9UKZ1	
Q9UKZ4	
Q9UKZ9	
Q9UL01	
Q9UL03	
Q9UL12	
Q9UL15	
Q9UL16	
Q9UL17	
Q9UL18	
Q9UL19	
Q9UL25	
Q9UL26	
Q9UL33	
Q9UL36	
Q9UL40	
Q9UL41	
Q9UL42	
Q9UL45	
Q9UL46	
Q9UL49	
Q9UL51	ENZYME REGULATION: Activated by cAMP, and at 10-100 times higher concentrations, also by cGMP. cAMP binding causes a conformation change that leads to the assembly of an active tetramer and channel opening. Channel activity is modulated by intracellular chloride ions and pH; acidic pH shifts the activation to more negative voltages. {ECO:0000269|PubMed:10228147, ECO:0000269|PubMed:22006928}.
Q9UL52	ENZYME REGULATION: Inhibited by SERPINA5. {ECO:0000269|PubMed:14696115}.
Q9UL54	ENZYME REGULATION: Selectively inhibited by the enantiopure organoruthenium inhibitor 9E1. Activated following arsenic trioxide (As(2)O(3)) treatment. {ECO:0000269|PubMed:19226137, ECO:0000269|PubMed:20159944}.
Q9UL58	
Q9UL59	
Q9UL62	ENZYME REGULATION: Calcium channel activity is enhanced by MYLK, that promotes its subcellular localization at the plasma membrane. {ECO:0000269|PubMed:16284075}.
Q9UL63	
Q9UL68	
Q9ULA0	ENZYME REGULATION: One of the zinc ions is readily exchangeable with other divalent cations such as manganese, which strongly stimulates the enzymatic activity. {ECO:0000250}.
Q9ULB1	
Q9ULB4	
Q9ULB5	
Q9ULC0	
Q9ULC3	
Q9ULC4	
Q9ULC5	
Q9ULC6	
Q9ULC8	
Q9ULD0	
Q9ULD2	
Q9ULD4	
Q9ULD5	
Q9ULD6	
Q9ULD8	
Q9ULD9	
Q9ULE0	
Q9ULE3	
Q9ULE4	
Q9ULE6	
Q9ULF5	
Q9ULG1	
Q9ULG3	
Q9ULG6	
Q9ULH0	
Q9ULH1	ENZYME REGULATION: Activity stimulated by phosphatidylinositol 4,5-bisphosphate (PIP2). {ECO:0000250}.
Q9ULH4	
Q9ULH7	
Q9ULI0	
Q9ULI1	
Q9ULI2	
Q9ULI3	
Q9ULI4	
Q9ULJ1	
Q9ULJ3	
Q9ULJ6	
Q9ULJ7	
Q9ULJ8	
Q9ULK0	
Q9ULK2	
Q9ULK4	
Q9ULK5	
Q9ULK6	
Q9ULL0	
Q9ULL1	
Q9ULL4	
Q9ULL5	
Q9ULL8	
Q9ULM0	
Q9ULM2	
Q9ULM3	
Q9ULM6	
Q9ULN7	
Q9ULP0	
Q9ULP9	
Q9ULQ0	
Q9ULQ1	
Q9ULR0	
Q9ULR3	
Q9ULR5	
Q9ULS5	
Q9ULS6	
Q9ULT0	
Q9ULT6	ENZYME REGULATION: Negatively regulated by R-spondin proteins such as RSPO1: interaction with RSPO1 induces the indirect association between ZNRF3 and LGR4, promoting membrane clearance of ZNRF3. {ECO:0000269|PubMed:22575959}.
Q9ULT8	
Q9ULU4	
Q9ULU8	
Q9ULV0	
Q9ULV1	
Q9ULV3	
Q9ULV4	
Q9ULV5	
Q9ULV8	ENZYME REGULATION: Phosphorylation at Tyr-341 is necessary and sufficient for the activation of E3 activity. {ECO:0000269|PubMed:20525694}.
Q9ULW0	
Q9ULW2	
Q9ULW3	
Q9ULW5	
Q9ULW6	
Q9ULW8	
Q9ULX3	
Q9ULX5	
Q9ULX6	
Q9ULX7	ENZYME REGULATION: Activated by histamine, L-adrenaline, L- and D-histidine, and L- and D-phenylalanine. Inhibited by coumarins, saccharin, sulfonamide derivatives such as acetazolamide (AZA) and Foscarnet (phosphonoformate trisodium salt). {ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16807956, ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:18618712, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.
Q9ULX9	
Q9ULY5	
Q9ULZ0	
Q9ULZ1	
Q9ULZ2	
Q9ULZ3	
Q9ULZ9	
Q9UM00	
Q9UM01	ENZYME REGULATION: Arginine transport is inhibited by protein kinase C (PKC) and treatment with phorbol-12-myristate-13-acetate (PMA).
Q9UM07	ENZYME REGULATION: Strongly Inhibited by F-amidine and N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide (Cl-amidine). These inhibitors are however not specific to PADI4 and also inhibit other members of the family (PubMed:17002273). Incorporation of a carboxylate ortho to the backbone amide of Cl-amidine results in inhibitors with increased specificity for PADI4: N-alpha-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-L-ornithine amide (o-F-amidine) and N-alpha-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-L-ornithine amide (o-Cl-amidine) (PubMed:21882827). Strongly and specifically inhibited by Thr-Asp-F-amidine (TDFA); other members of the family are not inhibited (PubMed:22004374). {ECO:0000269|PubMed:17002273, ECO:0000269|PubMed:21882827, ECO:0000269|PubMed:22004374}.
Q9UM11	
Q9UM13	
Q9UM19	
Q9UM21	
Q9UM22	
Q9UM44	
Q9UM47	
Q9UM54	
Q9UM63	
Q9UM73	ENZYME REGULATION: Activated by ligand-binding and subsequent phosphorylation. Inactivated through dephosphorylation by receptor protein tyrosine phosphatase beta and zeta complex (PTPRB/PTPRZ1) when there is no stimulation by a ligand. Staurosporine, crizotinib and CH5424802 act as inhibitors of ALK kinase activity. {ECO:0000269|PubMed:16317043, ECO:0000269|PubMed:17681947, ECO:0000269|PubMed:21575866}.
Q9UM82	
Q9UMD9	
Q9UMF0	
Q9UMN6	
Q9UMQ3	
Q9UMQ6	
Q9UMR2	
Q9UMR3	
Q9UMR5	
Q9UMR7	
Q9UMS0	
Q9UMS4	
Q9UMS5	
Q9UMS6	
Q9UMW8	
Q9UMX0	
Q9UMX1	
Q9UMX2	
Q9UMX3	
Q9UMX5	
Q9UMX6	
Q9UMX9	
Q9UMY1	
Q9UMY4	
Q9UMZ2	
Q9UMZ3	
Q9UN19	
Q9UN30	
Q9UN36	
Q9UN37	
Q9UN42	
Q9UN66	
Q9UN67	
Q9UN70	
Q9UN71	
Q9UN72	
Q9UN73	
Q9UN74	
Q9UN75	
Q9UN76	
Q9UN79	
Q9UN81	
Q9UN86	
Q9UN88	
Q9UNA0	
Q9UNA1	
Q9UNA3	
Q9UNA4	
Q9UND3	
Q9UNE0	
Q9UNE2	
Q9UNE7	
Q9UNF0	
Q9UNF1	
Q9UNG2	
Q9UNH5	
Q9UNH6	
Q9UNH7	
Q9UNI1	
Q9UNI6	
Q9UNK0	
Q9UNK4	
Q9UNK9	
Q9UNL2	
Q9UNL4	
Q9UNM6	
Q9UNN4	
Q9UNN5	
Q9UNN8	
Q9UNP4	
Q9UNP9	ENZYME REGULATION: Enzyme activity is inhibited by cyclosporin A. {ECO:0000269|PubMed:18258190, ECO:0000269|PubMed:8977107}.
Q9UNQ0	
Q9UNQ2	
Q9UNS1	
Q9UNS2	
Q9UNT1	
Q9UNU6	
Q9UNW1	
Q9UNW8	
Q9UNW9	
Q9UNX3	
Q9UNX4	
Q9UNX9	
Q9UNY4	
Q9UNY5	
Q9UNZ2	
Q9UNZ5	
Q9UP38	
Q9UP52	
Q9UP65	ENZYME REGULATION: Inhibited by palmitoyl-CoA (PubMed:14529291). Not regulated by calcium (PubMed:9705332, PubMed:10085124). {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:14529291, ECO:0000269|PubMed:9705332}.
Q9UP79	
Q9UP83	
Q9UP95	ENZYME REGULATION: Inhibited by WNK3. {ECO:0000269|PubMed:21613606}.
Q9UPA5	
Q9UPC5	
Q9UPE1	
Q9UPG8	
Q9UPI3	
Q9UPM6	
Q9UPM8	
Q9UPM9	
Q9UPN3	
Q9UPN4	
Q9UPN6	
Q9UPN7	
Q9UPN9	
Q9UPP1	
Q9UPP2	
Q9UPP5	
Q9UPQ0	
Q9UPQ3	ENZYME REGULATION: GAP activity stimulated by phosphatidylinositol 3,4,5-trisphosphate (PIP3) and, to a lesser extent, by phosphatidylinositol 4,5-bisphosphate (PIP2). Phosphatidic acid potentiates PIP2 stimulation.
Q9UPQ4	
Q9UPQ7	
Q9UPQ8	
Q9UPQ9	
Q9UPR0	
Q9UPR3	
Q9UPR5	ENZYME REGULATION: Calcium transport is down-regulated by Na(+) and stimulated by Ca(2+). {ECO:0000250|UniProtKB:P48768}.
Q9UPR6	
Q9UPS6	
Q9UPS8	
Q9UPT5	
Q9UPT6	
Q9UPT8	
Q9UPT9	
Q9UPU3	
Q9UPU5	
Q9UPU7	
Q9UPU9	
Q9UPV0	
Q9UPV7	
Q9UPV9	
Q9UPW0	
Q9UPW5	
Q9UPW6	
Q9UPW8	
Q9UPX0	
Q9UPX6	
Q9UPX8	
Q9UPY3	
Q9UPY5	
Q9UPY6	
Q9UPY8	
Q9UPZ3	
Q9UPZ6	
Q9UPZ9	
Q9UQ03	
Q9UQ05	
Q9UQ07	ENZYME REGULATION: Phosphorylation appears to increase the enzymatic activity. {ECO:0000250}.
Q9UQ10	
Q9UQ13	
Q9UQ16	
Q9UQ26	
Q9UQ35	
Q9UQ49	
Q9UQ52	
Q9UQ53	
Q9UQ72	
Q9UQ74	
Q9UQ80	
Q9UQ84	
Q9UQ88	ENZYME REGULATION: Phosphorylation at Thr-436 or Tyr-437 inactivates the enzyme, while phosphorylation at Thr-583 activates it. {ECO:0000250}.
Q9UQ90	
Q9UQB3	
Q9UQB8	
Q9UQB9	ENZYME REGULATION: Okadaic acid, an inhibitor of protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A) and protein phosphatase 5 (PP5), increases AURKC activity. AURKC is also stabilized through its interaction with INCENP, which acts also as an activator. {ECO:0000269|PubMed:15316025}.
Q9UQC2	
Q9UQC9	
Q9UQD0	
Q9UQE7	
Q9UQF0	
Q9UQF2	
Q9UQG0	
Q9UQK1	
Q9UQL6	
Q9UQM7	ENZYME REGULATION: Autophosphorylation of Thr-286 allows the kinase to switch from a calmodulin-dependent to a calmodulin-independent state. {ECO:0000250}.
Q9UQN3	
Q9UQP3	
Q9UQQ1	
Q9UQQ2	
Q9UQR0	
Q9UQR1	
Q9UQV4	
Q9WJR5	
Q9XRX5	
Q9Y210	
Q9Y215	
Q9Y216	
Q9Y217	
Q9Y219	
Q9Y221	
Q9Y222	
Q9Y223	ENZYME REGULATION: Allosterically regulated (Probable); feedback inhibited by cytidine monophosphate-N-acetylneuraminic acid (CMP-Neu5Ac), the end product of neuraminic acid biosynthesis. Activity is dependent on oligomerization. The monomer is inactive, whereas the dimer catalyzes only the phosphorylation of N-acetylmannosamine; the hexamer is fully active for both enzyme activities (By similarity). Up-regulated after PKC-dependent phosphorylation. {ECO:0000250, ECO:0000269|PubMed:2808337}.
Q9Y224	
Q9Y225	
Q9Y226	
Q9Y227	
Q9Y228	
Q9Y230	
Q9Y231	
Q9Y232	
Q9Y233	ENZYME REGULATION: Inhibited by dipyridamole and moderately by IBMX. cAMP acts as an allosteric activator. {ECO:0000269|PubMed:16330539}.
Q9Y234	
Q9Y235	
Q9Y236	
Q9Y237	
Q9Y238	
Q9Y239	
Q9Y240	
Q9Y241	
Q9Y242	
Q9Y243	ENZYME REGULATION: Two specific sites, one in the kinase domain (Thr-305) and the other in the C-terminal regulatory region (Ser-472), need to be phosphorylated for its full activation (By similarity). IGF-1 leads to the activation of AKT3, which may play a role in regulating cell survival. {ECO:0000250}.
Q9Y244	
Q9Y247	
Q9Y248	
Q9Y250	
Q9Y251	ENZYME REGULATION: Inhibited by EDTA, laminarin sulfate and, to a lower extent, by heparin and sulfamin and activated by calcium and magnesium. {ECO:0000250}.
Q9Y252	
Q9Y253	
Q9Y255	
Q9Y256	ENZYME REGULATION: Deubiquitination by USP17L2/USP17 negatively regulates the proteolytic activity toward Ras GTPases. {ECO:0000269|PubMed:19188362}.
Q9Y257	
Q9Y258	
Q9Y259	
Q9Y261	
Q9Y262	
Q9Y263	
Q9Y264	
Q9Y265	
Q9Y266	
Q9Y267	
Q9Y271	
Q9Y272	
Q9Y274	
Q9Y275	
Q9Y276	
Q9Y277	
Q9Y278	
Q9Y279	
Q9Y281	
Q9Y282	
Q9Y283	
Q9Y284	
Q9Y285	
Q9Y286	
Q9Y287	
Q9Y289	
Q9Y291	
Q9Y294	
Q9Y295	
Q9Y296	
Q9Y297	
Q9Y2A4	
Q9Y2A7	
Q9Y2A9	
Q9Y2B0	
Q9Y2B1	
Q9Y2B2	
Q9Y2B4	
Q9Y2B5	
Q9Y2B9	
Q9Y2C2	
Q9Y2C3	
Q9Y2C4	
Q9Y2C5	
Q9Y2C9	
Q9Y2D0	ENZYME REGULATION: Inhibited by coumarins, sulfonamide derivatives such as acetazolamide (AZA), saccharin and Foscarnet (phosphonoformate trisodium salt). {ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.
Q9Y2D1	
Q9Y2D2	
Q9Y2D4	
Q9Y2D5	
Q9Y2D8	
Q9Y2D9	
Q9Y2E4	
Q9Y2E5	
Q9Y2E6	
Q9Y2E8	
Q9Y2F5	
Q9Y2F9	
Q9Y2G0	
Q9Y2G1	
Q9Y2G2	
Q9Y2G3	
Q9Y2G4	
Q9Y2G5	ENZYME REGULATION: Inhibited by EDTA and by Zn(2+). {ECO:0000269|PubMed:22588082}.
Q9Y2G7	
Q9Y2G8	
Q9Y2G9	
Q9Y2H0	
Q9Y2H1	ENZYME REGULATION: Activated by binding of S100B which releases autoinhibitory N-lobe interactions, enabling ATP to bind and the autophosphorylation of Ser-282. Thr-442 then undergoes calcium-dependent phosphorylation by STK24/MST3. Interactions between phosphorylated Thr-442 and the N-lobe promote additional structural changes that complete the activation of the kinase. Autoinhibition is also released by the binding of MOB1/MOBKL1A and MOB2/HCCA2 to the N-terminal of STK38L. {ECO:0000269|PubMed:15037617, ECO:0000269|PubMed:15067004, ECO:0000269|PubMed:16314523}.
Q9Y2H2	
Q9Y2H5	
Q9Y2H6	
Q9Y2H8	
Q9Y2H9	
Q9Y2I1	
Q9Y2I2	
Q9Y2I6	
Q9Y2I7	
Q9Y2I8	
Q9Y2I9	
Q9Y2J0	
Q9Y2J2	
Q9Y2J4	
Q9Y2J8	
Q9Y2K1	
Q9Y2K2	ENZYME REGULATION: Activated by phosphorylation on Thr-221. {ECO:0000250}.
Q9Y2K3	
Q9Y2K5	
Q9Y2K6	
Q9Y2K7	
Q9Y2K9	
Q9Y2L1	
Q9Y2L5	
Q9Y2L6	
Q9Y2L8	
Q9Y2L9	
Q9Y2M0	
Q9Y2M2	
Q9Y2M5	
Q9Y2N7	
Q9Y2P0	
Q9Y2P4	
Q9Y2P5	
Q9Y2P7	
Q9Y2P8	
Q9Y2Q0	ENZYME REGULATION: ATPase activity is stimulated by phosphatidylserine (PS) and minimally by phosphatidylethanolamine (PE). {ECO:0000250}.
Q9Y2Q1	
Q9Y2Q3	
Q9Y2Q5	
Q9Y2Q9	
Q9Y2R0	
Q9Y2R2	ENZYME REGULATION: Down-regulated by phosphorylation.
Q9Y2R4	
Q9Y2R5	
Q9Y2R9	
Q9Y2S2	ENZYME REGULATION: Inhibited by malonate. {ECO:0000269|PubMed:15809331}.
Q9Y2S6	
Q9Y2S7	
Q9Y2T1	
Q9Y2T2	
Q9Y2T3	
Q9Y2T4	
Q9Y2T5	
Q9Y2T6	
Q9Y2T7	
Q9Y2U2	
Q9Y2U5	ENZYME REGULATION: Activated by phosphorylation on Thr-524. {ECO:0000250}.
Q9Y2U8	
Q9Y2U9	
Q9Y2V0	
Q9Y2V2	
Q9Y2V3	
Q9Y2V7	
Q9Y2W1	
Q9Y2W2	
Q9Y2W3	
Q9Y2W6	
Q9Y2W7	
Q9Y2X0	
Q9Y2X3	
Q9Y2X7	
Q9Y2X8	
Q9Y2X9	
Q9Y2Y0	
Q9Y2Y1	
Q9Y2Y4	
Q9Y2Y6	
Q9Y2Y8	
Q9Y2Y9	
Q9Y2Z0	
Q9Y2Z2	
Q9Y2Z4	
Q9Y2Z9	
Q9Y303	
Q9Y305	
Q9Y312	
Q9Y314	
Q9Y315	
Q9Y316	
Q9Y320	
Q9Y324	
Q9Y328	
Q9Y330	
Q9Y333	
Q9Y334	
Q9Y336	
Q9Y337	ENZYME REGULATION: Inhibited by Zn2+. {ECO:0000269|PubMed:17881000}.
Q9Y342	
Q9Y343	
Q9Y345	
Q9Y365	
Q9Y366	
Q9Y371	
Q9Y375	
Q9Y376	
Q9Y383	
Q9Y385	
Q9Y388	
Q9Y394	
Q9Y397	
Q9Y399	
Q9Y3A0	
Q9Y3A2	
Q9Y3A3	
Q9Y3A4	
Q9Y3A5	
Q9Y3A6	
Q9Y3B1	
Q9Y3B2	
Q9Y3B3	
Q9Y3B4	
Q9Y3B6	
Q9Y3B7	
Q9Y3B8	ENZYME REGULATION: Inhibited by adenosine 3',5'-bisphosphate. {ECO:0000269|PubMed:16682444}.
Q9Y3B9	
Q9Y3C0	
Q9Y3C1	
Q9Y3C4	
Q9Y3C5	
Q9Y3C6	ENZYME REGULATION: Inhibited by Cyclosporin A. {ECO:0000269|PubMed:16595688}.
Q9Y3C7	
Q9Y3C8	
Q9Y3D0	
Q9Y3D2	
Q9Y3D3	
Q9Y3D5	
Q9Y3D6	
Q9Y3D7	
Q9Y3D8	
Q9Y3D9	
Q9Y3E0	
Q9Y3E1	
Q9Y3E2	
Q9Y3E5	
Q9Y3E7	
Q9Y3F1	
Q9Y3F4	
Q9Y3I0	
Q9Y3I1	
Q9Y3L3	
Q9Y3L5	
Q9Y3M2	
Q9Y3M8	
Q9Y3M9	
Q9Y3N9	
Q9Y3P4	
Q9Y3P8	
Q9Y3P9	
Q9Y3Q0	ENZYME REGULATION: Inhibited by quisqualate.
Q9Y3Q3	
Q9Y3Q4	ENZYME REGULATION: Activated by cAMP. cAMP binding causes a conformation change that leads to the assembly of an active tetramer and channel opening. {ECO:0000269|PubMed:16407510, ECO:0000269|PubMed:20829353, ECO:0000269|PubMed:22006928}.
Q9Y3Q7	
Q9Y3Q8	
Q9Y3R0	
Q9Y3R4	
Q9Y3R5	
Q9Y3S1	ENZYME REGULATION: Activation requires autophosphorylation of Ser-356. Phosphorylation of Ser-352 also promotes increased activity (By similarity). {ECO:0000250|UniProtKB:Q9JIH7}.
Q9Y3S2	
Q9Y3T6	
Q9Y3T9	
Q9Y3U8	
Q9Y3V2	
Q9Y3X0	
Q9Y3Y2	
Q9Y3Y4	
Q9Y3Z3	ENZYME REGULATION: Allosterically stimulated by dGTP which binds in a cleft at the interface of the homodimer and promotes the formation of highly active homotetramers. Each allosteric site binds two molecules of dGTP (dGTP1 and dGTP 2) between adjoining subunits. Not activated by dATP, dCTP and dTTP. {ECO:0000269|PubMed:22056990, ECO:0000269|PubMed:24141705, ECO:0000269|PubMed:24217394}.
Q9Y421	
Q9Y426	
Q9Y442	
Q9Y446	
Q9Y448	
Q9Y450	
Q9Y458	
Q9Y462	
Q9Y463	ENZYME REGULATION: Inhibited by RANBP9.
Q9Y466	
Q9Y467	
Q9Y468	
Q9Y471	
Q9Y473	
Q9Y478	
Q9Y483	
Q9Y484	
Q9Y485	
Q9Y487	
Q9Y490	
Q9Y493	
Q9Y496	
Q9Y4A0	
Q9Y4A5	
Q9Y4A8	
Q9Y4A9	
Q9Y4B4	ENZYME REGULATION: Enzyme activity is enhanced by dsDNA (double-stranded DNA) and ssDNA (single-stranded DNA). {ECO:0000250}.
Q9Y4B5	
Q9Y4B6	
Q9Y4C0	
Q9Y4C1	
Q9Y4C2	
Q9Y4C4	
Q9Y4C5	
Q9Y4C8	
Q9Y4D1	
Q9Y4D2	ENZYME REGULATION: Inhibited by p-hydroxy-mercuri-benzoate and HgCl(2), but not to PMSF. Also inhibited by RHC80267, a drug that blocks 2-AG formation. {ECO:0000269|PubMed:14610053}.
Q9Y4D7	
Q9Y4D8	
Q9Y4E1	
Q9Y4E5	
Q9Y4E6	
Q9Y4E8	
Q9Y4F1	
Q9Y4F3	
Q9Y4F4	
Q9Y4F5	
Q9Y4F9	
Q9Y4G2	
Q9Y4G6	
Q9Y4G8	
Q9Y4H2	
Q9Y4H4	
Q9Y4I1	
Q9Y4I5	
Q9Y4J8	
Q9Y4K0	ENZYME REGULATION: According to some reports, it is inhibited by beta-aminopropionitrile (BAPN) (PubMed:20439985 and PubMed:23319596). According to another report, it is not inhibited by beta-aminopropionitrile (BAPN) (PubMed:20306300). Specifically inhibited by a mouse monoclonal antibody AB0023, inhibition occurs in a non-competitive manner. {ECO:0000269|PubMed:20306300, ECO:0000269|PubMed:20439985, ECO:0000269|PubMed:20818376, ECO:0000269|PubMed:23319596}.
Q9Y4K1	
Q9Y4K3	
Q9Y4K4	
Q9Y4L1	
Q9Y4L5	
Q9Y4M8	
Q9Y4P1	ENZYME REGULATION: Inhibited by N-ethylmaleimide. Redox-regulated during autophagy since reducing conditions activate ATG4A whereas an oxidizing environment such as the presence of H(2)O(2) inhibits its activity. {ECO:0000269|PubMed:17347651}.
Q9Y4P3	
Q9Y4P8	
Q9Y4P9	
Q9Y4R7	
Q9Y4R8	
Q9Y4U1	
Q9Y4W2	
Q9Y4W6	
Q9Y4X0	
Q9Y4X1	
Q9Y4X3	
Q9Y4X4	
Q9Y4X5	ENZYME REGULATION: Autoinhibited by the ariadne domain, which masks the second RING-type zinc finger that contains the active site and inhibits the E3 activity (PubMed:23707686). Inhibition is relieved upon binding to neddylated cullin-RING ubiquitin ligase complexes, which activate the E3 ligase activity of ARIH1 (PubMed:24076655, PubMed:27565346). {ECO:0000269|PubMed:23707686, ECO:0000269|PubMed:24076655, ECO:0000269|PubMed:27565346}.
Q9Y4Y9	
Q9Y4Z0	
Q9Y4Z2	
Q9Y508	
Q9Y512	
Q9Y519	
Q9Y520	
Q9Y530	ENZYME REGULATION: Subject to competitive inhibition by the product ADP-ribose. {ECO:0000269|PubMed:21849506}.
Q9Y534	
Q9Y535	
Q9Y536	
Q9Y543	
Q9Y546	
Q9Y547	
Q9Y548	
Q9Y561	
Q9Y566	
Q9Y570	
Q9Y572	
Q9Y573	
Q9Y574	
Q9Y575	
Q9Y576	
Q9Y577	
Q9Y580	
Q9Y581	
Q9Y584	
Q9Y585	
Q9Y586	
Q9Y587	
Q9Y592	
Q9Y597	
Q9Y5A6	
Q9Y5A7	
Q9Y5A9	
Q9Y5B0	
Q9Y5B6	
Q9Y5B8	
Q9Y5B9	
Q9Y5C1	
Q9Y5E1	
Q9Y5E2	
Q9Y5E3	
Q9Y5E4	
Q9Y5E5	
Q9Y5E6	
Q9Y5E7	
Q9Y5E8	
Q9Y5E9	
Q9Y5F0	
Q9Y5F1	
Q9Y5F2	
Q9Y5F3	
Q9Y5F6	
Q9Y5F7	
Q9Y5F8	
Q9Y5F9	
Q9Y5G0	
Q9Y5G1	
Q9Y5G2	
Q9Y5G3	
Q9Y5G4	
Q9Y5G5	
Q9Y5G6	
Q9Y5G7	
Q9Y5G8	
Q9Y5G9	
Q9Y5H0	
Q9Y5H1	
Q9Y5H2	
Q9Y5H3	
Q9Y5H4	
Q9Y5H5	
Q9Y5H6	
Q9Y5H7	
Q9Y5H8	
Q9Y5H9	
Q9Y5I0	
Q9Y5I1	
Q9Y5I2	
Q9Y5I3	
Q9Y5I4	
Q9Y5I7	
Q9Y5J1	
Q9Y5J3	
Q9Y5J5	
Q9Y5J6	
Q9Y5J7	
Q9Y5J9	
Q9Y5K1	
Q9Y5K2	
Q9Y5K3	
Q9Y5K5	ENZYME REGULATION: Activated by ADRM1. Inhibited by interaction with NFRKB. {ECO:0000269|PubMed:16906146, ECO:0000269|PubMed:17139257, ECO:0000269|PubMed:18922472}.
Q9Y5K6	
Q9Y5K8	
Q9Y5L0	
Q9Y5L2	
Q9Y5L3	
Q9Y5L4	
Q9Y5L5	
Q9Y5M1	
Q9Y5M6	
Q9Y5M8	
Q9Y5N1	
Q9Y5N5	
Q9Y5N6	
Q9Y5P0	
Q9Y5P1	
Q9Y5P2	
Q9Y5P3	
Q9Y5P4	
Q9Y5P6	
Q9Y5P8	
Q9Y5Q0	
Q9Y5Q3	
Q9Y5Q5	ENZYME REGULATION: Inhibited in a dose-dependent manner by non-specific trypsin-like serine protease inhibitors including benzamidine.
Q9Y5Q6	
Q9Y5Q8	
Q9Y5Q9	
Q9Y5R2	
Q9Y5R4	
Q9Y5R5	
Q9Y5R6	
Q9Y5R8	
Q9Y5S1	
Q9Y5S2	ENZYME REGULATION: Maintained in an inactive, closed conformation by an interaction between the kinase domain and the negative autoregulatory C-terminal coiled-coil region. Agonist binding to the phorbol ester binding site disrupts this, releasing the kinase domain to allow N-terminus-mediated dimerization and kinase activation by transautophosphorylation (By similarity). Inhibited by chelerythrine chloride. {ECO:0000250, ECO:0000269|PubMed:21457715}.
Q9Y5S8	ENZYME REGULATION: The oxidase activity is potentiated by NOXA1 and NOXO1. {ECO:0000269|PubMed:14617635, ECO:0000269|PubMed:16329988}.
Q9Y5S9	
Q9Y5T4	
Q9Y5T5	
Q9Y5U2	
Q9Y5U4	
Q9Y5U5	
Q9Y5U8	
Q9Y5U9	
Q9Y5V0	
Q9Y5V3	
Q9Y5W3	
Q9Y5W5	
Q9Y5W7	
Q9Y5W8	
Q9Y5W9	
Q9Y5X0	
Q9Y5X1	
Q9Y5X2	
Q9Y5X3	
Q9Y5X4	
Q9Y5X5	
Q9Y5X9	ENZYME REGULATION: Inhibited by serum.
Q9Y5Y0	
Q9Y5Y2	
Q9Y5Y3	
Q9Y5Y4	
Q9Y5Y5	
Q9Y5Y6	
Q9Y5Y7	
Q9Y5Y9	
Q9Y5Z0	
Q9Y5Z4	
Q9Y5Z6	
Q9Y5Z7	
Q9Y5Z9	
Q9Y600	
Q9Y603	
Q9Y605	
Q9Y606	
Q9Y608	
Q9Y613	
Q9Y614	
Q9Y615	
Q9Y616	
Q9Y617	
Q9Y618	
Q9Y619	
Q9Y620	
Q9Y623	
Q9Y624	
Q9Y625	
Q9Y639	
Q9Y644	
Q9Y646	
Q9Y651	
Q9Y653	ENZYME REGULATION: ADGRG1 NT is proposed to inhibit receptor signaling; its interactions with extracellular ligands and /or homophilic ADGRG1NT interactions may relieve the inhibition (PubMed:21708946, PubMed:24949629, PubMed:25918380). Following ligand binding to the N-terminal fragment, the N-terminal fragment is released from the seven-transmembrane C-terminal fragment to unveil a new N-terminal stalk, which then stimulates G-protein-dependent signaling activity (PubMed:25918380). The N-terminal stalk has also been shown to be dispensable for at least some G-protein-dependent signaling (PubMed:26710850). {ECO:0000269|PubMed:21708946, ECO:0000269|PubMed:24949629, ECO:0000269|PubMed:25918380, ECO:0000269|PubMed:26710850}.
Q9Y657	
Q9Y661	
Q9Y662	
Q9Y663	
Q9Y664	
Q9Y666	ENZYME REGULATION: Activated by N-ethylmaleimide (NEM). Inhibited by furosemide, DIDS and bumetanide. The inhibition is much stronger in the presence of 50 mM K(+) in the uptake medium. Inhibited by DIOA. Inhibited by WNK3. {ECO:0000269|PubMed:21613606}.
Q9Y672	
Q9Y673	
Q9Y675	
Q9Y676	
Q9Y678	
Q9Y679	
Q9Y680	
Q9Y689	
Q9Y691	
Q9Y692	
Q9Y693	
Q9Y694	
Q9Y696	
Q9Y697	
Q9Y698	
Q9Y6A1	ENZYME REGULATION: Slightly activated by Mg(2+) and inhibited by both Ca(+) and Mn(2+). EDTA ha no effect on activity in vitro. {ECO:0000269|PubMed:14699049}.
Q9Y6A2	
Q9Y6A4	
Q9Y6A5	
Q9Y6A9	
Q9Y6B2	
Q9Y6B6	
Q9Y6B7	
Q9Y6C2	
Q9Y6C5	
Q9Y6C7	
Q9Y6C9	
Q9Y6D0	
Q9Y6D5	ENZYME REGULATION: Inhibited by brefeldin A.
Q9Y6D6	ENZYME REGULATION: Inhibited by brefeldin A.
Q9Y6D9	
Q9Y6E0	
Q9Y6E2	
Q9Y6E7	
Q9Y6F1	
Q9Y6F6	
Q9Y6F7	
Q9Y6F8	
Q9Y6F9	
Q9Y6G1	
Q9Y6G3	
Q9Y6G5	
Q9Y6G9	
Q9Y6H1	
Q9Y6H3	
Q9Y6H5	
Q9Y6H6	
Q9Y6H8	
Q9Y6I0	
Q9Y6I3	
Q9Y6I4	
Q9Y6I7	
Q9Y6I8	
Q9Y6I9	
Q9Y6J0	
Q9Y6J3	
Q9Y6J6	
Q9Y6J8	
Q9Y6J9	
Q9Y6K0	
Q9Y6K1	ENZYME REGULATION: Activated by binding to the regulatory factor DNMT3L. {ECO:0000250}.
Q9Y6K5	ENZYME REGULATION: Produced as a latent enzyme which is activated by dsRNA generated during the course of viral infection (Probable). Strongly activated by long dsRNAs at least 50 nucleotides in length (PubMed:25775560). ssRNA does not activate the enzyme (PubMed:25775560). {ECO:0000269|PubMed:25775560, ECO:0000305}.
Q9Y6K8	
Q9Y6K9	
Q9Y6L6	
Q9Y6L7	
Q9Y6M0	
Q9Y6M1	
Q9Y6M4	ENZYME REGULATION: Inhibited by triazolodiamine 1, 5-amino-3-{[4-(aminosulfonyl)phenyl]amino}-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, (S)-propane-1,2-diol, 2-({6-[(3-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methylbutan-1-ol, N2-[(1R,2S)-2-aminocyclohexyl]-N6-(3-chlorophenyl)-9-ethyl-9H-purine-2,6-diamine and [4-amino-2-(3-chloroanilino)-1,3-thiazol-5-yl](4-fluorophenyl)methanone.
Q9Y6M5	
Q9Y6M7	ENZYME REGULATION: Transporter activity is regulated by CA2/carbonic anhydrase 2, cAMP and PKA. Insensitive to stilbene derivatives. PubMed:10347222 states it is inhibited by 5-(N-ethyl-N-isopropyl)-amiloride (EIPA).
Q9Y6M9	
Q9Y6N1	
Q9Y6N3	
Q9Y6N5	
Q9Y6N6	
Q9Y6N7	
Q9Y6N8	
Q9Y6N9	
Q9Y6P5	
Q9Y6Q1	
Q9Y6Q2	
Q9Y6Q3	
Q9Y6Q5	
Q9Y6Q6	
Q9Y6Q9	ENZYME REGULATION: Coactivator activity on nuclear receptors and NF-kappa-B pathways is enhanced by various hormones, and the TNF cytokine, respectively. TNF stimulation probably enhances phosphorylation, which in turn activates coactivator function. In contrast, acetylation by CREBBP apparently suppresses coactivation of target genes by disrupting its association with nuclear receptors. Binds to CSNK1D.
Q9Y6R0	
Q9Y6R1	ENZYME REGULATION: Inhibited by stilbene derivatives and regulated by cyclic AMP.
Q9Y6R4	ENZYME REGULATION: N-terminal autoinhibitory domain interacts with the C-terminal kinase domain, inhibiting kinase activity, and preventing interaction with its substrate, MAP2K6. The GADD45 proteins activate the kinase by binding to the N-terminal domain. Activated by phosphorylation on Thr-1505. {ECO:0000269|PubMed:12052864}.
Q9Y6R6	
Q9Y6R7	
Q9Y6R9	
Q9Y6S9	
Q9Y6T7	ENZYME REGULATION: Stimulated by phosphatidylserine. {ECO:0000250}.
Q9Y6U3	
Q9Y6U7	
Q9Y6V0	
Q9Y6V7	
Q9Y6W3	
Q9Y6W5	
Q9Y6W6	
Q9Y6W8	
Q9Y6X0	
Q9Y6X1	
Q9Y6X2	
Q9Y6X3	
Q9Y6X4	
Q9Y6X5	
Q9Y6X6	
Q9Y6X8	
Q9Y6X9	
Q9Y6Y0	
Q9Y6Y1	
Q9Y6Y8	
Q9Y6Y9	
Q9Y6Z2	
Q9Y6Z4	
Q9Y6Z5	
Q9Y6Z7	
Q9YNA8	
S4R3P1	
S4R3Y5	
U3KPV4	
W5XKT8	
